ID,Assembly,TrackClass,TrackType,CellClass,CellType,Description,ProcessingLogs,Title,MetaData
DRX013197,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"73409612,94.6,23.0,74569",HeLa H3K27Ac,"sample_name=DRS012996	sample comment=ChIP seq library. HeLa cell line, H3K27Ac IP"
DRX402466,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian tube secretory epithelial cell,,"77495813,98.5,15.7,32748",NextSeq 500 paired end sequencing of SAMD00555404,sample_name=HFTSEC_ATAC-seq	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=primary human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=primary human fallopian tube secretory epithelial cell
DRX402467,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian tube secretory epithelial cell,,"74138655,98.3,22.3,70754",NextSeq 500 paired end sequencing of SAMD00555405,sample_name=HF1_ATAC-seq	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402468,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian tube secretory epithelial cell,,"72713138,98.3,26.4,60771",NextSeq 500 paired end sequencing of SAMD00555406,sample_name=HF1_TP53_ATAC-seq	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402469,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian tube secretory epithelial cell,,"60232864,98.3,20.9,71232",NextSeq 500 paired end sequencing of SAMD00555407,sample_name=HF1_TP53_KRAS_ATAC-seq	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402470,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian tube secretory epithelial cell,,"60244869,98.1,17.0,30451",NextSeq 500 paired end sequencing of SAMD00555408,sample_name=HF1_TP53_KRAS_AKT_ATAC-seq	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402471,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian tube secretory epithelial cell,,"61672159,98.4,34.8,54624",NextSeq 500 paired end sequencing of SAMD00555409,sample_name=HF1_TP53_KRAS_MYC_ATAC-seq	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402472,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"71727606,99.0,11.0,15160",Illumina NovaSeq 6000 paired end sequencing of SAMD00555410,sample_name=HF1_ChIP-seq_H3K27ac	antibody=H3K27ac	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402474,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"63395041,99.0,11.1,8428",Illumina NovaSeq 6000 paired end sequencing of SAMD00555412,sample_name=HF1_TP53_ChIP-seq_H3K27ac	antibody=H3K27ac	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402476,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"73611688,98.9,10.8,8460",Illumina NovaSeq 6000 paired end sequencing of SAMD00555414,sample_name=HF1_TP53_KRAS_ChIP-seq_H3K27ac	antibody=H3K27ac	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402478,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"91392221,99.0,11.2,15825",Illumina NovaSeq 6000 paired end sequencing of SAMD00555416,sample_name=HF1_TP53_KRAS_AKT_ChIP-seq_H3K27ac	antibody=H3K27ac	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
DRX402480,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"67929671,93.8,9.6,11018",Illumina NovaSeq 6000 paired end sequencing of SAMD00555418,sample_name=HF1_TP53_KRAS_MYC_ChIP-seq_H3K27ac	antibody=H3K27ac	biomaterial_provider=Established by Dr. Kohei Nakamura	cell_type=immortalized human fallopian tube secretory epithelial cell	growth_protocol=maintained as adherent cells with EMEM and 10% fetal bovine serum (FBS)	sample_type=cultured cells	sex=female	strain=immortalized human fallopian tube secretory epithelial cell
SRX003937,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"3334448,69.1,26.3,744",-,cell line=MCF-7	chip antibody=ERalpha	treatment=mock
SRX003938,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12652745,93.0,24.5,10395",-,cell line=MCF-7	chip antibody=ERalpha	treatment=E2 10 nM 1h
SRX003939,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"7892759,92.7,14.0,8066",-,cell line=MCF-7	chip antibody=ERalpha	treatment=Tamoxifen 1 uM 1h
SRX003940,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8302024,92.6,13.4,3805",-,cell line=MCF-7	chip antibody=ERalpha	treatment=Fulvestrant 100 nM
SRX015140,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"21366481,80.3,7.8,22380",GSM487425: K562 Jun ChIPSeq,source_name=K562	biomaterial_provider=ATCC: CCL-243 http://www.atcc.org/ATCCAdvancedCatalogSearch/ProductDetails/tabid/452/Default.aspx?ATCCNum=CCL-243&amp;Template=cellBiology	growth properties=Suspension Morphology	lymphoblast antibody=Jun
SRX015141,hg38,TFs and others,FOS,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"18366063,82.7,9.4,15377",GSM487426: K562 Fos ChIPSeq,source_name=K562	biomaterial_provider=ATCC: CCL-243 http://www.atcc.org/ATCCAdvancedCatalogSearch/ProductDetails/tabid/452/Default.aspx?ATCCNum=CCL-243&amp;Template=cellBiology	growth properties=Suspension Morphology	lymphoblast antibody=Fos
SRX016326,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"5189798,70.3,16.2,184",GSM470418: MCF7 ethl ER,"source_name=MCF7	cell line=MCF7	cell type=estrogen-responsive breast cancer	antibody=Estrogen Receptor (ER)	treatment variable=hormone starved for 3 days, treated with 1% ethanol for 45 minutes"
SRX016327,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"3624961,59.3,18.0,4501",GSM470419: MCF7 E2 ER,"source_name=MCF7	cell line=MCF7	cell type=estrogen-responsive breast cancer	antibody=Estrogen Receptor (ER)	treatment variable=hormone starved for 3 days, treated with 10 nM β-estradiol for 45 minutes"
SRX026529,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"47942072,41.0,2.6,986",GSM589236: ERα sequencing in ETOH (ethanol) treated MCF-7 cells,source_name=MCF-7 breast cancer cells	cell line=MCF-7 breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=ETOH (ethanol)
SRX026530,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21220101,55.1,3.2,10023",GSM589237: ERα sequencing in E2 (estradiol) treated MCF-7 cells,source_name=MCF-7 breast cancer cells	cell line=MCF-7 breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=E2
SRX026531,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44523318,40.9,2.9,1092",GSM589238: ERα sequencing in ETOH (ethanol) treated T47D cells,source_name=T47D breast cancer cells	cell line=T47D breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=ETOH (ethanol)
SRX026532,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22111638,58.7,2.0,2388",GSM589239: ERα sequencing in E2 (estradiol) treated T47D cells,source_name=T47D breast cancer cells	cell line=T47D breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=ETOH (ethanol)
SRX026533,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30306165,46.6,3.4,2309",GSM589240: ERα sequencing in ETOH (ethanol) treated Ishikawa cells,source_name=Ishikawa breast cancer cells	cell line=Ishikawa breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=E2
SRX026534,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"29355816,48.9,3.6,1560",GSM589241: ERα sequencing in E2 (estradiol) treated Ishikawa cells,source_name=Ishikawa breast cancer cells	cell line=Ishikawa breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=E2
SRX026535,hg38,TFs and others,ESR1,Uterus,ECC-1,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21134429,68.1,4.6,911",GSM589242: ERα sequencing in ETOH (ethanol) treated ECC1 cells,source_name=ECC1 breast cancer cells	cell line=ECC1 breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=ETOH (ethanol)
SRX026536,hg38,TFs and others,ESR1,Uterus,ECC-1,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"15293757,67.5,6.9,1165",GSM589243: ERα sequencing in E2 (estradiol) treated ECC1 cells,source_name=ECC1 breast cancer cells	cell line=ECC1 breast cancer cells	fraction=ChIP DNA	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody=ERα	agent=E2
SRX026902,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20876237,64.0,91.8,1486",GSM594602: ER ChIP-Seq - Estrogen treated,source_name=MCF7 cell line	cell line=MCF7	chromatin ip antibody=ER	chromatin ip antibody description=anti-estrogen receptor	analysis batch=17
SRX026903,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20784564,77.8,86.0,115",GSM594603: ER ChIP-Seq,source_name=MCF7 cell line	cell line=MCF7	chromatin ip antibody=ER	chromatin ip antibody description=anti-estrogen receptor	analysis batch=17
SRX029087,hg38,TFs and others,FOS,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"53110999,80.3,12.7,28412",GSM610336: K562 TPA-FOS,"source_name=K562 Cells, 24 hours following induction with TPA	cell line=K562	treatment group=24 hours following induction with TPA	chip antibody=FOS"
SRX029088,hg38,TFs and others,FOS,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"47658387,84.8,22.2,44654",GSM610337: K562 TPA-FOSB,"source_name=K562 Cells, 24 hours following induction with TPA	cell line=K562	treatment group=24 hours following induction with TPA	chip antibody=FOS"
SRX036563,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14075733,54.9,16.5,101",GSM640421: ER control,"source_name=Tamoxifen resistance MCF7 cell line	cell type=Breast cancer cell	cell line=MCF7, tamoxifen resistance	agent=untreated	chip antibody=ER	vendor=Santa Cruz Biotechnology	catalog number=sc-8005"
SRX036564,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16401648,44.3,18.5,497",GSM640422: ER E2 treat,"source_name=Tamoxifen resistance MCF7 cell line	cell type=Breast cancer cell	cell line=MCF7, tamoxifen resistance	agent=E2 treated	chip antibody=ER	vendor=Santa Cruz Biotechnology	catalog number=sc-8005"
SRX036635,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","12854413,90.3,12.0,46645",GSM641426: ChIP ER E2,source_name=Cell line	strain=U2OS-ERalpha (stable)	antibody=anti-ERalpha HC20
SRX036636,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","11564730,84.6,9.9,487",GSM641427: ChIP ER Veh,source_name=Cell line	strain=U2OS-ERalpha (stable)	antibody=anti-ERalpha HC20
SRX039139,hg38,TFs and others,FOS,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22464712,96.7,4.0,3503",GSM659789: cFos sequencing in estradiol (E2) treated MCF-7 cells,"source_name=MCF-7 breast cancer cells	cell type=MCF-7 breast cancer cells, E2 treated	chip antibody=cFos - Cat# sc-7202, Santa Cruz"
SRX039140,hg38,TFs and others,FOS,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18991389,94.9,3.2,323",GSM659790: cFos sequencing in non-treated (DMSO as vehicle) MCF-7 cells,"source_name=MCF-7 breast cancer cells	cell type=MCF-7 breast cancer cells, non-treated	chip antibody=cFos - Cat# sc-7202, Santa Cruz"
SRX039141,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19619036,97.6,5.8,363",GSM659791: cJun sequencing in estradiol (E2) treated MCF-7 cells,"source_name=MCF-7 breast cancer cells	cell type=MCF-7 breast cancer cells, E2 treated	chip antibody=cJun - Cat# sc-45, Santa Cruz"
SRX039142,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18074227,96.3,4.2,423",GSM659792: cJun sequencing in non-treated (DMSO as vehicle) MCF-7 cells,"source_name=MCF-7 breast cancer cells	cell type=MCF-7 breast cancer cells, non-treated	chip antibody=cJun - Cat# sc-45, Santa Cruz"
SRX042342,hg38,TFs and others,ESR1,Breast,MCF-7-LTED,,"32479576,98.5,5.3,1088","GSM675073: MCF-7,LTED ER-ChIP-seq","source_name=MCF-7/LTED cells	cell type=MCF-7	chip antibody=Mouse-anti-ER*	vendor=Neomarkers, clone Ab-10 (TE111.5D11)	chip antibody=Rabbit-anti-ER*"
SRX042343,hg38,TFs and others,ESR1,Breast,HCC1428-LTED,,"28485756,97.3,6.5,723","GSM675074: HCC-1428,LTED ER-ChIP-seq","source_name=HCC-1428/LTED cells	cell type=HCC-1428	chip antibody=Mouse-anti-ER*	vendor=Neomarkers, clone Ab-10 (TE111.5D11)	chip antibody=Rabbit-anti-ER*"
SRX047083,hg38,TFs and others,MED12,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"25261293,19.8,2.7,85",GSM686945: LNCaP-MED12-dht-siCTRL-ChIP-Seq,source_name=Prostate cancer cell line (LNCaP)	cell line=LNCaP	sirna transfection=siCTRL (1027280)	agent=DHT	chip antibody=MED12	chip antibody vendor=Bethyl	transgenes=none
SRX047084,hg38,TFs and others,MED12,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"24893460,21.2,2.4,129",GSM686946: LNCaP-MED12-dht-siFoxA1-ChIP-Seq,source_name=Prostate cancer cell line (LNCaP)	cell line=LNCaP	sirna transfection=siFoxA1 (M-010319)	agent=DHT	chip antibody=MED12	chip antibody vendor=Bethyl	transgenes=none
SRX067435,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"51868873,82.5,12.5,39786",GSM733684: Bernstein HeLa-S3 H3K27ac,"source_name=HeLa-S3	biomaterial_provider=ATCC	biomaterial_type=immortalized cell line	line=HeLa-S3	lab=Broad	lab description=Bernstein - Broad Institute	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell organism=human	antibody antibodydescription=rabbit polyclonal. Antibody Target: H3K27ac	antibody targetdescription=Histone H3 (acetyl K27). As with H3K9ac, associated with transcriptional initiation and open chromatin structure. It remains unknown whether acetylation has can have different consequences depending on the specific lysine residue targeted. In general, though, there appears to be high redundancy. Histone acetylation is notable for susceptibility to small molecules and drugs that target histone deacetylases.	antibody vendorname=abcam	antibody vendorid=ab4729	treatment=None	treatment description=No special treatment or protocol applies	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH001013	replicate=1,2	softwareversion=ScriptureVPaperR3"
SRX070878,hg38,TFs and others,FOS,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"15236556,87.2,22.9,14707",GSM730703: cFOS ChIP-seq A,source_name=Chromatin IP against cFOS	cell-type=umbilical vein endothelial cells	passage=04/19/2010
SRX070879,hg38,TFs and others,FOS,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"39973835,97.1,20.9,42274",GSM730704: cFOS ChIP-seq B,source_name=Chromatin IP against cFOS	cell-type=umbilical vein endothelial cells	passage=07/06/2010
SRX082163,hg38,TFs and others,FOS,Blood,GM12878,"Tissue=blood|Lineage=mesoderm|Description=B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus","10045022,77.6,3.2,1444",GSM754332: cFos ChIP-Seq,source_name=Lymphoblastoid cell-line	cell-type=GM12878	description=lymphoblastoid cell-line derived from NA12878	antibody=c-Fos
SRX092306,hg38,TFs and others,FOS,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"54237091,98.0,4.8,14153",GSM777644: UChicago ChipSeq K562 eGFP-FOS Control eGFP-FOS,"source_name=K562	biomaterial_provider=ATCC	lab=UChicago	lab description=White - University of Chicago	data type=ChipSeq	data type description=ChIP-Seq	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	antibody=eGFP-FOS	antibody antibody description=Goat polyclonal	antibody target description=Fos	antibody vendor name=Kevin White	antibody vendor id=(None)	control=Control_eGFP-FOS	control description=This data represents a control being compared to experiments using antibody eGFP-FOS	control=Control_eGFP-FOS	control description=This data represents a control being compared to experiments using antibody eGFP-FOS	control id=K562/Input/Control_eGFP-FOS	replicate=1	replicate description=tier 1"
SRX10024461,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"65889644,97.7,15.3,1475",GSM5065095: ChIP-seq Luc KD-Veh Rep1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=LucKD	treatment=Vehicle	biological replicate=Replicate1	antibody=ERa
SRX10024462,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35627249,97.3,20.2,968",GSM5065096: ChIP-seq Luc KD-Veh Rep2 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=LucKD	treatment=Vehicle	biological replicate=Replicate 2	antibody=ERa
SRX10024465,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33808184,97.4,15.5,4007",GSM5065099: ChIP-seq Luc KD-E2 Rep1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=LucKD	treatment=E2	biological replicate=Replicate1	antibody=ERa
SRX10024466,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38550535,97.5,15.6,3763",GSM5065100: ChIP-seq Luc KD-E2 Rep2 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=LucKD	treatment=E2	biological replicate=Replicate 2	antibody=ERa
SRX10024469,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35635816,97.6,13.7,946",GSM5065103: ChIP-seq PARP-1 KD-Veh Rep1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=PARP-1KD	treatment=ERa	biological replicate=Replicate1	antibody=ERa
SRX10024470,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32434103,97.3,16.2,894",GSM5065104: ChIP-seq PARP-1 KD-Veh Rep2 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=PARP-1KD	treatment=ERa	biological replicate=Replicate 2	antibody=ERa
SRX10024473,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28893331,97.7,16.8,3627",GSM5065107: ChIP-seq PARP-1 KD-E2 Rep1 ER; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=PARP-1KD	treatment=ERa	biological replicate=Replicate1	antibody=ERa
SRX10024474,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42225267,97.8,15.7,2943",GSM5065108: ChIP-seq PARP-1 KD-E2 Rep2 ER; Homo sapiens; ChIP-Seq,source_name=MCF-7	cell line=MCF-7	genotype=PARP-1KD	treatment=ERa	biological replicate=Replicate 2	antibody=ERa
SRX100265,hg38,TFs and others,ESR1,Breast,H3396,,"6535267,94.8,28.6,1447",GSM801056: ERa E2,source_name=H3396 cells	cell line=H3396 cells	treatment=estrogen	comment=Santa Cruz: ERa (HC20)	chip antibody=ERa	chip antibody manufacturer=Santa Cruz
SRX100266,hg38,TFs and others,ESR1,Breast,H3396,,"4706909,93.0,29.1,445",GSM801057: ERa EtOH,source_name=H3396 cells	cell line=H3396 cells	treatment=ethanol	comment=Santa Cruz: ERa (HC20)	chip antibody=ERa	chip antibody manufacturer=Santa Cruz
SRX1002670,hg38,Histone,H3K27ac,Uterus,EEC16,,"52732293,96.0,10.5,56315",GSM1663010: iEEC16 H3K27ac NA rep1 1; Homo sapiens; ChIP-Seq,source_name=endometriosis epithelial cell line	cell line=EEC16	tissue=endometriosis epithelial cells	antibody=H3K27ac (Abcam ab4729)
SRX1002671,hg38,Histone,H3K27ac,Uterus,EEC16,,"57808111,96.9,13.5,60612",GSM1663011: iEEC16 H3K27ac NA rep2 1; Homo sapiens; ChIP-Seq,source_name=endometriosis epithelial cell line	cell line=EEC16	tissue=endometriosis epithelial cells	antibody=H3K27ac (Abcam ab4729)
SRX1002678,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"48547361,93.2,84.7,17054",GSM1663018: iFTSEC246 H3K27ac NA rep1 1; Homo sapiens; ChIP-Seq,source_name=fallopian tube secretory epithelial cell line	cell line=FT246	tissue=fallopian tube secretory epithelial cells	antibody=H3K27ac (Abcam ab4729)
SRX1002679,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"47106989,92.9,85.2,16632",GSM1663019: iFTSEC246 H3K27ac NA rep2 1; Homo sapiens; ChIP-Seq,source_name=fallopian tube secretory epithelial cell line	cell line=FT246	tissue=fallopian tube secretory epithelial cells	antibody=H3K27ac (Abcam ab4729)
SRX1002686,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"44343218,96.9,76.5,26454",GSM1663026: iFTSEC33 H3K27ac NA rep1 1; Homo sapiens; ChIP-Seq,source_name=fallopian tube secretory epithelial cell line	cell line=FT33	tissue=fallopian tube secretory epithelial cells	antibody=H3K27ac (Abcam ab4729)
SRX1002687,hg38,Histone,H3K27ac,Uterus,Fallopian tube secretory epithelial cell,,"46124518,96.1,78.6,24389",GSM1663027: iFTSEC33 H3K27ac NA rep2 1; Homo sapiens; ChIP-Seq,source_name=fallopian tube secretory epithelial cell line	cell line=FT33	tissue=fallopian tube secretory epithelial cells	antibody=H3K27ac (Abcam ab4729)
SRX100419,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"73273067,80.5,14.9,15312",GSM803374: HudsonAlpha ChipSeq T-47D ERalpha a Genistein 100nM v041610.2,"source_name=T-47D	biomaterial_provider=ATCC	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell description=epithelial cell line derived from a mammary ductal carcinoma.	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotechnology	antibody vendorid=sc-543	treatment description=1 h with 100 nM Genistein (Myers)	controlid=SL1216,SL1490	labexpid=SL1218,SL1492	labversion=Genestein 100nM treatment	replicate=1,2	softwareversion=MACS	antibody vendorid=sc-543	treatment=Genistein_100nM	treatment description=1 h with 100 nM Genistein (Myers)	protocol=v041610.2	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	controlid=SL1216	labexpid=SL1218	labversion=Genestein 100nM treatment	replicate=1	replicate description=tier 1"
SRX100466,hg38,TFs and others,ESR1,Uterus,ECC-1,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"46468633,61.4,6.7,2784",GSM803421: HudsonAlpha ChipSeq ECC-1 ERalpha a DMSO 0.02pct v041610.2,"source_name=ECC-1	biomaterial_provider=ATCC	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell description=epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes	cell lineage=endoderm	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotechnology	antibody vendorid=sc-543	treatment description=1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	controlid=SL1092,SL1034	labexpid=SL1092,SL1034	replicate=1,2	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-543	treatment=DMSO_0.02pct	treatment description=1 h with 0.02% DMSO (Myers)	protocol=v041610.2	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	controlid=SL1034	labexpid=SL1034	replicate=1	replicate description=tier 1"
SRX100467,hg38,TFs and others,ESR1,Uterus,ECC-1,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"40752127,74.5,7.3,19530",GSM803422: HudsonAlpha ChipSeq ECC-1 ERalpha a Estradiol 10nM v041610.2,"source_name=ECC-1	biomaterial_provider=ATCC	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell description=epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes	cell lineage=endoderm	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotechnology	antibody vendorid=sc-543	treatment description=1 h with 10 nM Estradiol (Myers)	controlid=SL1092,SL1034	labexpid=SL1093,SL1011	replicate=1,2	softwareversion=MACS	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-543	treatment=Estradiol_10nM	treatment description=1 h with 10 nM Estradiol (Myers)	protocol=v041610.2	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	controlid=SL1034	labexpid=SL1011	replicate=1	replicate description=tier 1"
SRX100564,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"41707848,80.4,7.0,3476",GSM803519: HudsonAlpha ChipSeq T-47D ERalpha a DMSO 0.02pct v041610.2,"source_name=T-47D	biomaterial_provider=ATCC	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell description=epithelial cell line derived from a mammary ductal carcinoma.	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotechnology	antibody vendorid=sc-543	treatment description=1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers)	controlid=SL1216,SL1490	labexpid=SL1216,SL1490	replicate=1,2	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-543	treatment=DMSO_0.02pct	treatment description=1 h with 0.02% DMSO (Myers)	protocol=v041610.2	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	controlid=SL1216	labexpid=SL1216	replicate=1	replicate description=tier 1"
SRX100584,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"54137947,74.4,10.6,17652",GSM803539: HudsonAlpha ChipSeq T-47D ERalpha a Estradiol 10nM v041610.2,"source_name=T-47D	biomaterial_provider=ATCC	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell description=epithelial cell line derived from a mammary ductal carcinoma.	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotechnology	antibody vendorid=sc-543	treatment description=1 h with 10 nM Estradiol (Myers)	controlid=SL1216,SL1490	labexpid=SL1217,SL1491	replicate=1,2	softwareversion=MACS	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-543	treatment=Estradiol_10nM	treatment description=1 h with 10 nM Estradiol (Myers)	protocol=v041610.2	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	controlid=SL1216	labexpid=SL1217	replicate=1	replicate description=tier 1"
SRX100586,hg38,TFs and others,ESR1,Uterus,ECC-1,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"31219549,83.1,13.9,14846",GSM803541: HudsonAlpha ChipSeq ECC-1 ERalpha a Genistein 100nM v041610.2,"source_name=ECC-1	biomaterial_provider=ATCC	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell description=epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes	cell lineage=endoderm	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorname=Santa Cruz Biotechnology	antibody vendorid=sc-543	treatment description=1 h with 100 nM Genistein (Myers)	controlid=SL1092,SL1034	labexpid=SL1049,SL1122	replicate=1,2	softwareversion=MACS	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-543	treatment=Genistein_100nM	treatment description=1 h with 100 nM Genistein (Myers)	protocol=v041610.2	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	controlid=SL1034	labexpid=SL1049	replicate=1	replicate description=tier 1"
SRX10119116,hg38,TFs and others,JUN,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"44861962,98.4,7.5,607",GSM5088813: ChIP JUN CRYBMIM rep1; Homo sapiens; ChIP-Seq,"source_name=MV411 cell line	cell line=MV411 leukemia cell line	treatment=CRYBMIM peptide	time=1 hr	chip antibody=Cell Signaling #9165 Anti-c-Jun, rabbit monoclonal, Clone 60A8"
SRX10119117,hg38,TFs and others,JUN,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"88572787,98.4,7.2,1246",GSM5088814: ChIP JUN CRYBMIM rep2; Homo sapiens; ChIP-Seq,"source_name=MV411 cell line	cell line=MV411 leukemia cell line	treatment=CRYBMIM peptide	time=1 hr	chip antibody=Cell Signaling #9165 Anti-c-Jun, rabbit monoclonal, Clone 60A8"
SRX10119118,hg38,TFs and others,JUN,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"35288496,98.7,6.1,494",GSM5088815: ChIP JUN CRYBMIM rep3; Homo sapiens; ChIP-Seq,"source_name=MV411 cell line	cell line=MV411 leukemia cell line	treatment=CRYBMIM peptide	time=1 hr	chip antibody=Cell Signaling #9165 Anti-c-Jun, rabbit monoclonal, Clone 60A8"
SRX10119119,hg38,TFs and others,JUN,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"34400168,98.5,6.9,667",GSM5088816: ChIP JUN PBS rep1; Homo sapiens; ChIP-Seq,"source_name=MV411 cell line	cell line=MV411 leukemia cell line	treatment=PBS control	time=1 hr	chip antibody=Cell Signaling #9165 Anti-c-Jun, rabbit monoclonal, Clone 60A8"
SRX10119120,hg38,TFs and others,JUN,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"38784905,98.4,7.7,715",GSM5088817: ChIP JUN PBS rep2; Homo sapiens; ChIP-Seq,"source_name=MV411 cell line	cell line=MV411 leukemia cell line	treatment=PBS control	time=1 hr	chip antibody=Cell Signaling #9165 Anti-c-Jun, rabbit monoclonal, Clone 60A8"
SRX10119121,hg38,TFs and others,JUN,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"38175569,98.4,7.1,742",GSM5088818: ChIP JUN PBS rep3; Homo sapiens; ChIP-Seq,"source_name=MV411 cell line	cell line=MV411 leukemia cell line	treatment=PBS control	time=1 hr	chip antibody=Cell Signaling #9165 Anti-c-Jun, rabbit monoclonal, Clone 60A8"
SRX1012594,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30153390,98.5,3.9,5150",GSM1669011: JC1553 T47D ER Full Media 3hr r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_Full_Media_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012595,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"25829577,98.7,2.9,2558",GSM1669012: JC1563 T47D ER Full Media 3hr r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_Full_Media_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012596,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27921736,98.5,3.4,3169",GSM1669013: JC1573 T47D ER Full Media 3hr r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_Full_Media_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012597,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26873885,98.5,4.2,11740",GSM1669014: JC1554 T47D ER Progesterone 3hr r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_Progesterone_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012598,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30891060,98.5,3.6,12138",GSM1669015: JC1564 T47D ER Progesterone 3hr r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_Progesterone_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012599,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29463703,98.9,2.9,8580",GSM1669016: JC1574 T47D ER Progesterone 3hr r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_Progesterone_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012600,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23288753,98.7,3.4,7439",GSM1669017: JC1555 T47D ER R5020 3hr r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_R5020_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012601,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29647996,98.4,2.7,7292",GSM1669018: JC1565 T47D ER R5020 3hr r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_R5020_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012602,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22249668,98.4,2.8,8369",GSM1669019: JC1575 T47D ER R5020 3hr r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_R5020_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012615,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28806441,98.3,3.3,790",GSM1669032: JC1556 T47D PR Full Media 3hr r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_Full_Media_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012616,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"24774804,97.9,3.0,878",GSM1669033: JC1566 T47D PR Full Media 3hr r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_Full_Media_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012617,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31947894,98.8,3.1,989",GSM1669034: JC1576 T47D PR Full Media 3hr r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_Full_Media_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012618,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23134880,98.5,7.6,29013",GSM1669035: JC1557 T47D PR Progesterone 3hr r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_Progesterone_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012619,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30202129,98.2,7.7,37187",GSM1669036: JC1567 T47D PR Progesterone 3hr r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_Progesterone_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012620,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43369672,98.8,5.4,30991",GSM1669037: JC1577 T47D PR Progesterone 3hr r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_Progesterone_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012621,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29069351,98.6,6.5,32930",GSM1669038: JC1558 T47D PR R5020 3hr r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_R5020_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012622,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29362674,98.9,6.0,34370",GSM1669039: JC1568 T47D PR R5020 3hr r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_R5020_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012623,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31713328,98.7,5.7,29459",GSM1669040: JC1578 T47D PR R5020 3hr r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_R5020_3hr	cell line=T47D	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012625,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23051326,96.0,8.5,26711",GSM1669042: JC1523 MCF7 ER Full Media 3hr r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_Full_Media_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012626,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30132218,98.6,4.0,12532",GSM1669043: JC1533 MCF7 ER Full Media 3hr r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_Full_Media_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012627,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16560835,93.2,18.7,11822",GSM1669044: JC1543 MCF7 ER Full Media 3hr r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_Full_Media_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012628,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26612366,97.0,10.8,26090",GSM1669045: JC1524 MCF7 ER Progesterone 3hr r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_Progesterone_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012629,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27323041,97.0,7.7,30593",GSM1669046: JC1534 MCF7 ER Progesterone 3hr r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_Progesterone_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012630,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21723555,88.8,10.9,23310",GSM1669047: JC1544 MCF7 ER Progesterone 3hr r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_Progesterone_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012631,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19855642,97.8,5.2,23957",GSM1669048: JC1525 MCF7 ER R5020 3hr r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012632,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25633932,95.8,8.2,26985",GSM1669049: JC1535 MCF7 ER R5020 3hr r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012633,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18183249,95.5,8.2,26329",GSM1669050: JC1545 MCF7 ER R5020 3hr r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012650,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29942436,97.3,2.9,544",GSM1669067: JC1526 MCF7 PR Full Media 3hr r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_Full_Media_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012651,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23850209,96.8,2.6,278",GSM1669068: JC1536 MCF7 PR Full Media 3hr r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_Full_Media_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012652,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29918583,98.4,3.3,373",GSM1669069: JC1546 MCF7 PR Full Media 3hr r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_Full_Media_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Full_Media	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012653,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30957775,97.1,5.1,19027",GSM1669070: JC1527 MCF7 PR Progesterone 3hr r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_Progesterone_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012654,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33621919,98.4,4.1,21863",GSM1669071: JC1537 MCF7 PR Progesterone 3hr r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_Progesterone_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012655,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33033505,95.2,13.2,31298",GSM1669072: JC1547 MCF7 PR Progesterone 3hr r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_Progesterone_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Progesterone	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012656,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"7823894,85.8,68.8,885",GSM1669073: JC1375 MCF7 PR R5020 3hr r0; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012657,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8605604,84.2,80.1,749",GSM1669074: JC1376 MCF7 PR R5020 24hr r0; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_R5020_24hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012658,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29981733,97.6,2.8,12283",GSM1669075: JC1528 MCF7 PR R5020 3hr r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012659,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25739630,96.6,6.1,18079",GSM1669076: JC1538 MCF7 PR R5020 3hr r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012660,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22262252,95.2,9.0,11938",GSM1669077: JC1548 MCF7 PR R5020 3hr r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_R5020_3hr	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=R5020	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012675,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34989706,95.4,5.9,1414",GSM1669105: JC2361 T47D ER 3hr E2+PG r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_E2+PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012676,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"40784517,96.3,6.1,1491",GSM1669106: JC2362 T47D ER 3hr Vehicle r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_Vehicle	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012677,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34897233,95.6,5.6,1557",GSM1669107: JC2363 T47D ER 3hr E2 r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_E2	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012678,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40368059,96.9,7.5,2002",GSM1669078: JC2334 MCF7 ER 3hr Vehicle r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_Vehicle	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=ERα Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012679,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33452351,96.0,10.1,6755",GSM1669079: JC2335 MCF7 ER 3hr E2 r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_E2	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=ERα Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012680,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44648164,97.4,6.9,1905",GSM1669080: JC2336 MCF7 ER 3hr PG r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=ERα Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012681,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19366914,94.7,9.0,9832",GSM1669081: JC2337 MCF7 ER 3hr E2+PG r1; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_E2+PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=ERα Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012682,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"54795844,98.3,6.5,1660",GSM1669082: JC2338 MCF7 ER 3hr Vehicle r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_Vehicle	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012683,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21596866,93.7,8.3,3520",GSM1669083: JC2339 MCF7 ER 3hr E2 r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_E2	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012684,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33919837,97.0,8.7,1254",GSM1669084: JC2340 MCF7 ER 3hr PG r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012685,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27860103,97.2,6.8,6920",GSM1669085: JC2341 MCF7 ER 3hr E2+PG r2; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_E2+PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012686,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55713454,97.8,6.4,1437",GSM1669086: JC2342 MCF7 ER 3hr Vehicle r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_Vehicle	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012687,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33396530,97.3,7.7,6872",GSM1669087: JC2343 MCF7 ER 3hr E2 r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_E2	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012688,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22248012,94.4,6.2,565",GSM1669088: JC2344 MCF7 ER 3hr PG r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012689,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13202967,91.7,12.3,3378",GSM1669089: JC2345 MCF7 ER 3hr E2+PG r3; Homo sapiens; ChIP-Seq,source_name=MCF7_ER_3hr_E2+PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012690,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34372811,97.6,6.0,865",GSM1669090: JC2346 MCF7 PR 3hr Vehicle r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_Vehicle	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012691,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34826944,97.7,6.0,1261",GSM1669091: JC2347 MCF7 PR 3hr E2 r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_E2	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012692,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19070543,93.9,7.3,841",GSM1669092: JC2348 MCF7 PR 3hr PG r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012693,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44603977,98.1,4.4,1549",GSM1669093: JC2349 MCF7 PR 3hr E2+PG r1; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_E2+PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012694,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"45310053,98.2,5.3,1473",GSM1669094: JC2350 MCF7 PR 3hr Vehicle r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_Vehicle	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012695,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37033193,96.6,4.9,1386",GSM1669095: JC2351 MCF7 PR 3hr E2 r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_E2	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012696,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33436010,97.8,3.7,861",GSM1669096: JC2352 MCF7 PR 3hr PG r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012697,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26272492,97.5,4.5,848",GSM1669097: JC2353 MCF7 PR 3hr E2+PG r2; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_E2+PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012698,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29654194,96.3,4.4,554",GSM1669098: JC2354 MCF7 PR 3hr Vehicle r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_Vehicle	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012699,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39727416,98.2,3.7,605",GSM1669099: JC2355 MCF7 PR 3hr E2 r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_E2	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012700,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33055269,97.4,3.3,594",GSM1669100: JC2356 MCF7 PR 3hr PG r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012701,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30705337,96.3,3.9,607",GSM1669101: JC2357 MCF7 PR 3hr E2+PG r3; Homo sapiens; ChIP-Seq,source_name=MCF7_PR_3hr_E2+PG	cell line=MCF7	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012702,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29040640,94.3,7.9,1107",GSM1669102: JC2358 T47D ER 3hr Vehicle r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_Vehicle	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012703,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44560481,97.4,5.2,1981",GSM1669103: JC2359 T47D ER 3hr E2 r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_E2	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012704,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28800346,92.5,6.4,1202",GSM1669104: JC2360 T47D ER 3hr PG r1; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012705,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"52917782,97.7,4.7,1794",GSM1669108: JC2364 T47D ER 3hr PG r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012706,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"39241834,96.7,5.9,1599",GSM1669109: JC2365 T47D ER 3hr E2+PG r2; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_E2+PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012707,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23536293,94.0,11.0,996",GSM1669110: JC2366 T47D ER 3hr Vehicle r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_Vehicle	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012708,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"25897625,94.7,5.8,1234",GSM1669111: JC2367 T47D ER 3hr E2 r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_E2	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012709,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43075434,97.8,10.4,1536",GSM1669112: JC2368 T47D ER 3hr PG r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012710,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"24328200,95.1,8.5,1125",GSM1669113: JC2369 T47D ER 3hr E2+PG r3; Homo sapiens; ChIP-Seq,source_name=T47D_ER_3hr_E2+PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012711,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"25966556,93.8,7.1,1010",GSM1669114: JC2370 T47D PR 3hr Vehicle r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_Vehicle	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012712,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26678834,95.4,6.7,1040",GSM1669115: JC2371 T47D PR 3hr E2 r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_E2	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012713,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27808064,95.4,6.6,6680",GSM1669116: JC2372 T47D PR 3hr PG r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012714,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34202426,96.8,5.4,5102",GSM1669117: JC2373 T47D PR 3hr E2+PG r1; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_E2+PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012715,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"52992509,98.0,6.8,1688",GSM1669118: JC2374 T47D PR 3hr Vehicle r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_Vehicle	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012716,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"45491821,97.9,5.9,1649",GSM1669119: JC2375 T47D PR 3hr E2 r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_E2	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012717,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"38106554,97.5,5.9,5273",GSM1669120: JC2376 T47D PR 3hr PG r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012718,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"45840338,98.3,5.3,7946",GSM1669121: JC2377 T47D PR 3hr E2+PG r2; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_E2+PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012719,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"32261939,96.8,6.6,1156",GSM1669122: JC2378 T47D PR 3hr Vehicle r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_Vehicle	cell line=T47D	cell type=ER+ breast cancer cell line	condition=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012720,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"38399303,98.3,8.1,1329",GSM1669123: JC2379 T47D PR 3hr E2 r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_E2	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012721,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"21834827,95.4,10.1,3773",GSM1669124: JC2380 T47D PR 3hr PG r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012722,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"18472799,94.1,9.5,2047",GSM1669125: JC2381 T47D PR 3hr E2+PG r3; Homo sapiens; ChIP-Seq,source_name=T47D_PR_3hr_E2+PG	cell line=T47D	cell type=ER+ breast cancer cell line	condition=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012737,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17414253,85.3,2.2,587",GSM1669132: JC2564 Xenograft MCF7 ER Vehicle r1; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_Vehicle	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012738,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16996031,85.3,2.7,620",GSM1669133: JC2565 Xenograft MCF7 ER Vehicle r2; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_Vehicle	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=Vehicle	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012739,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26440473,88.7,2.9,3400",GSM1669134: JC2566 Xenograft MCF7 ER E2+PG r3; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012740,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26112116,88.2,2.0,1869",GSM1669135: JC2567 Xenograft MCF7 ER E2+PG r4; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012741,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29509642,89.3,3.7,2350",GSM1669136: JC2568 Xenograft MCF7 ER E2+PG r5; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012742,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14780971,78.1,2.5,1030",GSM1669137: JC2569 Xenograft MCF7 ER E2+PG r6; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012743,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23934065,89.8,1.9,3169",GSM1669138: JC2570 Xenograft MCF7 ER E2+PG r7; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012744,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44179014,87.3,3.8,4061",GSM1669139: JC2571 Xenograft MCF7 ER E2+PG r8; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012745,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17440532,91.1,1.9,3381",GSM1669140: JC2572 Xenograft MCF7 ER E2 r9; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012746,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21288116,89.3,2.6,3052",GSM1669141: JC2573 Xenograft MCF7 ER E2 r10; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012747,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30861410,91.2,2.9,8142",GSM1669142: JC2574 Xenograft MCF7 ER E2 r11; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012748,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22599643,89.6,3.1,2677",GSM1669143: JC2575 Xenograft MCF7 ER E2 r12; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012749,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26360097,90.9,2.1,4229",GSM1669144: JC2576 Xenograft MCF7 ER E2 r13; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012750,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27326762,90.4,2.3,6049",GSM1669145: JC2577 Xenograft MCF7 ER E2 r14; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_ER_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=ERa Antibody (HC-20)	chip antibody vendor=Santa Cruz
SRX1012751,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21702800,85.6,2.4,669",GSM1669146: JC2578 Xenograft MCF7 PR Vehicle r1; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_Vehicle	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012752,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35526052,85.9,3.5,974",GSM1669147: JC2579 Xenograft MCF7 PR Vehicle r2; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_Vehicle	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=Vehicle	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012753,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12901997,89.0,1.2,500",GSM1669148: JC2580 Xenograft MCF7 PR E2+PG r3; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012754,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16797630,87.3,1.3,620",GSM1669149: JC2581 Xenograft MCF7 PR E2+PG r4; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012755,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16546858,89.1,1.9,641",GSM1669150: JC2582 Xenograft MCF7 PR E2+PG r5; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012756,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18974257,87.1,1.1,630",GSM1669151: JC2583 Xenograft MCF7 PR E2+PG r6; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012757,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21473432,89.7,1.6,753",GSM1669152: JC2584 Xenograft MCF7 PR E2+PG r7; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012758,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19589099,87.0,1.5,684",GSM1669153: JC2585 Xenograft MCF7 PR E2+PG r8; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2+PG	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2+PG	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012759,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18513532,91.2,1.4,625",GSM1669154: JC2586 Xenograft MCF7 PR E2 r9; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012760,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12892170,89.4,1.7,205",GSM1669155: JC2587 Xenograft MCF7 PR E2 r10; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012761,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27266454,90.7,2.2,995",GSM1669156: JC2588 Xenograft MCF7 PR E2 r11; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012762,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25700629,90.4,1.6,891",GSM1669157: JC2589 Xenograft MCF7 PR E2 r12; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012763,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26902495,90.6,1.8,956",GSM1669158: JC2590 Xenograft MCF7 PR E2 r13; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1012764,hg38,TFs and others,PGR,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32768904,90.0,2.0,1094",GSM1669159: JC2591 Xenograft MCF7 PR E2 r14; Homo sapiens; ChIP-Seq,source_name=Xenograft_MCF7_PR_E2	implated cell line/type=MCF7; MCF7-Luc2/YFP cells	host strain=age-matched female NOD/SCID/IL2Rg-/- (NSG)	tissue=xenografts tumors in vivo	treatment groupd=E2	chip antibody=PR Antibody (H-190)	chip antibody vendor=Santa Cruz
SRX1013959,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"28042580,95.8,12.4,25809",GSM1670864: CTRL K27 rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=control	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013960,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"34457871,95.8,15.4,24209",GSM1670865: CTRL EGF K27 rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=control EGF	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013961,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"41112038,95.1,14.9,28959",GSM1670866: DOX K27 rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=doxycyclin	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013962,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"46336420,95.4,14.0,27854",GSM1670867: DOX EGF K27 rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=doxycyclin EGF	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013963,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47792856,90.5,57.1,26521",GSM1670868: CTRL K27 rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=control	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013964,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"42705714,90.9,57.4,21560",GSM1670869: CTRL EGF K27 rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=control EGF	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013965,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35810643,90.7,43.8,26428",GSM1670870: DOX K27 rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=doxycyclin	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX1013966,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"48605362,90.5,39.9,28801",GSM1670871: DOX EGF K27 rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa cell line	cell type=Hela cell line	treatment=doxycyclin EGF	antibody=IP with rabbit anti-H3K27ac (Abcam ab4729, Lot: GR183919-2)"
SRX10164571,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"90486943,94.7,13.9,2709",GSM5105301: DMSO EtOH ER 1; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=EtOH	chip antibody=Estrogen Receptor
SRX10164576,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37511277,95.7,14.2,3541",GSM5105306: DMSO E2 ER 1; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=Estradiol	chip antibody=Estrogen Receptor
SRX10164581,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44817289,94.1,13.6,1446",GSM5105311: DMSO Tam ER 1; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=Tamoxifen	chip antibody=Estrogen Receptor
SRX10164586,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51506100,90.8,13.7,1506",GSM5105316: BBCA EtOH ER 1; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=EtOH	chip antibody=Estrogen Receptor
SRX10164591,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"61470432,94.1,16.6,12755",GSM5105321: BBCA E2 ER 1; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=Estradiol	chip antibody=Estrogen Receptor
SRX10164596,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"50761415,95.3,15.6,2802",GSM5105326: BBCA Tam ER 1; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=Tamoxifen	chip antibody=Estrogen Receptor
SRX10164601,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"48650838,94.7,12.0,1481",GSM5105331: DMSO EtOH ER 2; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=EtOH	chip antibody=Estrogen Receptor
SRX10164607,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38499911,93.7,11.4,3422",GSM5105337: DMSO E2 ER 2; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=Estradiol	chip antibody=Estrogen Receptor
SRX10164613,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43471266,95.3,14.1,1802",GSM5105343: DMSO Tam ER 2; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=Tamoxifen	chip antibody=Estrogen Receptor
SRX10164619,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"45222425,95.4,12.9,1481",GSM5105349: BBCA EtOH ER 2; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=EtOH	chip antibody=Estrogen Receptor
SRX10164625,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41670246,95.4,16.1,5148",GSM5105355: BBCA E2 ER 2; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=Estradiol	chip antibody=Estrogen Receptor
SRX10164631,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36373044,94.4,15.2,2080",GSM5105361: BBCA Tam ER 2; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=Tamoxifen	chip antibody=Estrogen Receptor
SRX10164637,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"61098272,92.7,17.8,1672",GSM5105367: DMSO EtOH ER 3; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=EtOH	chip antibody=Estrogen Receptor
SRX10164643,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"56192181,94.1,16.8,9742",GSM5105373: DMSO E2 ER 3; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=Estradiol	chip antibody=Estrogen Receptor
SRX10164649,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"49777191,94.1,18.8,2284",GSM5105379: DMSO Tam ER 3; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=DMSO	treatment=Tamoxifen	chip antibody=Estrogen Receptor
SRX10164655,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46239351,94.5,18.1,1387",GSM5105385: BBCA EtOH ER 3; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=EtOH	chip antibody=Estrogen Receptor
SRX10164661,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"56474146,94.6,19.6,10943",GSM5105391: BBCA E2 ER 3; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=Estradiol	chip antibody=Estrogen Receptor
SRX10164667,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"101743074,94.9,19.6,7820",GSM5105397: BBCA Tam ER 3; Homo sapiens; ChIP-Seq,source_name=ER+ breast cancer cell line	cell line=MCF7	cell type=ER+ breast cancer cell line	pre-treatment=BBCA	treatment=Tamoxifen	chip antibody=Estrogen Receptor
SRX10212115,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"29840349,98.1,24.6,2322",GSM5128944: ATAC-seq in HeLa cells in complete DMEM; Homo sapiens; ATAC-seq,source_name=Cervical cancer cell line (HeLa)	tissue=Cervical cancer cell line (HeLa)	treatment=Cells cultured in DMEM for 72h	cell type=Cell line derived from human cervical carcinoma
SRX10212116,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"24287545,98.1,31.9,6810",GSM5128945: ATAC-seq in HeLa cells in arginine-free DMEM; Homo sapiens; ATAC-seq,source_name=Cervical cancer cell line (HeLa)	tissue=Cervical cancer cell line (HeLa)	treatment=Cells cultured in arginine-free DMEM for 72h	cell type=Cell line derived from human cervical carcinoma
SRX10306472,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"41205712,92.4,11.4,3116",GSM5154420: T47D FM ER ChIPseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental	chip antibody=Anti-Estrogen Receptor alpha antibody (ab3575)
SRX10306474,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"37625665,96.3,19.3,943",GSM5154422: T47D LTED9M shcjun cjun ChIPseq; Homo sapiens; ChIP-Seq,"source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 9 months, plko-shcjun estable SHCLNG-NM_002228 (TRCN0000010366) Sigma Aldrich	chip antibody=Anti-c-Jun antibody (ab31419)"
SRX10306478,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36263386,95.3,20.7,941",GSM5154427: T47D LTED9M cjun ChIPseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 9 months	chip antibody=Anti-c-Jun antibody (ab31419)
SRX10306484,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34755850,76.9,24.1,842",GSM5154434: T47D LTED9M LSD1 KO cjun ChIPseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental long term estrogen deprived with CRISPR/Cas9 LSD1 KO	chip antibody=Anti-c-Jun antibody (ab31419)
SRX1032965,hg38,TFs and others,FOS,Blood,Acute myeloid leukemia,,"24414448,78.3,70.7,1585",GSM1690574: MV4/11 siMM cFos ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=FLT3-ITD AML cell line	antibody=anti-cFos	antibody manufacturer and catalog number=Santa Cruz Biotechnology; sc-253	cell type=AML	cell line=MV-4-11
SRX1032966,hg38,TFs and others,FOS,Blood,Acute myeloid leukemia,,"41874845,90.2,72.4,1724",GSM1690575: MV4/11 siFLT3 cFos ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=FLT3-ITD AML cell line	antibody=anti-cFos	antibody manufacturer and catalog number=Santa Cruz Biotechnology; sc-253	cell type=AML	cell line=MV-4-11
SRX10365520,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","19147383,93.8,27.2,785",GSM5176113: MDA-MB-231 ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-231 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)"
SRX10365521,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","16853923,91.7,26.1,755",GSM5176114: MDA-MB-231 ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-231 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)"
SRX10365524,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","30916415,98.2,3.9,5063",GSM5176117: MDA-MB-231ER ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-231ER cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)"
SRX10365525,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","26728446,92.7,24.7,3850",GSM5176118: MDA-MB-231ER ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-231ER cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)"
SRX10365532,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16001352,96.5,25.1,31571",GSM5176078: MCF-7 E2 ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=10 nM E2"
SRX10365533,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21712475,96.7,12.8,28619",GSM5176079: MCF-7 EHT ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=50 uM EHT 1864"
SRX10365534,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14889058,97.1,9.2,19793",GSM5176080: MCF-7 EHT ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=50 uM EHT 1864"
SRX10365535,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29910819,97.7,19.9,38786",GSM5176081: MCF-7 E2-EHT ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=10 nM E2 + 50 uM EHT 1864"
SRX10365536,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16580311,97.5,15.2,27453",GSM5176082: MCF-7 E2-EHT ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=10 nM E2 + 50 uM EHT 1864"
SRX10365556,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33280770,97.2,11.9,4430",GSM5176075: MCF-7 control ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=control"
SRX10365557,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13574619,96.8,20.9,7202",GSM5176076: MCF-7 control ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=control"
SRX10365558,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28962379,97.3,34.0,37631",GSM5176077: MCF-7 E2 ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7 cells	cell type=Breast cancer cell line	chip antibody=ER (Santa Cruz, sc543)	treatment=10 nM E2"
SRX1044411,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","56907776,98.4,27.2,13689",GSM1700784: AP1 Vehicle; Homo sapiens; ChIP-Seq,source_name=AP1_Vehicle	cell line=MDA-MB-231	cancer=Breast adenocarcinoma	type=TNBC	chip antibody=c-Jun Antibody (H-79) from Santa Cruz Biotechnology
SRX1044412,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","67589596,98.2,33.0,14377",GSM1700785: AP1 Dexamethasone; Homo sapiens; ChIP-Seq,source_name=AP1_Dexamethasone	cell line=MDA-MB-231	cancer=Breast adenocarcinoma	type=TNBC	chip antibody=c-Jun Antibody (H-79) from Santa Cruz Biotechnology
SRX1044413,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","67927474,98.3,22.1,15083",GSM1700786: AP1 Compound A; Homo sapiens; ChIP-Seq,source_name=AP1_Compound A	cell line=MDA-MB-231	cancer=Breast adenocarcinoma	type=TNBC	chip antibody=c-Jun Antibody (H-79) from Santa Cruz Biotechnology
SRX10468615,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"25638099,98.2,7.4,15237",GSM5218278: Gar15-13 Vehicle 1 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Vehicle tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Vehicle	replicate=1	chip antibody=ER (Millipore SC-543X)
SRX10468616,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"33297957,97.8,9.0,25839",GSM5218279: Gar15-13 Vehicle 2 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Vehicle tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Vehicle	replicate=2	chip antibody=ER (Millipore SC-543X)
SRX10468617,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"29328551,97.3,6.5,18060",GSM5218280: Gar15-13 Vehicle 3 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Vehicle tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Vehicle	replicate=3	chip antibody=ER (Millipore SC-543X)
SRX10468618,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"28859443,97.6,6.7,15552",GSM5218281: Gar15-13 Vehicle 4 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Vehicle tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Vehicle	replicate=4	chip antibody=ER (Millipore SC-543X)
SRX10468619,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"26925952,96.1,6.7,12400",GSM5218282: Gar15-13 Decitabine 4 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Decitabine tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Decitabine	replicate=4	chip antibody=ER (Millipore SC-543X)
SRX10468620,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"26699617,96.9,6.8,12438",GSM5218283: Gar15-13 Decitabine 5 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Decitabine tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Decitabine	replicate=5	chip antibody=ER (Millipore SC-543X)
SRX10468621,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"30304994,96.8,5.8,8462",GSM5218284: Gar15-13 Decitabine 9 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Decitabine tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Decitabine	replicate=9	chip antibody=ER (Millipore SC-543X)
SRX10468622,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"51534047,96.8,8.3,26458",GSM5218285: Gar15-13 Decitabine 10 ER; Homo sapiens; ChIP-Seq,source_name=Gar15-13 Decitabine tumour	tissue=Breast cancer PDX model Gar15-13	treatment=Decitabine	replicate=10	chip antibody=ER (Millipore SC-543X)
SRX10468624,hg38,TFs and others,ESR1,Lung,HCI005,,"50393090,86.8,5.9,15645",GSM5218287: HCI005 Vehicle 1 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Vehicle tumour	tissue=Breast cancer PDX model HCI005	treatment=Vehicle	replicate=1	chip antibody=ER (Millipore SC-543X)
SRX10468625,hg38,TFs and others,ESR1,Lung,HCI005,,"51215682,77.3,5.6,8325",GSM5218288: HCI005 Vehicle 2 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Vehicle tumour	tissue=Breast cancer PDX model HCI005	treatment=Vehicle	replicate=2	chip antibody=ER (Millipore SC-543X)
SRX10468626,hg38,TFs and others,ESR1,Lung,HCI005,,"52061216,85.6,6.1,13441",GSM5218289: HCI005 Vehicle 3 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Vehicle tumour	tissue=Breast cancer PDX model HCI006	treatment=Vehicle	replicate=3	chip antibody=ER (Millipore SC-543X)
SRX10468627,hg38,TFs and others,ESR1,Lung,HCI005,,"48544692,85.2,5.6,9818",GSM5218290: HCI005 Vehicle 4 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Vehicle tumour	tissue=Breast cancer PDX model HCI005	treatment=Vehicle	replicate=4	chip antibody=ER (Millipore SC-543X)
SRX10468629,hg38,TFs and others,ESR1,Lung,HCI005,,"54742681,77.0,5.7,7001",GSM5218292: HCI005 Decitabine 1 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Decitabine tumour	tissue=Breast cancer PDX model HCI005	treatment=Decitabine	replicate=1	chip antibody=ER (Millipore SC-543X)
SRX10468630,hg38,TFs and others,ESR1,Lung,HCI005,,"50161243,74.7,5.7,5543",GSM5218293: HCI005 Decitabine 2 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Decitabine tumour	tissue=Breast cancer PDX model HCI005	treatment=Decitabine	replicate=2	chip antibody=ER (Millipore SC-543X)
SRX10468631,hg38,TFs and others,ESR1,Lung,HCI005,,"44230297,73.1,5.9,5608",GSM5218294: HCI005 Decitabine 3 ER; Homo sapiens; ChIP-Seq,source_name=HCI005 Decitabine tumour	tissue=Breast cancer PDX model HCI005	treatment=Decitabine	replicate=3	chip antibody=ER (Millipore SC-543X)
SRX10474943,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","114730297,62.0,7.9,49483",GSM5213841: ATAC-seq from fallopian tube (ENCLB400DMG); Homo sapiens; ATAC-seq,"sample type=tissue	tissue=fallopian tube	sex=female	health state=DM: yes; HTN: yes; CAD: no	dev stage=adult	age=59 year	donor ID=ENCDO856ZOJ	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX10474944,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","111609801,62.8,7.0,49570",GSM5213842: ATAC-seq from fallopian tube (ENCLB022QIU); Homo sapiens; ATAC-seq,"sample type=tissue	tissue=fallopian tube	sex=female	health state=DM: yes; HTN: yes; CAD: no	dev stage=adult	age=59 year	donor ID=ENCDO856ZOJ	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX10475225,hg38,TFs and others,JUN,Liver,Hep G2,Primary Tissue=Liver|Tissue Diagnosis=Carcinoma Hepatocellular,"38298778,86.3,16.7,7893",GSM5214090: TF ChIP-seq from HepG2 (ENCLB319AAY); Homo sapiens; ChIP-Seq,"sample type=cell line	cell line=HepG2	sex=male	health state=hepatocellular carcinoma	dev stage=child	age=15 year	donor ID=ENCDO000AAC	lab=Richard Myers, HAIB	source=Richard Myers"
SRX10475226,hg38,TFs and others,JUN,Liver,Hep G2,Primary Tissue=Liver|Tissue Diagnosis=Carcinoma Hepatocellular,"37641355,86.8,19.1,5079",GSM5214091: TF ChIP-seq from HepG2 (ENCLB532JYQ); Homo sapiens; ChIP-Seq,"sample type=cell line	cell line=HepG2	sex=male	health state=hepatocellular carcinoma	dev stage=child	age=15 year	donor ID=ENCDO000AAC	lab=Richard Myers, HAIB	source=Richard Myers"
SRX10475422,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","150527505,84.2,15.6,38602",GSM5214248: ATAC-seq from uterus (ENCLB065SZZ); Homo sapiens; ATAC-seq,"sample type=tissue	tissue=uterus	sex=female	health state=DM: yes; HTN: yes; CAD: no	dev stage=adult	age=59 year	donor ID=ENCDO856ZOJ	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX10475423,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","136916655,82.1,13.9,34038",GSM5214249: ATAC-seq from uterus (ENCLB557IHG); Homo sapiens; ATAC-seq,"sample type=tissue	tissue=uterus	sex=female	health state=DM: yes; HTN: yes; CAD: no	dev stage=adult	age=59 year	donor ID=ENCDO856ZOJ	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX10475557,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43856055,98.7,32.0,13501",GSM5214383: TF ChIP-seq from MCF-7 (ENCLB396ZHI); Homo sapiens; ChIP-Seq,"sample type=cell line	cell line=MCF-7	sex=female	health state=breast cancer (adenocarcinoma)	dev stage=adult	age=69 year	donor ID=ENCDO000AAE	lab=Michael Snyder, Stanford	source=Michael Snyder"
SRX10475558,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31271263,98.7,28.7,12853",GSM5214384: TF ChIP-seq from MCF-7 (ENCLB608XPU); Homo sapiens; ChIP-Seq,"sample type=cell line	cell line=MCF-7	sex=female	health state=breast cancer (adenocarcinoma)	dev stage=adult	age=69 year	donor ID=ENCDO000AAE	lab=Michael Snyder, Stanford	source=Michael Snyder"
SRX1048945,hg38,TFs and others,PGR,Uterus,Endometrial stromal cells,,"33367151,91.7,64.9,4777",GSM1703567: PGR ChIPseq; Homo sapiens; ChIP-Seq,"source_name=endometrial stromal cells	cell type=primary cells	passages=2-4	health status=healthy, proliferative phase	antibody=PGR	antibody catalog=H-190/sc-7208"
SRX10659286,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"42261985,94.9,61.8,59614",GSM5260045: Control si; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=Control siRNA
SRX10659287,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"44277474,93.5,59.6,77816",GSM5260046: H2A.Z.1 si; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=H2A.Z.1 siRNA
SRX10659288,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"34106306,95.8,60.3,64414",GSM5260047: H2A.Z.2 si; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=H2A.Z.2 siRNA
SRX10665049,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"131816021,0.0,21.8,116547",HeLa ATAC-seq Paired End,"isolate=HeLa	age=N/A	biomaterial_provider=Victorial Belancio, Ph.D.	sex=female	tissue=Cervical	cell_line=HeLa	sample_type=ATAC, Paired-End 1"
SRX107363,hg38,TFs and others,ESR1,Breast,H3396,,"26091833,87.8,25.7,6910",GSM811208: ERa e2 100k LinDA rep1,source_name=ERa e2 100k LinDA	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=100k LinDA	treatment=E2
SRX107364,hg38,TFs and others,ESR1,Breast,H3396,,"26557726,83.5,24.6,4338",GSM811209: ERa e2 100k LinDA rep2,source_name=ERa e2 100k LinDA	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=100k LinDA	treatment=E2
SRX107365,hg38,TFs and others,ESR1,Breast,H3396,,"26172339,85.2,26.5,2502",GSM811210: ERa e2 10k LinDA rep1,source_name=ERa e2 10k LinDA	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=10k LinDA	treatment=E2
SRX107366,hg38,TFs and others,ESR1,Breast,H3396,,"31374642,74.2,26.8,4256",GSM811211: ERa e2 10k LinDA rep2,source_name=ERa e2 10k LinDA	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=10k LinDA	treatment=E2
SRX107367,hg38,TFs and others,ESR1,Breast,H3396,,"23108536,79.1,24.9,2026",GSM811212: ERa e2 5k LinDA rep1,source_name=ERa e2 5k LinDA	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=5k LinDA	treatment=E2
SRX107368,hg38,TFs and others,ESR1,Breast,H3396,,"36568662,70.7,26.6,7492",GSM811213: ERa e2 5k LinDA rep2,source_name=ERa e2 5k LinDA	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=5k LinDA	treatment=E2
SRX107369,hg38,TFs and others,ESR1,Breast,H3396,,"31649051,93.3,44.1,13719",GSM811214: ERa e2 2M rep1,source_name=ERa e2 2M	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=2M	treatment=E2
SRX107370,hg38,TFs and others,ESR1,Breast,H3396,,"39301169,98.7,21.4,6940",GSM811215: ERa e2 2M rep2,source_name=ERa e2 2M	cell type=breast cancer cells	cell line=H3396	comment=chromatin IP against ER-alpha (Santa Cruz Biotech: HC20 )	chip antibody=ER-alpha	chip antibody manufacturer=Santa Cruz	amplification=2M	treatment=E2
SRX10760660,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"36672116,95.9,11.0,41475",GSM5278097: ChIPseq H3K27ac HeLa 6hours DMSO Control; Homo sapiens; ChIP-Seq,"source_name=Cervical adenocarcinoma	cell line=HeLa	timepoint=6 hours	ectopic expression=NA	chip antibody=H3K27ac (Abcam, ab4729)"
SRX10760661,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"29464074,92.7,11.7,28220",GSM5278098: ChIPseq H3K27ac HeLa 2hours A485; Homo sapiens; ChIP-Seq,"source_name=Cervical adenocarcinoma	cell line=HeLa	timepoint=2 hours	ectopic expression=NA	chip antibody=H3K27ac (Abcam, ab4729)"
SRX10760662,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"37585029,92.8,7.4,29922",GSM5278099: ChIPseq H3K27ac HeLa 6hours A485; Homo sapiens; ChIP-Seq,"source_name=Cervical adenocarcinoma	cell line=HeLa	timepoint=6 hours	ectopic expression=NA	chip antibody=H3K27ac (Abcam, ab4729)"
SRX10775015,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"35067511,95.0,29.2,1190",GSM5281999: rep2 DMSO HD ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775018,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"38951727,97.3,24.7,1312",GSM5282002: rep2 Trip HD ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775021,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44261656,96.5,24.8,3836",GSM5282005: rep2 DMSO E2 ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775024,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"40091185,95.2,31.6,5570",GSM5282008: rep2 Trip E2 ER; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775026,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"37069281,65.8,31.3,3923",GSM5282010: rep1 rChIP ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775028,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"40293334,97.3,26.8,4023",GSM5282012: rep2 rChIP ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775042,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27006790,82.2,34.2,955",GSM5281983: rep1 DMSO HD ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775046,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31592678,67.7,23.6,948",GSM5281987: rep1 Trip HD ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775050,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30000296,82.7,35.2,4100",GSM5281991: rep1 DMSO E2 ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10775054,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34104126,84.5,19.6,2944",GSM5281995: rep1 Trip E2 ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=none	chip antibody=Abcam 3575
SRX10852989,hg38,TFs and others,MED12,Blood,T cells,,"93458400,94.6,52.1,44473",GSM5290941: MED12 DN59 AAVS1 unstim; Homo sapiens; ChIP-Seq,source_name=primary T cells	treatment=unstimulated	genotype=AAVS1-null	chip antibody=MED12 Bethyl laboratories - A300-774A
SRX10852990,hg38,TFs and others,MED12,Blood,T cells,,"104864899,92.4,58.5,44180",GSM5290942: MED12 DN63 AAVS1 unstim; Homo sapiens; ChIP-Seq,source_name=primary T cells	treatment=unstimulated	genotype=AAVS1-null	chip antibody=MED12 Bethyl laboratories - A300-774A
SRX10852991,hg38,TFs and others,MED12,Blood,T cells,,"107637831,94.7,44.1,49004",GSM5290943: MED12 DN67 AAVS1 unstim; Homo sapiens; ChIP-Seq,source_name=primary T cells	treatment=unstimulated	genotype=AAVS1-null	chip antibody=MED12 Bethyl laboratories - A300-774A
SRX10852992,hg38,TFs and others,MED12,Blood,T cells,,"101992602,96.5,49.2,48076",GSM5290944: MED12 DN59 AAVS1 stim; Homo sapiens; ChIP-Seq,source_name=primary T cells	treatment=stimulated	genotype=AAVS1-null	chip antibody=MED12 Bethyl laboratories - A300-774A
SRX10852993,hg38,TFs and others,MED12,Blood,T cells,,"125749452,93.8,38.1,53235",GSM5290945: MED12 DN63 AAVS1 stim; Homo sapiens; ChIP-Seq,source_name=primary T cells	treatment=stimulated	genotype=AAVS1-null	chip antibody=MED12 Bethyl laboratories - A300-774A
SRX10852994,hg38,TFs and others,MED12,Blood,T cells,,"81298869,94.5,56.0,33451",GSM5290946: MED12 DN67 AAVS1 stim; Homo sapiens; ChIP-Seq,source_name=primary T cells	treatment=stimulated	genotype=AAVS1-null	chip antibody=MED12 Bethyl laboratories - A300-774A
SRX10921861,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"7853165,71.4,42.5,9158",GSM5321299: HeLa ATAC-seq; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell type=HeLa
SRX10971491,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55473699,95.9,4.8,10391",GSM5333141: MCF7-P E2 ER rep2; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10971493,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"64955019,95.5,4.2,2929",GSM5333133: FOXA1-Dox ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10971494,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51016545,95.6,4.4,3472",GSM5333134: FOXA1-Dox ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10971495,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"59320041,95.7,4.1,1373",GSM5333135: FOXA1+Dox ER ChIPSeq rep1; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10971496,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34316124,95.6,3.4,864",GSM5333136: FOXA1+Dox ER ChIPSeq rep2; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10971499,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"56027093,96.2,4.5,1191",GSM5333139: MCF7-P EtOH ER; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10971500,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"54977427,96.3,4.4,9336",GSM5333140: MCF7-P E2 ER rep1; Homo sapiens; ChIP-Seq,"source_name=breast cancer MCF7 cells	sample type=Parental	chip antibody=ER (Santa Cruz Biotechnology, sc-543X)"
SRX10976151,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"23861192,98.7,8.6,25567",GSM5330449: TF ChIP-seq from A549 (ENCLB900XJY); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 10; duration_units: minute;"
SRX10976152,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"28468781,98.9,13.7,28609",GSM5330447: TF ChIP-seq from A549 (ENCLB570USV); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 10; duration_units: minute;"
SRX10976153,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"29562329,98.4,9.0,31591",GSM5330448: TF ChIP-seq from A549 (ENCLB754RHL); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 10; duration_units: minute;"
SRX10976237,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"30039931,98.9,8.8,38627",GSM5330563: TF ChIP-seq from A549 (ENCLB375PQU); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 25; duration_units: minute;"
SRX10976238,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"24243709,98.8,8.2,16820",GSM5330564: TF ChIP-seq from A549 (ENCLB524BZC); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 25; duration_units: minute;"
SRX10976239,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"18680920,98.0,7.5,15611",GSM5330565: TF ChIP-seq from A549 (ENCLB807NVC); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 25; duration_units: minute;"
SRX10976447,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20749182,98.9,6.8,19797",GSM5330660: TF ChIP-seq from A549 (ENCLB269MUF); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 5; duration_units: minute;"
SRX10976448,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"28196004,98.3,8.7,28712",GSM5330661: TF ChIP-seq from A549 (ENCLB734LBR); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 5; duration_units: minute;"
SRX10976449,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"29172420,98.4,10.7,28848",GSM5330662: TF ChIP-seq from A549 (ENCLB427AJF); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 5; duration_units: minute;"
SRX10976451,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22506059,99.0,8.6,18868",GSM5330664: TF ChIP-seq from A549 (ENCLB615BJI); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 20; duration_units: minute;"
SRX10976452,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"37887203,98.9,13.5,37388",GSM5330665: TF ChIP-seq from A549 (ENCLB845LHJ); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 20; duration_units: minute;"
SRX10976453,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"38731391,98.6,9.6,25909",GSM5330666: TF ChIP-seq from A549 (ENCLB400HRQ); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 20; duration_units: minute;"
SRX10976694,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"25418723,98.5,6.8,12045",GSM5330818: TF ChIP-seq from A549 (ENCLB344UGC); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549"
SRX10976695,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"31862683,98.6,8.0,20784",GSM5330819: TF ChIP-seq from A549 (ENCLB710HQW); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549"
SRX10976696,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"26735486,98.8,8.0,10820",GSM5330820: TF ChIP-seq from A549 (ENCLB673JUM); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549"
SRX10976727,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22092754,98.3,6.9,17467",GSM5330826: TF ChIP-seq from A549 (ENCLB723RJN); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 15; duration_units: minute;"
SRX10976728,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"33230149,98.8,9.4,25923",GSM5330827: TF ChIP-seq from A549 (ENCLB632KBK); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 15; duration_units: minute;"
SRX10976729,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"26601750,98.9,7.8,15995",GSM5330828: TF ChIP-seq from A549 (ENCLB355YNF); Homo sapiens; ChIP-Seq,"sample_type=cell line	sex=male	dev stage=adult	age=58 year	donor ID=ENCDO000AAZ	lab=Tim Reddy, Duke	source=ATCC	cell line=A549	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 15; duration_units: minute;"
SRX10977212,hg38,Histone,H3K27ac,Uterus,Vagina,"MeSH Description=The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)","17055124,90.4,2.2,13351",GSM5331051: Histone ChIP-seq from vagina (ENCLB358LCR); Homo sapiens; ChIP-Seq,"sample_type=tissue	tissue=vagina	sex=female	dev_stage=adult	age=51 year	donor ID=ENCDO271OUW	lab=Bradley Bernstein, Broad	source=Kristin Ardlie"
SRX10977213,hg38,Histone,H3K27ac,Uterus,Vagina,"MeSH Description=The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)","17933842,98.8,3.8,13253",GSM5331052: Histone ChIP-seq from vagina (ENCLB286GKL); Homo sapiens; ChIP-Seq,"sample_type=tissue	tissue=vagina	sex=female	dev_stage=adult	age=51 year	donor ID=ENCDO271OUW	lab=Bradley Bernstein, Broad	source=Kristin Ardlie"
SRX11051031,hg38,TFs and others,JUN,Neural,hTERT RPE-1,Primary Tissue=Eye|Tissue Diagnosis=Normal,"33697287,98.5,21.8,98941",GSM5353421: SCR cJUN; Homo sapiens; ChIP-Seq,"source_name=retina epithelial cells RPE1	cell line=RPE1	genotype=pINDUCER11-shControl	chip antibody=anti-c-JUN (Cell Signaling Technology, 9165)	treatment=48 hours doxycycline"
SRX11051032,hg38,TFs and others,JUN,Neural,hTERT RPE-1,Primary Tissue=Eye|Tissue Diagnosis=Normal,"26542564,98.2,15.5,95359",GSM5353422: D5 cJUN; Homo sapiens; ChIP-Seq,"source_name=retina epithelial cells RPE1	cell line=RPE1	genotype=pINDUCER11-shRB1	chip antibody=anti-c-JUN (Cell Signaling Technology, 9165)	treatment=48 hours doxycycline"
SRX11051045,hg38,TFs and others,JUN,Neural,hTERT RPE-1,Primary Tissue=Eye|Tissue Diagnosis=Normal,"32703909,98.2,23.1,92253",GSM5353435: RBwt CTRL JUN 9; Homo sapiens; ChIP-Seq,"source_name=retina epithelial cells RPE1	cell line=RPE1	genotype=sgControl (Nicolay et al. 2015)	chip antibody=anti-c-JUN (Cell Signaling Technology, 9165)"
SRX11051046,hg38,TFs and others,JUN,Neural,hTERT RPE-1,Primary Tissue=Eye|Tissue Diagnosis=Normal,"33934875,98.5,23.0,81650",GSM5353436: RBKO1 2 CTRL JUN 11; Homo sapiens; ChIP-Seq,"source_name=retina epithelial cells RPE1	cell line=RPE1	genotype=sgRB1 (Nicolay et al. 2015)	chip antibody=anti-c-JUN (Cell Signaling Technology, 9165)"
SRX11120902,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15002382,88.2,15.3,10937",GSM5373147: ChIPseq MCF7 ER Ctrl; Homo sapiens; ChIP-Seq,source_name=MCF7 cell line	cell type=MCF7 cell line	antibody=ER	treatment=Estrogen -
SRX11120903,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15450131,94.0,25.0,45119",GSM5373148: ChIPseq MCF7 ER E2; Homo sapiens; ChIP-Seq,source_name=MCF7 cell line	cell type=MCF7 cell line	antibody=ER	treatment=Estrogen +
SRX1116522,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13496092,95.5,6.3,715",GSM1831736: MCF7 ER ChIP-seq CTRL; Homo sapiens; ChIP-Seq,source_name=prostate tumor	cell line=MCF7	transgene=GFP	treatment=EtOH	antibody=ER
SRX1116523,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15126983,95.5,8.5,1527",GSM1831737: MCF7 ER ChIP-seq HOTAIR; Homo sapiens; ChIP-Seq,source_name=prostate tumor	cell line=MCF7	transgene=HOTAIR	treatment=EtOH	antibody=ER
SRX1116524,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13010384,96.3,11.6,10286",GSM1831738: MCF7 ER ChIP-seq E2 CTRL; Homo sapiens; ChIP-Seq,source_name=prostate tumor	cell line=MCF7	transgene=GFP	treatment=E2	antibody=ER
SRX1116525,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12432968,94.1,10.7,12733",GSM1831739: MCF7 ER ChIP-seq E2 HOTAIR; Homo sapiens; ChIP-Seq,source_name=prostate tumor	cell line=MCF7	transgene=HOTAIR	treatment=E2	antibody=ER
SRX11169859,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32233446,97.2,12.7,5556",GSM5388443: DMSO; Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	cell line=MCF7	cell type=breast cancer cell line	treatment=DMSO	chip antibody=ERa (Santa Cruz polyclonal sc-543)
SRX11169860,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33293026,96.9,18.2,11217",GSM5388444: H3B-6545 (1uM); Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	cell line=MCF7	cell type=breast cancer cell line	treatment=H3B-6545 (1uM)	chip antibody=ERa (Santa Cruz polyclonal sc-543)
SRX11169861,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32211019,96.9,20.0,9772",GSM5388445: H3B-9709 (1uM); Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	cell line=MCF7	cell type=breast cancer cell line	treatment=H3B-9709 (1uM)	chip antibody=ERa (Santa Cruz polyclonal sc-543)
SRX11169862,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30998392,90.4,34.8,6263",GSM5388446: Tamoxifen (1uM); Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	cell line=MCF7	cell type=breast cancer cell line	treatment=Tamoxifen (1uM)	chip antibody=ERa (Santa Cruz polyclonal sc-543)
SRX11169863,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31675330,94.9,34.6,11276",GSM5388447: Fulvestrant (100nM); Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	cell line=MCF7	cell type=breast cancer cell line	treatment=Fulvestrant (100nM)	chip antibody=ERa (Santa Cruz polyclonal sc-543)
SRX11169864,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30308917,96.1,30.7,10533",GSM5388448: E2 (10nM); Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	cell line=MCF7	cell type=breast cancer cell line	treatment=E2 (10nM)	chip antibody=ERa (Santa Cruz polyclonal sc-543)
SRX11374758,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"64982965,98.8,11.6,1145",GSM5425947: T47D T0 ChIP PR rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq PR T0 rep1	cell line=T47D
SRX11374759,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"57779743,98.8,9.8,1039","GSM5425948: T47D T30 R5020 0,1nM ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 0.1 nm R5020 rep1	cell line=T47D
SRX11374760,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"60829129,98.8,10.6,1114","GSM5425949: T47D T30 R5020 0,05nM ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 0.05 nm R5020 rep1	cell line=T47D
SRX11374761,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"66831233,98.8,10.3,1199","GSM5425950: T47D T30 R5020 0,1 nM ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 1 nm R5020 rep1	cell line=T47D
SRX11374762,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"64260412,98.8,10.6,1177","GSM5425951: T47D T30 R5020 0,5 nM ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 0.5 nm R5020 rep1	cell line=T47D
SRX11374763,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"217351136,98.8,21.3,4799","GSM5425952: T47D T30 0,05nM R5020 ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 0.05 nm R5020 rep2	cell line=T47D
SRX11374764,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"214454085,98.6,24.2,10704","GSM5425953: T47D T30 0,1nM R5020 ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 0.1 nm R5020 rep2	cell line=T47D
SRX11374765,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"222538919,98.8,20.7,34892","GSM5425954: T47D T30 0,5nM R5020 ChIP PR; Homo sapiens; ChIP-Seq",source_name=ChIP-seq PR T30 R5020 0.5 nm R5020 rep2	cell line=T47D
SRX11374766,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"135026404,98.0,15.2,42591",GSM5425955: T47D T30 1nM R5020 ChIP PR; Homo sapiens; ChIP-Seq,source_name=ChIP-seq PR T30 R5020 1 nm R5020 rep2	cell line=T47D
SRX11374767,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"101082598,98.8,12.3,39764",GSM5425956: T47D T30 10nM R5020 ChIP PR; Homo sapiens; ChIP-Seq,source_name=ChIP-seq PR T30 R5020 10 nm R5020 rep2	cell line=T47D
SRX11374768,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"129937548,98.3,11.5,2197",GSM5425957: T47D T0 ChIP PR rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq PR T0 rep2	cell line=T47D
SRX1142761,hg38,TFs and others,JUN,Breast,BT-549,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43986380,98.7,47.6,1952",GSM1848883: Jun no TNF; Homo sapiens; ChIP-Seq,"source_name=BT549_without TNFalpha_c-Jun antibody	cell line=BT549	cell type=Triple negative breast cancer cells	chip antibody=c-Jun (H-79, Santa Cruz)"
SRX1142763,hg38,TFs and others,JUN,Breast,BT-549,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"48368562,98.6,47.7,2686",GSM1848885: Jun TNF; Homo sapiens; ChIP-Seq,"source_name=BT549_TNFalpha_c-Jun antibody	cell line=BT549	cell type=Triple negative breast cancer cells	treated with=TNFα for 6 h	chip antibody=c-Jun (H-79, Santa Cruz)"
SRX11513948,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"18213242,55.1,53.2,9679",GSM5464619: ATAC-seq FUSNLAMPS-HS2-Dark rep1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX11513949,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"15884770,56.5,54.8,7917",GSM5464620: ATAC-seq FUSNLAMPS-HS2-Dark rep2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX11513950,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"19086956,24.8,53.6,2506",GSM5464621: ATAC-seq FUSNLAMPS-HS2-Light rep1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX11513951,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"15638212,27.4,50.1,1957",GSM5464622: ATAC-seq FUSNLAMPS-HS2-Light rep2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX11525507,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"92584508,98.0,24.2,47332","GSM5467904: SK-UT-1 cells, H3K27ac WT ChIP; Homo sapiens; ChIP-Seq","source_name=SK-UT-1	cell line=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	treatment=DMSO	chip antibody=H3K27ac (Abcam, ab4729)"
SRX11525508,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"83384685,97.0,11.3,42101","GSM5467905: SK-UT-1 cells, H3K27ac NKL54 ChIP; Homo sapiens; ChIP-Seq","source_name=SK-UT-1	cell line=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	treatment=NKL54	chip antibody=H3K27ac (Abcam, ab4729)"
SRX115966,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"76982518,79.2,13.0,1444",GSM862178: ERα ChIP-seq 1; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	cell lines=MCF-7	agent=DMSO	time=0 hr	chip antibody=ERα, Santa Cruz Biotechnology, sc-8005 X"
SRX115967,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"70292794,88.4,27.4,1372",GSM862179: ERα ChIP-seq 2; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	cell lines=MCF-7	agent=E2	time=1 hr	chip antibody=ERα, Santa Cruz Biotechnology, sc-8005 X"
SRX115968,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"58660856,91.3,63.9,1090",GSM862180: ERα ChIP-seq 3; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	cell lines=MCF-7	agent=E2	time=4 hr	chip antibody=ERα, Santa Cruz Biotechnology, sc-8005 X"
SRX115969,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"81003638,84.8,18.3,1567",GSM862181: ERα ChIP-seq 4; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	cell lines=MCF-7	agent=E2	time=24 hr	chip antibody=ERα, Santa Cruz Biotechnology, sc-8005 X"
SRX1161168,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51673676,96.6,11.1,7777",GSM1858620: untreated rep#1 ER ChIP-seq GH620; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell line=MCF-7	cell type=Pleural effusion from an adenocarcinoma of the breast	treatment=untreated	time=30 minutes	replicate=replicate 1	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in DMEM supplemented 10% calf serum, 2mM L-glutamine, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161169,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51217891,97.0,9.4,3399",GSM1858621: untreated rep#2 ER ChIP-seq GH628; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell line=MCF-7	cell type=Pleural effusion from an adenocarcinoma of the breast	treatment=untreated	time=30 minutes	replicate=replicate 2	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in DMEM supplemented 10% calf serum, 2mM L-glutamine, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161170,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28653143,97.2,5.1,9247",GSM1858622: E2 rep#1 ER ChIP-seq GH622; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell line=MCF-7	cell type=Pleural effusion from an adenocarcinoma of the breast	treatment=17β-estradiol	concentration=100nM	time=30 minutes	replicate=replicate 1	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in DMEM supplemented 10% calf serum, 2mM L-glutamine, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161171,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37621131,92.4,31.0,14470",GSM1858623: E2 rep#2 ER ChIP-seq GH630; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell line=MCF-7	cell type=Pleural effusion from an adenocarcinoma of the breast	treatment=17β-estradiol	concentration=100nM	time=30 minutes	replicate=replicate 2	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in DMEM supplemented 10% calf serum, 2mM L-glutamine, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161183,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"38992757,95.5,7.2,16223",GSM1858635: untreated rep#1 ER ChIP-seq GH999; Homo sapiens; ChIP-Seq,"source_name=ZR-75-1 breast cancer cell line	cell line=ZR-75-1	cell type=Ascites from a ductal carcinoma of the breast	treatment=untreated	time=30 minutes	replicate=replicate 1	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161184,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26230524,96.1,15.6,18025",GSM1858636: untreated rep#2 ER ChIP-seq GH1008; Homo sapiens; ChIP-Seq,"source_name=ZR-75-1 breast cancer cell line	cell line=ZR-75-1	cell type=Ascites from a ductal carcinoma of the breast	treatment=untreated	time=30 minutes	replicate=replicate 2	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161185,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31438631,96.8,8.6,31809",GSM1858637: E2 rep#1 ER ChIP-seq GH1001; Homo sapiens; ChIP-Seq,"source_name=ZR-75-1 breast cancer cell line	cell line=ZR-75-1	cell type=Ascites from a ductal carcinoma of the breast	treatment=17β-estradiol	concentration=100nM	time=30 minutes	replicate=replicate 1	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161186,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31366279,96.5,9.9,24276",GSM1858638: E2 rep#2 ER ChIP-seq GH1010; Homo sapiens; ChIP-Seq,"source_name=ZR-75-1 breast cancer cell line	cell line=ZR-75-1	cell type=Ascites from a ductal carcinoma of the breast	treatment=17β-estradiol	concentration=100nM	time=30 minutes	replicate=replicate 2	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161198,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29279772,95.6,15.6,9965",GSM1858650: untreated rep#1 ER ChIP-seq GH983; Homo sapiens; ChIP-Seq,"source_name=T-47D breast cancer cell line	cell line=T-47D	cell type=Pleural effusion from a ductal carcinoma of the breast	treatment=untreated	time=30 minutes	replicate=replicate 1	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161199,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"38105134,94.5,14.4,10898",GSM1858651: untreated rep#2 ER ChIP-seq GH991; Homo sapiens; ChIP-Seq,"source_name=T-47D breast cancer cell line	cell line=T-47D	cell type=Pleural effusion from a ductal carcinoma of the breast	treatment=untreated	time=30 minutes	replicate=replicate 2	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161200,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"45821647,96.4,17.0,16833",GSM1858652: E2 rep#1 ER ChIP-seq GH985; Homo sapiens; ChIP-Seq,"source_name=T-47D breast cancer cell line	cell line=T-47D	cell type=Pleural effusion from a ductal carcinoma of the breast	treatment=17β-estradiol	concentration=100nM	time=30 minutes	replicate=replicate 1	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX1161201,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"40925137,97.5,11.0,11751",GSM1858653: E2 rep#2 ER ChIP-seq GH993; Homo sapiens; ChIP-Seq,"source_name=T-47D breast cancer cell line	cell line=T-47D	cell type=Pleural effusion from a ductal carcinoma of the breast	treatment=17β-estradiol	concentration=100nM	time=30 minutes	replicate=replicate 2	antibody=ER cocktail: Ab-10 Thermo Scientific Lab Vision, HC-20 sc-543 Santa Cruz	growth proptocol=For maintenance cells were cultured in RPMI containing 2mM L-glutamine supplemented 10% calf serum, 1mM sodium pyruvate, 1X non-essential amino acids, and 1% penicillin-streptomycin"
SRX11647483,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23652950,86.3,12.3,674",GSM5502737: MCF7 WT noE2 ER; Homo sapiens; ChIP-Seq,source_name=MCF7 breast cancer cell lines	cell type=breast cancer cell line	passage=12-18	origin tissue=breast	genotype/variation=wild type	chip antibody=anti-ER-alpha	chip antibody vendor=Cell Signaling Technology	treatment=E2 starvation for 3 days
SRX11647484,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23627196,88.8,18.9,2627",GSM5502738: MCF7 WT E2 ER; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cell lines	cell type=breast cancer cell line	passage=12-18	origin tissue=breast	genotype/variation=wild type	chip antibody=anti-ER-alpha	chip antibody vendor=Cell Signaling Technology	treatment=E2 starvation for 3 days, then treat with 100 nM E2 for 2 hours"
SRX11647485,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17085169,75.1,30.2,416",GSM5502739: MCF7 L12KO noE2 ER; Homo sapiens; ChIP-Seq,source_name=MCF7 breast cancer cell lines	cell type=breast cancer cell line	passage=12-18	origin tissue=breast	genotype/variation=LATS1 and LATS2 double knock-out	chip antibody=anti-ER-alpha	chip antibody vendor=Cell Signaling Technology	treatment=E2 starvation for 3 days
SRX11647486,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29087011,81.3,16.8,752",GSM5502740: MCF7 L12KO E2 ER; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cell lines	cell type=breast cancer cell line	passage=12-18	origin tissue=breast	genotype/variation=LATS1 and LATS2 double knock-out	chip antibody=anti-ER-alpha	chip antibody vendor=Cell Signaling Technology	treatment=E2 starvation for 3 days, then treat with 100 nM E2 for 2 hours"
SRX12121312,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"64753949,97.9,0.3,6960",GSM5570628: P7 182007; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=38	day of cycle=7	live births=0	miscarriages=3
SRX12121313,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"140598699,97.8,0.6,15421",GSM5570629: P10 182006; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=39	day of cycle=10	live births=1	miscarriages=5
SRX12121314,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"58847134,98.1,0.3,7882",GSM5570630: S18 18205; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=33	day of cycle=18	live births=0	miscarriages=4
SRX12121315,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"182983428,97.0,0.3,5013",GSM5570631: S19a 18189 Run1; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=35	day of cycle=19	live births=0	miscarriages=4
SRX12121316,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"189839103,97.2,0.2,5764",GSM5570632: S19a 18189 Run2; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=35	day of cycle=19	live births=0	miscarriages=4
SRX12121317,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"61607641,97.6,0.2,5528",GSM5570633: S19 17204; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=36	day of cycle=19	live births=0	miscarriages=2
SRX12121318,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"127374005,97.8,0.5,14207",GSM5570634: S20 18212; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=32	day of cycle=20	live births=0	miscarriages=1
SRX12121319,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"89913269,96.4,0.1,4023",GSM5570635: S21 18272; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=34	day of cycle=21	live births=1	miscarriages=0
SRX12121320,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"40854022,98.0,0.3,5824",GSM5570636: S21a 18325; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=41	day of cycle=21	live births=0	miscarriages=2
SRX12121321,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"63972071,98.1,0.4,8309",GSM5570637: S22 18061; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=36	day of cycle=22	live births=0	miscarriages=4
SRX12121322,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"135522396,97.7,0.5,15580",GSM5570638: S23 18016; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=37	day of cycle=23	live births=0	miscarriages=1
SRX12121323,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"73763980,97.8,0.5,10204",GSM5570639: S24 17667; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=38	day of cycle=24	live births=0	miscarriages=2
SRX12121324,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial cells,,"56119872,97.9,0.4,7966",GSM5570640: S25 17406; Homo sapiens; ATAC-seq,source_name=Endometrial cells	tissue=Endometrial cells	age=41	day of cycle=25	live births=1	miscarriages=7
SRX1212811,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"53788340,96.8,2.4,946",GSM1873367: MED12; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=Breast Cancer MCF-7 cells	passages=15-20	chip antibody=MED12 (Bethyl, A300-774A)"
SRX12193399,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46423483,99.7,0.0,285",GSM5579295: ChIP ECM Bone input; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193400,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37129995,99.6,0.1,716",GSM5579296: ChIP ECM Bone PD; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193401,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46005871,99.8,0.0,38",GSM5579297: ChIP ECM Liver input; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193402,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25724507,99.6,0.1,390",GSM5579298: ChIP ECM Liver PD; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193403,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55016571,99.7,0.0,303",GSM5579299: ChIP ECM Lung input; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193404,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35541758,99.6,0.0,439",GSM5579300: ChIP ECM Lung PD; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193405,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46111780,99.7,0.0,303",GSM5579301: ChIP ECM No ECM input; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12193406,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31759712,99.4,0.1,615",GSM5579302: ChIP ECM No ECM PD; Homo sapiens; ChIP-Seq,source_name=MCF7-ESR1Y537S	biomaterial_provider=ATCC	Sex=female	treatment=ERα- specific F10 and HC20 antibodies	tissue=Human Breast cancer cell	strain=ATCC HTB-22 (RRID:CVCL_0031)
SRX12287234,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","300140474,90.3,41.9,16660",GSM5589411: ATAC-Seq uterus SM-A87A2; Homo sapiens; ATAC-seq,source_name=uterus	sample type=normal	biosample=flash-frozen tissue	donor sex=female	race=asian	case of death=cerebral vascular accident
SRX12287235,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","88309009,94.7,36.8,24500",GSM5589412: ATAC-Seq uterus SM-IOBHX; Homo sapiens; ATAC-seq,source_name=uterus	sample type=normal	biosample=flash-frozen tissue	donor sex=female	race=asian	case of death=cerebral vascular accident
SRX12287236,hg38,ATAC-Seq,ATAC-Seq,Uterus,Vagina,"MeSH Description=The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)","150954555,93.6,51.8,23891",GSM5589413: ATAC-Seq vagina SM-A9HOS; Homo sapiens; ATAC-seq,source_name=vagina	sample type=normal	biosample=flash-frozen tissue	donor sex=female	race=asian	case of death=cerebral vascular accident
SRX12622623,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"57855766,3.6,2.5,342",GSM5627352: Med1313lfl UNT CDK8 rep1; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, untreated control, Med13/13l fl/fl CDK8 ChIP-seq	cell line=Med13;Med13l flfl	strain=Rosa26::ERT2-Cre	treatment=untreated	treatment time=0h	additional treatment=none	additional treatment time=none	replicate=1	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622624,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"40244651,3.8,2.1,224",GSM5627353: Med1313lfl UNT CDK8 rep2; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, untreated control, Med13/13l fl/fl CDK8 ChIP-seq	cell line=Med13;Med13l flfl	strain=Rosa26::ERT2-Cre	treatment=untreated	treatment time=0h	additional treatment=none	additional treatment time=none	replicate=2	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622625,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"52682584,3.5,2.3,328",GSM5627354: Med1313lfl UNT CDK8 rep3; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, untreated control, Med13/13l fl/fl CDK8 ChIP-seq	cell line=Med13;Med13l flfl	strain=Rosa26::ERT2-Cre	treatment=untreated	treatment time=0h	additional treatment=none	additional treatment time=none	replicate=3	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622626,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"34936915,3.8,2.0,165",GSM5627355: Med1313lfl TAM CDK8 rep1; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, tamoxifen treated, Med13/13l fl/fl CDK8 ChIP-seq	cell line=Med13;Med13l flfl	strain=Rosa26::ERT2-Cre	treatment=tamoxifen	treatment time=96h	additional treatment=none	additional treatment time=none	replicate=1	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622627,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"41927884,3.5,2.2,185",GSM5627356: Med1313lfl TAM CDK8 rep2; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, tamoxifen treated, Med13/13l fl/fl CDK8 ChIP-seq	cell line=Med13;Med13l flfl	strain=Rosa26::ERT2-Cre	treatment=tamoxifen	treatment time=96h	additional treatment=none	additional treatment time=none	replicate=2	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622628,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"41346114,3.5,2.4,195",GSM5627357: Med1313lfl TAM CDK8 rep3; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, tamoxifen treated, Med13/13l fl/fl CDK8 ChIP-seq	cell line=Med13;Med13l flfl	strain=Rosa26::ERT2-Cre	treatment=tamoxifen	treatment time=96h	additional treatment=none	additional treatment time=none	replicate=3	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622686,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"40982326,5.9,2.8,269",GSM5627415: Pcgf4-/-Pcgf2fl CDK8 UNT rep1; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, untreated control, Pcgf4-/-Pcgf2 fl/fl, CDK8 ChIP-seq	cell line=Pcgf4-/-Pcgf2 flfl	strain=Rosa26::ERT2-Cre	treatment=untreated	treatment time=0h	additional treatment=none	additional treatment time=none	replicate=1	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622687,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"34647497,4.9,2.4,240",GSM5627416: Pcgf4-/-Pcgf2fl CDK8 UNT rep2; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, untreated control, Pcgf4-/-Pcgf2 fl/fl, CDK8 ChIP-seq	cell line=Pcgf4-/-Pcgf2 flfl	strain=Rosa26::ERT2-Cre	treatment=untreated	treatment time=0h	additional treatment=none	additional treatment time=none	replicate=2	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622688,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"35825337,5.9,2.7,138",GSM5627417: Pcgf4-/-Pcgf2fl CDK8 UNT rep3; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, untreated control, Pcgf4-/-Pcgf2 fl/fl, CDK8 ChIP-seq	cell line=Pcgf4-/-Pcgf2 flfl	strain=Rosa26::ERT2-Cre	treatment=untreated	treatment time=0h	additional treatment=none	additional treatment time=none	replicate=3	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622689,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"33887245,5.4,2.4,158",GSM5627418: Pcgf4-/-Pcgf2fl CDK8 TAM rep1; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, tamoxifen treated,Pcgf4-/-Pcgf2 fl/fl, CDK8 ChIP-seq	cell line=Pcgf4-/-Pcgf2 flfl	strain=Rosa26::ERT2-Cre	treatment=tamoxifen	treatment time=72h	additional treatment=none	additional treatment time=none	replicate=1	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622690,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"39362966,4.6,2.3,222",GSM5627419: Pcgf4-/-Pcgf2fl CDK8 TAM rep2; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, tamoxifen treated,Pcgf4-/-Pcgf2 fl/fl, CDK8 ChIP-seq	cell line=Pcgf4-/-Pcgf2 flfl	strain=Rosa26::ERT2-Cre	treatment=tamoxifen	treatment time=72h	additional treatment=none	additional treatment time=none	replicate=2	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12622691,hg38,TFs and others,CDK8,Unclassified,Unclassified,,"40395280,4.8,2.6,208",GSM5627420: Pcgf4-/-Pcgf2fl CDK8 TAM rep3; Homo sapiens; Mus musculus; ChIP-Seq,"source_name=Mouse embryonic stem cells with human HEK293T cells spike-in, tamoxifen treated,Pcgf4-/-Pcgf2 fl/fl, CDK8 ChIP-seq	cell line=Pcgf4-/-Pcgf2 flfl	strain=Rosa26::ERT2-Cre	treatment=tamoxifen	treatment time=72h	additional treatment=none	additional treatment time=none	replicate=3	spike-in reference organism=Homo sapiens	spike-in cell line=HEK293T	type of chip=cross-linked	ChIP=CDK8	antibody=rabbit polyclonal anti-CDK8 (A302-500A, Bethyl laboratories)"
SRX12684075,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"128763340,98.2,21.4,109411",GSM5638901: Control rep1; Homo sapiens; ATAC-seq,source_name=HeLa_control	cell line=HeLa	treatment=DMSO
SRX12684076,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"133713968,97.9,18.5,105221",GSM5638902: Control rep2; Homo sapiens; ATAC-seq,source_name=HeLa_control	cell line=HeLa	treatment=DMSO
SRX12684077,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"98289174,97.5,26.4,95709",GSM5638903: VH298 rep1; Homo sapiens; ATAC-seq,source_name=HeLa_VH298	cell line=HeLa	treatment=100 µM VH298 for 24 hs
SRX12684078,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"122243983,97.8,24.1,106622",GSM5638904: VH298 rep2; Homo sapiens; ATAC-seq,source_name=HeLa_VH298	cell line=HeLa	treatment=100 µM VH298 for 24 hs
SRX12727825,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"143294675,98.0,29.8,105645",GSM5645874: 0h Hpx Control rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 0 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727826,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"120564452,98.6,26.0,99873",GSM5645875: 0h Hpx Control rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 0 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727827,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"93464836,98.2,23.5,91513",GSM5645876: 0h Hpx siHIF1β rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=HIF1B siRNA, 0 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727828,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"86718694,98.4,23.0,92089",GSM5645877: 0h Hpx siHIF1β rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=HIF1B siRNA, 0 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727829,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"108441181,97.3,25.4,96070",GSM5645878: 1h Hpx Control rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 1 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727830,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"111951847,95.8,25.8,93857",GSM5645879: 1h Hpx Control rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 1 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727831,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"116200146,97.7,24.9,104591",GSM5645880: 1h Hpx siHIF1β rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=HIF1B siRNA, 1 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727832,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"102133279,98.3,23.2,98877",GSM5645881: 1h Hpx siHIF1β rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=HIF1B siRNA, 1 h 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727833,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"98143927,97.7,22.7,98035",GSM5645882: 24h Hpx Control rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 24 hs 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727834,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"86768252,97.7,21.1,94269",GSM5645883: 24h Hpx Control rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 24 hs 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727835,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"74835472,97.1,18.8,88406",GSM5645884: 24h Hpx siHIF1β rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=HIF1B siRNA, 24 hs 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727836,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"80886943,96.6,20.6,90052",GSM5645885: 24h Hpx siHIF1β rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=HIF1B siRNA, 24 hs 1% oxygen (hypoxia)	cell line=HeLa"
SRX12727837,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"94908516,97.5,24.7,93996",GSM5645886: Reox Control rep1; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 24 hs 1% oxygen then 1 h 21% oxygen (reoxygenation)	cell line=HeLa"
SRX12727838,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"103133862,97.2,26.2,97172",GSM5645887: Reox Control rep2; Homo sapiens; ATAC-seq,"source_name=HeLa	treatment=Control siRNA, 24 hs 1% oxygen then 1 h 21% oxygen (reoxygenation)	cell line=HeLa"
SRX1272813,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"4352509,99.0,44.3,29",GSM1890761: MCF7 ERa E2 ChIP; Homo sapiens; ChIP-Seq,"source_name=MCF breast cancer cells	cell line=MCF7	cell type=ERalpha-positive breast cancer cells	chip antibody=ERalpha (H-20, Santa Cruz)"
SRX1287844,hg38,TFs and others,CDK8,Blood,MOLM-14,,"61706490,92.2,11.2,71152",GSM1893926: MOLM-14 CDK8 DMSO1 1; Homo sapiens; ChIP-Seq,source_name=MOLM14	cell type=MLL-AF9-rearranged AML	treatment protocol=DMSO	chip epitope=CDK8	ca sensitivity=sensitive
SRX1287846,hg38,TFs and others,CDK8,Blood,MOLM-14,,"66917874,92.6,10.7,70465",GSM1893928: MOLM-14 CDK8 DMSO2 2; Homo sapiens; ChIP-Seq,source_name=MOLM14	cell type=MLL-AF9-rearranged AML	treatment protocol=DMSO	chip epitope=CDK8	ca sensitivity=sensitive
SRX1287848,hg38,TFs and others,CDK8,Blood,MOLM-14,,"58843482,92.2,8.1,44148",GSM1893930: MOLM-14 CDK8 iBET1 3; Homo sapiens; ChIP-Seq,source_name=MOLM14	cell type=MLL-AF9-rearranged AML	treatment protocol=iBET151_500	chip epitope=CDK8	ca sensitivity=sensitive
SRX1287850,hg38,TFs and others,CDK8,Blood,MOLM-14,,"68770126,92.9,6.5,31285",GSM1893932: MOLM-14 CDK8 iBET2 4; Homo sapiens; ChIP-Seq,source_name=MOLM14	cell type=MLL-AF9-rearranged AML	treatment protocol=iBET151_500	chip epitope=CDK8	ca sensitivity=sensitive
SRX13052788,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"210451704,86.3,41.1,122722",GSM5680697: Uterine Epithelial Cells ATAC-seq; Homo sapiens; ATAC-seq,source_name=Endometrial Epithelial Cells	treatment=untreated
SRX1336216,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"47674108,98.5,23.5,8061",GSM1908537: ERα ChIPseq E2 T47D; Homo sapiens; ChIP-Seq,"source_name=T47D breast cancer cell line	cell line=T47D	cell type=ERalpha-positive breast cancer cells	chip antibody=ERalpha (H-20, Santa Cruz)"
SRX13427190,hg38,TFs and others,ESR1,Breast,MDA-MB-453,"Primary Tissue=Breast|Site of Extraction=Effusion, Pericardial|Tissue Diagnosis=Carcinoma","11068554,99.2,3.9,64279",GSM5738188: WT-Dox [ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-453	cell line=MDA-MB-453	treatment=treated with doxycycline for 2 days	chip antibody=Anti-ERa (D8H8), CST Japan, #8644"
SRX13427191,hg38,TFs and others,ESR1,Breast,MDA-MB-453,"Primary Tissue=Breast|Site of Extraction=Effusion, Pericardial|Tissue Diagnosis=Carcinoma","11272918,99.2,4.2,64188",GSM5738189: WT-DoxE2 [ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-453	cell line=MDA-MB-453	treatment=treated with doxycycline/E2 for 2 days	chip antibody=Anti-ERa (D8H8), CST Japan, #8644"
SRX13427192,hg38,TFs and others,ESR1,Breast,MDA-MB-453,"Primary Tissue=Breast|Site of Extraction=Effusion, Pericardial|Tissue Diagnosis=Carcinoma","9474527,99.2,4.2,61174",GSM5738190: Y537S-Dox [ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-453	cell line=MDA-MB-453	treatment=treated with doxycycline for 2 days	chip antibody=Anti-ERa (D8H8), CST Japan, #8644"
SRX13427193,hg38,TFs and others,ESR1,Breast,MDA-MB-453,"Primary Tissue=Breast|Site of Extraction=Effusion, Pericardial|Tissue Diagnosis=Carcinoma","10942650,99.2,4.2,65728",GSM5738191: Y537S-DoxE2 [ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-453	cell line=MDA-MB-453	treatment=treated with doxycycline/E2 for 2 days	chip antibody=Anti-ERa (D8H8), CST Japan, #8644"
SRX13427194,hg38,TFs and others,ESR1,Breast,MDA-MB-453,"Primary Tissue=Breast|Site of Extraction=Effusion, Pericardial|Tissue Diagnosis=Carcinoma","10652437,99.1,4.8,47446",GSM5738192: K303R-Dox [ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-453	cell line=MDA-MB-453	treatment=treated with doxycycline for 2 days	chip antibody=Anti-ERa (D8H8), CST Japan, #8644"
SRX13427195,hg38,TFs and others,ESR1,Breast,MDA-MB-453,"Primary Tissue=Breast|Site of Extraction=Effusion, Pericardial|Tissue Diagnosis=Carcinoma","10447520,99.2,3.8,54449",GSM5738193: K303R-DoxE2 [ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-453	cell line=MDA-MB-453	treatment=treated with doxycycline/E2 for 2 days	chip antibody=Anti-ERa (D8H8), CST Japan, #8644"
SRX13466111,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"64781521,98.0,19.8,40059",GSM5745494: H3K27ac WT ChIP rep2; Homo sapiens; ChIP-Seq,"source_name=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	strain=na	chip antibody=H3K27ac (Abcam, ab4729)"
SRX13466112,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"91927218,98.4,12.7,43260",GSM5745495: H3K27ac NKL54 ChIP rep2; Homo sapiens; ChIP-Seq,"source_name=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	strain=na	chip antibody=H3K27ac (Abcam, ab4729)"
SRX13639258,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"72435417,94.6,5.3,27799",GSM5775744: H3K27ac CMV; Homo sapiens; ChIP-Seq,source_name=Endometrial cancer cell lines	cell type=Endometrial cancer cell lines	cell line=Ishikawa cells	chip antibody=H3K27ac	treatment=empty vector
SRX13639259,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"64316586,88.5,9.7,12799",GSM5775745: H3K27ac FOXA2; Homo sapiens; ChIP-Seq,source_name=Endometrial cancer cell lines	cell type=Endometrial cancer cell lines	cell line=Ishikawa cells	chip antibody=H3K27ac	treatment=transfected with FOXA2
SRX13899352,hg38,TFs and others,FOS,Blood,MM.1S,Primary Tissue=Blood|Tissue Diagnosis=Multiple Myeloma,"41602992,93.5,46.2,12248",GSM5834860: MM.1S c-Fos ChIP; Homo sapiens; ChIP-Seq,source_name=Multiple Myeloma	cell type=Multiple Myeloma_MM.1S	tissue=Hematopoietic cells	chip antibody=c-Fos (CST#2250)
SRX13965903,hg38,Histone,H3K27ac,Uterus,C-33 A,Primary Tissue=Cervix|Tissue Diagnosis=Carcinoma,"39218541,96.9,18.1,17216",GSM5842002: C33A ChIP H3K27Ac; Homo sapiens; ChIP-Seq,source_name=C33A cell	cell line=C33A	chip antibody=H3K27Ac
SRX13965906,hg38,Histone,H3K27ac,Uterus,Ca Ski,Primary Tissue=Cervix|Tissue Diagnosis=Carcinoma,"32656598,98.3,14.1,13761",GSM5842005: CaSki ChIP H3K27Ac; Homo sapiens; ChIP-Seq,source_name=CaSki cell	cell line=CaSki	chip antibody=H3K27Ac
SRX13965909,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"32669275,97.4,15.9,28230",GSM5842008: HeLa ChIP H3K27Ac; Homo sapiens; ChIP-Seq,source_name=HeLa cell	cell line=HeLa	chip antibody=H3K27Ac
SRX13965915,hg38,Histone,H3K27ac,Uterus,SiHa,Primary Tissue=Cervix|Tissue Diagnosis=Carcinoma Squamous Cell,"40718880,97.3,12.4,30508",GSM5842014: SiHa ChIP H3K27Ac; Homo sapiens; ChIP-Seq,source_name=SiHa cell	cell line=SiHa	chip antibody=H3K27Ac
SRX13980391,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"62709815,67.3,61.6,20709",GSM5848498: HeLaS3-I 1; Homo sapiens; ATAC-seq,source_name=HeLaS3 cells	protocol=ATAC	cell type=HeLaS3 cells	cell cycle=interphase
SRX13980392,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"45389617,60.2,59.3,9767",GSM5848499: HeLaS3-I 2; Homo sapiens; ATAC-seq,source_name=HeLaS3 cells	protocol=ATAC	cell type=HeLaS3 cells	cell cycle=interphase
SRX13980393,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"67419763,66.8,63.0,7193",GSM5848500: HeLaS3-M 1; Homo sapiens; ATAC-seq,source_name=HeLaS3 cells	protocol=ATAC	cell type=HeLaS3 cells	cell cycle=mitosis
SRX13980394,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"50606242,67.2,55.0,7721",GSM5848501: HeLaS3-M 2; Homo sapiens; ATAC-seq,source_name=HeLaS3 cells	protocol=ATAC	cell type=HeLaS3 cells	cell cycle=mitosis
SRX14096294,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"25556054,76.2,21.6,315",GSM5876167: con JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=empty vector overexpression	chip antibody=JUN
SRX14096295,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"20943245,68.7,17.5,299",GSM5876168: con p-JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=empty vector overexpression	chip antibody=p-JUN
SRX14096298,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"22104603,78.1,16.4,247",GSM5876171: JUN WT JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=JUN WT overexpression	chip antibody=JUN
SRX14096299,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"21490278,71.6,19.4,261",GSM5876172: JUN WT p-JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=JUN WT overexpression	chip antibody=p-JUN
SRX14096302,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"23081156,80.5,18.7,244",GSM5876175: JUN AA JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=JUN AA overexpression	chip antibody=JUN
SRX14096303,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"22793567,67.8,20.2,383",GSM5876176: JUN AA p-JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=JUN AA overexpression	chip antibody=p-JUN
SRX14096306,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"21315055,72.1,17.6,221",GSM5876179: iCAFs JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=induced CAFs (iCAFs)	chip antibody=JUN
SRX14096307,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"21715347,69.9,22.4,475",GSM5876180: iCAFs p-JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=induced CAFs (iCAFs)	chip antibody=p-JUN
SRX14096310,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"22503971,77.7,27.1,416",GSM5876183: iCAFs+JNKi JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=JNKi-treated iCAFs	chip antibody=JUN
SRX14096311,hg38,TFs and others,JUN,Lung,MRC-5,Primary Tissue=Lung|Tissue Diagnosis=Normal,"15953022,74.2,18.4,373",GSM5876184: iCAFs+JNKi p-JUN; Homo sapiens; ChIP-Seq,source_name=fibroblasts	cell line=MRC5	treatment=JNKi-treated iCAFs	chip antibody=p-JUN
SRX14255714,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15650648,100.0,0.0,8808",GSM5911404: MCF-7 ER Control; Homo sapiens; ChIP-Seq,source_name=MCF-7 cells	cell line=MCF-7 cells	treatment=DMSO	antibody=ER
SRX14255715,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15230872,100.0,0.0,1552",GSM5911405: MCF-7 ER Treatment; Homo sapiens; ChIP-Seq,source_name=MCF-7 cells	cell line=MCF-7 cells	treatment=XMU-MP-1	antibody=ER
SRX14367141,hg38,Histone,H3K27ac,Uterus,Endometriosis,"MeSH Description=An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.","137802356,96.6,12.6,26670",GSM5934078: Endometriosis 375; Homo sapiens; ChIP-Seq,source_name=Endometriosis	tissue=Endometriosis	treatment=untreated	chip antibody=H3K27ac
SRX14367142,hg38,Histone,H3K27ac,Uterus,Endometriosis,"MeSH Description=An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.","87695035,96.8,16.6,14732",GSM5934079: Endometriosis 589; Homo sapiens; ChIP-Seq,source_name=Endometriosis	tissue=Endometriosis	treatment=untreated	chip antibody=H3K27ac
SRX14367145,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","44600648,85.8,7.4,58205",GSM5934082: Fallopian Tube 19123 - side B - cultured; Homo sapiens; ATAC-seq,source_name=Fallopian Tube	tissue=Fallopian Tube	treatment=cultured cells
SRX14367146,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","42657144,92.5,19.5,96377",GSM5934083: Fallopian Tube 19123 - side B; Homo sapiens; ATAC-seq,source_name=Fallopian Tube	tissue=Fallopian Tube	treatment=untreated
SRX14367147,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","41569783,91.3,25.7,79968",GSM5934084: Fallopian Tube 19123 - side A; Homo sapiens; ATAC-seq,source_name=Fallopian Tube	tissue=Fallopian Tube	treatment=untreated
SRX14367148,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","34905448,94.3,17.7,40097",GSM5934085: Fallopian Tube 19155; Homo sapiens; ATAC-seq,source_name=Fallopian Tube	tissue=Fallopian Tube	treatment=untreated
SRX14367153,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","37293274,97.5,22.5,51306",GSM5934086: Fallopian Tube 64090; Homo sapiens; ATAC-seq,source_name=Fallopian Tube	tissue=Fallopian Tube	treatment=untreated
SRX14612962,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44968144,92.1,23.0,1182",GSM5972285: T47D LTED21M DMSO cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 21 months treated with DMSO 48h	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14612963,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"39092399,88.9,25.2,1018",GSM5972286: T47D LTED21M Corin cjun ChIPseq rep1; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 21 months treated with Corin 1uM 48h	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14612964,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"39598671,85.0,33.8,960",GSM5972287: T47D LTED21M Corin cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 21 months treated with Corin 1uM 48h	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14612980,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36203289,82.7,23.0,894",GSM5972303: T47D LTED LSD1 KO cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=LSD1 KO parental cells generated with CRISPR/Cas9	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14612984,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"33987311,86.5,29.5,949",GSM5972307: T47D LTED shcontrol cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 9 months	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14612985,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43862638,85.9,34.2,1025",GSM5972308: T47D LTED shcjun cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 9 months, plko-shcjun estable SHCLNG-NM_002228 (TRCN0000010366) Sigma Aldrich	chip antibody=Anti-c-Jun antibody (ab31419)"
SRX14612993,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"38400302,89.0,11.1,1559",GSM5972262: T47D FM ER ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental	chip antibody=Anti-Estrogen Receptor alpha antibody (ab3575)
SRX14612997,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"45952736,96.3,19.9,1197",GSM5972266: T47D FM cjun ChIPseq rep1; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14612998,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"45374848,93.7,23.3,1209",GSM5972267: T47D FM cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14613009,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44665421,96.4,21.7,1564",GSM5972278: T47D LTED9M cjun ChIPseq rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 9 months	chip antibody=Anti-c-Jun antibody (ab31419)
SRX14613015,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44989953,89.2,28.5,1158",GSM5972284: T47D LTED21M DMSO cjun ChIPseq rep1; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental estrogen deprived for 21 months treated with DMSO 48h	chip antibody=Anti-c-Jun antibody (ab31419)
SRX1469949,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28573711,94.7,6.2,29494",GSM1967545: MCF-7 cntrl; Homo sapiens; ChIP-Seq,source_name=Human breast cancer cell line	cell line=MCF-7	condition=control	procedure=ChIP-seq	antibody=anti-ERa (SC-543; Santa Cruz)
SRX1469950,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25636130,90.5,4.8,22305",GSM1967546: MCF-7 sgRNA enh588  rep1; Homo sapiens; ChIP-Seq,source_name=Human breast cancer cell line	cell line=MCF-7	condition=sgRNA_enh588	procedure=ChIP-seq	antibody=anti-ERa (SC-543; Santa Cruz)
SRX1469951,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24136816,92.8,5.7,28094",GSM1967547: MCF-7 sgRNA enh588  rep2; Homo sapiens; ChIP-Seq,source_name=Human breast cancer cell line	cell line=MCF-7	condition=sgRNA_enh588	procedure=ChIP-seq	antibody=anti-ERa (SC-543; Santa Cruz)
SRX1469952,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27823422,91.8,2.4,6369",GSM1967548: T47D cntrl; Homo sapiens; ChIP-Seq,source_name=Human breast cancer cell line	cell line=T47D	condition=control	procedure=ChIP-seq	antibody=anti-ERa (SC-543; Santa Cruz)
SRX1469953,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27445234,91.1,2.4,5324",GSM1967549: T47D sgRNA enh588  rep1; Homo sapiens; ChIP-Seq,source_name=Human breast cancer cell line	cell line=T47D	condition=sgRNA_enh588	procedure=ChIP-seq	antibody=anti-ERa (SC-543; Santa Cruz)
SRX1469954,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28009591,89.6,2.8,6341",GSM1967550: T47D sgRNA enh588  rep2; Homo sapiens; ChIP-Seq,source_name=Human breast cancer cell line	cell line=T47D	condition=sgRNA_enh588	procedure=ChIP-seq	antibody=anti-ERa (SC-543; Santa Cruz)
SRX14733320,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"52362990,97.2,30.1,26844",GSM6016067: MCF7 shEV+E2 ER ChIP-seq rep1; Homo sapiens; ChIP-Seq,source_name=breast cancer MCF7 cells	cell line=MCF7	cell type=breast cancer MCF7 cells	treatment=treated with E2	RNAi=EV	chip antibody=anti-ER
SRX14733321,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39576912,97.3,22.5,24469",GSM6016068: MCF7 shEV+E2 ER ChIP-seq rep2; Homo sapiens; ChIP-Seq,source_name=breast cancer MCF7 cells	cell line=MCF7	cell type=breast cancer MCF7 cells	treatment=treated with E2	RNAi=EV	chip antibody=anti-ER
SRX14733326,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"50150458,97.9,29.0,21063",GSM6016073: MCF7 shBRCA1 ER ChIP-seq rep1; Homo sapiens; ChIP-Seq,source_name=breast cancer MCF7 cells	cell line=MCF7	cell type=breast cancer MCF7 cells	treatment=treated with ETOH	RNAi=BRCA1 knockdown	chip antibody=anti-ER
SRX14733327,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"48755068,97.4,25.9,21145",GSM6016074: MCF7 shBRCA1 ER ChIP-seq rep2; Homo sapiens; ChIP-Seq,source_name=breast cancer MCF7 cells	cell line=MCF7	cell type=breast cancer MCF7 cells	treatment=treated with ETOH	RNAi=BRCA1 knockdown	chip antibody=anti-ER
SRX14733330,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"64444810,98.0,32.3,25863",GSM6016077: MCF7 shBRCA1+E2 ER ChIP-seq rep1; Homo sapiens; ChIP-Seq,source_name=breast cancer MCF7 cells	cell line=MCF7	cell type=breast cancer MCF7 cells	treatment=treated with E2	RNAi=BRCA1 knockdown	chip antibody=anti-ER
SRX14733331,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41005802,97.9,21.0,22470",GSM6016078: MCF7 shBRCA1+E2 ER ChIP-seq rep2; Homo sapiens; ChIP-Seq,source_name=breast cancer MCF7 cells	cell line=MCF7	cell type=breast cancer MCF7 cells	treatment=treated with E2	RNAi=BRCA1 knockdown	chip antibody=anti-ER
SRX14758833,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17888109,0.0,0.0,0","GSM6030594: MCF7, parental, DMSO, ER; Homo sapiens; ChIP-Seq","source_name=MCF7	cell line=MCF7	cell type=human breast cancer	chip antibody=ERalpha, Abcam #ab32063"
SRX14758836,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15947672,0.0,0.0,0","GSM6030597: MCF7, parental, ENZ, ER; Homo sapiens; ChIP-Seq","source_name=MCF7	cell line=MCF7	cell type=human breast cancer	chip antibody=ERalpha, Abcam #ab32063"
SRX14758839,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14569089,0.0,0.0,0","GSM6030600: MCF7, AROE, DMSO, ER; Homo sapiens; ChIP-Seq","source_name=MCF7	cell line=MCF7	cell type=human breast cancer	chip antibody=ERalpha, Abcam #ab32063"
SRX14758842,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12816001,0.0,0.0,0","GSM6030603: MCF7, AROE, ENZ, ER; Homo sapiens; ChIP-Seq","source_name=MCF7	cell line=MCF7	cell type=human breast cancer	chip antibody=ERalpha, Abcam #ab32063"
SRX1477664,hg38,TFs and others,MED12,Blood,CD34 Hematopoietic stem cells,,"30706330,83.2,46.8,3348",GSM1970175: Input DNA; Homo sapiens; ChIP-Seq,source_name=human CD34+	cell type=hematopoietis stem and progenitor cells	culture=6 days expanded	antibody=Med12 (A-300-774A)
SRX1477665,hg38,TFs and others,MED12,Blood,CD34 Hematopoietic stem cells,,"30055108,92.7,20.8,3279",GSM1970176: ChIP Seq MED12 1; Homo sapiens; ChIP-Seq,source_name=human CD34+	cell type=hematopoietis stem and progenitor cells	culture=6 days expanded	antibody=Med12 (A-300-774A)
SRX1477666,hg38,TFs and others,MED12,Blood,CD34 Hematopoietic stem cells,,"33444651,93.9,29.0,9624",GSM1970177: ChIP Seq MED12 2; Homo sapiens; ChIP-Seq,source_name=human CD34+	cell type=hematopoietis stem and progenitor cells	culture=6 days expanded	antibody=Med12 (A-300-774A)
SRX14853137,hg38,TFs and others,ESR1,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","73691676,97.0,43.0,35452",GSM6043914: ESR1 Prolif endo; Homo sapiens; ChIP-Seq,"source_name=endometrial biopsy	sample source=proliferative	sample type=endometrial biopsy	treament=none	antibody=ESR1 (Millipore, cat# 06-935)"
SRX14853138,hg38,TFs and others,ESR1,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","92752459,98.1,54.6,8444",GSM6043915: ESR1 MS endo; Homo sapiens; ChIP-Seq,"source_name=endometrial biopsy	sample source=mid-secretory	sample type=endometrial biopsy	treament=none	antibody=ESR1 (Millipore, cat# 06-935)"
SRX14853139,hg38,TFs and others,ESR1,Uterus,Uterine epithelial cells,,"47759818,91.1,51.6,5713",GSM6043916: ESR1 d1 org; Homo sapiens; ChIP-Seq,"source_name=uterine epithelial cells	sample source=donor1	sample type=organoid culture	treament=E2+MPA	antibody=ESR1 (Millipore, cat# 06-935)"
SRX14853140,hg38,TFs and others,PGR,Uterus,Uterine epithelial cells,,"45861779,89.3,59.6,18551",GSM6043917: PGR d1 org; Homo sapiens; ChIP-Seq,source_name=uterine epithelial cells	sample source=donor1	sample type=organoid culture	treament=E2+MPA	antibody=PGR (Santa Cruz sc-7208)
SRX14853141,hg38,TFs and others,ESR1,Uterus,Uterine epithelial cells,,"47330152,91.4,51.7,4957",GSM6043918: ESR1 d2 org; Homo sapiens; ChIP-Seq,"source_name=uterine epithelial cells	sample source=donor2	sample type=organoid culture	treament=E2+MPA	antibody=ESR1 (Millipore, cat# 06-935)"
SRX14853142,hg38,TFs and others,PGR,Uterus,Uterine epithelial cells,,"55341606,92.0,51.0,19808",GSM6043919: PGR d2 org; Homo sapiens; ChIP-Seq,source_name=uterine epithelial cells	sample source=donor2	sample type=organoid culture	treament=E2+MPA	antibody=PGR (Santa Cruz sc-7208)
SRX14875683,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"48334400,93.7,6.7,9014","GSM6046136: MCF7, ChIP, ERa, siCtl, EtOH; Homo sapiens; ChIP-Seq",source_name=MCF-7	cell line=MCF-7	antibody=ERa	treatment=control
SRX14875684,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38840816,98.1,6.4,9358","GSM6046137: MCF7, ChIP, ERa, siCtl, E2; Homo sapiens; ChIP-Seq",source_name=MCF-7	cell line=MCF-7	antibody=ERa	treatment=estrogen
SRX14875685,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42058934,98.0,6.1,4049","GSM6046138: MCF7, ChIP, ERa, siSET, EtOH; Homo sapiens; ChIP-Seq",source_name=MCF-7	cell line=MCF-7	antibody=ERa	treatment=control
SRX14875686,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39295722,98.0,6.2,6864","GSM6046139: MCF7, ChIP, ERa, siSET, E2; Homo sapiens; ChIP-Seq",source_name=MCF-7	cell line=MCF-7	antibody=ERa	treatment=estrogen
SRX149659,hg38,TFs and others,CDK8,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"68335557,97.5,14.2,20053","GSM937561: CDK8-ChIP enriched DNA, normoxia; Homo sapiens; ChIP-Seq","source_name=colorectal cancer cells, normoxia, CDK8 ChIP	cell line=HCT116	treatment=normoxia	chip antibody=CDK8	antibody vendor=Santa Cruz"
SRX149660,hg38,TFs and others,CDK8,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"164134451,97.7,11.5,26431","GSM937562: CDK8-ChIP enriched DNA, hypoxia, replicate1; Homo sapiens; ChIP-Seq","source_name=colorectal cancer cells, hypoxia, CDK8 ChIP	cell line=HCT116	treatment=24hrs hypoxia (1%O2)	chip antibody=CDK8	antibody vendor=Santa Cruz"
SRX149661,hg38,TFs and others,CDK8,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"60114830,97.5,19.1,14522","GSM937563: CDK8-ChIP enriched DNA, hypoxia, replicate2; Homo sapiens; ChIP-Seq","source_name=colorectal cancer cells, hypoxia, CDK8 ChIP	cell line=HCT116	treatment=24hrs hypoxia (1%O2)	chip antibody=CDK8	antibody vendor=Santa Cruz"
SRX150358,hg38,TFs and others,JUN,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"46845015,72.9,4.2,30968",GSM935278: Stanford ChipSeq HUVEC c-Jun std,source_name=HUVEC	biomaterial_provider=Lonza	lab=Stanford	lab description=Snyder - Stanford University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=HUVEC	cell organism=human	cell description=umbilical vein endothelial cells	cell karyotype=normal	cell lineage=mesoderm	cell sex=U	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000780	replicate=1
SRX150397,hg38,TFs and others,FOS,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"13462568,88.1,5.5,17003",GSM935317: Yale ChipSeq HeLa-S3 c-Fos std,source_name=HeLa-S3	biomaterial_provider=ATCC	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=HeLa-S3	cell organism=human	cell description=cervical carcinoma	cell karyotype=cancer	cell lineage=ectoderm	cell sex=F	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000612	labversion=Contains incomplete fastq files	replicate=1
SRX150421,hg38,TFs and others,JUN,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"55327071,71.6,14.0,21514",GSM935341: Stanford ChipSeq HeLa-S3 c-Jun IgG-rab,source_name=HeLa-S3	biomaterial_provider=ATCC	lab=Stanford	lab description=Snyder - Stanford University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=HeLa-S3	cell organism=human	cell description=cervical carcinoma	cell karyotype=cancer	cell lineage=ectoderm	cell sex=F	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	controlid=wgEncodeEH000744	labversion=remapped from hg18	replicate=1
SRX150435,hg38,TFs and others,FOS,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"18366063,82.7,9.4,15324",GSM935355: Yale ChipSeq K562 c-Fos std,"source_name=K562	biomaterial_provider=ATCC	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000615	replicate=1"
SRX150444,hg38,TFs and others,JUN,Liver,Hep G2,Primary Tissue=Liver|Tissue Diagnosis=Carcinoma Hepatocellular,"57054097,78.9,5.2,16664",GSM935364: Stanford ChipSeq HepG2 c-Jun IgG-rab,source_name=HepG2	biomaterial_provider=ATCC	lab=Stanford	lab description=Snyder - Stanford University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=HepG2	cell organism=human	cell description=hepatocellular carcinoma	cell karyotype=cancer	cell lineage=endoderm	cell sex=M	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	controlid=wgEncodeEH001791	replicate=1
SRX150476,hg38,TFs and others,FOS,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"60050220,95.2,17.5,85712",GSM935396: Harvard ChipSeq MCF10A-Er-Src 4OHTAM 1uM 36hr c-Fos Harvard Control,"source_name=MCF10A-Er-Src	biomaterial_provider=Struhl laboratory	lab=Harvard	lab description=Struhl - Harvard University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=MCF10A-Er-Src	cell organism=human	cell description=mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER)	cell karyotype=normal	cell lineage=ectoderm	cell sex=F	treatment=4OHTAM_1uM_36hr	treatment description=(To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=Harvard_Control	control description=input library was prepared at Harvard.	control=Harvard_Control	control description=input library was prepared at Harvard.	controlid=wgEncodeEH002871	replicate=1"
SRX150477,hg38,TFs and others,FOS,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"70636654,98.2,23.7,106540",GSM935397: Harvard ChipSeq MCF10A-Er-Src 4OHTAM 1uM 4hr c-Fos Harvard Control,"source_name=MCF10A-Er-Src	biomaterial_provider=Struhl laboratory	lab=Harvard	lab description=Struhl - Harvard University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=MCF10A-Er-Src	cell organism=human	cell description=mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER)	cell karyotype=normal	cell lineage=ectoderm	cell sex=F	treatment=4OHTAM_1uM_4hr	treatment description=4 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=Harvard_Control	control description=input library was prepared at Harvard.	control=Harvard_Control	control description=input library was prepared at Harvard.	controlid=wgEncodeEH002871	replicate=1"
SRX150478,hg38,TFs and others,FOS,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"66690540,98.5,24.3,110387",GSM935398: Harvard ChipSeq MCF10A-Er-Src 4OHTAM 1uM 12hr c-Fos Harvard Control,"source_name=MCF10A-Er-Src	biomaterial_provider=Struhl laboratory	lab=Harvard	lab description=Struhl - Harvard University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=MCF10A-Er-Src	cell organism=human	cell description=mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER)	cell karyotype=normal	cell lineage=ectoderm	cell sex=F	treatment=4OHTAM_1uM_12hr	treatment description=12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=Harvard_Control	control description=input library was prepared at Harvard.	control=Harvard_Control	control description=input library was prepared at Harvard.	controlid=wgEncodeEH002871	replicate=1"
SRX150489,hg38,TFs and others,FOS,Blood,GM12878,"Tissue=blood|Lineage=mesoderm|Description=B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus","16278787,76.0,4.7,2811",GSM935409: Yale ChipSeq GM12878 c-Fos std,"source_name=GM12878	biomaterial_provider=Coriell; http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12878	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=GM12878	cell organism=human	cell description=B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus	cell karyotype=normal	cell lineage=mesoderm	cell sex=F	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000625	replicate=1"
SRX150491,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"21366481,80.3,7.8,22426",GSM935411: Yale ChipSeq K562 c-Jun std,"source_name=K562	biomaterial_provider=ATCC	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000615	replicate=1"
SRX150517,hg38,TFs and others,FOS,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"50667127,93.9,23.1,81051",GSM935438: Harvard ChipSeq MCF10A-Er-Src EtOH 0.01pct c-Fos Harvard Control,"source_name=MCF10A-Er-Src	biomaterial_provider=Struhl laboratory	lab=Harvard	lab description=Struhl - Harvard University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=MCF10A-Er-Src	cell organism=human	cell description=mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER)	cell karyotype=normal	cell lineage=ectoderm	cell sex=F	treatment=EtOH_0.01pct	treatment description=36 h with 0.01% Ethanol (Snyder)	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=Harvard_Control	control description=input library was prepared at Harvard.	control=Harvard_Control	control description=input library was prepared at Harvard.	controlid=wgEncodeEH002871	replicate=1"
SRX150546,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"37482252,51.5,5.5,6506",GSM935467: Yale ChipSeq K562 IFNg6h c-Jun std,"source_name=K562	biomaterial_provider=ATCC	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=IFNg6h	treatment description=Interferon gamma treatment - 6 hours (Snyder)	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000658	labversion=remapped from hg18	replicate=1"
SRX150547,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"37188738,60.5,6.1,5179",GSM935468: Yale ChipSeq K562 IFNa6h c-Jun std,"source_name=K562	biomaterial_provider=ATCC	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=IFNa6h	treatment description=Interferon alpha treatment - 6 hours (Snyder)	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000656	labversion=remapped from hg18	replicate=1"
SRX150600,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"40535201,85.7,23.4,13586",GSM935521: Stanford ChipSeq K562 IFNa30 c-Jun std,"source_name=K562	biomaterial_provider=ATCC	lab=Stanford	lab description=Snyder - Stanford University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=IFNa30	treatment description=30 m of Interferon alpha (Snyder)	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000655	replicate=1"
SRX150664,hg38,TFs and others,FOS,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"67017139,85.2,23.3,48200",GSM935585: USC ChipSeq HUVEC c-Fos UCDavis,source_name=HUVEC	biomaterial_provider=Lonza	lab=USC	lab description=Farnham - University of Southern California	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=HUVEC	cell organism=human	cell description=umbilical vein endothelial cells	cell karyotype=normal	cell lineage=mesoderm	cell sex=U	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Fos	antibody antibodydescription=Rabbit polyclonal to amino acids 210-335 mapping at the C-terminus of c-Fos of human origin. Antibody Target: c-Fos	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-7202	control=UCDavis	control description=Input library was prepared at UC Davis.	control=UCDavis	control description=Input library was prepared at UC Davis.	controlid=wgEncodeEH001759	replicate=1
SRX150681,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"37068110,54.9,9.0,9744",GSM935602: Yale ChipSeq K562 IFNg30 c-Jun std,"source_name=K562	biomaterial_provider=ATCC	lab=Yale	lab description=Snyder - Yale University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=IFNg30	treatment description=Interferon gamma treatment - 30 minutes (Snyder)	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=std	control description=Standard input signal for most experiments.	control=std	control description=Standard input signal for most experiments.	controlid=wgEncodeEH000657	labversion=remapped from hg18	replicate=1"
SRX150693,hg38,TFs and others,JUN,Pluripotent stem cell,hESC H1,,"64134919,86.5,14.2,1994",GSM935614: Stanford ChipSeq H1-hESC c-Jun IgG-rab,source_name=H1-hESC	biomaterial_provider=WiCell Research Institute	lab=Stanford	lab description=Snyder - Stanford University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=H1-hESC	cell organism=human	cell description=embryonic stem cells	cell karyotype=normal	cell lineage=inner cell mass	cell sex=M	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	controlid=wgEncodeEH001834	replicate=1
SRX1521227,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"14134518,57.4,9.1,8580",GSM2029132: H3K27ac-mono rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa cells	treatment=Paraformaldehyde fixation (1%, 30 minutes)	chip antibody=H3K27ac monoclonal Ref: Active motif 39685"
SRX1521228,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"53756134,99.1,35.2,38525",GSM2029133: H3K27ac-mono rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa cells	treatment=Paraformaldehyde fixation (1%, 30 minutes)	chip antibody=H3K27ac monoclonal Ref: Active motif 39685"
SRX1521229,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"9716692,12.4,5.5,80",GSM2029134: H3K27ac-poly rep1-A; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa cells	treatment=Paraformaldehyde fixation (1%, 30 minutes)	chip antibody=H3K27ac polyclonal Ref: Active motif 39133"
SRX1521230,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"28110514,98.9,72.1,21243",GSM2029135: H3K27ac-poly rep1-B; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa cells	treatment=Paraformaldehyde fixation (1%, 30 minutes)	chip antibody=H3K27ac polyclonal Ref: Active motif 39133"
SRX1521231,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"54837367,97.4,45.7,45826",GSM2029136: H3K27ac-poly rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa cells	treatment=Paraformaldehyde fixation (1%, 30 minutes)	chip antibody=H3K27ac polyclonal Ref: Active motif 39133"
SRX1531791,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25733844,96.4,12.9,46550",GSM2040043: MCF7 ChIP ERa sc543x NA E2 100nM 120min Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7-E2-CHIP-ERA	cell line=MCF7 (ATCC, HTB-22)	cell type=Breast adenocarcinoma-derived cells	passages=N/A	treated with=100nM E2, 120min	chip antibody=Era (Santa-Cruz, sc543x, lot:"
SRX1531796,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21540836,88.7,6.0,28858",GSM2040048: MCF7 ChIP ERa sc543x NA E2 100nM 120min Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7-E2-CHIP-ERA	cell line=MCF7 (ATCC, HTB-22)	cell type=Breast adenocarcinoma-derived cells	passages=11	treated with=100nM E2, 120min	chip antibody=Era (Santa-Cruz, sc543x, lot:"
SRX15391845,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"37562531,94.1,9.7,1414",GSM6172149: T47D 537 ER rep1; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Y537S Point mutation in ESR1	chip antibody=Anti-Estrogen Receptor alpha antibody (ab3575)
SRX15391846,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"37552112,94.9,13.4,1451",GSM6172150: T47D 537 ER rep2; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Y537S Point mutation in ESR1	chip antibody=Anti-Estrogen Receptor alpha antibody (ab3575)
SRX15482815,hg38,TFs and others,MED12,Unclassified,Unclassified,,"35650485,91.0,5.8,1075",GSM6203186: 910MM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #910	tissue/cell type=MM	genotype=wild type	antibody=anti-MED12
SRX15482816,hg38,TFs and others,MED12,Unclassified,Unclassified,,"56385368,93.7,7.7,1586",GSM6203187: 910LM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #910	tissue/cell type=LM	genotype=G44D	antibody=anti-MED12
SRX15482821,hg38,TFs and others,MED12,Unclassified,Unclassified,,"33293606,97.5,5.2,3321",GSM6203192: 965MM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #965	tissue/cell type=MM	genotype=wild type	antibody=anti-MED12
SRX15482822,hg38,TFs and others,MED12,Unclassified,Unclassified,,"37716850,98.2,7.1,1352",GSM6203193: 965LM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #965	tissue/cell type=LM	genotype=G44D	antibody=anti-MED12
SRX15482829,hg38,TFs and others,MED12,Unclassified,Unclassified,,"36175424,97.3,5.4,4234",GSM6203200: 967MM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #967	tissue/cell type=MM	genotype=wild type	antibody=anti-MED12
SRX15482830,hg38,TFs and others,MED12,Unclassified,Unclassified,,"33185055,97.6,5.2,1463",GSM6203201: 967LM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #967	tissue/cell type=LM	genotype=G44D	antibody=anti-MED12
SRX15482837,hg38,TFs and others,MED12,Unclassified,Unclassified,,"54432481,97.8,6.1,1376",GSM6203208: 858MM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #858	tissue/cell type=MM	genotype=wild type	antibody=anti-MED12
SRX15482838,hg38,TFs and others,MED12,Unclassified,Unclassified,,"51185657,97.9,5.9,1126",GSM6203209: 858LM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #858	tissue/cell type=LM	genotype=wild type	antibody=anti-MED12
SRX15482846,hg38,TFs and others,MED12,Unclassified,Unclassified,,"43936526,98.2,5.9,884",GSM6203217: 975MM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #975	tissue/cell type=MM	genotype=wild type	antibody=anti-MED12
SRX15482847,hg38,TFs and others,MED12,Unclassified,Unclassified,,"46762338,98.1,6.1,997",GSM6203218: 975LM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #975	tissue/cell type=LM	genotype=wild type	antibody=anti-MED12
SRX15482854,hg38,TFs and others,MED12,Unclassified,Unclassified,,"63473948,96.1,9.9,1533",GSM6203225: 865MM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #865	tissue/cell type=MM	genotype=wild type	antibody=anti-MED12
SRX15482855,hg38,TFs and others,MED12,Unclassified,Unclassified,,"49541749,94.8,7.5,3435",GSM6203226: 865LM MED12; Homo sapiens; ChIP-Seq,source_name=fresh frozn tissue	tissue=fresh frozn tissue	subject id=patient #865	tissue/cell type=LM	genotype=wild type	antibody=anti-MED12
SRX15597006,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"248613426,90.0,72.2,81747",GSM6213335: P1-siNT-Pre-dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siNT	hormone treatment=vehicle	geo_loc_name=missing	collection_date=missing
SRX15597007,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"226464317,89.7,36.4,162824",GSM6213336: P1-siNT-Dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siNT	hormone treatment=EPC	geo_loc_name=missing	collection_date=missing
SRX15597008,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"185503371,87.2,80.2,41640",GSM6213337: P1-siTRIM28-Pre-dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siTRIM28	hormone treatment=vehicle	geo_loc_name=missing	collection_date=missing
SRX15597009,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"235200272,81.7,73.0,68900",GSM6213338: P1-siTRIM28-Dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siTRIM28	hormone treatment=EPC	geo_loc_name=missing	collection_date=missing
SRX15597010,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"322404708,92.8,78.2,56422",GSM6213339: P2-siNT-Pre-dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siNT	hormone treatment=vehicle	geo_loc_name=missing	collection_date=missing
SRX15597011,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"263138362,96.3,46.1,175734",GSM6213340: P2-siNT-Dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siNT	hormone treatment=EPC	geo_loc_name=missing	collection_date=missing
SRX15597012,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"298884246,96.5,66.7,141618",GSM6213341: P2-siTRIM28-Pre-dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siTRIM28	hormone treatment=vehicle	geo_loc_name=missing	collection_date=missing
SRX15597013,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"321416289,93.7,79.5,99126",GSM6213342: P2-siTRIM28-Dec-ATAC; Homo sapiens; ATAC-seq,source_name=Primary human endometrial stromal cells	cell type=Primary human endometrial stromal cells	sirna treatment=siTRIM28	hormone treatment=EPC	geo_loc_name=missing	collection_date=missing
SRX15672803,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"56805548,97.8,18.9,12569",GSM6234804: ChIP-Seq ERY537SClone1 E2; Homo sapiens; ChIP-Seq,source_name=Ishikawa ER-Y537S Clone 1	cell line=Ishikawa ER-Y537S Clone 1	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 10 nM E2	geo_loc_name=missing	collection_date=missing
SRX15672804,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"50038547,97.0,18.4,8338",GSM6234805: ChIP-Seq ERY537SClone1 DMSO; Homo sapiens; ChIP-Seq,source_name=Ishikawa ER-Y537S Clone 1	cell line=Ishikawa ER-Y537S Clone 1	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 0.1% DMSO	geo_loc_name=missing	collection_date=missing
SRX15672805,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"59821786,96.8,18.8,18276",GSM6234806: ChIP-Seq ERY537SClone2 E2; Homo sapiens; ChIP-Seq,source_name=Ishikawa ER-Y537S Clone 2	cell line=Ishikawa ER-Y537S Clone 2	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 10 nM E2	geo_loc_name=missing	collection_date=missing
SRX15672806,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"75686159,73.2,14.4,10824",GSM6234807: ChIP-Seq ERY537SClone2 DMSO; Homo sapiens; ChIP-Seq,source_name=Ishikawa ER-Y537S Clone 2	cell line=Ishikawa ER-Y537S Clone 2	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 0.1% DMSO	geo_loc_name=missing	collection_date=missing
SRX15674066,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"43235499,93.6,27.7,24696",GSM6234772: ATAC-Seq ERY537SClone1 DMSO; Homo sapiens; ATAC-seq,source_name=Ishikawa ER-Y537S Clone 1	cell line=Ishikawa ER-Y537S Clone 1	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 0.1% DMSO	geo_loc_name=missing	collection_date=missing
SRX15674067,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35801730,93.6,28.5,21250",GSM6234773: ATAC-Seq ERY537SClone1 E2; Homo sapiens; ATAC-seq,source_name=Ishikawa ER-Y537S Clone 1	cell line=Ishikawa ER-Y537S Clone 1	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 10 nM E2	geo_loc_name=missing	collection_date=missing
SRX15674068,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"31068767,91.9,31.4,20794",GSM6234774: ATAC-Seq ERY537SClone2 DMSO; Homo sapiens; ATAC-seq,source_name=Ishikawa ER-Y537S Clone 2	cell line=Ishikawa ER-Y537S Clone 2	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 0.1% DMSO	geo_loc_name=missing	collection_date=missing
SRX15674069,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28147519,88.8,38.2,20612",GSM6234775: ATAC-Seq ERY537SClone2 E2; Homo sapiens; ATAC-seq,source_name=Ishikawa ER-Y537S Clone 2	cell line=Ishikawa ER-Y537S Clone 2	cell type=endometrioid adenocarcinoma	genotype=ESR1 mutant	treatment=1 hr 10 nM E2	geo_loc_name=missing	collection_date=missing
SRX15674070,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"37573591,89.1,45.6,28883",GSM6234776: ATAC-Seq ERWTClone1 E2; Homo sapiens; ATAC-seq,source_name=Ishikawa ER-WT Clone 1	cell line=Ishikawa ER-WT Clone 1	cell type=endometrioid adenocarcinoma	genotype=ESR1 wildtype	treatment=1 hr 10 nM E2	geo_loc_name=missing	collection_date=missing
SRX15674071,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"31725063,82.3,41.6,23103",GSM6234777: ATAC-Seq ERWTClone2 E2; Homo sapiens; ATAC-seq,source_name=Ishikawa ER-WT Clone 2	cell line=Ishikawa ER-WT Clone 2	cell type=endometrioid adenocarcinoma	genotype=ESR1 wildtype	treatment=1 hr 10 nM E2	geo_loc_name=missing	collection_date=missing
SRX1585242,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24269971,98.0,18.6,30869",GSM2061656: Eralpha ChIP-seq MCF7 cells; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell line=MCF7	chip antibody=ERα antibody (HC-20) (Santa Cruz, catalog# sc-543)	passage=&lt;10"
SRX1585243,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24539889,96.4,19.4,13300",GSM2061657: ERalpha ChIP-seq MCF7 Tamoxifen resistant cells; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells, Tamoxifen resistant	cell line=MCF7T	chip antibody=ERα antibody (HC-20) (Santa Cruz, catalog# sc-543)	passage=&lt;10"
SRX1585244,hg38,TFs and others,ESR1,Breast,LTED cells,,"30386317,98.4,14.3,9845",GSM2061658: ERalpha ChIP-seq LTED cells; Homo sapiens; ChIP-Seq,"source_name=LTED breast cancer cells	cell line=LTED	chip antibody=ERα antibody (HC-20) (Santa Cruz, catalog# sc-543)	passage=&lt;10"
SRX1585245,hg38,TFs and others,ESR1,Breast,LTED cells,,"22464275,99.1,8.9,1292",GSM2061659: ERalpha ChIP-seq LTED Tamoxifen resistant cells; Homo sapiens; ChIP-Seq,"source_name=LTED breast cancer cells, Tamoxifen resistant	cell line=LTEDT	chip antibody=ERα antibody (HC-20) (Santa Cruz, catalog# sc-543)	passage=&lt;10"
SRX16005824,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"50028124,83.5,36.7,8198",GSM6285668: ARID1a KNOCKDOWN -DEX 1 [ATAC-seq]; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	cell type=Cervical cancer	treatment=na
SRX16005825,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"58080792,73.8,32.7,12647",GSM6285669: ARID1a KNOCKDOWN +DEX 1 [ATAC-seq]; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	cell type=Cervical cancer	treatment=Dex
SRX16005827,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47292874,81.2,34.4,13317",GSM6285671: ARID1a KNOCKDOWN +DEX 2 [ATAC-seq]; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	cell type=Cervical cancer	treatment=Dex
SRX16005828,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"44946501,80.6,40.2,14301",GSM6285672: CONTROL SIRNA - DEX 1 [ATAC-seq]; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	cell type=Cervical cancer	treatment=na
SRX16005831,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"67916384,76.8,43.0,21129",GSM6285675: CONTROL SIRNA + DEX 2 [ATAC-seq]; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	cell type=Cervical cancer	treatment=Dex
SRX16091532,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"43390841,95.3,5.1,13182","GSM6318206: HeLa, treated with A485, IP for H3K27ac; Homo sapiens; ChIP-Seq","source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=H3K27ac, ActiveMotif 39133 #06921017	treatment=p300 inhibitor A485"
SRX16091533,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"32239690,96.0,2.8,21414","GSM6318207: HeLa, treated with CBP30, IP for H3K27ac; Homo sapiens; ChIP-Seq","source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=H3K27ac, ActiveMotif 39133 #06921017	treatment=p300 inhibitor CBP30"
SRX16091534,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"34735869,96.5,2.5,20970","GSM6318208: HeLa, treated with DMSO, IP for H3K27ac; Homo sapiens; ChIP-Seq","source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=H3K27ac, ActiveMotif 39133 #06921017	treatment=vehicle DMSO"
SRX16314542,hg38,TFs and others,FOS,Placenta,Trophoblast stem cells,,"14663736,95.3,57.2,7938","GSM6341895: hTSC, FOS, ChIPseq; Homo sapiens; ChIP-Seq",source_name=Placenta	tissue=Placenta	cell line=CT27	cell type=Human trophoblast stem cells	antibody=FOS
SRX16364101,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"103630263,95.4,27.2,4196",GSM6360816: CHIP MCF7control EtOH; Homo sapiens; ChIP-Seq,"source_name=MCF7	experimental conditions=2D monolayer, DMEM 2percent charcoal strip FBS	antibody=ER alpha antibody, HC-20 Santa Cruz : sc-543"
SRX16364102,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"156709777,97.2,29.7,20431",GSM6360817: CHIP MCF7control E2; Homo sapiens; ChIP-Seq,"source_name=MCF7	experimental conditions=2D monolayer, DMEM 2percent charcoal strip FBS	antibody=ER alpha antibody, HC-20 Santa Cruz : sc-543"
SRX16364103,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"121701565,96.1,27.9,3830",GSM6360818: CHIP MCF7Hypoxia EtOH; Homo sapiens; ChIP-Seq,"source_name=MCF7	experimental conditions=2D monolayer, DMEM 2percent charcoal strip FBS	antibody=ER alpha antibody, HC-20 Santa Cruz : sc-543	agent=Cobalt Chloride 200uM"
SRX16364104,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"90330137,94.6,32.1,7460",GSM6360819: CHIP MCF7Hypoxia E2; Homo sapiens; ChIP-Seq,"source_name=MCF7	experimental conditions=2D monolayer, DMEM 2percent charcoal strip FBS	antibody=ER alpha antibody, HC-20 Santa Cruz : sc-543	agent=Cobalt Chloride 200uM"
SRX16364105,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"153687583,97.6,24.9,5380",GSM6360820: CHIP MCF7rescue EtOH; Homo sapiens; ChIP-Seq,"source_name=MCF7	experimental conditions=2D monolayer, DMEM 2percent charcoal strip FBS	antibody=ER alpha antibody, HC-20 Santa Cruz : sc-543"
SRX16364106,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"119442446,96.3,25.2,16929",GSM6360821: CHIP MCF7rescue E2; Homo sapiens; ChIP-Seq,"source_name=MCF7	experimental conditions=2D monolayer, DMEM 2percent charcoal strip FBS	antibody=ER alpha antibody, HC-20 Santa Cruz : sc-543"
SRX16495812,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"44868489,89.1,11.5,1623",GSM6372621: TF ChIP-seq from K562 (ENCLB747QVJ); Homo sapiens; ChIP-Seq,"age=53 year	sample type=cell line	cell line=K562	sex=female	health state=chronic myelogenous leukemia (CML)	dev stage=adult	donor ID=ENCDO000AAD	lab=Richard Myers, HAIB	source=Richard Myers"
SRX16495813,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"40645322,89.5,12.5,5577",GSM6372622: TF ChIP-seq from K562 (ENCLB476FEU); Homo sapiens; ChIP-Seq,"age=53 year	sample type=cell line	cell line=K562	sex=female	health state=chronic myelogenous leukemia (CML)	dev stage=adult	donor ID=ENCDO000AAD	lab=Richard Myers, HAIB	source=Richard Myers"
SRX16712046,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"64879786,98.1,10.0,44116",GSM6411354: ATACseq.AN3CA.ARID1A.CBR.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A CBR truncation mutant	geo_loc_name=missing	collection_date=missing
SRX16712047,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"69444114,98.1,13.2,71886",GSM6411355: ATACseq.AN3CA.ARID1A.CBR.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A CBR truncation mutant	geo_loc_name=missing	collection_date=missing
SRX16712048,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"59279612,98.5,17.5,59428",GSM6411356: ATACseq.AN3CA.ARID1A.DBDmut.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A DBDmut ARID domain mutant	geo_loc_name=missing	collection_date=missing
SRX16712049,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"37792525,98.5,11.3,49343",GSM6411357: ATACseq.AN3CA.ARID1A.DBDmut.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A DBDmut ARID domain mutant	geo_loc_name=missing	collection_date=missing
SRX16712050,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"53522797,98.9,11.0,12382",GSM6411358: ATACseq.AN3CA.ARID1A.DDX4.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A DDX4 IDR hybrid mutant	geo_loc_name=missing	collection_date=missing
SRX16712051,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"52296423,98.7,11.6,14896",GSM6411359: ATACseq.AN3CA.ARID1A.DDX4.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A DDX4 IDR hybrid mutant	geo_loc_name=missing	collection_date=missing
SRX16712052,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"48815017,99.1,37.1,38780",GSM6411360: ATACseq.AN3CA.ARID1A.FUS.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A FUS IDR hybrid mutant	geo_loc_name=missing	collection_date=missing
SRX16712053,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"49654762,99.0,26.8,29035",GSM6411361: ATACseq.AN3CA.ARID1A.FUS.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A FUS IDR hybrid mutant	geo_loc_name=missing	collection_date=missing
SRX16712054,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"55349355,98.4,10.0,80461",GSM6411362: ATACseq.AN3CA.ARID1A.WT.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A wild-type	geo_loc_name=missing	collection_date=missing
SRX16712055,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"42320341,98.2,8.6,57812",GSM6411363: ATACseq.AN3CA.ARID1A.WT.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A wild-type	geo_loc_name=missing	collection_date=missing
SRX16712056,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38727667,97.9,7.2,42326",GSM6411364: ATACseq.AN3CA.ARID1A.delIDR1.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A delIDR1 truncation mutant	geo_loc_name=missing	collection_date=missing
SRX16712057,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"41997713,98.5,14.8,61871",GSM6411365: ATACseq.AN3CA.ARID1A.delIDR1.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1A delIDR1 truncation mutant	geo_loc_name=missing	collection_date=missing
SRX16712060,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"41411305,99.1,40.4,60501",GSM6411368: ATACseq.AN3CA.ARID1B.S320 G327del.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1B mutant M2 (S320_G327del)	geo_loc_name=missing	collection_date=missing
SRX16712061,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"53148256,98.9,44.0,72175",GSM6411369: ATACseq.AN3CA.ARID1B.S320 G327del.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1B mutant M2 (S320_G327del)	geo_loc_name=missing	collection_date=missing
SRX16712062,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"46382435,99.0,46.7,65737",GSM6411370: ATACseq.AN3CA.ARID1B.WT.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1B wild-type	geo_loc_name=missing	collection_date=missing
SRX16712063,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38224055,99.3,47.6,57937",GSM6411371: ATACseq.AN3CA.ARID1B.WT.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing ARID1B wild-type	geo_loc_name=missing	collection_date=missing
SRX16712064,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"56239462,98.6,12.5,53647",GSM6411372: ATACseq.AN3CA.Empty.Vector.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX16712065,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"69248033,98.4,12.6,55550",GSM6411373: ATACseq.AN3CA.Empty.Vector.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX16712066,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"48828935,98.3,38.9,19283",GSM6411374: ATACseq.AN3CA.Empty.Vector.Rep3; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX16712067,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"50557649,99.0,48.7,32770",GSM6411375: ATACseq.AN3CA.Empty.Vector.Rep4; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX16741293,hg38,TFs and others,ESR1,Others,HCI-EC-23,,"45803293,97.8,15.7,6237",GSM6421755: HCI-EC-23 1hrE2 rep1; Homo sapiens; ChIP-Seq,"source_name=HCI-EC-23	cell line=HCI-EC-23	cell type=endometrioid adenocarcinoma	chip antibody=ESR1 (Millipore Sigma, 06-935)	treatment=10 nM E2"
SRX16741294,hg38,TFs and others,ESR1,Others,HCI-EC-23,,"45043748,97.9,13.5,5343",GSM6421756: HCI-EC-23 1hrE2 rep2; Homo sapiens; ChIP-Seq,"source_name=HCI-EC-23	cell line=HCI-EC-23	cell type=endometrioid adenocarcinoma	chip antibody=ESR1 (Millipore Sigma, 06-935)	treatment=10 nM E2"
SRX16741296,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"32578584,96.5,13.3,34486",GSM6421758: Ishikawa 1hrE2 rep1; Homo sapiens; ChIP-Seq,"source_name=Ishikawa	cell line=Ishikawa	cell type=endometrioid adenocarcinoma	chip antibody=ESR1 (Millipore Sigma, 06-935)	treatment=10 nM E2"
SRX16741297,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28297219,95.6,13.2,28284",GSM6421759: Ishikawa 1hrE2 rep2; Homo sapiens; ChIP-Seq,"source_name=Ishikawa	cell line=Ishikawa	cell type=endometrioid adenocarcinoma	chip antibody=ESR1 (Millipore Sigma, 06-935)	treatment=10 nM E2"
SRX16874136,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28616467,97.3,3.9,799",GSM6433415: MockHD ER; Homo sapiens; ChIP-Seq,source_name=MCF7	cell line=MCF7	cell type=breast cancer	type=IP	condition=MockHD	antibody=ERα (HC-20) antibodies (sc-543. Santa Cruz Biotechnology)	geo_loc_name=missing	collection_date=missing
SRX16874138,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36472160,97.2,4.3,2685",GSM6433417: MockE2 ER; Homo sapiens; ChIP-Seq,source_name=MCF7	cell line=MCF7	cell type=breast cancer	type=IP	condition=MockE2	antibody=ERα (HC-20) antibodies (sc-543. Santa Cruz Biotechnology)	geo_loc_name=missing	collection_date=missing
SRX16874140,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34284729,97.4,4.7,945",GSM6433419: MAFHD ER; Homo sapiens; ChIP-Seq,source_name=MCF7	cell line=MCF7	cell type=breast cancer	type=IP	condition=MAFHD	antibody=ERα (HC-20) antibodies (sc-543. Santa Cruz Biotechnology)	geo_loc_name=missing	collection_date=missing
SRX16874142,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35303544,96.5,5.0,3691",GSM6433421: MAFE2 ER; Homo sapiens; ChIP-Seq,source_name=MCF7	cell line=MCF7	cell type=breast cancer	type=IP	condition=MAFE2	antibody=ERα (HC-20) antibodies (sc-543. Santa Cruz Biotechnology)	geo_loc_name=missing	collection_date=missing
SRX17036112,hg38,TFs and others,FOS,Blood,KO52,Primary Tissue=Blood|Tissue Diagnosis=Leukemia,"39219360,98.3,41.4,5567",GSM6449876: KO52 cFOS ChIP; Homo sapiens; ChIP-Seq,source_name=KO52	cell line=KO52	genotype=CEBPA double mutant	chip antibody=Invitrogen MA5-15055	target=cFOS	disease=Acute Myeloid Leukemia
SRX1709953,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"14503886,52.5,86.3,63",GSM2125098: T47D-R5020 45 mins ERPRComplex reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ T47D cell models	er/pr status=ER+/PR+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-PR (inhouse KD68)"
SRX1709954,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"10927279,45.6,93.0,9",GSM2125099: T47D-R5020 45 mins ERIgG(Control) reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ T47D cell models	er/pr status=ER+/PR+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-rabbit IgG Control (cat# sc-2027, lot# E2914 or H2615)"
SRX1709955,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"14741219,53.9,85.7,32",GSM2125100: T47D-Vehicle 45 mins ERPRComplex reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ T47D cell models	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-PR (inhouse KD68)"
SRX1709956,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"9403117,51.6,89.9,8",GSM2125101: T47D-Vehicle 45 mins ERIgG(Control) reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ T47D cell models	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-rabbit IgG Control (cat# sc-2027, lot# E2914 or H2615)"
SRX1709957,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23209606,15.3,78.9,18",GSM2125102: T47D-A R5020 45 mins ERPRAComplex reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-PR (inhouse KD68)"
SRX1709958,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26410365,40.6,95.8,16",GSM2125103: T47D-A R5020 45 mins ERIgG(Control) reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-rabbit IgG Control (cat# sc-2027, lot# E2914 or H2615)"
SRX1709959,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22401013,44.9,85.3,48",GSM2125104: T47D-A Vehicle 45 mins ERPRAComplex reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-PR (inhouse KD68)"
SRX1709960,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"14112336,49.1,95.1,6",GSM2125105: T47D-A Vehicle 45 mins ERIgG(Control) reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-rabbit IgG Control (cat# sc-2027, lot# E2914 or H2615)"
SRX1709961,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"21400411,38.9,74.4,138",GSM2125106: T47D-B R5020 45 mins ERPRBComplex reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-PR (inhouse KD68)"
SRX1709962,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"7946795,51.1,80.5,18",GSM2125107: T47D-B R5020 45 mins ERIgG(Control) reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-rabbit IgG Control (cat# sc-2027, lot# E2914 or H2615)"
SRX1709963,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"17267422,43.6,79.2,85",GSM2125108: T47D-B Vehicle 45 mins ERPRBComplex reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-PR (inhouse KD68)"
SRX1709964,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29752231,36.1,84.4,105",GSM2125109: T47D-B Vehicle 45 mins ERIgG(Control) reChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515) plus anti-rabbit IgG Control (cat# sc-2027, lot# E2914 or H2615)"
SRX1709971,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23698107,95.6,4.1,669",GSM2125116: T47D-A Vehicle 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709972,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23102769,94.5,10.2,706",GSM2125117: T47D-A Vehicle 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709973,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"16039330,98.4,13.0,595",GSM2125118: T47D-A E2 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10 nM Estradiol	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709974,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44179734,97.2,77.0,458",GSM2125119: T47D-A E2 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10 nM Estradiol	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709975,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44473194,97.5,69.4,1361",GSM2125120: T47D-A R5020 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709976,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"10851528,98.4,7.8,380",GSM2125121: T47D-A R5020 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709977,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27675067,97.8,21.5,6195",GSM2125122: T47D-A E2+R5020 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10nM Estradiol + 10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709978,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"20937481,98.3,34.6,724",GSM2125123: T47D-A E2+R5020 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA+/PRB- T47D cell models	er/pr status=ER+/PRA+/PRB-	drug treatment=10nM Estradiol + 10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709983,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"33289426,95.4,10.2,867",GSM2125128: T47D-B Vehicle 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709984,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26070012,95.2,11.4,1045",GSM2125129: T47D-B Vehicle 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709985,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30143502,97.6,5.7,802",GSM2125130: T47D-B E2 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10 nM Estradiol	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709986,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26114331,96.7,6.5,2085",GSM2125131: T47D-B E2 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10 nM Estradiol	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709987,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"24788228,97.0,8.6,1610",GSM2125132: T47D-B R5020 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709988,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27037646,97.7,9.3,780",GSM2125133: T47D-B R5020 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1709989,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"20539080,96.9,23.9,1157",GSM2125134: T47D-B E2+R5020 45 mins PR ChIP; Homo sapiens; ChIP-Seq,source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10nM Estradiol + 10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-PR (inhouse KD68)
SRX1709990,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"20564069,97.2,13.4,2711",GSM2125135: T47D-B E2+R5020 45 mins ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PRA-/PRB+ T47D cell models	er/pr status=ER+/PRA-/PRB+	drug treatment=10nM Estradiol + 10 nM R5020	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX1733712,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42052230,96.7,2.3,1106",GSM2135489: Vehicle DMSO ER; Homo sapiens; ChIP-Seq,"source_name=Vehicle DMSO, ER ChIP	cell line=MCF7-tet-on-shCtr9	cell type=ER{alpha}-positive breast cancer cells	culture conditions=Vehicle	treatment=DMSO	chip antibody=Anti-ERα (Santa Cruz, sc-543, clone HC-20)"
SRX1733713,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36284283,96.7,2.7,3861",GSM2135490: Vehicle E2 ER; Homo sapiens; ChIP-Seq,"source_name=Vehicle E2, ER ChIP	cell line=MCF7-tet-on-shCtr9	cell type=ER{alpha}-positive breast cancer cells	culture conditions=Vehicle	treatment=E2	chip antibody=Anti-ERα (Santa Cruz, sc-543, clone HC-20)"
SRX1733714,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43405926,98.2,2.3,1037",GSM2135491: Dox DMSO ER; Homo sapiens; ChIP-Seq,"source_name=Dox DMSO, ER ChIP	cell line=MCF7-tet-on-shCtr9	cell type=ER{alpha}-positive breast cancer cells	culture conditions=Dox	treatment=DMSO	chip antibody=Anti-ERα (Santa Cruz, sc-543, clone HC-20)"
SRX1733715,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46048808,98.3,3.0,2554",GSM2135492: Dox E2 ER; Homo sapiens; ChIP-Seq,"source_name=Dox E2, ER ChIP	cell line=MCF7-tet-on-shCtr9	cell type=ER{alpha}-positive breast cancer cells	culture conditions=Dox	treatment=E2	chip antibody=Anti-ERα (Santa Cruz, sc-543, clone HC-20)"
SRX17380076,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"55207568,95.2,2.9,16462","GSM6529227: HeLa, Active Motif 2.5ug H3K27ac; Homo sapiens; ChIP-Seq",source_name=cervical	biomaterial_provider=Drosophila spike-in chromatin (Active Motif 53083) was added to chromatin at 1% of total mass. This master mix of sample chromatin plus spike-in chromatin was distributed to each IP.	tissue=cervical	cell line=HeLa	chip antibody=Active Motif H3K27ac #39133 lot: 06921014	treatment=none	geo_loc_name=missing	collection_date=missing
SRX17380077,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"61686944,97.5,3.5,16590","GSM6529228: HeLa, Active Motif 20ug H3K27ac; Homo sapiens; ChIP-Seq",source_name=cervical	biomaterial_provider=Drosophila spike-in chromatin (Active Motif 53083) was added to chromatin at 1% of total mass. This master mix of sample chromatin plus spike-in chromatin was distributed to each IP.	tissue=cervical	cell line=HeLa	chip antibody=Active Motif H3K27ac #39133 lot: 06921014	treatment=none	geo_loc_name=missing	collection_date=missing
SRX17380078,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"63327524,97.5,3.0,9975","GSM6529229: HeLa, Diagenode 2.5ug H3K27ac; Homo sapiens; ChIP-Seq",source_name=cervical	biomaterial_provider=Drosophila spike-in chromatin (Active Motif 53083) was added to chromatin at 1% of total mass. This master mix of sample chromatin plus spike-in chromatin was distributed to each IP.	tissue=cervical	cell line=HeLa	chip antibody=Diagenode #15410196 lot: A1723-0041D	treatment=none	geo_loc_name=missing	collection_date=missing
SRX17380079,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"64501390,97.7,2.7,407","GSM6529230: HeLa, Diagenode 20ug H3K27ac; Homo sapiens; ChIP-Seq",source_name=cervical	biomaterial_provider=Drosophila spike-in chromatin (Active Motif 53083) was added to chromatin at 1% of total mass. This master mix of sample chromatin plus spike-in chromatin was distributed to each IP.	tissue=cervical	cell line=HeLa	chip antibody=Diagenode #15410196 lot: A1723-0041D	treatment=none	geo_loc_name=missing	collection_date=missing
SRX17380084,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"13053036,93.1,1.8,3193","GSM6529235: HeLa, Active Motif 2.5ug K27ac, 12.5M reads; Homo sapiens; ChIP-Seq",source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=Active Motif #39133 lot: 16119013	treatment=none
SRX17380085,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"11513184,96.0,1.3,1734","GSM6529236: HeLa, Active Motif 20ug K27ac, 12.5M reads; Homo sapiens; ChIP-Seq",source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=Active Motif #39133 lot: 16119013	treatment=none
SRX17380086,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"15190017,96.7,1.3,1439","GSM6529237: HeLa, Diagenode 2.5ug K27ac, 12.5M reads; Homo sapiens; ChIP-Seq",source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=Diagenode #15410196 lot: A1723-0041D	treatment=none
SRX17380087,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"16711507,91.8,0.9,173","GSM6529238: HeLa, Diagenode 20ug K27ac, 12.5M reads; Homo sapiens; ChIP-Seq",source_name=cervical	tissue=cervical	cell line=HeLa	chip antibody=Diagenode #15410196 lot: A1723-0041D	treatment=none
SRX17408419,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"90826659,95.8,93.0,45",GSM6538286: HeLa 56ug mito ATAC; Homo sapiens; ATAC-seq,source_name=HeLa S3	cell line=HeLa S3	genotype=WT	geo_loc_name=missing	collection_date=missing
SRX17408420,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"55943122,97.3,88.5,67",GSM6538287: HeLa 5ug mito ATAC; Homo sapiens; ATAC-seq,source_name=HeLa S3	cell line=HeLa S3	genotype=WT	geo_loc_name=missing	collection_date=missing
SRX1745724,hg38,TFs and others,ESR1,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","15331544,94.9,2.0,983",GSM2144746: Tumor A ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)
SRX1745727,hg38,Histone,H3K27ac,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","23175814,96.6,4.1,33780",GSM2144749: Tumor A H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)
SRX1745728,hg38,TFs and others,ESR1,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","34593703,98.0,3.6,3130",GSM2144750: Tumor B ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)
SRX1745731,hg38,Histone,H3K27ac,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","32025533,98.5,9.9,47219",GSM2144753: Tumor B H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)
SRX1745732,hg38,TFs and others,ESR1,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","21716690,98.0,1.9,3709",GSM2144754: Tumor C ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)
SRX1745735,hg38,Histone,H3K27ac,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","25380006,93.8,4.0,26799",GSM2144757: Tumor C H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)
SRX1745736,hg38,TFs and others,ESR1,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","19603948,93.6,7.1,7165",GSM2144758: Tumor D ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)
SRX1745738,hg38,TFs and others,ESR1,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","14930170,83.3,4.4,10176",GSM2144760: Tumor E ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)
SRX1745741,hg38,Histone,H3K27ac,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","20390107,95.6,2.3,18742",GSM2144763: Tumor E H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)
SRX1745742,hg38,TFs and others,ESR1,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","19287976,96.5,4.7,1205",GSM2144764: biological replicate Tumor B ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)
SRX1745745,hg38,Histone,H3K27ac,Uterus,Endometrial Stromal Tumors,"MeSH Description=Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).","23442310,94.1,10.6,35269",GSM2144767: biological replicate Tumor B H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)
SRX17491549,hg38,Histone,H3K27ac,Uterus,L-02,,"123870929,93.6,20.6,68211",GSM6564285: L02 H3K27ac WT ChIP; Homo sapiens; ChIP-Seq,"source_name=cell line	tissue=cell line	cell line=L02	cell type=human liver cell line	genotype=WT	antibody=H3K27ac(Active Motif,39133)"
SRX17561461,hg38,TFs and others,JUN,Adipocyte,LPS141,,"33465039,98.2,6.4,56601","GSM6578452: LPS141, DMSO, cJun, rep2; Homo sapiens; ChIP-Seq",source_name=LPS141	cell line=LPS141	cell type=liposarcoma cell	treatment=DMSO	timepoint=0h	chip antibody=cJun	geo_loc_name=missing	collection_date=missing
SRX17658338,hg38,ATAC-Seq,ATAC-Seq,Uterus,Cervical cancer cells,,"51928561,74.9,29.6,9464",GSM6595262: ATAC-seq of SiHa; Homo sapiens; ATAC-seq,source_name=SiHa	cell line=SiHa	cell type=cervical cancer cells	genotype=WT	geo_loc_name=missing	collection_date=missing
SRX17658339,hg38,ATAC-Seq,ATAC-Seq,Uterus,Cervical epithelial cell line,,"47395581,30.6,26.7,11771",GSM6595263: ATAC-seq of H8; Homo sapiens; ATAC-seq,source_name=H8	cell line=H8	cell type=Immortalized human cervical epithelial cells	genotype=WT	geo_loc_name=missing	collection_date=missing
SRX17658341,hg38,ATAC-Seq,ATAC-Seq,Uterus,Cervical cancer cells,,"56200180,69.6,34.4,5186",GSM6595265: ATAC-seq of KOE6E7SiHa; Homo sapiens; ATAC-seq,source_name=KOE6E7SiHa	cell line=KOE6E7SiHa	cell type=cervical cancer cells	genotype=KOE6E7	geo_loc_name=missing	collection_date=missing
SRX176856,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29991295,99.2,9.5,23616",GSM986059: siNT ER E2 r1; Homo sapiens; ChIP-Seq,"source_name=siNT_ER_estrogen	cell line=MCF-7	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=negative control	tranfected with=AllStars Negative Control siRNA (Cat nr:1027281, Qiagen)	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176857,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19920141,99.1,7.9,21899",GSM986060: siGATA ER E2 r1; Homo sapiens; ChIP-Seq,"source_name=siGATA_ER_estrogen	cell line=MCF-7	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=GATA knockdown	tranfected with=ON-TARGET plus siRNA J-0033781-09, siGATA3-Custom-1, siGATA3-Custom-2	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176858,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16749008,98.3,10.3,24481",GSM986061: siNT ER E2 r2; Homo sapiens; ChIP-Seq,"source_name=siNT_ER_estrogen	cell line=MCF-7	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=negative control	tranfected with=AllStars Negative Control siRNA (Cat nr:1027281, Qiagen)	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176859,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16503175,97.2,7.9,19151",GSM986062: siGATA ER E2 r2; Homo sapiens; ChIP-Seq,"source_name=siGATA_ER_estrogen	cell line=MCF-7	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=GATA knockdown	tranfected with=ON-TARGET plus siRNA J-0033781-09, siGATA3-Custom-1, siGATA3-Custom-2	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176860,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33806462,99.3,25.3,77212",GSM986063: siNT ER E2 r3; Homo sapiens; ChIP-Seq,"source_name=siNT_ER_estrogen	cell line=MCF-7	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=negative control	tranfected with=AllStars Negative Control siRNA (Cat nr:1027281, Qiagen)	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176861,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35210153,99.3,20.0,72023",GSM986064: siGATA ER E2 r3; Homo sapiens; ChIP-Seq,"source_name=siGATA_ER_estrogen	cell line=MCF-7	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=GATA knockdown	tranfected with=ON-TARGET plus siRNA J-0033781-09, siGATA3-Custom-1, siGATA3-Custom-2	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176886,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"35754325,98.9,2.5,2337",GSM986089: ZR751 siNT ER E2 r1; Homo sapiens; ChIP-Seq,"source_name=ZR751_siNT_ER_estrogen	cell line=ZR751	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=negative control	tranfected with=AllStars Negative Control siRNA (Cat nr:1027281, Qiagen)	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX176887,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"33377016,98.8,2.6,1569",GSM986090: ZR751 siGATA ER E2 r1; Homo sapiens; ChIP-Seq,"source_name=ZR751_siGATA_ER_estrogen	cell line=ZR751	cell type=breast cancer cells	stimulated with=E2 at final conc. 100nM for 3 hrs	genotype/variation=GATA knockdown	tranfected with=ON-TARGET plus siRNA J-0033781-09, siGATA3-Custom-1, siGATA3-Custom-2	chip antibody=anti-ERa	chip antibody vendor=Santa Cruz"
SRX17911898,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","110042070,68.8,7.1,24982",GSM6637791: ATAC-seq from fallopian tube (ENCLB012EOB); Homo sapiens; ATAC-seq,"description=Homo sapiens female adult (46 years) fallopian tube tissue, preserved by flash-freezing	sample type=tissue	tissue=fallopian tube	sex=female	health state=DM: no; HTN: no; CAD: no	dev stage=adult	age=46 year	donor ID=ENCDO411EVD	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX17911899,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","154870957,68.3,7.3,31115",GSM6637792: ATAC-seq from fallopian tube (ENCLB033AEY); Homo sapiens; ATAC-seq,"description=Homo sapiens female adult (46 years) fallopian tube tissue, preserved by flash-freezing	sample type=tissue	tissue=fallopian tube	sex=female	health state=DM: no; HTN: no; CAD: no	dev stage=adult	age=46 year	donor ID=ENCDO411EVD	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX17911948,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","100734578,71.6,5.0,8776",GSM6637869: ATAC-seq from uterus (ENCLB186VLL); Homo sapiens; ATAC-seq,"description=Homo sapiens female adult (46 years) uterus tissue, preserved by flash-freezing	sample type=tissue	tissue=uterus	sex=female	health state=DM: no; HTN: no; CAD: no	dev stage=adult	age=46 year	donor ID=ENCDO411EVD	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX17911949,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","65586723,77.0,4.7,6403",GSM6637870: ATAC-seq from uterus (ENCLB017DBL); Homo sapiens; ATAC-seq,"description=Homo sapiens female adult (46 years) uterus tissue, preserved by flash-freezing	sample type=tissue	tissue=uterus	sex=female	health state=DM: no; HTN: no; CAD: no	dev stage=adult	age=46 year	donor ID=ENCDO411EVD	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX17912017,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","109524430,59.6,5.7,13422",GSM6638024: ATAC-seq from fallopian tube (ENCLB901UJK); Homo sapiens; ATAC-seq,"description=Homo sapiens female adult (61 years) fallopian tube tissue, preserved by flash-freezing	sample type=tissue	tissue=fallopian tube	sex=female	health state=DM: no; HTN: no; CAD: no; lungs with moderate emphysema	dev stage=adult	age=61 year	donor ID=ENCDO186XRB	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX17912018,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","114755459,61.4,5.5,11468",GSM6638025: ATAC-seq from fallopian tube (ENCLB946DTY); Homo sapiens; ATAC-seq,"description=Homo sapiens female adult (61 years) fallopian tube tissue, preserved by flash-freezing	sample type=tissue	tissue=fallopian tube	sex=female	health state=DM: no; HTN: no; CAD: no; lungs with moderate emphysema	dev stage=adult	age=61 year	donor ID=ENCDO186XRB	lab=Michael Snyder, Stanford	source=Yiing Lin, MD, PhD"
SRX18014930,hg38,TFs and others,JUN,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"41832800,85.6,9.7,3398",GSM6672404: c-Jun - MCF10A; Homo sapiens; ChIP-Seq,"source_name=MCF10A	cell line=MCF10A	cell type=Normal human breast epithelial cell	chip antibody=c-Jun (CST, #9165)	treatment=TGF-beta (-)	geo_loc_name=missing	collection_date=missing"
SRX18014931,hg38,TFs and others,JUN,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"43892355,86.9,9.3,4056",GSM6672405: c-Jun + MCF10A; Homo sapiens; ChIP-Seq,"source_name=MCF10A	cell line=MCF10A	cell type=Normal human breast epithelial cell	chip antibody=c-Jun (CST, #9165)	treatment=TGF-beta (+,24h)	geo_loc_name=missing	collection_date=missing"
SRX18191636,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"58015053,98.5,26.8,2593",GSM6716975: 1-AO3 FM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNT	chip antibody=ER (Millipore, #06-935)"
SRX18191637,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"50382941,98.5,25.7,2420",GSM6716976: 2-AO5 FM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191638,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"45378611,98.3,24.8,1591",GSM6716977: 3-AO6 FM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2	chip antibody=ER (Millipore, #06-935)"
SRX18191639,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55024825,98.5,26.5,2947",GSM6716978: 4-AO8 FM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2+sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191646,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"79409869,98.5,30.2,2801",GSM6716985: 13-AO3 FM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNT	chip antibody=ER (Millipore, #06-935)"
SRX18191647,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"49627672,98.1,24.9,1764",GSM6716986: 14-AO5 FM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191648,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"60384828,98.3,27.4,1703",GSM6716987: 15-AO6 FM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2	chip antibody=ER (Millipore, #06-935)"
SRX18191649,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55454552,98.5,25.3,2824",GSM6716988: 16-AO8 FM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2+sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191656,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44637824,98.7,25.9,727",GSM6716995: 57-AO3 EDM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNT	chip antibody=ER (Millipore, #06-935)"
SRX18191657,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51212628,98.6,25.3,857",GSM6716996: 58-AO5 EDM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191658,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43390131,98.6,25.0,665",GSM6716997: 59-AO6 EDM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2	chip antibody=ER (Millipore, #06-935)"
SRX18191659,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"49703288,98.7,28.5,821",GSM6716998: 60-AO8 EDM-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2+sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191660,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46534475,98.7,26.6,1374",GSM6716999: 61-AO3 E2-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNT	chip antibody=ER (Millipore, #06-935)"
SRX18191661,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31925079,98.7,23.7,1033",GSM6717000: 62-AO5 E2-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191662,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44445739,98.6,26.1,841",GSM6717001: 63-AO6 E2-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2	chip antibody=ER (Millipore, #06-935)"
SRX18191663,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"47748339,98.7,26.1,1421",GSM6717002: 64-AO8 E2-ER-Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2+sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191672,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46338346,98.6,29.8,884",GSM6717011: 73-AO3 EDM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNT	chip antibody=ER (Millipore, #06-935)"
SRX18191673,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41740676,98.7,25.6,915",GSM6717012: 74-AO5 EDM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191674,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44093180,98.7,27.9,978",GSM6717013: 75-AO6 EDM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2	chip antibody=ER (Millipore, #06-935)"
SRX18191675,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40361050,98.7,25.3,926",GSM6717014: 76-AO8 EDM-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2+sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191676,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"53562457,98.7,28.4,1281",GSM6717015: 77-AO3 E2-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNT	chip antibody=ER (Millipore, #06-935)"
SRX18191677,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44877165,98.7,25.9,1034",GSM6717016: 78-AO5 E2-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18191678,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39718150,98.6,25.4,910",GSM6717017: 79-AO6 E2-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2	chip antibody=ER (Millipore, #06-935)"
SRX18191679,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38047015,98.7,24.6,898",GSM6717018: 80-AO8 E2-ER-Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=ER+ breast cancer cell line	genotype=sgNF1-2+sgNR2F2-2	chip antibody=ER (Millipore, #06-935)"
SRX18241830,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30826461,95.9,14.7,35666",GSM6727286: Ishikawa 8hrDMSO H3K27Ac rep1; Homo sapiens; ChIP-Seq,"source_name=Ishikawa	cell line=Ishikawa	cell type=endometrioid adenocarcinoma	chip antibody=H3K27ac (Active Motif, 39133)	treatment=0.1% DMSO"
SRX18241831,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"16777569,92.8,13.1,20749",GSM6727287: Ishikawa 8hrDMSO H3K27Ac rep2; Homo sapiens; ChIP-Seq,"source_name=Ishikawa	cell line=Ishikawa	cell type=endometrioid adenocarcinoma	chip antibody=H3K27ac (Active Motif, 39133)	treatment=0.1% DMSO"
SRX18346411,hg38,ATAC-Seq,ATAC-Seq,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"20270876,89.3,10.4,39572",GSM6751414: SK-UT-1 1; Homo sapiens; ATAC-seq,source_name=SK-UT-1	cell line=SK-UT-1	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346412,hg38,ATAC-Seq,ATAC-Seq,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"18597112,88.6,10.1,38171",GSM6751415: SK-UT-1 2; Homo sapiens; ATAC-seq,source_name=SK-UT-1	cell line=SK-UT-1	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346413,hg38,ATAC-Seq,ATAC-Seq,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"24730671,87.1,10.9,43900",GSM6751416: SK-UT-1 3; Homo sapiens; ATAC-seq,source_name=SK-UT-1	cell line=SK-UT-1	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346414,hg38,ATAC-Seq,ATAC-Seq,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"27054268,87.5,7.3,16651",GSM6751417: SK-UT1-B 1; Homo sapiens; ATAC-seq,source_name=SK-UT1-B	cell line=SK-UT1-B	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346415,hg38,ATAC-Seq,ATAC-Seq,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"24106488,85.6,11.1,25756",GSM6751418: SK-UT1-B 2; Homo sapiens; ATAC-seq,source_name=SK-UT1-B	cell line=SK-UT1-B	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346416,hg38,ATAC-Seq,ATAC-Seq,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"22411779,88.0,13.2,32012",GSM6751419: SK-UT1-B 3; Homo sapiens; ATAC-seq,source_name=SK-UT1-B	cell line=SK-UT1-B	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346417,hg38,ATAC-Seq,ATAC-Seq,Uterus,MES-SA,Primary Tissue=Uterus|Tissue Diagnosis=Sarcoma,"17619694,85.0,12.2,28558",GSM6751420: MES-SA 1; Homo sapiens; ATAC-seq,source_name=MES-SA	cell line=MES-SA	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346418,hg38,ATAC-Seq,ATAC-Seq,Uterus,MES-SA,Primary Tissue=Uterus|Tissue Diagnosis=Sarcoma,"23500998,83.8,13.1,28789",GSM6751421: MES-SA 2; Homo sapiens; ATAC-seq,source_name=MES-SA	cell line=MES-SA	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18346419,hg38,ATAC-Seq,ATAC-Seq,Uterus,MES-SA,Primary Tissue=Uterus|Tissue Diagnosis=Sarcoma,"21227648,88.2,14.1,31286",GSM6751422: MES-SA 3; Homo sapiens; ATAC-seq,source_name=MES-SA	cell line=MES-SA	cell type=leiomyosarcoma	geo_loc_name=missing	collection_date=missing
SRX18379042,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"43618177,91.7,17.2,26933",GSM6756520: HeLa H3K27ac NT 1; Homo sapiens; ChIP-Seq,source_name=HeLa	cell line=HeLa	cell type=epithelial cell	chip antibody=H3K27ac	treatment=NT
SRX18379043,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"51486527,73.1,15.1,19724",GSM6756521: HeLa H3K27ac NT 2; Homo sapiens; ChIP-Seq,source_name=HeLa	cell line=HeLa	cell type=epithelial cell	chip antibody=H3K27ac	treatment=NT
SRX18379044,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"28951167,97.3,15.1,22544",GSM6756522: HeLa H3K27ac STV 1; Homo sapiens; ChIP-Seq,source_name=HeLa	cell line=HeLa	cell type=epithelial cell	chip antibody=H3K27ac	treatment=HBSS starvation
SRX18379045,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"38910482,95.0,15.9,25237",GSM6756523: HeLa H3K27ac STV 2; Homo sapiens; ChIP-Seq,source_name=HeLa	cell line=HeLa	cell type=epithelial cell	chip antibody=H3K27ac	treatment=HBSS starvation
SRX18425713,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"104581242,7.9,56.4,4138",GSM6766709: ATAC-seq BRD4LAMPS-HS2-Dark rep1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425716,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"37437630,30.8,53.5,11022",GSM6766710: ATAC-seq BRD4LAMPS-HS2-Dark rep2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425718,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"13487688,65.6,45.4,8682",GSM6766711: ATAC-seq BRD4LAMPS-HS2-Light rep1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425720,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"9149536,69.4,43.7,4926",GSM6766712: ATAC-seq BRD4LAMPS-HS2-Light rep2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425721,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35873864,70.9,68.0,16944",GSM6766713: ATAC-seq pFusNmutCL-HS2-Dark rep1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425723,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"33778728,67.3,67.9,15694",GSM6766714: ATAC-seq pFusNmutCL-HS2-Dark rep2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425724,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47351074,85.6,78.0,26327",GSM6766715: ATAC-seq pFusNmutCL-HS2-Light rep1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18425726,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"19074157,0.0,0.3,0",GSM6766716: ATAC-seq pFusNmutCL-HS2-Light rep2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=Human HeLa cells
SRX18549782,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"125996739,98.0,13.0,19664",GSM6807141: siCtrl (Control knockdown); Homo sapiens; ATAC-seq,source_name=Uterus; Cervix	tissue=Uterus; Cervix	cell line=HeLa	cell type=Epithelial cells	treatment=siRNA (control) transfected sample
SRX18549783,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"139946778,97.8,9.4,21710",GSM6807142: siPP2A (PP2A-A knockdown); Homo sapiens; ATAC-seq,source_name=Uterus; Cervix	tissue=Uterus; Cervix	cell line=HeLa	cell type=Epithelial cells	treatment=siRNA (PP2A) transfected sample
SRX185708,hg38,TFs and others,PGR,Muscle,Leiomyoma,"MeSH Description=A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.","10225801,98.0,6.1,7002",GSM999792: PR-binding Leiomyoma ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=Leiomyoma cells	cell type=Leiomyoma cells	treatment=RU486	chip antibody=PR	chip antibody manufacturer=Santa Cruz
SRX185709,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"17688759,98.8,5.0,36666",GSM999793: PR-binding T47D ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=T47D	treatment=RU486	chip antibody=PR	chip antibody manufacturer=Santa Cruz
SRX186614,hg38,TFs and others,JUN,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"43798981,96.0,10.3,22587",GSM1003609: Stanford ChipSeq K562 c-Jun IgG-rab,"source_name=K562	biomaterial_provider=ATCC	lab=Stanford	lab description=Snyder - Stanford University	datatype=ChipSeq	datatype description=Chromatin IP Sequencing	cell=K562	cell organism=human	cell description=leukemia, ""The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises."" - ATCC	cell karyotype=cancer	cell lineage=mesoderm	cell sex=F	treatment=None	treatment description=No special treatment or protocol applies	antibody=c-Jun	antibody antibodydescription=Rabbit polyclonal to amino acids 1-79 mapping at the N-terminus of c-Jun p39 of human origin. Antibody Target: c-Jun	antibody targetdescription=Heterodimer of Fos and Jun constitute transcription factor AP1. Proto-oncogene c-Jun is a leucine-zipper.	antibody vendorname=Santa Cruz Biotech	antibody vendorid=sc-1694	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	control=IgG-rab	control description=Input signal from Normal Rabbit IgG ChIP-seq.	controlid=wgEncodeEH001795"
SRX186798,hg38,TFs and others,ESR1,Breast,Breast cancer,,"28556249,89.7,2.5,1457",GSM1003708: good outcome 1 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=good
SRX186801,hg38,TFs and others,ESR1,Breast,Breast cancer,,"28745770,89.1,2.5,1559",GSM1003711: good outcome 2 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=good
SRX186804,hg38,TFs and others,ESR1,Breast,Breast cancer,,"20789758,89.0,5.8,9410",GSM1003714: good outcome 3 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=good
SRX186807,hg38,TFs and others,ESR1,Breast,Breast cancer,,"22555195,96.0,2.4,2618",GSM1003717: good outcome 4 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=good
SRX186810,hg38,TFs and others,ESR1,Breast,Breast cancer,,"20623693,89.6,2.7,5278",GSM1003720: good outcome 5 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=good
SRX186813,hg38,TFs and others,ESR1,Breast,Breast cancer,,"24005555,91.5,3.5,3178",GSM1003723: poor outcome 1 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX186816,hg38,TFs and others,ESR1,Breast,Breast cancer,,"19907444,82.0,1.8,1114",GSM1003726: poor outcome 2 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX186818,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21552073,85.8,3.0,1213",GSM1003728: poor outcome 3 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX186821,hg38,TFs and others,ESR1,Breast,Breast cancer,,"15620215,92.5,1.8,2616",GSM1003731: poor outcome 4 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX186824,hg38,TFs and others,ESR1,Breast,Breast cancer,,"22851650,83.7,2.5,7492",GSM1003734: poor outcome 5 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX186827,hg38,TFs and others,ESR1,Breast,Breast cancer,,"25288873,87.1,2.4,1174",GSM1003737: poor outcome 6 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX186830,hg38,TFs and others,ESR1,Breast,Breast cancer,,"13499179,94.9,1.4,740",GSM1003740: poor outcome 7 ER; Homo sapiens; ChIP-Seq,source_name=breast carcinoma	tissue=primary breast tumor	procedure=ChIP-seq	chip antibody=SC-543 (Santa Cruz)	aromatase inhibitor treatment outcome=poor
SRX190203,hg38,TFs and others,ESR1,Uterus,ECC-1,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"50165922,87.6,9.7,8214",GSM1010747: HudsonAlpha ChipSeq ECC-1 ERalpha a BPA 100nM v041610.2,"GEO Accession=GSM1010747	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor  of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorid=sc-543	antibody vendorname=Santa Cruz Biotechnology	antibody=ERalpha_a	cell description=epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes	cell karyotype=cancer	cell lineage=endoderm	cell organism=human	cell sex=F	cell=ECC-1	controlid=SL1092,SL1034	datatype description=Chromatin IP Sequencing	datatype=ChipSeq	lab description=Myers - Hudson Alpha Institute for Biotechnology	lab=HudsonAlpha	labexpid=SL2082,SL1050	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	protocol=v041610.2	replicate=1,2	softwareversion=MACS	treatment description=1 h with 100 nM Bisphenol A  (Myers)	treatment=BPA_100nM"
SRX19024871,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28360852,97.7,3.2,10435",GSM6932410: MCF7 ER ChIP rep 1 - dex; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell type=Breast Cancer Cells	cell line=MCF-7	genotype=WT	treatment=Vehicle	time point=2h	chip antibody=ER (06-935, Merck)	geo_loc_name=missing	collection_date=missing"
SRX19024872,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27392514,97.5,3.0,10222",GSM6932411: MCF7 ER ChIP rep 1 + dex; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell type=Breast Cancer Cells	cell line=MCF-7	genotype=WT	treatment=100nM Dexamethasone	time point=2h	chip antibody=ER (06-935, Merck)	geo_loc_name=missing	collection_date=missing"
SRX19024873,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28934030,98.2,3.3,10315",GSM6932412: MCF7 ER ChIP rep 2 - dex; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell type=Breast Cancer Cells	cell line=MCF-7	genotype=WT	treatment=Vehicle	time point=2h	chip antibody=ER (06-935, Merck)	geo_loc_name=missing	collection_date=missing"
SRX19024874,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26990515,98.1,3.3,10820",GSM6932413: MCF7 ER ChIP rep 2 + dex; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell type=Breast Cancer Cells	cell line=MCF-7	genotype=WT	treatment=100nM Dexamethasone	time point=2h	chip antibody=ER (06-935, Merck)	geo_loc_name=missing	collection_date=missing"
SRX19024875,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29588037,98.3,3.5,13011",GSM6932414: MCF7 ER ChIP rep 3 - dex; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell type=Breast Cancer Cells	cell line=MCF-7	genotype=WT	treatment=Vehicle	time point=2h	chip antibody=ER (06-935, Merck)	geo_loc_name=missing	collection_date=missing"
SRX19024876,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25586904,98.5,2.2,2794",GSM6932415: MCF7 ER ChIP rep 3 + dex; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell type=Breast Cancer Cells	cell line=MCF-7	genotype=WT	treatment=100nM Dexamethasone	time point=2h	chip antibody=ER (06-935, Merck)	geo_loc_name=missing	collection_date=missing"
SRX190279,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"70820678,87.5,12.4,7183",GSM1010823: HudsonAlpha ChipSeq T-47D ERalpha a BPA 100nM v041610.2,"GEO Accession=GSM1010823	antibody antibodydescription=Rabbit affinity purified polyclonal antibody. Epitope is the C-terminus of human estrogen receptor alpha (ESR1). Recommended for detection of estrogen receptor  of m, r and h origin by WB, IP, IF, IHC(P) and ELISA. Antibody Target: ESR1	antibody targetdescription=This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5-prime UTRs and use different promoters. (provided by RefSeq)	antibody vendorid=sc-543	antibody vendorname=Santa Cruz Biotechnology	antibody=ERalpha_a	cell description=epithelial cell line derived from a mammary ductal carcinoma.	cell karyotype=cancer	cell organism=human	cell sex=F	cell=T-47D	controlid=SL1490	datatype description=Chromatin IP Sequencing	datatype=ChipSeq	lab description=Myers - Hudson Alpha Institute for Biotechnology	lab=HudsonAlpha	labexpid=SL1877,SL1493	protocol description=2x10^7 cells, fragmentation by probe-in sonicator, one 15-cycle round of PCR (Myers)	protocol=v041610.2	replicate=1,2	softwareversion=MACS	treatment description=1 h with 100 nM Bisphenol A  (Myers)	treatment=BPA_100nM"
SRX19107399,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35044906,46.8,25.4,235","GSM6946075: HeLa S3, KO G9a, rep1; Homo sapiens; ATAC-seq",source_name=Human cervical carcinoma	tissue=Human cervical carcinoma	cell line=HeLa S3	cell type=Human cervical carcinoma cell	genotype=KO G9a	treatment=knockout G9a	geo_loc_name=missing	collection_date=missing
SRX19107400,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"30274274,53.5,24.1,262","GSM6946076: HeLa S3, KO G9a, rep2; Homo sapiens; ATAC-seq",source_name=Human cervical carcinoma	tissue=Human cervical carcinoma	cell line=HeLa S3	cell type=Human cervical carcinoma cell	genotype=KO G9a	treatment=knockout G9a	geo_loc_name=missing	collection_date=missing
SRX19107401,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"42116051,15.4,18.4,127","GSM6946077: HeLa S3,KO+T1045E, rep1; Homo sapiens; ATAC-seq",source_name=Human cervical carcinoma	tissue=Human cervical carcinoma	cell line=HeLa S3	cell type=Human cervical carcinoma cell	genotype=T1045E	treatment=knockout G9a transfect T1045E G9a	geo_loc_name=missing	collection_date=missing
SRX19107402,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"41990608,15.9,25.8,108","GSM6946078: HeLa S3,KO+T1045E, rep2; Homo sapiens; ATAC-seq",source_name=Human cervical carcinoma	tissue=Human cervical carcinoma	cell line=HeLa S3	cell type=Human cervical carcinoma cell	genotype=T1045E	treatment=knockout G9a transfect T1045E G9a	geo_loc_name=missing	collection_date=missing
SRX19107403,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"31072862,39.0,25.5,191","GSM6946079: HeLa S3, KO+WT,rep1; Homo sapiens; ATAC-seq",source_name=Human cervical carcinoma	tissue=Human cervical carcinoma	cell line=HeLa S3	cell type=Human cervical carcinoma cell	genotype=WT	treatment=knockout G9a transfect WT G9a	geo_loc_name=missing	collection_date=missing
SRX19107404,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35167942,40.8,22.6,240","GSM6946080: HeLa S3, KO+WT,rep2; Homo sapiens; ATAC-seq",source_name=Human cervical carcinoma	tissue=Human cervical carcinoma	cell line=HeLa S3	cell type=Human cervical carcinoma cell	genotype=WT	treatment=knockout G9a transfect WT G9a	geo_loc_name=missing	collection_date=missing
SRX19243841,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","51990821,39.9,9.8,54826","GSM7017467: ESC, lentivirus-vector, DMSO; Homo sapiens; ATAC-seq","source_name=Endometrium	tissue=Endometrium	cell type=stromal cells	genotype=WT	treatment=Lentivirus-vector, DMSO"
SRX19243842,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","46597369,40.0,10.1,44803","GSM7017468: ESC, lentivirus-vector, 1 μM P4 + 0.25 mM db-cAMP; Homo sapiens; ATAC-seq","source_name=Endometrium	tissue=Endometrium	cell type=stromal cells	genotype=WT	treatment=Lentivirus-vector, 1 microM P4 + 0.25 mM db-cAMP"
SRX19243843,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","53411582,17.2,12.4,24219","GSM7017469: ESC, lentivirus-CIP2A, 1 μM P4 + 0.25 mM db-cAMP; Homo sapiens; ATAC-seq","source_name=Endometrium	tissue=Endometrium	cell type=stromal cells	genotype=WT	treatment=Lentivirus-CIP2A, 1 micorM P4 + 0.25 mM db-cAMP"
SRX193384,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"6743109,0.1,15.2,0",GSM1017847: PR-T0 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D-MTVL breast cancer cell line	treatment=unstimulated cells	chip antibody=anti-PR (H190, Santa Cruz, #sc 7208, D2705 lot)	cell line=T47D-MTVL"
SRX193385,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"8020433,2.2,76.4,0",GSM1017848: PR-R5 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D-MTVL breast cancer cell line	treatment=R5020 5 minutes	chip antibody=anti-PR (H190, Santa Cruz, #sc 7208, D2705 lot)	cell line=T47D-MTVL"
SRX193386,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"7546307,1.8,63.9,0",GSM1017849: PR-R30 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D-MTVL breast cancer cell line	treatment=R5020 30 minutes	chip antibody=anti-PR (H190, Santa Cruz, #sc 7208, D2705 lot)	cell line=T47D-MTVL"
SRX193387,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"5755741,1.4,56.6,0",GSM1017850: PR-R60 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D-MTVL breast cancer cell line	treatment=R5020 60 minutes	chip antibody=anti-PR (H190, Santa Cruz, #sc 7208, D2705 lot)	cell line=T47D-MTVL"
SRX193388,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"6334761,3.3,69.6,0",GSM1017851: PR-R360 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D-MTVL breast cancer cell line	treatment=R5020 360 minutes	chip antibody=anti-PR (H190, Santa Cruz, #sc 7208, D2705 lot)	cell line=T47D-MTVL"
SRX194569,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26825998,99.1,21.3,49246",GSM1019125: ER REP1; Homo sapiens; ChIP-Seq,source_name=ER_ChIP	cell line=MCF7	library id=JC398	antibody=ER; sc-534 (santa cruz) Lot-(HC-20)	treatment=MCF7 cells in Complete DMEM media
SRX194572,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27404636,99.1,6.1,34645",GSM1019128: ER REP2; Homo sapiens; ChIP-Seq,source_name=ER_ChIP	cell line=MCF7	library id=JC430	antibody=ER; sc-534 (santa cruz) Lot-(HC-20)	treatment=MCF7 cells in Complete DMEM media
SRX194575,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24689879,90.8,14.3,29500",GSM1019131: ER XENO REP1; Homo sapiens; ChIP-Seq,source_name=ER_XENO_ChIP	cell line=MCF7	library id=JC546	antibody=ER; sc-534 (santa cruz) Lot-(HC-20)	treatment=MCF7 xenograft tumour in mouse
SRX19553531,hg38,TFs and others,FOS,Blood,Kasumi-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"34511100,95.3,23.8,20706",GSM7078445: FOS dnFOS CTRL; Homo sapiens; ChIP-Seq,"source_name=Kasumi-1	cell line=Kasumi-1	genotype=t(8;21)	treatment=dnFOS uninduced	antibody=cFOS (Invitrogen Cat# MA5-15055, RRID:AB_10984728)	geo_loc_name=missing	collection_date=missing"
SRX19553532,hg38,TFs and others,FOS,Blood,Kasumi-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"25754517,91.3,61.5,9308",GSM7078446: FOS dnFOS plusdnFOS; Homo sapiens; ChIP-Seq,"source_name=Kasumi-1	cell line=Kasumi-1	genotype=t(8;21)	treatment=dnFOS induced	antibody=cFOS (Invitrogen Cat# MA5-15055, RRID:AB_10984728)	geo_loc_name=missing	collection_date=missing"
SRX19553533,hg38,TFs and others,FOS,Blood,Kasumi-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"31248365,98.1,53.1,867",GSM7078447: FOS minusBEV; Homo sapiens; ChIP-Seq,"source_name=Kasumi-1	cell line=Kasumi-1	genotype=t(8;21)	treatment=Control	antibody=cFOS (Invitrogen Cat# MA5-15055, RRID:AB_10984728)	geo_loc_name=missing	collection_date=missing"
SRX19553534,hg38,TFs and others,FOS,Blood,Kasumi-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"32264215,98.2,64.6,1715",GSM7078448: FOS plusBEV; Homo sapiens; ChIP-Seq,"source_name=Kasumi-1	cell line=Kasumi-1	genotype=t(8;21)	treatment=Bevacizumab	antibody=cFOS (Invitrogen Cat# MA5-15055, RRID:AB_10984728)	geo_loc_name=missing	collection_date=missing"
SRX19553535,hg38,TFs and others,FOS,Blood,Kasumi-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"23164582,98.8,11.8,6189",GSM7078449: FOS shRE CTRL; Homo sapiens; ChIP-Seq,"source_name=Kasumi-1	cell line=Kasumi-1	genotype=t(8;21)	treatment=shRUNX1-ETO uninduced	antibody=cFOS (Invitrogen Cat# MA5-15055, RRID:AB_10984728)	geo_loc_name=missing	collection_date=missing"
SRX19553543,hg38,TFs and others,FOS,Blood,Kasumi-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"19994914,97.9,25.0,8578",GSM7078450: FOS shRE shRE; Homo sapiens; ChIP-Seq,"source_name=Kasumi-1	cell line=Kasumi-1	genotype=t(8;21)	treatment=shRUNX1-ETO induced	antibody=cFOS (Invitrogen Cat# MA5-15055, RRID:AB_10984728)	geo_loc_name=missing	collection_date=missing"
SRX1961155,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44629288,92.3,8.2,8332",GSM2242426: ER ChIP-seq BYL719 1; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=T47D	passages=5 to 10	chip-antibody=ER alpha (sc543) Santa Cruz
SRX1961156,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"39327871,91.8,6.2,8345",GSM2242427: ER ChIP-seq BYL719 2; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=T47D	passages=5 to 10	chip-antibody=ER alpha (sc543) Santa Cruz
SRX1961161,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"46088662,90.0,9.6,6771",GSM2242431: ER ChIP-seq DMSO 1; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=T47D	passages=5 to 10	chip-antibody=ER alpha (sc543) Santa Cruz
SRX1961162,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43084823,94.0,6.0,5833",GSM2242432: ER ChIP-seq DMSO 2; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=T47D	passages=5 to 10	chip-antibody=ER alpha (sc543) Santa Cruz
SRX19662626,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"13479205,94.6,21.9,20658",GSM7093735: T-47D c-JUN DMSO; Homo sapiens; ChIP-Seq,source_name=T-47D	cell line=T-47D	cell type=Breast; Ductal Carcinoma	chip antibody=c-JUN (BD Biosciences 558036)	treatment=DMSO (veh)	time=1 hour
SRX19662627,hg38,TFs and others,JUN,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"11499096,88.3,21.5,17476",GSM7093736: T-47D c-JUN E2; Homo sapiens; ChIP-Seq,source_name=T-47D	cell line=T-47D	cell type=Breast; Ductal Carcinoma	chip antibody=c-JUN (BD Biosciences 558036)	treatment=10 nM 17beta-estradiol	time=1 hour
SRX19662655,hg38,TFs and others,JUN,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23525583,95.5,15.0,21529",GSM7093713: Ishikawa c-JUN E2; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	cell type=Endometrial Adenocarcinoma	chip antibody=c-JUN (BD Biosciences 558036)	treatment=10 nM 17beta-estradiol	time=1 hour
SRX19662656,hg38,TFs and others,JUN,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"19599592,70.9,8.6,3102",GSM7093712: Ishikawa c-JUN DMSO; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	cell type=Endometrial Adenocarcinoma	chip antibody=c-JUN (BD Biosciences 558036)	treatment=DMSO (veh)	time=1 hour
SRX19732891,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","45552541,96.3,5.6,137250",GSM7108077: AT-FT282-1; Homo sapiens; ATAC-seq,source_name=Cell Line	tissue=Cell Line	cell line=FT282	cell type=Fallopian Tube Secretory Epithelium	antibody=NA	geo_loc_name=missing	collection_date=missing
SRX19732892,hg38,ATAC-Seq,ATAC-Seq,Uterus,Fallopian Tubes,"MeSH Description=A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.","45740309,96.2,5.9,136260",GSM7108078: AT-FT282-2; Homo sapiens; ATAC-seq,source_name=Cell Line	tissue=Cell Line	cell line=FT282	cell type=Fallopian Tube Secretory Epithelium	antibody=NA	geo_loc_name=missing	collection_date=missing
SRX19885613,hg38,TFs and others,MED12,Pancreas,SUIT-2,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma Tubular,"72984476,86.3,38.5,7497",GSM7151541: SUIT2-DELTAN-5-chip-MED12 CRISPRa; Homo sapiens; ChIP-Seq,"source_name=SUIT2	cell type=human pancreatic cancer cell line	cell line=SUIT2	genotype=sgTP63-2 (CRISPRa)	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX19885616,hg38,TFs and others,MED12,Pancreas,SUIT-2,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma Tubular,"73711256,86.5,15.5,3980",GSM7151544: SUIT2-NEG-1-chip-MED12 CRISPRa; Homo sapiens; ChIP-Seq,"source_name=SUIT2	cell type=human pancreatic cancer cell line	cell line=SUIT2	genotype=sgNT-1 (CRISPRa)	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX19885618,hg38,TFs and others,MED12,Pancreas,SUIT-2,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma Tubular,"59323105,88.2,23.8,4526",GSM7151546: SUIT2-NEG-2-chip-MED12 CRISPRa; Homo sapiens; ChIP-Seq,"source_name=SUIT2	cell type=human pancreatic cancer cell line	cell line=SUIT2	genotype=sgNT-2 (CRISPRa)	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX19885675,hg38,TFs and others,MED12,Pancreas,KLM-1,Primary Tissue=Pancreas|Tissue Diagnosis=Carcinoma,"56820067,84.2,45.7,16438",GSM7151533: klm1-ko-tp63-2-chip-p63; Homo sapiens; ChIP-Seq,"source_name=KLM1	cell type=human pancreatic cancer cell line	cell line=KLM1	genotype=sgTP63-187e4	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX19885818,hg38,TFs and others,MED12,Pancreas,KLM-1,Primary Tissue=Pancreas|Tissue Diagnosis=Carcinoma,"44194540,92.2,8.5,7106",GSM7151516: klm1-parental-chip-med12; Homo sapiens; ChIP-Seq,"source_name=KLM1	cell type=human pancreatic cancer cell line	cell line=KLM1	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX19885821,hg38,TFs and others,MED12,Pancreas,T3M-4,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma,"56546595,93.9,21.7,1428",GSM7151519: t3m4-parental-chip-med12; Homo sapiens; ChIP-Seq,"source_name=T3M4	cell type=human pancreatic cancer cell line	cell line=T3M4	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX19885825,hg38,TFs and others,MED12,Pancreas,KLM-1,Primary Tissue=Pancreas|Tissue Diagnosis=Carcinoma,"91121896,90.8,29.0,19386",GSM7151523: klm1-ko-rosa26-chip-med12; Homo sapiens; ChIP-Seq,"source_name=KLM1	cell type=human pancreatic cancer cell line	cell line=KLM1	genotype=sgROSA26	chip antibody=MED12, CST, D9K5J	geo_loc_name=missing	collection_date=missing"
SRX1995220,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"83271980,99.6,93.2,346",GSM2257819: ER E0h ChIPseq; Homo sapiens; ChIP-Seq,source_name=Luminal breast cancer cell line	cell line=MCF-7	chip antibody=ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	treatment=control	time=0h
SRX1995221,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"61389542,99.7,94.1,227",GSM2257820: ER E45m ChIPseq; Homo sapiens; ChIP-Seq,source_name=Luminal breast cancer cell line	cell line=MCF-7	chip antibody=ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	treatment=estrogen	time=45min
SRX1995222,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"54829580,99.2,91.0,217",GSM2257821: ER 3hE2 ChIPseq; Homo sapiens; ChIP-Seq,source_name=Luminal breast cancer cell line	cell line=MCF-7	chip antibody=ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	treatment=estrogen	time=3h
SRX1995229,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"130767449,97.8,39.9,49259",GSM2257828: siCTCF ER ChIPseq; Homo sapiens; ChIP-Seq,source_name=Luminal breast cancer cell line	cell line=MCF-7	chip antibody=ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	treatment=siCTCF
SRX1995230,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"152973299,97.9,31.7,47785",GSM2257829: siNT ER ChIPseq; Homo sapiens; ChIP-Seq,source_name=Luminal breast cancer cell line	cell line=MCF-7	chip antibody=ER-alpha: Santa Cruz Biotechnology sc-543 (lot #F1215)	treatment=siNT
SRX2010842,hg38,TFs and others,JUN,Lung,Calu-3,Primary Tissue=Lung|Tissue Diagnosis=Adenocarcinoma,"25281846,86.5,3.4,7128",GSM2266291: Calu-3 c-Jun ChIP-seq replicate 1; Homo sapiens; ChIP-Seq,source_name=c-Jun ChIP-seq	cell line=Calu-3 cells	cell type=Lung adenocarcinoma cells	chip antibody=c-Jun (sc-1694)	input used for homer peak calling=Calu-3 Input
SRX2010843,hg38,TFs and others,JUN,Lung,Calu-3,Primary Tissue=Lung|Tissue Diagnosis=Adenocarcinoma,"53091280,87.7,7.5,3748",GSM2266292: Calu-3 c-Jun ChIP-seq replicate 2; Homo sapiens; ChIP-Seq,source_name=c-Jun ChIP-seq	cell line=Calu-3 cells	cell type=Lung adenocarcinoma cells	chip antibody=c-Jun (sc-1694)	input used for homer peak calling=Calu-3 Input
SRX20282938,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35133111,99.4,37.0,35047","GSM7324191: MCF7,ERα,DIM, Biol Rep1; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282939,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32213155,99.4,31.8,50140","GSM7324192: MCF7,ERα,DIM, Biol Rep2; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282940,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34444022,98.8,63.9,45676","GSM7324193: MCF7,ERα,DIM, Biol Rep3; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282944,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28391115,99.2,26.6,14090","GSM7324197: MCF7,ERα,DMSO, Biol Rep1; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282945,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29603132,99.0,40.4,17864","GSM7324198: MCF7,ERα,DMSO, Biol Rep2; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282946,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24321273,98.6,43.0,30096","GSM7324199: MCF7,ERα,DMSO,Biol Rep3; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282953,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21741737,99.2,35.0,35713","GSM7324206: MCF7,ERα,E2, Biol Rep1; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282954,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28176775,99.2,40.1,47098","GSM7324207: MCF7,ERα,E2, Biol Rep2; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282955,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24988119,99.0,36.0,44210","GSM7324208: MCF7,ERα,E2, Biol Rep3; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282959,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22635762,99.4,33.3,22465","GSM7324212: MCF7,ERα,RES, Biol Rep1; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282960,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26310479,99.3,38.8,49112","GSM7324213: MCF7,ERα,RES, Biol Rep2; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282961,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40859738,99.2,52.4,51408","GSM7324214: MCF7,ERα,RES, Biol Rep3; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282965,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21277888,99.4,15.2,6051","GSM7324218: MCF7,ERα,TCDD, Biol Rep1; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282966,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25927842,98.1,34.4,20743","GSM7324219: MCF7,ERα,TCDD, Biol Rep2; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282967,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25211309,99.0,38.5,19073","GSM7324220: MCF7,ERα,TCDD, Biol Rep3; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282971,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27543914,98.8,43.4,40838","GSM7324224: MCF7,ERα,E2+TCDD, Biol Rep1; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282972,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31510645,99.2,39.0,48156","GSM7324225: MCF7,ERα,E2+TCDD, Biol Rep2; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20282973,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24515465,99.2,50.8,49243","GSM7324226: MCF7,ERα,E2+TCDD, Biol Rep3; Homo sapiens; ChIP-Seq","source_name=Human Breast Cancer Cell	cell line=Human Breast Cancer Cell	cell type=MCF-7	chip antibody=ERα (Santa Cruz, #sc-542)	geo_loc_name=missing	collection_date=missing"
SRX20355950,hg38,TFs and others,JUN,Prostate,NCI-H660,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma Small Cell,"41369127,74.0,31.9,5033","GSM7350174: NCI-H660 cells, siFOXA2, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=NCI-H660	cell line=NCI-H660	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=FOXA2 knockdown	geo_loc_name=missing	collection_date=missing
SRX20355951,hg38,TFs and others,JUN,Prostate,NCI-H660,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma Small Cell,"36795407,79.0,29.9,7991","GSM7350175: NCI-H660 cells, siNC, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=NCI-H660	cell line=NCI-H660	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=Negative control knockdown	geo_loc_name=missing	collection_date=missing
SRX20355955,hg38,TFs and others,JUN,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"49026334,39.0,61.0,6466","GSM7350179: LNCaP FOXA2OE cells, vehicle, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=LNCaP_FOXA2OE	cell line=LNCaP_FOXA2OE	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=vehicle	geo_loc_name=missing	collection_date=missing
SRX20355956,hg38,TFs and others,JUN,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"47914993,67.1,53.4,791","GSM7350180: LNCaP cells, siFOXA1, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=LNCaP	cell line=LNCaP	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=FOXA1 knockdown	geo_loc_name=missing	collection_date=missing
SRX20355957,hg38,TFs and others,JUN,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"35888058,66.5,44.2,947","GSM7350181: LNCaP cells, siNC, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=LNCaP	cell line=LNCaP	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=Negative control knockdown	geo_loc_name=missing	collection_date=missing
SRX20355962,hg38,TFs and others,JUN,Prostate,PC-3,Primary Tissue=Prostate|Tissue Diagnosis=Adenocarcinoma,"24710650,82.1,27.0,1376","GSM7350186: PC3 cells, siFOXA2, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=PC3	cell line=PC3	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=FOXA2 knockdown	geo_loc_name=missing	collection_date=missing
SRX20355964,hg38,TFs and others,JUN,Prostate,PC-3,Primary Tissue=Prostate|Tissue Diagnosis=Adenocarcinoma,"36034608,76.8,30.7,15231","GSM7350188: PC3 cells, siNC, ChIP-JUN; Homo sapiens; ChIP-Seq",source_name=PC3	cell line=PC3	cell type=Prostate cancer cell line	chip antibody=anti-JUN	treatment=Negative control knockdown	geo_loc_name=missing	collection_date=missing
SRX20519358,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ect1/E6E7,Tissue=Ectocervix; Cervix|Cell Type=Epithelial,"41406008,95.4,12.4,27550",GSM7428174: ecto LC bacteria supernatants r2; Homo sapiens; ATAC-seq,"source_name=ectocervical, Ect1/E6E7	cell type=ectocervical, Ect1/E6E7	treatment=Bacteria Supernatants	strain=Lactobacillus crispatus	geo_loc_name=missing	collection_date=missing"
SRX20519359,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ect1/E6E7,Tissue=Ectocervix; Cervix|Cell Type=Epithelial,"34445569,94.0,11.1,63896",GSM7428175: ecto LC bacteria supernatants r3; Homo sapiens; ATAC-seq,"source_name=ectocervical, Ect1/E6E7	cell type=ectocervical, Ect1/E6E7	treatment=Bacteria Supernatants	strain=Lactobacillus crispatus	geo_loc_name=missing	collection_date=missing"
SRX20519365,hg38,ATAC-Seq,ATAC-Seq,Uterus,End1/E6E7,Tissue=Endocervix; Cervix|Cell Type=Epithelial|Disease=Endometriosis,"39681955,94.2,12.6,40202",GSM7428181: endo LC bacteria supernatants r3; Homo sapiens; ATAC-seq,"source_name=endocervical, End1/E6E7	cell type=endocervical, End1/E6E7	treatment=Bacteria Supernatants	strain=Lactobacillus crispatus	geo_loc_name=missing	collection_date=missing"
SRX20519366,hg38,ATAC-Seq,ATAC-Seq,Uterus,End1/E6E7,Tissue=Endocervix; Cervix|Cell Type=Epithelial|Disease=Endometriosis,"46714540,95.6,15.2,55441",GSM7428182: endo bacteria supernatant NYC control r1; Homo sapiens; ATAC-seq,"source_name=endocervical, End1/E6E7	cell type=endocervical, End1/E6E7	treatment=Bacteria Supernatants	strain=NYC bacteria media	geo_loc_name=missing	collection_date=missing"
SRX20519368,hg38,ATAC-Seq,ATAC-Seq,Uterus,End1/E6E7,Tissue=Endocervix; Cervix|Cell Type=Epithelial|Disease=Endometriosis,"49067436,94.6,18.9,30376",GSM7428184: endo bacteria supernatant NYC control r3; Homo sapiens; ATAC-seq,"source_name=endocervical, End1/E6E7	cell type=endocervical, End1/E6E7	treatment=Bacteria Supernatants	strain=NYC bacteria media	geo_loc_name=missing	collection_date=missing"
SRX20519369,hg38,ATAC-Seq,ATAC-Seq,Uterus,VK2/E6E7,"Tissue=Vagina, Mucosa|Cell Type=Epithelial|Disease=Endometriosis","49265461,92.6,16.3,76988",GSM7428185: vag LC bacteria supernatants r1; Homo sapiens; ATAC-seq,"source_name=vaginal, VK2/E6E7	cell type=vaginal, VK2/E6E7	treatment=Bacteria Supernatants	strain=Lactobacillus crispatus	geo_loc_name=missing	collection_date=missing"
SRX20519370,hg38,ATAC-Seq,ATAC-Seq,Uterus,VK2/E6E7,"Tissue=Vagina, Mucosa|Cell Type=Epithelial|Disease=Endometriosis","48305837,94.3,13.4,48535",GSM7428186: vag LC bacteria supernatants r2; Homo sapiens; ATAC-seq,"source_name=vaginal, VK2/E6E7	cell type=vaginal, VK2/E6E7	treatment=Bacteria Supernatants	strain=Lactobacillus crispatus	geo_loc_name=missing	collection_date=missing"
SRX20519372,hg38,ATAC-Seq,ATAC-Seq,Uterus,VK2/E6E7,"Tissue=Vagina, Mucosa|Cell Type=Epithelial|Disease=Endometriosis","46577558,93.8,15.5,73869",GSM7428188: vag bacteria supernatant NYC control r1; Homo sapiens; ATAC-seq,"source_name=vaginal, VK2/E6E7	cell type=vaginal, VK2/E6E7	treatment=Bacteria Supernatants	strain=NYC bacteria media	geo_loc_name=missing	collection_date=missing"
SRX20519373,hg38,ATAC-Seq,ATAC-Seq,Uterus,VK2/E6E7,"Tissue=Vagina, Mucosa|Cell Type=Epithelial|Disease=Endometriosis","49113144,94.0,14.6,61262",GSM7428189: vag bacteria supernatant NYC control r2; Homo sapiens; ATAC-seq,"source_name=vaginal, VK2/E6E7	cell type=vaginal, VK2/E6E7	treatment=Bacteria Supernatants	strain=NYC bacteria media	geo_loc_name=missing	collection_date=missing"
SRX20519374,hg38,ATAC-Seq,ATAC-Seq,Uterus,VK2/E6E7,"Tissue=Vagina, Mucosa|Cell Type=Epithelial|Disease=Endometriosis","59112035,93.7,17.1,74061",GSM7428190: vag bacteria supernatant NYC control r3; Homo sapiens; ATAC-seq,"source_name=vaginal, VK2/E6E7	cell type=vaginal, VK2/E6E7	treatment=Bacteria Supernatants	strain=NYC bacteria media	geo_loc_name=missing	collection_date=missing"
SRX2055845,hg38,TFs and others,JUN,Kidney,Renal cell carcinoma,,"73151483,96.3,37.1,14072",GSM2293479: 786-O C-Jun ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=ccRCC cell line	transcription factor=C-Jun	chip antibody=c-Jun (sc-1694, Santa Cruz)	source=786-O (ATCC CRL1932)"
SRX20579070,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"21400264,74.7,18.0,15980","GSM7440422: H3K27ac,TSA,rep1; Homo sapiens; ChIP-Seq",source_name=HeLa	cell line=HeLa	treatment=TSA	chip antibody=H3K27ac	geo_loc_name=missing	collection_date=missing
SRX20579071,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"22519926,75.3,18.9,16212","GSM7440423: H3K27ac,TSA,rep2; Homo sapiens; ChIP-Seq",source_name=HeLa	cell line=HeLa	treatment=TSA	chip antibody=H3K27ac	geo_loc_name=missing	collection_date=missing
SRX20579072,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"22819401,77.1,17.3,17005","GSM7440424: H3K27ac,TSA,rep3; Homo sapiens; ChIP-Seq",source_name=HeLa	cell line=HeLa	treatment=TSA	chip antibody=H3K27ac	geo_loc_name=missing	collection_date=missing
SRX20579073,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"21842308,75.4,17.6,916","GSM7440425: H3K27ac,DMSO,rep1; Homo sapiens; ChIP-Seq",source_name=HeLa	cell line=HeLa	treatment=DMSO	chip antibody=H3K27ac	geo_loc_name=missing	collection_date=missing
SRX20579074,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"22195506,74.4,17.1,958","GSM7440426: H3K27ac,DMSO,rep2; Homo sapiens; ChIP-Seq",source_name=HeLa	cell line=HeLa	treatment=DMSO	chip antibody=H3K27ac	geo_loc_name=missing	collection_date=missing
SRX20579075,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"22078960,74.3,17.3,911","GSM7440427: H3K27ac,DMSO,rep3; Homo sapiens; ChIP-Seq",source_name=HeLa	cell line=HeLa	treatment=DMSO	chip antibody=H3K27ac	geo_loc_name=missing	collection_date=missing
SRX20783691,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"65694627,98.3,46.0,31536",GSM7493779: ATACseq.AN3CA.ARID1A AQGscramC1C2.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783692,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"81595924,98.3,59.5,45145",GSM7493780: ATACseq.AN3CA.ARID1A AQGscramC1C2.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783693,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"43947920,96.2,55.0,35240",GSM7493781: ATACseq.AN3CA.ARID1A Y42S.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783694,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"60749318,95.5,27.1,13297",GSM7493782: ATACseq.AN3CA.ARID1A Y42S.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783695,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"47753304,96.3,46.5,56356",GSM7493783: ATACseq.AN3CA.ARID1B A457 G461del.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783696,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"46293062,95.8,49.3,51121",GSM7493784: ATACseq.AN3CA.ARID1B A457 G461del.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783697,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"48320529,95.6,56.7,35861",GSM7493785: ATACseq.AN3CA.ARID1B Block13del.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783698,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35174330,96.7,52.0,34595",GSM7493786: ATACseq.AN3CA.ARID1B Block13del.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783699,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"44657225,95.9,51.3,36575",GSM7493787: ATACseq.AN3CA.ARID1B Block9del.Rep1; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20783700,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"50114332,95.8,54.8,35833",GSM7493788: ATACseq.AN3CA.ARID1B Block9del.Rep2; Homo sapiens; ATAC-seq,source_name=AN3CA	cell line=AN3CA	cell type=human endometrial carcinoma	genotype=AN3CA cells expressing empty vector control	geo_loc_name=missing	collection_date=missing
SRX20827910,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"16978357,97.1,14.2,5759","GSM7519156: HeLa Parental, H3K27ac; Homo sapiens; ChIP-Seq","source_name=HeLa	cell line=HeLa	cell type=Cervical cancer cells	chip antibody=H3K27ac (CST, #4353)	geo_loc_name=missing	collection_date=missing"
SRX20827911,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"17703116,98.4,18.1,4912","GSM7519157: HeLa sgKDM5C, H3K27ac; Homo sapiens; ChIP-Seq","source_name=HeLa	cell line=HeLa	cell type=Cervical cancer cells	chip antibody=H3K27ac (CST, #4353)	geo_loc_name=missing	collection_date=missing"
SRX20830442,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"42741557,87.5,9.8,4087",GSM7519228: T47D Clone28 ER DMSO rep2; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830443,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"45203464,87.7,10.4,4838",GSM7519227: T47D Clone28 ER DMSO rep1; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830444,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"42060911,89.3,11.2,4568",GSM7519229: T47D Clone28 ER DMSO rep3; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830445,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"41195875,90.0,15.6,4662",GSM7519230: T47D Clone28 ER DMSO rep4; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830446,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43128391,89.9,9.3,4851",GSM7519231: T47D Clone28 ER dTAG rep1; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830447,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"40572860,90.6,10.1,4682",GSM7519232: T47D Clone28 ER dTAG rep2; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830448,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44474736,89.9,11.2,4445",GSM7519233: T47D Clone28 ER dTAG rep3; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830451,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"40001315,86.2,14.2,5146",GSM7519234: T47D Clone28 ER dTAG rep4; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=ER	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830469,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"15231511,97.9,2.4,445",GSM7519267: T47D Clone28 PR DMSO rep1; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830470,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"11537595,97.8,2.3,300",GSM7519268: T47D Clone28 PR DMSO rep2; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830471,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"13166978,97.9,2.5,423",GSM7519269: T47D Clone28 PR DMSO rep3; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830472,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"11116268,97.7,2.4,377",GSM7519270: T47D Clone28 PR DMSO rep4; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=0.1% v/v DMSO for 24 hours	geo_loc_name=missing	collection_date=missing
SRX20830473,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"13983910,97.5,2.4,520",GSM7519271: T47D Clone28 PR dTAG rep1; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830474,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"14012125,97.5,2.4,582",GSM7519272: T47D Clone28 PR dTAG rep2; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830475,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"10684565,97.4,2.4,318",GSM7519273: T47D Clone28 PR dTAG rep3; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX20830476,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"18073288,97.7,2.6,829",GSM7519274: T47D Clone28 PR dTAG rep4; Homo sapiens; ChIP-Seq,source_name=T47D_dTAG_TRPS1_Clone_28	cell line=T47D_dTAG_TRPS1_Clone_28	chip antibody=PR	treatment=50nM dTAG-13 + 50nM dTAG-V-1 for 30 minutes	geo_loc_name=missing	collection_date=missing
SRX21168139,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"12443632,98.8,47.5,18429",GSM7662908: HEC1B siNC 24hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=WT	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168140,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"8171526,98.8,44.4,13770",GSM7662909: HEC1B siNC 36hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=WT	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168141,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"10084590,98.6,44.9,17403",GSM7662910: HEC1B siNC 48hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=WT	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168142,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"10682150,98.5,63.0,12387",GSM7662911: HEC1B siPRMT6-1 24hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=PRMT6 knockdown	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168143,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"10355014,98.7,44.6,18972",GSM7662912: HEC1B siPRMT6-1 36hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=PRMT6 knockdown	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168144,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"5838065,97.2,40.6,14639",GSM7662913: HEC1B siPRMT6-1 48hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=PRMT6 knockdown	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168145,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"11116684,98.6,22.7,20413",GSM7662914: HEC1B siPRMT6-2 24hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=PRMT6 knockdown	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168146,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"7448394,98.8,36.6,12783",GSM7662915: HEC1B siPRMT6-2 36hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=PRMT6 knockdown	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21168147,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"9628104,98.7,41.6,18436",GSM7662916: HEC1B siPRMT6-2 48hr H3K27ac; Homo sapiens; ChIP-Seq,"source_name=HEC1B	cell line=HEC1B	cell type=endometrial cancer	genotype=PRMT6 knockdown	chip antibody=H3K27ac (Cell Signaling Technology, 8173S)	geo_loc_name=missing	collection_date=missing"
SRX21439722,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"49251718,96.5,7.7,81309",GSM7720706: LNCaP 3X ERa 4h rep1; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Neutral MACC construct (3X) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of the neutral MACC construct (3X)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439723,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"45559888,95.9,6.8,53465",GSM7720707: LNCaP 3X ERa 4h rep2; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Neutral MACC construct (3X) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of the neutral MACC construct (3X)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439724,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"46527839,95.1,7.1,51125",GSM7720708: LNCaP 3X ERa 4h rep3; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Neutral MACC construct (3X) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of the neutral MACC construct (3X)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439732,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"49500874,91.0,7.8,5040",GSM7720716: LNCaP KRAB ERa 4h rep1; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Repressive MACC construct (KRAB) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of Repressive MACC construct (KRAB)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439733,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"57090561,93.5,8.5,6312",GSM7720717: LNCaP KRAB ERa 4h rep2; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Repressive MACC construct (KRAB) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of Repressive MACC construct (KRAB)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439734,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"57530834,92.7,7.4,17448",GSM7720718: LNCaP KRAB ERa 4h rep3; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Repressive MACC construct (KRAB) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of Repressive MACC construct (KRAB)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439742,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"42055888,95.5,6.9,10463",GSM7720726: LNCaP VP64 ERa 4h rep1; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Activating MACC construct (VP64) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of Activating MACC construct (VP64)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439743,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"43645429,95.1,10.1,26860",GSM7720727: LNCaP VP64 ERa 4h rep2; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Activating MACC construct (VP64) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of Activating MACC construct (VP64)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX21439744,hg38,TFs and others,ESR1,Prostate,LNCAP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"49774399,95.5,8.5,14065",GSM7720728: LNCaP VP64 ERa 4h rep3; Homo sapiens; ChIP-Seq,"source_name=4h	cell line=ectopic Activating MACC construct (VP64) expressed LNCaP cell line	cell type=human prostate cancer cell line	genotype=Ectopic expression of Activating MACC construct (VP64)	treatment=2.5uM Tamoxifen, 4h	chip antibody=ERalpha (ERa) antibody from Santa Cruz Biotechnology (Cat# sc-8002, AB_627558)	geo_loc_name=missing	collection_date=missing"
SRX2145563,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"81097310,82.8,73.6,11743",GSM2305313: MCF7 E2 ER ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF7_E2_ER_ChIPseq	cell type=MCF7	cell subtype=Wild Type	condition=White Medium + E2
SRX2145566,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"123161277,98.0,63.3,3808",GSM2305316: MCF7 LTED noE2 ER ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF7_LTED_noE2_ER_ChIPseq	cell type=MCF7	cell subtype=Long Term Estrogen Deprivation	condition=White Medium
SRX2145567,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"110304053,88.6,82.8,14832",GSM2305317: MCF7 LTED E2 ER ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF7_LTED_E2_ER_ChIPseq	cell type=MCF7	cell subtype=Long Term Estrogen Deprivation	condition=White Medium + E2
SRX21480181,hg38,TFs and others,FOS,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"17026042,97.5,57.5,15451",GSM7732659: P1137 MV411 cFOS ChIP FLT3i Rep1; Homo sapiens; ChIP-Seq,"source_name=MV411	cell line=MV411	genotype=FLT3-ITD	target=cFOS	antibody=Invitrogen, MA5-15055	treatment=FLT3i	geo_loc_name=missing	collection_date=missing"
SRX21480182,hg38,TFs and others,FOS,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"51542889,98.3,27.8,12237",GSM7732660: P1137 MV411 cFOS ChIP Untreated Rep1; Homo sapiens; ChIP-Seq,"source_name=MV411	cell line=MV411	genotype=FLT3-ITD	target=cFOS	antibody=Invitrogen, MA5-15055	treatment=Untreated	geo_loc_name=missing	collection_date=missing"
SRX21480183,hg38,TFs and others,FOS,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"5480899,56.3,54.1,180",GSM7732661: P1383 MV411 cFOS ChIP FLT3i Rep2; Homo sapiens; ChIP-Seq,"source_name=MV411	cell line=MV411	genotype=FLT3-ITD	target=cFOS	antibody=Invitrogen, MA5-15055	treatment=FLT3i	geo_loc_name=missing	collection_date=missing"
SRX21480184,hg38,TFs and others,FOS,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"18838883,32.3,66.4,1124",GSM7732662: P1383 MV411 cFOS ChIP Untreated Rep2; Homo sapiens; ChIP-Seq,"source_name=MV411	cell line=MV411	genotype=FLT3-ITD	target=cFOS	antibody=Invitrogen, MA5-15055	treatment=Untreated	geo_loc_name=missing	collection_date=missing"
SRX2158966,hg38,Histone,H3K27ac,Uterus,Endometriosis,"MeSH Description=An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.","22375367,94.8,14.7,43905",GSM2308934: SCR rep1 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometriosis	cell type=hTERT immortalized endometriosis cells	genotype/variation=Control	antibody=H3K27ac
SRX2158970,hg38,Histone,H3K27ac,Uterus,Endometriosis,"MeSH Description=An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.","23988603,86.2,5.7,30326",GSM2308938: SCR rep2 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometriosis	cell type=hTERT immortalized endometriosis cells	genotype/variation=Control	antibody=H3K27ac
SRX2158975,hg38,Histone,H3K27ac,Uterus,Endometriosis,"MeSH Description=An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.","21663817,94.0,25.6,26419",GSM2308943: KD1 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometriosis	cell type=hTERT immortalized endometriosis cells	genotype/variation=ARID1A Knockdown	antibody=H3K27ac
SRX2158979,hg38,Histone,H3K27ac,Uterus,Endometriosis,"MeSH Description=An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.","13829111,88.3,9.4,23326",GSM2308947: KD2 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometriosis	cell type=hTERT immortalized endometriosis cells	genotype/variation=ARID1A Knockdown	antibody=H3K27ac
SRX22001606,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","92556217,95.5,30.3,48836","GSM7825096: H3K27ac histone mark of subject 1, term not in labor; Homo sapiens; ChIP-Seq","source_name=Myometrium	chip target=H3K27ac	pregnancy day=Term not in labor	antibody=Active Motif, cat # 39133	geo_loc_name=missing	collection_date=missing"
SRX22001609,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","58486974,88.5,51.1,26220","GSM7825099: H3K27ac histone mark of subject 2, term not in labor; Homo sapiens; ChIP-Seq","source_name=Myometrium	chip target=H3K27ac	pregnancy day=Term not in labor	antibody=Active Motif, cat # 39133	geo_loc_name=missing	collection_date=missing"
SRX22001612,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","96255040,94.4,25.4,59756","GSM7825102: H3K27ac histone mark of subject 3, term not in labor; Homo sapiens; ChIP-Seq","source_name=Myometrium	chip target=H3K27ac	pregnancy day=Term not in labor	antibody=Active Motif, cat # 39133	geo_loc_name=missing	collection_date=missing"
SRX220061,hg38,TFs and others,PGR,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"22100036,79.7,6.1,904",GSM1071296: PR PR infected; Homo sapiens; ChIP-Seq,source_name=primary HUVECs	cell type=endothelial cells	treatment=PR infected	ChIP=PR
SRX220062,hg38,TFs and others,PGR,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"23518196,74.0,6.0,4053",GSM1071297: PR PR infected+Prog; Homo sapiens; ChIP-Seq,source_name=primary HUVECs	cell type=endothelial cells	treatment=PR infected + Progesterone	ChIP=PR
SRX220063,hg38,TFs and others,PGR,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"17433554,83.6,5.7,689",GSM1071298: IgG PR infected; Homo sapiens; ChIP-Seq,source_name=primary HUVECs	cell type=endothelial cells	treatment=PR infected	ChIP=PR
SRX222272,hg38,TFs and others,ESR1,Prostate,VCaP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"253164359,68.9,70.8,3587",GSM1076109: VCaP  [ERα ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=VCaP cell line	cell line=Prostate cancer cell line	passages=3 to 4	chip antibody=ERα (diagenode, AC-066-100, lot # 001)"
SRX222273,hg38,TFs and others,ESR1,Prostate,VCaP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"35641982,36.0,31.2,18148",GSM1076110: VCaP + E2 [ERα ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=VCaP cell line	cell line=Prostate cancer cell line	agent=E2	passages=3 to 4	chip antibody=ERα (diagenode, AC-066-100, lot # 001)"
SRX222274,hg38,TFs and others,ESR1,Prostate,VCaP,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma,"247782619,73.9,35.0,4089",GSM1076111: VCaP ERa + E2 [ERα ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=VCaP ERa cell line	cell line=Prostate cancer cell line overexpressing ERa	agent=E2	passages=10 to 12	chip antibody=ERα (diagenode, AC-066-100, lot # 001)"
SRX222275,hg38,TFs and others,ESR1,Prostate,NCI-H660,Primary Tissue=Prostate|Tissue Diagnosis=Carcinoma Small Cell,"37192796,48.3,27.9,14537",GSM1076112: NCI H660 + E2 [ERα ChIP-Seq]; Homo sapiens; ChIP-Seq,"source_name=NCI H660 cell line	cell line=Prostate cancer cell line	agent=E2	passages=4 to 5	chip antibody=ERα (diagenode, AC-066-100, lot # 001)"
SRX22482859,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"56840366,71.5,59.1,52413",GSM7890684: HeLaS3-NT1; Homo sapiens; ATAC-seq,source_name=Cervical adenocarcinoma	tissue=Cervical adenocarcinoma	cell line=HeLaS3	treatment=none	geo_loc_name=missing	collection_date=missing
SRX22482860,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"33471421,49.1,58.2,20942",GSM7890685: HeLaS3-TRIP12-IDR1; Homo sapiens; ATAC-seq,source_name=Cervical adenocarcinoma	tissue=Cervical adenocarcinoma	cell line=HeLaS3	treatment=transfected	geo_loc_name=missing	collection_date=missing
SRX22482861,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"31929728,66.1,52.0,33125",GSM7890686: HeLaS3-NT2; Homo sapiens; ATAC-seq,source_name=Cervical adenocarcinoma	tissue=Cervical adenocarcinoma	cell line=HeLaS3	treatment=none	geo_loc_name=missing	collection_date=missing
SRX22482862,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"33582861,61.7,40.4,8349",GSM7890687: HeLaS3-TRIP12-IDR2; Homo sapiens; ATAC-seq,source_name=Cervical adenocarcinoma	tissue=Cervical adenocarcinoma	cell line=HeLaS3	treatment=transfected	geo_loc_name=missing	collection_date=missing
SRX2355072,hg38,TFs and others,JUN,Cardiovascular,HAEC,Primary Tissue=Aorta|Tissue Diagnosis=Normal,"39057812,89.7,71.5,47262",GSM2394414: HAEC.ChIP.JUN.control.4h.rep1; Homo sapiens; ChIP-Seq,"source_name=human aortic endothelial cell	cell type=HAEC	passage=6 to 10	chip antibody=JUN, Santa Cruz #sc-13032X	treatment=control, 4h"
SRX2355073,hg38,TFs and others,JUN,Cardiovascular,HAEC,Primary Tissue=Aorta|Tissue Diagnosis=Normal,"32324622,90.2,63.0,54296",GSM2394415: HAEC.ChIP.JUN.control.4h.rep2; Homo sapiens; ChIP-Seq,"source_name=human aortic endothelial cell	cell type=HAEC	passage=6 to 10	chip antibody=JUN, Santa Cruz #sc-13032X	treatment=control, 4h"
SRX23612300,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"45589329,20.2,66.8,50",GSM8076234: Sample 9; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=WT	treatment=dCas9-SunTag + sgR-Ctrl + 500 nM Bio-PDC	geo_loc_name=missing	collection_date=missing
SRX23612301,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"41953086,24.2,73.5,40",GSM8076235: Sample 10; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=WT	treatment=dCas9-SunTag + sgR-Ctrl + 500 nM Bio-PDC	geo_loc_name=missing	collection_date=missing
SRX23612302,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"45169279,24.6,75.8,44",GSM8076236: Sample 11; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=NEAT1/MALAT1 inhibition	treatment=dCas9-SunTag + sgR-lncRNAs + 500 nM Bio-PDC	geo_loc_name=missing	collection_date=missing
SRX23612303,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"50121072,20.7,68.9,60",GSM8076237: Sample 12; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=NEAT1/MALAT1 inhibition	treatment=dCas9-SunTag + sgR-lncRNAs + 500 nM Bio-PDC	geo_loc_name=missing	collection_date=missing
SRX23612304,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"51522678,27.1,70.2,78",GSM8076238: Sample 13; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=WT	treatment=dCas9-nucleolin + sgR-Ctrl	geo_loc_name=missing	collection_date=missing
SRX23612305,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"45378645,22.2,67.6,61",GSM8076239: Sample 14; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=WT	treatment=dCas9-nucleolin + sgR-Ctrl	geo_loc_name=missing	collection_date=missing
SRX23612306,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"49498885,22.6,64.7,66",GSM8076240: Sample 15; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=MYC inhibition	treatment=dCas9-nucleolin + sgR-5	geo_loc_name=missing	collection_date=missing
SRX23612307,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"50700111,34.3,72.7,89",GSM8076241: Sample 16; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa cells	genotype=MYC inhibition	treatment=dCas9-nucleolin + sgR-5	geo_loc_name=missing	collection_date=missing
SRX24151138,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22636118,99.0,11.9,1339","GSM8187003: BRD4-dTAG, Veh, ER; Homo sapiens; ChIP-Seq","source_name=breast	tissue=breast	cell line=MCF7	cell type=breast cancer cells	chip antibody=ER, Santa Cruz F-10, D-12	treatment=DMSO, ethanol	geo_loc_name=missing	collection_date=missing"
SRX24151139,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19510014,99.1,11.7,7791","GSM8187004: BRD4-dTAG, E2, ER; Homo sapiens; ChIP-Seq","source_name=breast	tissue=breast	cell line=MCF7	cell type=breast cancer cells	chip antibody=ER, Santa Cruz F-10, D-12	treatment=DMSO, E2	geo_loc_name=missing	collection_date=missing"
SRX24151140,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20461683,99.0,13.1,11443","GSM8187005: BRD4-dTAG, dTAG, E2, ER; Homo sapiens; ChIP-Seq","source_name=breast	tissue=breast	cell line=MCF7	cell type=breast cancer cells	chip antibody=ER, Santa Cruz F-10, D-12	treatment=dTAG, E2	geo_loc_name=missing	collection_date=missing"
SRX2423570,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28575262,97.9,16.5,2126",GSM2423124: ChIP-seq from MCF-7 (ENCLB720CSU); Homo sapiens; ChIP-Seq,"dev stage=adult	cell line=MCF-7	sex=female	sample type=immortalized cell line	donor ID=ENCDO000AAE	age=69 year	health state=breast cancer (adenocarcinoma)	lab=Michael Snyder, Stanford"
SRX2423571,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41595398,97.9,5.1,2527",GSM2423125: ChIP-seq from MCF-7 (ENCLB508LER); Homo sapiens; ChIP-Seq,"dev stage=adult	cell line=MCF-7	sex=female	sample type=immortalized cell line	donor ID=ENCDO000AAE	age=69 year	health state=breast cancer (adenocarcinoma)	lab=Michael Snyder, Stanford"
SRX2424722,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"30740986,98.9,10.1,870",GSM2424253: ChIP-seq from A549 (ENCLB747WRD); Homo sapiens; ChIP-Seq,"dev stage=adult	cell line=A549	sex=male	sample type=immortalized cell line	donor ID=ENCDO000AAZ	age=58 year	lab=Michael Snyder, Stanford"
SRX2424723,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"26939456,97.2,3.8,883",GSM2424254: ChIP-seq from A549 (ENCLB481CKC); Homo sapiens; ChIP-Seq,"dev stage=adult	cell line=A549	sex=male	sample type=immortalized cell line	donor ID=ENCDO000AAZ	age=58 year	lab=Michael Snyder, Stanford"
SRX2443742,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"19596777,98.3,2.5,9320",GSM2437720: ChIP-seq from A549 (ENCLB403GIO); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	sample type=immortalized cell line	cell line=A549"
SRX2443743,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21526589,98.3,2.8,2564",GSM2437721: ChIP-seq from A549 (ENCLB894JSW); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	sample type=immortalized cell line	cell line=A549"
SRX2443747,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"25106058,98.8,5.8,24558",GSM2437725: ChIP-seq from A549 (ENCLB284UFR); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 10; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443748,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22049962,98.5,2.5,3173",GSM2437726: ChIP-seq from A549 (ENCLB968UIB); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 10; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443749,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21029089,98.8,2.4,5492",GSM2437727: ChIP-seq from A549 (ENCLB767WAP); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 10; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443784,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"23104149,98.5,2.9,4172",GSM2437801: ChIP-seq from A549 (ENCLB106MTE); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 3; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443785,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20587730,98.4,2.5,3689",GSM2437802: ChIP-seq from A549 (ENCLB185DPX); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 3; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443786,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21305214,98.8,2.9,6401",GSM2437803: ChIP-seq from A549 (ENCLB784ODX); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 3; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443787,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"27866876,98.3,2.8,6523",GSM2437814: ChIP-seq from A549 (ENCLB988JSG); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 5; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443788,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"23492047,98.5,2.3,6561",GSM2437815: ChIP-seq from A549 (ENCLB287CBS); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 5; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443789,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22129604,98.3,3.8,3701",GSM2437816: ChIP-seq from A549 (ENCLB718QTY); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 5; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443809,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20705299,98.4,6.5,19788",GSM2437828: ChIP-seq from A549 (ENCLB200YWK); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 6; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443810,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21497629,98.3,2.2,9429",GSM2437829: ChIP-seq from A549 (ENCLB667WWZ); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 6; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443811,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22167046,98.8,3.5,9844",GSM2437830: ChIP-seq from A549 (ENCLB389NSI); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 6; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443849,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"23786787,98.5,3.2,15103",GSM2437851: ChIP-seq from A549 (ENCLB185NUD); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443850,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22481318,98.7,2.8,10560",GSM2437852: ChIP-seq from A549 (ENCLB907FIF); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443851,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"19715537,98.5,3.8,11697",GSM2437853: ChIP-seq from A549 (ENCLB865UCI); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 4; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443852,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20806007,98.8,2.5,9304",GSM2437870: ChIP-seq from A549 (ENCLB954NHO); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 2; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443853,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20141789,98.7,4.0,17526",GSM2437871: ChIP-seq from A549 (ENCLB770OST); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 2; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443857,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"23134783,98.3,2.4,10247",GSM2437865: ChIP-seq from A549 (ENCLB565GJB); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 30; duration_units: minute;	sample type=immortalized cell line	cell line=A549"
SRX2443858,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21978169,98.6,2.8,2077",GSM2437866: ChIP-seq from A549 (ENCLB429DJB); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 30; duration_units: minute;	sample type=immortalized cell line	cell line=A549"
SRX2443862,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20440061,98.0,2.3,6120",GSM2437842: ChIP-seq from A549 (ENCLB937ZYA); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 12; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443863,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"26106908,99.0,3.1,14982",GSM2437843: ChIP-seq from A549 (ENCLB242XBI); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 12; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443864,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21901313,98.5,3.4,25872",GSM2437844: ChIP-seq from A549 (ENCLB961XBF); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 12; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443879,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22016571,98.8,2.5,4191",GSM2437887: ChIP-seq from A549 (ENCLB703MPM); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 1; duration_units: hour; UCSC-ENCODE-cv:DEX_100nM;	sample type=immortalized cell line	cell line=A549"
SRX2443880,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21775759,98.6,2.6,10739",GSM2437888: ChIP-seq from A549 (ENCLB843ZFC); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 1; duration_units: hour; UCSC-ENCODE-cv:DEX_100nM;	sample type=immortalized cell line	cell line=A549"
SRX2443890,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21949976,98.5,3.3,5388",GSM2437867: ChIP-seq from A549 (ENCLB863NOO); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 8; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443891,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21180704,98.5,3.0,14338",GSM2437868: ChIP-seq from A549 (ENCLB261AYG); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 8; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443892,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"22185739,98.9,3.2,10919",GSM2437869: ChIP-seq from A549 (ENCLB381ZXB); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 8; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443914,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21152150,98.5,3.3,7720",GSM2437884: ChIP-seq from A549 (ENCLB471JCX); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 7; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443915,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"20200606,98.5,2.6,7007",GSM2437885: ChIP-seq from A549 (ENCLB298TDQ); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 7; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2443916,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"19815303,99.0,7.6,21932",GSM2437886: ChIP-seq from A549 (ENCLB863LKG); Homo sapiens; ChIP-Seq,"dev stage=adult	donor ID=ENCDO000AAZ	age=58 year	sex=male	lab=Tim Reddy, Duke	treatments=treatment_term_id: CHEBI:41879; treatment_term_name: dexamethasone; treatment_type: chemical; duration: 7; duration_units: hour;	sample type=immortalized cell line	cell line=A549"
SRX2460046,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"19195198,90.6,23.6,2997",GSM2443983: UCD4 E2 replicate 1 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen	chip antibody=ER (sc-543X, Santa Cruz Biotechnology), lot# F1215"
SRX2460047,hg38,TFs and others,PGR,Breast,Breast cancer cells,,"14922858,91.2,45.5,374",GSM2443984: UCD4 E2 replicate 1 PR ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen	chip antibody=PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415"
SRX2460050,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"15942306,89.8,20.6,2551",GSM2443987: UCD4 E2 replicate 2 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen	chip antibody=ER (sc-543X, Santa Cruz Biotechnology), lot# F1215"
SRX2460051,hg38,TFs and others,PGR,Breast,Breast cancer cells,,"16850251,92.5,25.4,238",GSM2443988: UCD4 E2 replicate 2 PR ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen	chip antibody=PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415"
SRX2460054,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"18579404,90.4,17.5,2590",GSM2443991: UCD4 E2 replicate 3 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen	chip antibody=ER (sc-543X, Santa Cruz Biotechnology), lot# F1215"
SRX2460055,hg38,TFs and others,PGR,Breast,Breast cancer cells,,"16565789,85.7,32.9,405",GSM2443992: UCD4 E2 replicate 3 PR ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen	chip antibody=PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415"
SRX2460058,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"15414916,87.3,23.3,2899",GSM2443995: UCD4 E2+P4 replicate 1 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen plus progesterone	chip antibody=ER (sc-543X, Santa Cruz Biotechnology), lot# F1215"
SRX2460059,hg38,TFs and others,PGR,Breast,Breast cancer cells,,"13532455,89.8,28.3,335",GSM2443996: UCD4 E2+P4 replicate 1 PR ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen plus progesterone	chip antibody=PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415"
SRX2460062,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"15811690,91.5,7.8,1088",GSM2443999: UCD4 E2+P4 replicate 2 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen plus progesterone	chip antibody=ER (sc-543X, Santa Cruz Biotechnology), lot# F1215"
SRX2460063,hg38,TFs and others,PGR,Breast,Breast cancer cells,,"14497349,90.7,43.0,261",GSM2444000: UCD4 E2+P4 replicate 2 PR ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen plus progesterone	chip antibody=PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415"
SRX2460066,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"17458074,89.3,23.0,3129",GSM2444003: UCD4 E2+P4 replicate 3 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen plus progesterone	chip antibody=ER (sc-543X, Santa Cruz Biotechnology), lot# F1215"
SRX2460067,hg38,TFs and others,PGR,Breast,Breast cancer cells,,"19082980,87.6,10.3,396",GSM2444004: UCD4 E2+P4 replicate 3 PR ChIP; Homo sapiens; ChIP-Seq,"source_name=Breast tumor xenograft	xenograft=UCD4	treatment=estrogen plus progesterone	chip antibody=PR (sc-7208X, Santa Cruz Biotechnology), lot# H1415"
SRX2513516,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31399999,96.8,17.2,6358",GSM2467220: MCF7 NoTreat ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=NoTreat"
SRX2513517,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33828436,98.5,14.9,37372",GSM2467221: MCF7 E2 5min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=5min"
SRX2513518,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32986622,95.5,16.6,29915",GSM2467222: MCF7 E2 10min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=10min"
SRX2513519,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34127834,97.6,14.2,32604",GSM2467223: MCF7 E2 20min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=20min"
SRX2513520,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33355539,95.8,17.6,35219",GSM2467224: MCF7 E2 40min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=40min"
SRX2513521,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32711707,95.1,17.4,27824",GSM2467225: MCF7 E2 80min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=80min"
SRX2513522,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29077885,93.3,21.9,10707",GSM2467226: MCF7 E2 160min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=160min"
SRX2513523,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31162742,94.0,18.6,18726",GSM2467227: MCF7 E2 320min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=320min"
SRX2513524,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16297635,78.9,50.6,2039",GSM2467228: MCF7 E2 640min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=640min"
SRX2513525,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27281821,91.6,37.8,11236",GSM2467229: MCF7 E2 1280 min ERalpha; Homo sapiens; ChIP-Seq,"source_name=MCF7	tissue=mammary gland	cell line=MCF7	chip antibody=F3A6 (to ERalpha, Gronemeyer)	treatment=1280min"
SRX2514244,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"18754169,94.4,7.2,5163",GSM2467294: Tumor F ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor F (same patient as tumor B)	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514245,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"18569672,91.3,5.9,892",GSM2467295: Tumor G ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor G	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514246,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"23924152,67.3,15.0,761",GSM2467296: Tumor H ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor H	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514247,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"32296216,84.0,18.8,998",GSM2467297: Tumor I ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor I	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514248,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"20680117,98.2,1.4,1074",GSM2467298: Tumor J ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor J	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514249,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"15611205,96.6,6.9,715",GSM2467299: Tumor K ERa; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor K	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514250,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"20899419,92.7,10.4,859",GSM2467300: Tumor 1 ERa; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 1	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514251,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"19444847,96.2,8.6,12421",GSM2467301: Tumor 2 ERa; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 2	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514252,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"30403020,62.0,7.8,5506",GSM2467302: Tumor 3 ERa; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 3	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514253,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"32936222,91.8,6.8,1518",GSM2467303: Tumor 4 ERa; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 4	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514254,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"14880365,94.9,4.6,617",GSM2467304: Tumor 5 ERa; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 5	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514255,hg38,TFs and others,ESR1,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"22411738,96.0,11.0,1120",GSM2467305: Tumor 6 ERa; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 6	tissue=endometrioid adenocarcinoma	chip antibody=ERa (SC-543; Santa Cruz)	procedure=Chromatin IP against ERa
SRX2514256,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"22900854,99.0,2.7,21046",GSM2467306: Tumor F H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor F (same patient as tumor B)	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514257,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"29613393,97.4,4.1,31326",GSM2467307: Tumor G H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor G	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514258,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"24977421,96.7,3.4,30074",GSM2467308: Tumor H H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor H	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514259,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"31443859,96.6,3.6,27933",GSM2467309: Tumor I H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor I	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514260,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"20886714,97.1,4.9,30001",GSM2467310: Tumor D H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor D	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514261,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"26601717,98.2,2.9,22560",GSM2467311: Tumor K H3K27ac; Homo sapiens; ChIP-Seq,source_name=Tamoxifen-associated endometrial tumor K	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514262,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"27210981,99.0,6.3,40428",GSM2467312: Tumor 1 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 1	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514263,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"28796446,98.9,3.2,29432",GSM2467313: Tumor 2 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 2	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514264,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"23348596,98.8,4.8,32132",GSM2467314: Tumor 3 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 3	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514265,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"29667180,98.8,2.1,15600",GSM2467315: Tumor 4 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 4	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514266,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"22491570,98.8,4.9,33744",GSM2467316: Tumor 5 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 5	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX2514267,hg38,Histone,H3K27ac,Uterus,"Carcinoma, Endometrioid",MeSH Description=An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.,"22791103,98.8,3.8,31222",GSM2467317: Tumor 6 H3K27ac; Homo sapiens; ChIP-Seq,source_name=Endometrial tumor of a non-tamoxifen-user 6	tissue=endometrioid adenocarcinoma	chip antibody=H3K27ac (39133; Active motif)	procedure=Chromatin IP against H3K27ac
SRX25152567,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"38797216,96.9,29.2,1735",GSM8368549: D5-Teff-Stim-AAVS1-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=AAVS1-KO	condition=Stim	donor=D5	geo_loc_name=missing	collection_date=missing
SRX25152571,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"39763311,96.6,26.6,1306",GSM8368569: D4-Teff-Stim-AAVS1-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=AAVS1-KO	condition=Stim	donor=D4	geo_loc_name=missing	collection_date=missing
SRX25152585,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"53068849,94.8,35.1,4379",GSM8368559: D5-Teff-Rest-AAVS1-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=AAVS1-KO	condition=Rest	donor=D5	geo_loc_name=missing	collection_date=missing
SRX25152597,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"41903853,95.8,26.8,4449",GSM8368579: D4-Teff-Rest-AAVS1-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=AAVS1-KO	condition=Rest	donor=D4	geo_loc_name=missing	collection_date=missing
SRX25152599,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"48096676,95.5,28.1,4793",GSM8368581: D4-Teff-Rest-MED12-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=MED12-KO	condition=Rest	donor=D4	geo_loc_name=missing	collection_date=missing
SRX25152600,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"38645457,97.1,25.6,2632",GSM8368582: D4-Teff-Stim-MED12-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=MED12-KO	condition=Stim	donor=D4	geo_loc_name=missing	collection_date=missing
SRX25152601,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"48570402,94.8,34.8,3407",GSM8368583: D5-Teff-Rest-MED12-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=MED12-KO	condition=Rest	donor=D5	geo_loc_name=missing	collection_date=missing
SRX25152602,hg38,TFs and others,MED12,Blood,CD4+ T cells,,"33796974,97.0,26.1,8079",GSM8368584: D5-Teff-Stim-MED12-KO-MED12Thermo ChIP; Homo sapiens; ChIP-Seq,source_name=Blood	tissue=Blood	chip antibody=MED12Thermo (Bethyl/Thermo A300-774A)	cell type=CD4+ Teff	genotype=MED12-KO	condition=Stim	donor=D5	geo_loc_name=missing	collection_date=missing
SRX2578866,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","19104194,97.9,77.6,364",GSM2496479: ERα ChIP-seq 231ERαWT 0min rep1; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_0min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 0 min"
SRX2578867,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","12205922,87.9,95.2,28",GSM2496480: ERα ChIP-seq 231ERαWT 0min rep2; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_0min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 0 min"
SRX2578868,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","18093818,96.3,7.8,3003",GSM2496481: ERα ChIP-seq 231ERαWT 0min rep3; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_0min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 0 min"
SRX2578869,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","22034884,96.8,6.6,543",GSM2496482: ERα ChIP-seq 231ERαWT 0min rep4; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_0min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 0 min"
SRX2578870,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","14267874,97.9,59.0,16236",GSM2496483: ERα ChIP-seq 231ERαWT 45min rep1; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_45min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 45 min"
SRX2578871,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","15301312,96.3,72.5,3435",GSM2496484: ERα ChIP-seq 231ERαWT 45min rep2; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_45min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 45 min"
SRX2578872,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","18081949,96.0,7.5,11412",GSM2496485: ERα ChIP-seq 231ERαWT 45min rep3; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_45min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 45 min"
SRX2578873,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","22171649,97.3,6.1,6755",GSM2496486: ERα ChIP-seq 231ERαWT 45min rep4; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαWT_45min	cell line background=MDA-MB-231	transduced with=ERα wt	treated with=E2, 100 nM, 45 min"
SRX2578874,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","12596026,98.0,54.1,223",GSM2496487: ERα ChIP-seq 231ERαLQ 0min rep1; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_0min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 0 min"
SRX2578875,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","12341467,96.5,89.2,112",GSM2496488: ERα ChIP-seq 231ERαLQ 0min rep2; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_0min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 0 min"
SRX2578876,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","16294639,94.3,8.1,9796",GSM2496489: ERα ChIP-seq 231ERαLQ 0min rep3; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_0min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 45 min"
SRX2578877,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","20691505,97.6,4.6,635",GSM2496490: ERα ChIP-seq 231ERαLQ 0min rep4; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_0min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 45 min"
SRX2578878,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","13556173,98.1,57.5,19950",GSM2496491: ERα ChIP-seq 231ERαLQ 45min rep1; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_45min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 0 min"
SRX2578879,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","14854821,93.0,82.7,2564",GSM2496492: ERα ChIP-seq 231ERαLQ 45min rep2; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_45min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 0 min"
SRX2578880,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","14579986,93.7,15.0,22854",GSM2496493: ERα ChIP-seq 231ERαLQ 45min rep3; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_45min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 45 min"
SRX2578881,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","21211160,96.9,12.1,17524",GSM2496494: ERα ChIP-seq 231ERαLQ 45min rep4; Homo sapiens; ChIP-Seq,"source_name=ERα_ChIP-seq_231ERαLQ_45min	cell line background=MDA-MB-231	transduced with=ERα L540Q	treated with=E2, 100 nM, 45 min"
SRX2607383,hg38,TFs and others,JUN,Lung,HCC827,Primary Tissue=Lung|Tissue Diagnosis=Adenocarcinoma,"24247064,44.5,49.1,154",GSM2516998: Parental Cells ChIP Seq; Homo sapiens; ChIP-Seq,source_name=HCC827 cells _ Lung cancer	cell line=Parental HCC827 cells	antibody=C-Jun Santa Cruz catalog# SC-1694X
SRX2607385,hg38,TFs and others,JUN,Lung,HCC827,Primary Tissue=Lung|Tissue Diagnosis=Adenocarcinoma,"32625749,98.6,2.4,1372",GSM2517000: Resistance Cells ChIP Seq; Homo sapiens; ChIP-Seq,source_name=HCC827 cells _ Lung cancer	cell line=Resistance HCC827 ZDR3 Cells	antibody=C-Jun Santa Cruz catalog# SC-1694X
SRX261273,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"119841250,68.5,48.4,21151",GSM1115990: ERa ChIPSeq repeat1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=ERa	chip vendor/catalog=Santa Cruz Biotech, SC-543	treatment=1hr treatment with 100nM E2"
SRX261274,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41014965,84.0,36.0,6948",GSM1115991: ERa ChIPSeq repeat2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=ERa	chip vendor/catalog=Santa Cruz Biotech, SC-543	treatment=1hr treatment with 100nM E2"
SRX2636246,hg38,Histone,H3K27ac,Uterus,Vagina,"MeSH Description=The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)","43012941,96.0,13.6,44369",GSM2534359: ChIP-seq from vagina (ENCLB777PWZ); Homo sapiens; ChIP-Seq,"dev stage=adult	sex=female	sample type=tissue	donor ID=ENCDO793LXB	age=53 year	lab=Bradley Bernstein, Broad	tissue=vagina"
SRX2636247,hg38,Histone,H3K27ac,Uterus,Vagina,"MeSH Description=The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)","10787401,92.3,1.4,12405",GSM2534360: ChIP-seq from vagina (ENCLB699GSB); Homo sapiens; ChIP-Seq,"dev stage=adult	sex=female	sample type=tissue	donor ID=ENCDO793LXB	age=53 year	lab=Bradley Bernstein, Broad	tissue=vagina"
SRX268299,hg38,TFs and others,JUN,Breast,BT-549,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"46734670,98.6,40.2,16636",GSM1125262: cJun ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=BT549 breast cancer cells, cJun ChIP	cell line=BT549	cell type=triple negative breast cancer cells	chip antibody=c-Jun (H-79, Santa Cruz)"
SRX278610,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44010631,98.1,53.9,791",GSM1143123: Med12 MCF7; Homo sapiens; ChIP-Seq,source_name=MCF-7_Med12_ChIP-seq	cell line=MCF-7	cell type=breast adenocarcinoma cells	chip antibody=Med12	chip antibody vendor=Bethyl
SRX2842441,hg38,TFs and others,FOS,Bone,MNNG,,"65035170,97.7,3.5,2108",GSM2635307: MNNG: c-Fos ChIP Seq; Homo sapiens; ChIP-Seq,source_name=highly metastatic osteosarcoma cell line	cell line=MNNG	chip antibody=rabbit anti-c-Fos (Santa Cruz #sc-52)
SRX2842443,hg38,TFs and others,FOS,Bone,143B,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,"69838064,97.9,2.8,2018",GSM2635309: 143B: c-Fos ChIP Seq; Homo sapiens; ChIP-Seq,source_name=highly metastatic osteosarcoma cell line	cell line=143B	chip antibody=rabbit anti-c-Fos (Santa Cruz #sc-52)
SRX2842445,hg38,TFs and others,FOS,Bone,MG-63,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,"68281489,96.1,3.3,1042",GSM2635311: MG63: c-Fos ChIP Seq; Homo sapiens; ChIP-Seq,source_name=highly metastatic osteosarcoma cell line	cell line=MG63	chip antibody=rabbit anti-c-Fos (Santa Cruz #sc-52)
SRX2842447,hg38,TFs and others,FOS,Bone,MG-63,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,"49367925,90.0,3.8,11556",GSM2635313: MG63.3: c-Fos ChIP Seq; Homo sapiens; ChIP-Seq,source_name=highly metastatic osteosarcoma cell line	cell line=MG63.3	chip antibody=rabbit anti-c-Fos (Santa Cruz #sc-52)
SRX2842449,hg38,TFs and others,FOS,Bone,HOS,Primary Tissue=Bone|Tissue Diagnosis=Osteosarcoma,"67517935,93.7,3.6,2162",GSM2635315: HOS: c-Fos ChIP Seq; Homo sapiens; ChIP-Seq,source_name=highly metastatic osteosarcoma cell line	cell line=HOS	chip antibody=rabbit anti-c-Fos (Santa Cruz #sc-52)
SRX2871338,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36502481,92.7,29.5,10650",GSM2644567: ChIP-seq ERalpha T47Dflp rep1; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D Flp control cells	passages=&lt;10	antibody=anti-ERalpha (Santa Cruz, HC-20)"
SRX2871339,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"50297783,95.1,48.3,10561",GSM2644568: ChIP-seq ERalpha T47Dflp rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D Flp control cells	passages=&lt;10	antibody=anti-ERalpha (Santa Cruz, HC-20)"
SRX2871340,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"55742804,92.3,48.3,8469",GSM2644569: ChIP-seq ERalpha CR3flp rep1; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D wt/R330fsl cells	passages=&lt;10	antibody=anti-ERalpha (Santa Cruz, HC-20)"
SRX2871341,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"58537939,92.9,47.2,9479",GSM2644570: ChIP-seq ERalpha CR3flp rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D wt/R330fsl cells	passages=&lt;10	antibody=anti-ERalpha (Santa Cruz, HC-20)"
SRX2871358,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26316293,98.6,6.6,1443",GSM2644587: ChIP-seq PR T47Dflp Ve rep1; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D Flp control cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871359,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26048105,97.7,6.8,2027",GSM2644588: ChIP-seq PR T47Dflp Ve rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D Flp control cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871360,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31672567,98.8,5.2,51883",GSM2644589: ChIP-seq PR T47Dflp P4 rep1; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D wt/R330fsl cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871361,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34741378,98.7,5.1,52572",GSM2644590: ChIP-seq PR T47Dflp P4 rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D wt/R330fsl cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871362,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34022233,98.6,12.9,1210",GSM2644591: ChIP-seq PR CR3flp Ve rep1; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D Flp control cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871363,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29373617,98.1,11.3,1635",GSM2644592: ChIP-seq PR CR3flp Ve rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D Flp control cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871364,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31358141,98.5,7.5,28879",GSM2644593: ChIP-seq PR CR3flp P4 rep1; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D wt/R330fsl cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2871365,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30952723,98.6,7.3,30701",GSM2644594: ChIP-seq PR CR3flp P4 rep2; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D wt/R330fsl cells	passages=&lt;10	antibody=anti-PR (Santa Cruz, H-190)"
SRX2880999,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28302544,78.0,7.9,12375",GSM2648914: ER ChIP-seq MCF7 4hrs Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=4 hours	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881000,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16977176,72.5,12.4,35676",GSM2648915: ER ChIP-seq MCF7 4hrs E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2	hormone exposure time=4 hours	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881001,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23636211,51.6,14.5,26925",GSM2648916: ER ChIP-seq MCF7 4hrs E2+Dex; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2+10 nM Progesterone	hormone exposure time=4 hours	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881002,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28187787,60.7,20.5,38322",GSM2648917: ER ChIP-seq MCF7 4hrs E2+DHT; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2+10 nM Dexamethasone	hormone exposure time=4 hours	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881003,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23862948,69.3,8.4,13305",GSM2648918: ER ChIP-seq MCF7 4hrs E2+Aldo; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2+10 nM DHT	hormone exposure time=4 hours	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881004,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16786456,59.1,9.8,16703",GSM2648919: ER ChIP-seq MCF7 4hrs E2+Prog; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2+10 nM Aldosterone	hormone exposure time=4 hours	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881006,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23977827,97.8,2.7,905",GSM2648921: ER ChIP-seq MCF7 45min Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=45 minutes	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881007,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25162281,97.8,2.6,5006",GSM2648922: ER ChIP-seq MCF7 45min E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2	hormone exposure time=45 minutes	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881008,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28718964,97.8,3.2,1043",GSM2648923: ER ChIP-seq MCF7 45min R5020; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM R5020	hormone exposure time=45 minutes	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2881009,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27203231,98.0,2.8,2883",GSM2648924: ER ChIP-seq MCF7 45min E2+R5020; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	er/pr status=ER+/PR+	drug treatment=10 nM E2 + 10 nM R5020	hormone exposure time=45 minutes	protocol=Cell models ChIP-seq	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# L1911)"
SRX2897197,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"27607164,93.0,16.3,30788",GSM2654035: T2 JG2B ERChIP IDX4-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=37	type=ductal	grade=III	protocol=ChIP-seq
SRX2897198,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"37066639,88.9,34.4,1842",GSM2654036: T3 JG3B-2 ERChIP IDX6-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897199,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"33050110,84.3,62.7,1498",GSM2654037: T4 JG4B-2 ERChIP IDX8-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=38	type=ductal	grade=II	protocol=ChIP-seq
SRX2897200,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"34429575,80.6,75.2,1123",GSM2654038: T5 JG5B-1 ERChIP IDX10-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=negative	her2 status=negative	her2_notes=negative (0 or 1+)	age=41	type=ductal	grade=II	protocol=ChIP-seq
SRX2897201,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"37197005,89.9,48.7,10495",GSM2654039: T7 JG10A ERChIP IDX19-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=48	type=mixed	grade=III	protocol=ChIP-seq
SRX2897202,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"38823328,84.3,64.3,1274",GSM2654040: T9 JG9B ERChIP IDX18-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=43	type=ductal	grade=II	protocol=ChIP-seq
SRX2897203,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"36378894,88.8,41.7,3360",GSM2654041: T10 JG10B ERChIP IDX20-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=38	type=mixed	grade=III	protocol=ChIP-seq
SRX2897204,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"30260803,86.3,59.9,783",GSM2654042: T11 JG11B ERChIP IDX22-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=48	type=ductal	grade=III	protocol=ChIP-seq
SRX2897205,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"29573311,89.8,44.6,16757",GSM2654043: T12 JG15B ERChIP IDX6-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=positive	her2_notes=positive (3+)	age=37	type=ductal	grade=II	protocol=ChIP-seq
SRX2897206,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"41727387,82.3,83.7,793",GSM2654044: T14 JG7B ERChIP IDX14-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=55	type=ductal	grade=III	protocol=ChIP-seq
SRX2897207,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"47849401,92.5,47.1,1761",GSM2654045: T3-rep1 IdxC1 JG3B H3K27acChIP 11.4.15-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897208,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"40597210,97.4,7.2,44852",GSM2654046: T3-rep2 IdxA2 JG3B Breast H3K27ac 11.24.15-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897209,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"30405016,86.8,19.1,15615",GSM2654047: T3-rep3 JG3B-2 H3K27acChIP IDX14-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897210,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"35791985,86.2,41.0,689",GSM2654048: T4 JG4B-2 H3K27acChIP IDX16-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=38	type=ductal	grade=II	protocol=ChIP-seq
SRX2897211,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"28821754,85.4,37.6,5356",GSM2654049: T5 JG5B-1 H3K27acChIP IDX18-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=negative	her2 status=negative	her2_notes=negative (0 or 1+)	age=41	type=ductal	grade=II	protocol=ChIP-seq
SRX2897212,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"27494864,86.8,43.3,3039",GSM2654050: T6 JG6B-1 H3K27acChIP IDX20-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=40	type=mixed	grade=III	protocol=ChIP-seq
SRX2897213,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"23901616,80.3,17.3,943",GSM2654051: T8 JG8B H3K27acChIP IDX24-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=40	type=lobular	grade=II	protocol=ChIP-seq
SRX2897214,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"24973746,70.9,22.1,4014",GSM2654052: T9 JG9B H3K27acChIP IDX2-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=43	type=ductal	grade=II	protocol=ChIP-seq
SRX2897215,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"20696909,77.7,42.5,1680",GSM2654053: T10 JG10B H3K27acChIP IDX4-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=38	type=mixed	grade=III	protocol=ChIP-seq
SRX2897216,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"20730151,74.1,11.8,6243",GSM2654054: T11 JG11B H3K27acChIP IDX5-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=48	type=ductal	grade=III	protocol=ChIP-seq
SRX2897217,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"14912681,86.1,26.9,9792",GSM2654055: T12 JG15B H3K27acChIP IDX12-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=positive	her2_notes=positive (3+)	age=37	type=ductal	grade=II	protocol=ChIP-seq
SRX2897218,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"16400206,79.2,31.7,3901",GSM2654056: T13 JG13B H3K27acChIP IDX8-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=43	type=ductal	grade=II	protocol=ChIP-seq
SRX2897219,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"36538624,84.4,28.3,2274",GSM2654057: T14 JG7B H3K27acChIP IDX22-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=55	type=ductal	grade=III	protocol=ChIP-seq
SRX2897220,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"46928196,93.9,8.0,23170",GSM2654058: T15 IdxD1 JG14B H3K27acChIP 11.4.15-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=negative	pr status=negative	her2 status=negative	her2_notes=negative	age=66	type=ductal	grade=III	protocol=ChIP-seq
SRX2897221,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"18813111,88.1,2.0,651",GSM2654059: T2 JG2B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=37	type=ductal	grade=III	protocol=ChIP-seq
SRX2897222,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"43215115,96.1,6.4,1182",GSM2654060: T3 JG3B-2-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897223,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"46370934,97.9,4.0,1189",GSM2654061: T4 JG4B-2-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=38	type=ductal	grade=II	protocol=ChIP-seq
SRX2897224,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"7234566,97.3,2.3,273",GSM2654062: T5 JG5B-1-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=negative	her2 status=negative	her2_notes=negative (0 or 1+)	age=41	type=ductal	grade=II	protocol=ChIP-seq
SRX2897225,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"47032752,98.0,4.6,964",GSM2654063: T7 JG10A-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=48	type=mixed	grade=III	protocol=ChIP-seq
SRX2897226,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"53033466,97.7,5.3,1264",GSM2654064: T9 JG9B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=43	type=ductal	grade=II	protocol=ChIP-seq
SRX2897227,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"47669341,97.5,4.6,944",GSM2654065: T10 JG10B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=38	type=mixed	grade=III	protocol=ChIP-seq
SRX2897228,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"47491924,96.5,3.4,1236",GSM2654066: T11 JG11B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=48	type=ductal	grade=III	protocol=ChIP-seq
SRX2897229,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"39080790,98.0,6.2,961",GSM2654067: T12 JG15B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=positive	her2_notes=positive (3+)	age=37	type=ductal	grade=II	protocol=ChIP-seq
SRX2897230,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"63821608,98.3,4.0,1569",GSM2654068: T14 JG7B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=55	type=ductal	grade=III	protocol=ChIP-seq
SRX2897231,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"50530723,96.1,4.0,1873",GSM2654069: T3-rep1 11.4.15-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897232,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"43810578,90.4,10.5,5843",GSM2654070: T3-rep2-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative	age=39	type=ductal	grade=II	protocol=ChIP-seq
SRX2897233,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"63303875,96.2,5.0,1648",GSM2654071: T6 JG6B-1-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=40	type=mixed	grade=III	protocol=ChIP-seq
SRX2897234,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"57918596,98.2,4.1,1387",GSM2654072: T8 JG8B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=40	type=lobular	grade=II	protocol=ChIP-seq
SRX2897235,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"56640895,98.1,6.1,1386",GSM2654073: T13 JG13B-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=positive	pr status=positive	her2 status=negative	her2_notes=negative (0 or 1+)	age=43	type=ductal	grade=II	protocol=ChIP-seq
SRX2897236,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"65429381,89.5,7.2,3309",GSM2654074: T15 JG14B 11.4.15-Control-INPUT; Homo sapiens; ChIP-Seq,source_name=ER+ breast tumor	tissue type=ER+ breast tumor	er status=negative	pr status=negative	her2 status=negative	her2_notes=negative	age=66	type=ductal	grade=III	protocol=ChIP-seq
SRX2901931,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18681832,93.3,23.0,15882",GSM2664030: H3K27ac Enhi; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=H3K27ac	grna treatment=Enhancer-I	drug treatment=DMSO	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901932,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22013393,92.2,22.6,11874",GSM2664031: H3K27ac IL1RN; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=H3K27ac	grna treatment=Control	drug treatment=DMSO	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901933,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20431130,93.5,19.8,17691",GSM2664032: H3K27ac EnhiE2; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=H3K27ac	grna treatment=Enhancer-I	drug treatment=10 nM E2	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901934,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20287530,92.6,19.9,18411",GSM2664033: H3K27ac IL1RNE2; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=H3K27ac	grna treatment=Control	drug treatment=10 nM E2	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901935,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"44036652,98.2,15.8,50990",GSM2664034: Ishikawa H3K27ac Regular; Homo sapiens; ChIP-Seq,source_name=Ishikawa endometrial cancer cell line	antibody=H3K27ac	grna treatment=none	drug treatment=1 nM E2	growth conditions=regular RPMI (with phenol red)	time point=6 days
SRX2901936,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21562015,88.1,11.8,34041",GSM2664035: Ishikawa H3K27ac Strip; Homo sapiens; ChIP-Seq,source_name=Ishikawa endometrial cancer cell line	antibody=H3K27ac	grna treatment=none	drug treatment=none	growth conditions=charcoal-stripped RPMI
SRX2901939,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"14301746,87.0,25.7,5418",GSM2664038: ER EnhiE2 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=ER alpha	grna treatment=Enhancer-I	drug treatment=10 nM E2	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901940,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"9921638,85.8,36.6,970",GSM2664039: ER IL1E2 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=ER alpha	grna treatment=Control	drug treatment=10 nM E2	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901941,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18623068,78.4,6.8,1358",GSM2664040: ER EnhiE2 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=ER alpha	grna treatment=Enhancer-I	drug treatment=10 nM E2	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2901942,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20771519,81.4,5.9,19834",GSM2664041: ER IL1E2 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa SID4x-dCas9-KRAB	antibody=ER alpha	grna treatment=Control	drug treatment=10 nM E2	growth conditions=charcoal-stripped RPMI	time point=8hr
SRX2912045,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26754848,97.3,16.8,453",GSM2125141: MCF7 Vehicle 45 mins ERChIP (H2); Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912047,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"47039140,98.0,14.7,1663",GSM2125143: MCF7 E2 45 mins ERChIP (H4); Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10 nM Estradiol	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912049,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38173813,97.5,19.5,3549",GSM2125145: MCF7 DHT 45 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10 nM DHT	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912051,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40611171,97.3,16.4,2206",GSM2125147: MCF7 E2+DHT 45 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10nM Estradiol + 10 nM DHT	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912053,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"267099886,80.9,48.2,6978",GSM2125149: MCF7 Vehicle 60 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=60 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912055,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"250849745,38.5,42.4,28522",GSM2125151: MCF7 E2 75 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10 nM Estradiol	hormone exposure time=75 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912057,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"252430185,49.9,65.5,8000",GSM2125153: MCF7 Dexamethasone 60 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10 nM Dexamethasone	hormone exposure time=60 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912059,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"223517069,67.3,83.5,15741",GSM2125155: MCF7 E2+Dexamethasone 75 mins (15 min E2 and 60 min E2+Dex) ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10nM Estradiol + 10 nM Dexamethasone	hormone exposure time=75 minutes (15 min E2 and 60 min E2+Dexamethasone)	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912061,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"11773506,95.2,12.7,205",GSM2125157: MCF7 Vehicle 45 mins ERChIP (I2); Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=Vehicle	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912063,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18049614,62.4,9.2,3815",GSM2125159: MCF7 E2 45 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10 nM Estradiol	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912065,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27507374,86.1,8.9,4452",GSM2125161: MCF7 Aldosterone 45 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10 nM Aldosterone	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2912067,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19744158,89.6,13.1,1946",GSM2125163: MCF7 E2+Aldosterone 45 mins ERChIP; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cells	tissue type=ER+/PR+ MCF7 cell models	er/pr status=ER+/PR+	drug treatment=10nM Estradiol + 10 nM Aldosterone	hormone exposure time=45 minutes	chip antibody=anti-ER (SC biotech HC-20, cat# SC-543, lot# F0515)"
SRX2915387,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"12995120,99.9,9.3,170",GSM2666985: T47D Dose Ser294 Veh 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=Vehicle	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=anti-phospho-PR Ser294 (from Dean Edwards, Baylor College of Medicine)"
SRX2915388,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"11913609,99.9,9.2,149",GSM2666986: T47D Dose Ser294 Low 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=0.1 nM R5020	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=anti-phospho-PR Ser294 (from Dean Edwards, Baylor College of Medicine)"
SRX2915389,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"5557193,99.9,13.5,6021",GSM2666987: T47D Dose Ser294 High 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=10 nM R5020	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=anti-phospho-PR Ser294 (from Dean Edwards, Baylor College of Medicine)"
SRX2915390,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"4968317,99.9,7.7,103",GSM2666988: T47D Dose PR SC Veh 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=Vehicle	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=Anti-PR SC-7208, Lot#B1115"
SRX2915391,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"12562272,99.9,7.1,119",GSM2666989: T47D Dose PR SC Low 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=0.1 nM R5020	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=Anti-PR SC-7208, Lot#B1115"
SRX2915392,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"39162381,99.9,2.2,566",GSM2666990: T47D Dose PR SC High 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=10 nM R5020	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=Anti-PR SC-7208, Lot#B1115"
SRX2915393,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"16319802,99.9,5.8,203",GSM2666991: T47D Dose PR KD68 Veh 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=Vehicle	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=anti-PR KD68 (Greene, Mol. End. 1988)"
SRX2915394,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"5765640,99.9,8.6,36",GSM2666992: T47D Dose PR KD68 Low 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=0.1 nM R5020	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=anti-PR KD68 (Greene, Mol. End. 1988)"
SRX2915395,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"8027837,99.9,19.7,104",GSM2666993: T47D Dose PR KD68 High 45mins ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=T47D cells	tissue type=T47D cells	er/pr/her2 status=ER+ PR+	drug treatment=10 nM R5020	hormone exposure time=45 mins	protocol=ChIP-seq	antibody=anti-PR KD68 (Greene, Mol. End. 1988)"
SRX2922225,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17584659,93.8,7.2,14045",GSM2670862: MCF7 WT; Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=MCF7	estrogen=Yes	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=None
SRX2922226,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15112369,97.7,9.4,4160",GSM2670863: MCF7 LTED WT; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=MCF7	estrogen=No, LTED (long term estrogen deprived) ESR1 wildtype	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=None"
SRX2922227,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46231355,98.2,19.2,11022",GSM2670864: MCF7 LTED MUT; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=MCF7	estrogen=No, LTED (long term estrogen deprived) ESR1 mutant	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=Y537C"
SRX2922231,hg38,TFs and others,ESR1,Breast,SUM 44PE,Primary Tissue=Breast|Tissue Diagnosis=Unknown,"29046549,98.7,15.6,29836",GSM2670868: SUM44 wt repl1; Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=SUM44	estrogen=Yes	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=none
SRX2922232,hg38,TFs and others,ESR1,Breast,SUM 44PE,Primary Tissue=Breast|Tissue Diagnosis=Unknown,"26225628,98.5,18.4,25223",GSM2670869: SUM44 wt repl2; Homo sapiens; ChIP-Seq,source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=SUM44	estrogen=Yes	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=None
SRX2922233,hg38,TFs and others,ESR1,Breast,SUM 44PE,Primary Tissue=Breast|Tissue Diagnosis=Unknown,"33353693,98.6,13.7,44750",GSM2670870: SUM44 LTED repl1; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=SUM44	estrogen=No, LTED (long term estrogen deprived)	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=Y537S"
SRX2922234,hg38,TFs and others,ESR1,Breast,SUM 44PE,Primary Tissue=Breast|Tissue Diagnosis=Unknown,"25580942,98.6,20.1,18226",GSM2670871: SUM44 LTED repl2; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	tissue=breast cancer cell line	biomaterial provider=ATCC	cell line=SUM44	estrogen=No, LTED (long term estrogen deprived)	antibody=ESR1 (Santa-Cruz sc543)	esr1 mutation=Y537S"
SRX2943580,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32290161,97.8,3.8,7905",GSM2677919: MCF7 shKMT2C 1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell type=metastatic ER+ breast cancer	antibody=ER antibody (Santa Cruz HC-20)	cell line=MCF7	knockdown=shKMT2C_1
SRX2943585,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33095086,98.0,4.0,10477",GSM2677922: MCF7 shKMT2C 2 ERa; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell type=metastatic ER+ breast cancer	antibody=ER antibody (Santa Cruz HC-20)	cell line=MCF7	knockdown=shKMT2C
SRX2943589,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"48885446,97.8,42.3,28387",GSM2677925: MCF7 shKMT2C R ER rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell type=metastatic ER+ breast cancer	antibody=ER antibody (Santa Cruz HC-20)	cell line=MCF7	knockdown=shKMT2C
SRX2943591,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"53232475,97.7,15.0,34938",GSM2677927: MCF7 shKMT2C R ER rep2; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell type=metastatic ER+ breast cancer	antibody=ER antibody (Santa Cruz HC-20)	cell line=MCF7	knockdown=shKMT2C
SRX2943597,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31669658,98.2,3.5,5614",GSM2677933: MCF7 shRenilla ERa; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell type=metastatic ER+ breast cancer	antibody=ER antibody (Santa Cruz HC-20)	cell line=MCF7	knockdown=shRenilla
SRX3010010,hg38,Histone,H3K27ac,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","34258634,97.5,4.5,30181",GSM2698835: ChIP-seq from uterus (ENCLB643BVJ); Homo sapiens; ChIP-Seq,"dev_stage=adult	tissue=uterus	sample_type=tissue	lab=Bradley Bernstein, Broad	age=53 year	donor ID=ENCDO793LXB	sex=female"
SRX3011700,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20587851,83.5,30.1,246",GSM2706101: Med12-siCTL-CTL-MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	antibody=Med12	sirna=siCTL	treatment=none	cell line=Michigan Cancer Foundation-7 cells(MCF-7 cells)	antibody catalog/vendor=A300-774A(Bethyl Laboratory)
SRX3011701,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20002849,77.2,9.4,1283",GSM2706102: Med12-siCTL-E2-MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	antibody=Med12	sirna=siCTL	treatment=E2	cell line=Michigan Cancer Foundation-7 cells(MCF-7 cells)	antibody catalog/vendor=A300-774A(Bethyl Laboratory)
SRX3011702,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36128872,83.1,49.2,430",GSM2706103: Med12-siJMJD6-CTL-MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	antibody=Med12	sirna=siJMJD6	treatment=none	cell line=Michigan Cancer Foundation-7 cells(MCF-7 cells)	antibody catalog/vendor=A300-774A(Bethyl Laboratory)
SRX3011703,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51234880,88.5,22.2,815",GSM2706104: Med12-siJMJD6-E2-MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	antibody=Med12	sirna=siJMJD6	treatment=E2	cell line=Michigan Cancer Foundation-7 cells(MCF-7 cells)	antibody catalog/vendor=A300-774A(Bethyl Laboratory)
SRX3012981,hg38,Histone,H3K27ac,Uterus,Cervical cancer cells,,"22182440,94.7,4.1,11679",GSM2706139: KDM5C H3K27Ac ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=cervical cancer cells	genotype/variation=KDM5C overexpression	chip antibody=H3K27Ac(Cell Signaling Technology, 8173)"
SRX3012983,hg38,Histone,H3K27ac,Uterus,Cervical cancer cells,,"27077101,61.0,40.9,38726",GSM2706141: parental H3K27Ac ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=cervical cancer cells	genotype/variation=wild type	chip antibody=H3K27Ac(Cell Signaling Technology, 8173)"
SRX3012987,hg38,Histone,H3K27ac,Uterus,Cervical cancer cells,,"23371591,70.9,28.7,30671",GSM2706145: vector H3K27Ac ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=cervical cancer cells	genotype/variation=vector	chip antibody=H3K27Ac(Cell Signaling Technology, 8173)"
SRX3080209,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29728626,99.0,5.6,2641",GSM2736190: c-Jun ChIPseq Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF-7/c-Jun -Tet cells	cell line=MCF-7	cell type=ERalpha-positive breast cancer cells	chip antibody=c-Jun (H-79, Santa Cruz)"
SRX3080210,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34889832,98.5,7.6,10948",GSM2736191: c-Jun ChIPseq E2; Homo sapiens; ChIP-Seq,"source_name=MCF-7/c-Jun -Tet cells	cell line=MCF-7	cell type=ERalpha-positive breast cancer cells	chip antibody=c-Jun (H-79, Santa Cruz)"
SRX3080211,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36990407,99.2,7.9,13332",GSM2736192: c-Jun ChIPseq Tamoxifen; Homo sapiens; ChIP-Seq,"source_name=MCF-7/c-Jun -Tet cells	cell line=MCF-7	cell type=ERalpha-positive breast cancer cells	chip antibody=c-Jun (H-79, Santa Cruz)"
SRX3080212,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25387124,99.0,5.7,3392",GSM2736193: ERα ChIPseq Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF-7/c-Jun -Tet cells	cell line=MCF-7	cell type=ERalpha-positive breast cancer cells	chip antibody=ERalpha (H-20, Santa Cruz)"
SRX3080213,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29970916,98.9,10.3,17990",GSM2736194: ERα ChIPseq E2; Homo sapiens; ChIP-Seq,"source_name=MCF-7/c-Jun -Tet cells	cell line=MCF-7	cell type=ERalpha-positive breast cancer cells	chip antibody=ERalpha (H-20, Santa Cruz)"
SRX3080214,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29278526,99.2,9.1,18486",GSM2736195: ERα ChIPseq Tamoxifen; Homo sapiens; ChIP-Seq,"source_name=MCF-7/c-Jun -Tet cells	cell line=MCF-7	cell type=ERalpha-positive breast cancer cells	chip antibody=ERalpha (H-20, Santa Cruz)"
SRX3110709,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17918167,24.8,4.7,1126",GSM2747691: SLX-8047 1a ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_Fulvestrant_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=Fulvestrant	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=1"
SRX3110710,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18911967,38.7,3.7,5522",GSM2747692: SLX-8047 1b ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=none	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=1"
SRX3110711,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21476231,53.9,3.0,3258",GSM2747693: SLX-8047 2a ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_Fulvestrant_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=Fulvestrant	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=2"
SRX3110712,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20930329,56.7,6.8,8939",GSM2747694: SLX-8047 2b ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=none	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=2"
SRX3110713,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17794642,59.6,3.8,2348",GSM2747695: SLX-8047 3a ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_Fulvestrant_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=Fulvestrant	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=3"
SRX3110714,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12284081,50.8,6.3,5758",GSM2747696: SLX-8047 3b ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=none	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=3"
SRX3110715,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22810854,20.0,6.3,759",GSM2747697: SLX-8047 4a ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_Fulvestrant_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=Fulvestrant	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=4"
SRX3110716,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17593888,60.5,4.9,7200",GSM2747698: SLX-8047 4b ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=none	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=4"
SRX3110717,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"11782901,50.3,12.3,1016",GSM2747699: SLX-8047 Input None; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_H2av_S2	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-8047	chip antibody=ER (sc-543, Santa Cruz)	control antibody=H2av (39715, ActiveMotif)	condition=None	spike-in cell line=S2	spike-in organism=drosophila melanogaster	replicate=Input"
SRX3110718,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35019516,89.2,21.2,7923",GSM2747700: SLX-12998 4 ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_Fulvestrant_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=Fulvestrant	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=4"
SRX3110719,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35752501,90.9,22.9,4287",GSM2747701: SLX-12998 1 ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_Fulvestrant_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=Fulvestrant	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=1"
SRX3110720,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36132578,89.5,26.1,25435",GSM2747702: SLX-12998 4 ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=none	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=4"
SRX3110721,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38748570,90.3,28.9,12231",GSM2747703: SLX-12998 3 ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_Fulvestrant_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=Fulvestrant	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=3"
SRX3110722,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36598690,89.6,21.9,14063",GSM2747704: SLX-12998 2 ER Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_Fulvestrant_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=Fulvestrant	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=2"
SRX3110723,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35029654,89.7,23.0,29155",GSM2747705: SLX-12998 1 ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=none	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=1"
SRX3110724,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37049289,88.3,22.6,15627",GSM2747706: SLX-12998 3 ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=none	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=3"
SRX3110725,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40693093,91.2,24.9,40915",GSM2747707: SLX-12998 2 ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=none	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=2"
SRX3110726,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35349601,82.8,14.9,833",GSM2747708: SLX-12998 Input none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=none	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=Input"
SRX3110727,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40616157,91.0,17.3,974",GSM2747709: SLX-12998 Input Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_ER_Fulvestrant_HC11	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-12998	chip antibody=ER (sc-543, Santa Cruz)	control antibody=ER (sc-543, Santa Cruz)	condition=Fulvestrant	spike-in cell line=HC11	spike-in organism=mus musculus	replicate=Input"
SRX3110728,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31892818,90.2,50.2,70878",GSM2747710: SLX-14229 1b ERCTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=1"
SRX3110729,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20447091,84.7,40.7,43881",GSM2747711: SLX-14229 1a ERCTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=1"
SRX3110730,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39119572,89.2,51.1,59518",GSM2747712: SLX-14229 2b ERCTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=2"
SRX3110731,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"68479443,83.2,56.1,79526",GSM2747713: SLX-14229 2a ERCTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=2"
SRX3110732,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23544444,81.7,53.9,49854",GSM2747714: SLX-14229 3a ERCTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=3"
SRX3110733,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24079862,90.3,49.9,66513",GSM2747715: SLX-14229 3b ERCTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=3"
SRX3110734,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23686927,89.8,50.7,63106",GSM2747716: SLX-14229 Ca CTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=CTCF"
SRX3110735,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16587588,81.1,50.1,43370",GSM2747717: SLX-14229 Cb CTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=CTCF"
SRX3110736,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43528146,72.5,45.4,1284",GSM2747718: SLX-14229 Input Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=Input"
SRX3110737,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"7203878,86.2,41.6,85",GSM2747719: SLX-14229 Input none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14429	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=Input"
SRX3110738,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"54413148,90.2,45.0,91288",GSM2747720: SLX-14438 1b ERCTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=1"
SRX3110739,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14055530,84.7,26.7,40620",GSM2747721: SLX-14438 1a ERCTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=1"
SRX3110740,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30180008,88.3,39.3,56197",GSM2747722: SLX-14438 2b ERCTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=2"
SRX3110741,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18131434,82.9,38.1,54543",GSM2747723: SLX-14438 2a ERCTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=2"
SRX3110742,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23215448,80.7,44.4,50219",GSM2747724: SLX-14438 3a ERCTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=3"
SRX3110743,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24711071,90.4,38.5,71548",GSM2747725: SLX-14438 3b ERCTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=3"
SRX3110744,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26134894,89.9,40.1,69529",GSM2747726: SLX-14438 Ca CTCF Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=CTCF"
SRX3110745,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24366113,80.6,42.3,51570",GSM2747727: SLX-14438 Cb CTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=CTCF"
SRX3110746,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24720617,72.3,33.9,618",GSM2747728: SLX-14438 Input Fulvestrant; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF_Fulvestrant	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=Fulvestrant	spike-in cell line=None	spike-in organism=None	replicate=Input"
SRX3110747,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17802317,86.3,26.0,245",GSM2747729: SLX-14438 Input none; Homo sapiens; ChIP-Seq,"source_name=MCF7_ER_CTCF	cell line=MCF7	cell type=mammary epithelial cells	experiment number=SLX-14438	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, CST)	condition=none	spike-in cell line=None	spike-in organism=None	replicate=Input"
SRX3123810,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33869709,97.7,4.6,17820",GSM2752578: jc2906 MCF7 ER Veh; Homo sapiens; ChIP-Seq,source_name=ERa untreated	cell type=Breast cancer	passages=p19	cell line=MCF7	chip antibody=ERa sc-543	agent=No treatment
SRX3123811,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32335601,97.8,2.9,9099",GSM2752579: jc2907 MCF7 ER RAD001; Homo sapiens; ChIP-Seq,source_name=ERa RAD001 treatment	cell type=Breast cancer	passages=p19	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with RAD001
SRX3123812,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28768112,97.6,3.1,10503",GSM2752580: jc2908 MCF7 ER AZD2014; Homo sapiens; ChIP-Seq,source_name=ERa AZD2014 treatment	cell type=Breast cancer	passages=p19	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with AZD201
SRX3123816,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35926973,97.5,3.4,12003",GSM2752584: jc2912 MCF7 ER Veh; Homo sapiens; ChIP-Seq,source_name=ERa untreated	cell type=Breast cancer	passages=p20	cell line=MCF7	chip antibody=ERa sc-543	agent=No treatment
SRX3123817,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32548155,97.9,3.8,14184",GSM2752585: jc2913 MCF7 ER RAD001; Homo sapiens; ChIP-Seq,source_name=ERa RAD001 treatment	cell type=Breast cancer	passages=p20	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with RAD001
SRX3123818,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34036073,97.8,2.8,9203",GSM2752586: jc2914 MCF7 ER AZD2014; Homo sapiens; ChIP-Seq,source_name=ERa AZD2014 treatment	cell type=Breast cancer	passages=p20	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with AZD201
SRX3123822,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30944126,97.7,4.1,15587",GSM2752590: jc2918 MCF7 ER Veh; Homo sapiens; ChIP-Seq,source_name=ERa untreated	cell type=Breast cancer	passages=p21	cell line=MCF7	chip antibody=ERa sc-543	agent=No treatment
SRX3123823,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29621668,97.8,5.9,22898",GSM2752591: jc2919 MCF7 ER RAD001; Homo sapiens; ChIP-Seq,source_name=ERa RAD001 treatment	cell type=Breast cancer	passages=p21	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with RAD001
SRX3123824,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35891242,97.7,4.2,13743",GSM2752592: jc2920 MCF7 ER AZD2014; Homo sapiens; ChIP-Seq,source_name=ERa AZD2014 treatment	cell type=Breast cancer	passages=p21	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with AZD201
SRX3123828,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19304738,97.4,3.7,14573",GSM2752596: jc2924 MCF7 ER Veh; Homo sapiens; ChIP-Seq,source_name=ERa untreated	cell type=Breast cancer	passages=p22	cell line=MCF7	chip antibody=ERa sc-543	agent=No treatment
SRX3123829,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32393507,98.0,6.0,29103",GSM2752597: jc2925 MCF7 ER RAD001; Homo sapiens; ChIP-Seq,source_name=ERa RAD001 treatment	cell type=Breast cancer	passages=p22	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with RAD001
SRX3123830,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35214403,98.0,5.0,19650",GSM2752598: jc2926 MCF7 ER AZD2014; Homo sapiens; ChIP-Seq,source_name=ERa AZD2014 treatment	cell type=Breast cancer	passages=p22	cell line=MCF7	chip antibody=ERa sc-543	agent=Treatment with AZD201
SRX3141136,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35280679,98.8,6.0,1316",GSM2756965: HeLa nonCSC H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=HeLa, nonCSC, H3K27Ac	cell type=HeLa cells transfected with ZsGreen-cODCdegron	chip antibody=H3K27Ac (abcam, ab4729)"
SRX3141137,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"33990861,98.4,6.4,1125",GSM2756966: HeLa CSC H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=HeLa, CSC, H3K27Ac	cell type=HeLa cells transfected with ZsGreen-cODCdegron	chip antibody=H3K27Ac (abcam, ab4729)"
SRX3229120,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21779344,98.3,2.0,3051",GSM2797074: ER ChIP-seq Female 1; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Female_1	tissue=Human breast tumor	Sex=female
SRX3229121,hg38,TFs and others,ESR1,Breast,Breast cancer,,"18714970,96.9,1.9,6777",GSM2797075: ER ChIP-seq Female 2; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Female_2	tissue=Human breast tumor	Sex=female
SRX3229122,hg38,TFs and others,ESR1,Breast,Breast cancer,,"19308939,98.0,1.3,804",GSM2797076: ER ChIP-seq Female 3; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Female_3	tissue=Human breast tumor	Sex=female
SRX3229127,hg38,TFs and others,ESR1,Breast,Breast cancer,,"24391614,98.4,1.5,1018",GSM2797081: ER ChIP-seq Female 5; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Female_5	tissue=Human breast tumor	Sex=female
SRX3229128,hg38,TFs and others,ESR1,Breast,Breast cancer,,"20689654,98.4,2.0,7455",GSM2797082: ER ChIP-seq Female 6; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Female_6	tissue=Human breast tumor	Sex=female
SRX3229132,hg38,TFs and others,ESR1,Breast,Breast cancer,,"47092811,96.7,3.1,12811",GSM2797086: ER ChIP-seq Female 8; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Female_8	tissue=Human breast tumor	Sex=female
SRX3229136,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21011611,94.9,4.7,5296",GSM2797090: ER ChIP-seq Male 1; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_1	tissue=Human breast tumor	Sex=male
SRX3229137,hg38,TFs and others,ESR1,Breast,Breast cancer,,"24150981,96.2,2.2,1472",GSM2797091: ER ChIP-seq Male 2; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_2	tissue=Human breast tumor	Sex=male
SRX3229138,hg38,TFs and others,ESR1,Breast,Breast cancer,,"16355024,96.3,5.4,3655",GSM2797092: ER ChIP-seq Male 3; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_3	tissue=Human breast tumor	Sex=male
SRX3229139,hg38,TFs and others,ESR1,Breast,Breast cancer,,"24152962,92.5,4.8,9803",GSM2797093: ER ChIP-seq Male 4; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_4	tissue=Human breast tumor	Sex=male
SRX3229140,hg38,TFs and others,ESR1,Breast,Breast cancer,,"18048948,97.4,4.4,8743",GSM2797094: ER ChIP-seq Male 5; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_5	tissue=Human breast tumor	Sex=male
SRX3229141,hg38,TFs and others,ESR1,Breast,Breast cancer,,"17580147,96.2,6.8,1918",GSM2797095: ER ChIP-seq Male 6; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_6	tissue=Human breast tumor	Sex=male
SRX3229142,hg38,TFs and others,ESR1,Breast,Breast cancer,,"25817454,97.0,8.5,13517",GSM2797096: ER ChIP-seq Male 7; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_7	tissue=Human breast tumor	Sex=male
SRX3229143,hg38,TFs and others,ESR1,Breast,Breast cancer,,"23164111,98.3,4.1,3922",GSM2797097: ER ChIP-seq Male 8; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_8	tissue=Human breast tumor	Sex=male
SRX3229144,hg38,TFs and others,ESR1,Breast,Breast cancer,,"24352188,95.7,15.0,2657",GSM2797098: ER ChIP-seq Male 9; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_9	tissue=Human breast tumor	Sex=male
SRX3229145,hg38,TFs and others,ESR1,Breast,Breast cancer,,"22128278,96.4,15.8,37694",GSM2797099: ER ChIP-seq Male 10; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_10	tissue=Human breast tumor	Sex=male
SRX3229146,hg38,TFs and others,ESR1,Breast,Breast cancer,,"23456333,93.4,16.8,13841",GSM2797100: ER ChIP-seq Male 11; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_11	tissue=Human breast tumor	Sex=male
SRX3229147,hg38,TFs and others,ESR1,Breast,Breast cancer,,"22658504,96.5,9.8,4181",GSM2797101: ER ChIP-seq Male 12; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_12	tissue=Human breast tumor	Sex=male
SRX3229148,hg38,TFs and others,ESR1,Breast,Breast cancer,,"29297868,96.7,14.3,4141",GSM2797102: ER ChIP-seq Male 13; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_13	tissue=Human breast tumor	Sex=male
SRX3229149,hg38,TFs and others,ESR1,Breast,Breast cancer,,"16084850,95.6,7.9,14297",GSM2797103: ER ChIP-seq Male 14; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_14	tissue=Human breast tumor	Sex=male
SRX3229150,hg38,TFs and others,ESR1,Breast,Breast cancer,,"12884548,94.9,7.5,7634",GSM2797104: ER ChIP-seq Male 15; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_15	tissue=Human breast tumor	Sex=male
SRX3229151,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21622499,96.6,11.4,2843",GSM2797105: ER ChIP-seq Male 16; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_16	tissue=Human breast tumor	Sex=male
SRX3229152,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21232014,98.5,3.7,2265",GSM2797106: ER ChIP-seq Male 17; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_17	tissue=Human breast tumor	Sex=male
SRX3229153,hg38,TFs and others,ESR1,Breast,Breast cancer,,"25821293,96.7,12.7,10041",GSM2797107: ER ChIP-seq Male 18; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_18	tissue=Human breast tumor	Sex=male
SRX3229154,hg38,TFs and others,ESR1,Breast,Breast cancer,,"14930828,95.5,7.9,13150",GSM2797108: ER ChIP-seq Male 19; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_19	tissue=Human breast tumor	Sex=male
SRX3229155,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21235219,94.8,16.1,9505",GSM2797109: ER ChIP-seq Male 20; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_20	tissue=Human breast tumor	Sex=male
SRX3229156,hg38,TFs and others,ESR1,Breast,Breast cancer,,"14282252,94.0,10.2,15654",GSM2797110: ER ChIP-seq Male 21; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_21	tissue=Human breast tumor	Sex=male
SRX3229157,hg38,TFs and others,ESR1,Breast,Breast cancer,,"23100795,95.1,12.0,1538",GSM2797111: ER ChIP-seq Male 22; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_22	tissue=Human breast tumor	Sex=male
SRX3229158,hg38,TFs and others,ESR1,Breast,Breast cancer,,"13918401,90.0,18.6,398",GSM2797112: ER ChIP-seq Male 23; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_23	tissue=Human breast tumor	Sex=male
SRX3229159,hg38,TFs and others,ESR1,Breast,Breast cancer,,"19127336,96.8,5.2,1121",GSM2797113: ER ChIP-seq Male 24; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_24	tissue=Human breast tumor	Sex=male
SRX3229160,hg38,TFs and others,ESR1,Breast,Breast cancer,,"21295245,87.0,20.0,854",GSM2797114: ER ChIP-seq Male 25; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_25	tissue=Human breast tumor	Sex=male
SRX3229161,hg38,TFs and others,ESR1,Breast,Breast cancer,,"27327025,97.6,10.9,43333",GSM2797115: ER ChIP-seq Male 26; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_26	tissue=Human breast tumor	Sex=male
SRX3229162,hg38,TFs and others,ESR1,Breast,Breast cancer,,"22952375,98.3,3.6,1140",GSM2797116: ER ChIP-seq Male 27; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_27	tissue=Human breast tumor	Sex=male
SRX3229163,hg38,TFs and others,ESR1,Breast,Breast cancer,,"22067070,98.1,4.1,9215",GSM2797117: ER ChIP-seq Male 28; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_28	tissue=Human breast tumor	Sex=male
SRX3229164,hg38,TFs and others,ESR1,Breast,Breast cancer,,"23395883,86.4,2.0,2426",GSM2797118: ER ChIP-seq Male 29; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_29	tissue=Human breast tumor	Sex=male
SRX3229165,hg38,TFs and others,ESR1,Breast,Breast cancer,,"13521868,65.9,6.7,4455",GSM2797119: ER ChIP-seq Male 30; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=ER	patient id=Male_30	tissue=Human breast tumor	Sex=male
SRX3229189,hg38,TFs and others,PGR,Breast,Breast cancer,,"22484333,94.0,6.2,28133",GSM2797143: PR ChIP-seq Male 26; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=PR	patient id=Male_26	tissue=Human breast tumor	Sex=male
SRX3229190,hg38,TFs and others,PGR,Breast,Breast cancer,,"22949167,94.7,4.8,12012",GSM2797144: PR ChIP-seq Male 28; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=PR	patient id=Male_28	tissue=Human breast tumor	Sex=male
SRX3229191,hg38,TFs and others,PGR,Breast,Breast cancer,,"21621674,95.8,2.0,737",GSM2797145: PR ChIP-seq Male 29; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=PR	patient id=Male_29	tissue=Human breast tumor	Sex=male
SRX3229192,hg38,TFs and others,PGR,Breast,Breast cancer,,"26484363,96.8,1.9,12548",GSM2797146: PR ChIP-seq Male 30; Homo sapiens; ChIP-Seq,source_name=Human breast tumor	antibody=PR	patient id=Male_30	tissue=Human breast tumor	Sex=male
SRX323398,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33768557,95.3,51.3,16808",GSM1187116: s01 MCF7 ER rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell type=MCF-7 breast cancer cell line	chip antibody=ERα (sc543; Santa Cruz Biotechnology)	chip treatment conditions=10nM E2, 45 minutes"
SRX323399,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36978860,97.4,46.6,18086",GSM1187117: s02 MCF7 ER rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell type=MCF-7 breast cancer cell line	chip antibody=ERα (sc543; Santa Cruz Biotechnology)	chip treatment conditions=10nM E2, 45 minutes"
SRX323400,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27258888,91.5,56.4,16215",GSM1187118: s03 MCF7 ER rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7 breast cancer cell line	cell type=MCF-7 breast cancer cell line	chip antibody=ERα (sc543; Santa Cruz Biotechnology)	chip treatment conditions=10nM E2, 45 minutes"
SRX3260338,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"8066733,83.2,12.5,21141",GSM2806607: ATAC Undecidualized sample 1; Homo sapiens; ATAC-seq,source_name=Endometrial stromal cells	passage=2	cell type=Endometrial stromal cells
SRX3260339,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"15221537,78.0,23.0,46039",GSM2806608: ATAC Decidualized sample 1; Homo sapiens; ATAC-seq,source_name=Endometrial stromal cells	passage=2	cell type=Endometrial stromal cells
SRX3260340,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"18777059,67.9,15.0,43386",GSM2806609: ATAC Undecidualized sample 2; Homo sapiens; ATAC-seq,source_name=Endometrial stromal cells	passage=2	cell type=Endometrial stromal cells
SRX3260341,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"48918813,69.9,23.6,96952",GSM2806610: ATAC Decidualized sample 2; Homo sapiens; ATAC-seq,source_name=Endometrial stromal cells	passage=2	cell type=Endometrial stromal cells
SRX3260342,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial stromal cells,,"20413279,70.9,14.9,49449",GSM2806611: ATAC Decidualized sample 3; Homo sapiens; ATAC-seq,source_name=Endometrial stromal cells	passage=2	cell type=Endometrial stromal cells
SRX3285553,hg38,TFs and others,ESR1,Breast,C49R,,"66946222,97.6,50.5,4322",GSM2813067: Group4 C49R CSS ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=C49R	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=None"
SRX3285554,hg38,TFs and others,ESR1,Breast,C49R,,"29042059,97.6,44.4,8716",GSM2813068: Group4 C49R E2 45min ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=C49R	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=E2_45min"
SRX3285555,hg38,TFs and others,ESR1,Breast,C70R,,"76264886,97.1,51.6,6667",GSM2813069: Group4 C70R CSS ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=C70R	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=None"
SRX3285556,hg38,TFs and others,ESR1,Breast,C70R,,"61489512,97.2,45.8,11848",GSM2813070: Group4 C70R E2 45min ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=C70R	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=E2_45min"
SRX3285557,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55268651,97.3,45.9,2861",GSM2813071: Group4 MCF7 CSS ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=None"
SRX3285558,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"67073232,97.0,18.7,2617",GSM2813072: Group4 MCF7 CSS input (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=-"
SRX3285559,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"67297555,97.3,51.7,10867",GSM2813073: Group4 MCF7 E2 45min ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=E2_45min"
SRX3285599,hg38,TFs and others,ESR1,Breast,FULR,,"65946189,97.1,46.7,10070",GSM2813113: Group9 FULR C70 ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=FULR	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=C70"
SRX3285600,hg38,TFs and others,ESR1,Breast,FULR,,"69675057,97.0,52.2,7679",GSM2813114: Group9 FULR C70plusFUL ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=FULR	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=C70_&amp;_FUL"
SRX3285601,hg38,TFs and others,ESR1,Breast,FULR,,"62068697,97.1,56.1,9107",GSM2813115: Group9 FULR FUL ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=FULR	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=Fulvestrant"
SRX3285603,hg38,TFs and others,ESR1,Breast,FULR,,"68206393,97.1,55.0,19415",GSM2813117: Group9 FULR ER (ChIP-Seq); Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=FULR	antibody=anti-ERα (Cell signaling, 8644)	treatment_time=None"
SRX3288574,hg38,TFs and others,FOS,Pluripotent stem cell,hESC H9,,"30423826,98.0,7.6,379",GSM2816633: cFos ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=H9 hESCs	cell line=H9 human Embryonic Stem Cell Line	chip-antibody=cFos	condition=under normal conditions
SRX3288575,hg38,TFs and others,FOS,Pluripotent stem cell,hESC H9,,"20545510,98.0,6.3,274",GSM2816634: HS cFos ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=H9 hESCs	cell line=H9 human Embryonic Stem Cell Line	chip-antibody=cFos	condition=under heat shock conditions
SRX330067,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32102078,88.5,15.3,41413",GSM1198711: Chromatin IP for ERα in MCF-7 cells transfected with a control siRNA Replicate 1; Homo sapiens; ChIP-Seq,source_name=MCF-7 cells	cell line=MCF-7	cell type=breast cancer	chip antibody=ERα (Santa Cruz; sc-543)
SRX330068,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26636036,90.5,8.7,26874",GSM1198712: Chromatin IP for ERα in MCF-7 cells transfected with a LRH-1 siRNA Replicate 1; Homo sapiens; ChIP-Seq,source_name=MCF-7 cells	cell line=MCF-7	cell type=breast cancer	chip antibody=ERα (Santa Cruz; sc-543)
SRX330069,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25505703,97.1,6.6,34079",GSM1198713: Chromatin IP for ERα in MCF-7 cells transfected with a control siRNA Replicate 2; Homo sapiens; ChIP-Seq,source_name=MCF-7 cells	cell line=MCF-7	cell type=breast cancer	chip antibody=ERα (Santa Cruz; sc-543)
SRX330070,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20358839,95.9,6.2,30522",GSM1198714: Chromatin IP for ERα in MCF-7 cells transfected with a LRH-1 siRNA Replicate 2; Homo sapiens; ChIP-Seq,source_name=MCF-7 cells	cell line=MCF-7	cell type=breast cancer	chip antibody=ERα (Santa Cruz; sc-543)
SRX3321960,hg38,TFs and others,FOS,Lung,IMR-90,Primary Tissue=Lung|Tissue Diagnosis=Normal,"22332869,93.8,3.9,17725",GSM2825448: ChIP-seq from IMR-90 (ENCLB063BCL); Homo sapiens; ChIP-Seq,"sex=female	cell type=IMR-90	lab=Michael Snyder, Stanford	sample_type=primary cell	health state=unknown	age=16 week	donor ID=ENCDO000AAX	dev_stage=embryonic"
SRX3321961,hg38,TFs and others,FOS,Lung,IMR-90,Primary Tissue=Lung|Tissue Diagnosis=Normal,"24084460,95.4,6.3,27740",GSM2825449: ChIP-seq from IMR-90 (ENCLB185HFY); Homo sapiens; ChIP-Seq,"dev stage=fetal	donor ID=ENCDO000AAX	age=16 week	sex=female	lab=Michael Snyder, Stanford	cell type=IMR-90	health state=unknown	sample type=primary cell"
SRX3322636,hg38,TFs and others,FOS,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"47717258,98.0,3.2,40951",GSM2827569: ChIP-seq from MCF-7 (ENCLB200WLX); Homo sapiens; ChIP-Seq,"dev stage=adult	cell line=MCF-7	sex=female	sample type=immortalized cell line	donor ID=ENCDO000AAE	age=69 year	health state=breast cancer (adenocarcinoma)	lab=Michael Snyder, Stanford"
SRX3322637,hg38,TFs and others,FOS,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35307449,99.1,3.1,28231",GSM2827570: ChIP-seq from MCF-7 (ENCLB859HNT); Homo sapiens; ChIP-Seq,"dev stage=adult	cell line=MCF-7	sex=female	sample type=immortalized cell line	donor ID=ENCDO000AAE	age=69 year	health state=breast cancer (adenocarcinoma)	lab=Michael Snyder, Stanford"
SRX3324889,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"13218480,84.7,1.5,39540",GSM2830381: HeLa replicate 1; Homo sapiens; ATAC-seq,source_name=HeLa cell line	cell line=HeLa
SRX3324890,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"11144725,84.5,1.5,35953",GSM2830382: HeLa replicate 2; Homo sapiens; ATAC-seq,source_name=HeLa cell line	cell line=HeLa
SRX3410404,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"88257333,97.3,66.2,2382",GSM2862205: T47D ERa ChIP-seq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=Parental cells	chip antibody=Diagenode # C15100066
SRX3428652,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31435861,98.1,50.2,705",GSM2868064: MCF-7 Control ChIP ER Ethanol; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	cell line=MCF-7	integrated vectors=pcDNA6/TR and pcDNA4/TO, Invitrogen	hormone treatment=Ethanol (0.01% final)	chip antibody=HC-20, sc-543, Santa Cruz Biotechnology"
SRX3428653,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"67038917,98.8,22.3,1916",GSM2868065: MCF-7 Control ChIP ER E2; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	cell line=MCF-7	integrated vectors=pcDNA6/TR and pcDNA4/TO, Invitrogen	hormone treatment=10-8M Estradiol (Sigma)	chip antibody=HC-20, sc-543, Santa Cruz Biotechnology"
SRX3428654,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"58367414,99.3,14.8,873",GSM2868066: MCF-7 MKL1D200 ChIP ER Ethanol; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	cell line=MCF-7	integrated vectors=pcDNA6/TR and pcDNA4/TO -MKL1 deltaN200, Invitrogen	hormone treatment=Ethanol (0.01% final)	chip antibody=HC-20, sc-543, Santa Cruz Biotechnology"
SRX3428655,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38681817,97.4,52.7,1087",GSM2868067: MCF-7 MKL1D200 ChIP ER E2; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	cell line=MCF-7	integrated vectors=pcDNA6/TR and pcDNA4/TO -MKL1 deltaN200, Invitrogen	hormone treatment=10-8M Estradiol (Sigma)	chip antibody=HC-20, sc-543, Santa Cruz Biotechnology"
SRX3447351,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32306775,99.4,17.9,63663",GSM2877976: SLX-15091 1a ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=none	replicate=1"
SRX3447352,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27890411,99.4,19.0,67584",GSM2877977: SLX-15091 2a ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=none	replicate=2"
SRX3447353,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33281979,98.9,10.8,813",GSM2877978: SLX-15091 Input none; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=none	replicate=Input"
SRX3447354,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24942864,99.3,18.7,64901",GSM2877979: SLX-15091 3a ER none; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=none	replicate=3"
SRX3447355,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32540105,98.4,15.9,48184",GSM2877980: SLX-15091 3b ER 45min; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=Estrogen	replicate=3"
SRX3447356,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37164705,99.4,18.4,68384",GSM2877981: SLX-15091 CTCF 45min; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=Estrogen	replicate=CTCF"
SRX3447357,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27064734,99.4,19.1,65874",GSM2877982: SLX-15091 CTCF none; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=none	replicate=CTCF"
SRX3447358,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30261012,98.8,9.3,740",GSM2877983: SLX-15091 Input 45min; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=Estrogen	replicate=Input"
SRX3447359,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31140838,99.4,18.4,76816",GSM2877984: SLX-15091 1b ER 45min; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=Estrogen	replicate=1"
SRX3447360,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24344514,99.4,17.7,73552",GSM2877985: SLX-15091 2b ER 45min; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	experiment number=SLX-15091	cell type=mammary epithelial cells	chip antibody=ER (sc-543, Santa Cruz)	control antibody=CTCF (3418 XP, Cell Signaling)	treatment=Estrogen	replicate=2"
SRX3478056,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35920536,93.8,32.7,6464",GSM2891722: H3K27ac S rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa-S3	cell population=synchronized	tsa treated=no	cell line=HeLa-S3	chip antibody=anti H3K27ac (D5E4, Cell Signaling Technologies)"
SRX3478057,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"24562848,95.1,51.5,1347",GSM2891723: H3K27ac S rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa-S3	cell population=synchronized	tsa treated=no	cell line=HeLa-S3	chip antibody=anti H3K27ac (D5E4, Cell Signaling Technologies)"
SRX3478058,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35033555,94.5,18.1,33303",GSM2891724: H3K27ac Un rep1; Homo sapiens; ChIP-Seq,"source_name=HeLa-S3	cell population=unsynchronized	tsa treated=no	cell line=HeLa-S3	chip antibody=anti H3K27ac (D5E4, Cell Signaling Technologies)"
SRX3478059,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"29834696,91.1,28.2,22205",GSM2891725: H3K27ac Un rep2; Homo sapiens; ChIP-Seq,"source_name=HeLa-S3	cell population=unsynchronized	tsa treated=no	cell line=HeLa-S3	chip antibody=anti H3K27ac (D5E4, Cell Signaling Technologies)"
SRX3541094,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36163968,97.0,25.6,1978",GSM2915375: DSP250 EtOH ERa; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541095,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39522002,76.3,4.5,1884",GSM2915376: DSP488 V 30 ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541096,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37589738,83.1,5.9,1167",GSM2915377: DSP514 V 30 ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541097,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36679486,96.8,36.6,6120",GSM2915378: DSP250 ICI ERa; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541098,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33095249,64.1,5.3,3424",GSM2915379: DSP488 ICI 30 ERa N2; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541099,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44255408,81.3,3.4,2723",GSM2915380: DSP514 ICI 30 ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541100,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37243214,97.0,56.4,11999",GSM2915381: DSP250 E2 ERa; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541101,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37467928,71.6,73.1,4980",GSM2915382: DSP460 E2 30 ERa N2; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541102,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44418946,80.2,7.4,10842",GSM2915383: DSP488 E2 30 ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541103,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33193964,74.0,64.8,573",GSM2915384: DSP488 V 3h ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541104,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33199571,85.0,8.7,1570",GSM2915385: DSP488 V 3h ERa N2; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541105,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40032563,60.4,4.4,3331",GSM2915386: DSP514 V 3h ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541106,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37567355,77.8,4.1,1388",GSM2915387: DSP514 V 3h ERa N2; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541107,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46670049,79.2,6.0,2849",GSM2915388: DSP488 ICI 3h ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541108,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40061311,40.0,5.1,2042",GSM2915389: DSP514 ICI 3h ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541109,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25887922,80.8,22.1,668",GSM2915390: DSP514 ICI 3h ERa N2; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541110,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39257214,68.8,10.9,5578",GSM2915391: DSP488 E2 3h ERa N1; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3541111,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31377356,82.9,13.5,4537",GSM2915392: DSP488 E2 3h ERa N2; Homo sapiens; ChIP-Seq,source_name=breast cancer cells	cell type=MCF-7 cells	chip antibody=ERα HC-20 (Santa Cruz Biotechnology sc-543)
SRX3554400,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"12854746,76.4,54.9,1114",GSM2931693: ERα DMSO ChIP-seq replicate 1; Homo sapiens; ChIP-Seq,"source_name=ERα DMSO ChIP-seq	cell line=MDA-MB-134	cell type=Epithelial ERalpha positive breast cancer cell line	passage=between 10 and 12	treated with=DMSO	chip antibodies=ERα (Bethyl Laboratories, A300-498A )"
SRX3554401,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"33696960,21.4,68.7,1030",GSM2931694: ERα DMSO ChIP-seq replicate 2; Homo sapiens; ChIP-Seq,"source_name=ERα DMSO ChIP-seq	cell line=MDA-MB-134	cell type=Epithelial ERalpha positive breast cancer cell line	passage=between 10 and 12	treated with=DMSO	chip antibodies=ERα (Bethyl Laboratories, A300-498A )"
SRX3554402,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"23272804,89.3,38.3,19233",GSM2931695: ERα E2 ChIP-seq replicate 1; Homo sapiens; ChIP-Seq,"source_name=ERα E2 ChIP-seq	cell line=MDA-MB-134	cell type=Epithelial ERalpha positive breast cancer cell line	passage=between 10 and 12	treated with=100 nM estradiol (E2) for 1hr	chip antibodies=ERα (Bethyl Laboratories, A300-498A )"
SRX3554403,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"25914194,97.1,47.0,27249",GSM2931696: ERα E2 ChIP-seq replicate 2; Homo sapiens; ChIP-Seq,"source_name=ERα E2 ChIP-seq	cell line=MDA-MB-134	cell type=Epithelial ERalpha positive breast cancer cell line	passage=between 10 and 12	treated with=100 nM estradiol (E2) for 1hr	chip antibodies=ERα (Bethyl Laboratories, A300-498A )"
SRX3554404,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"6708654,66.7,44.9,1955",GSM2931697: ERα FI ChIP-seq replicate 1; Homo sapiens; ChIP-Seq,"source_name=ERα FI ChIP-seq	cell line=MDA-MB-134	cell type=Epithelial ERalpha positive breast cancer cell line	passage=between 10 and 12	treated with=a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr	chip antibodies=ERα (Bethyl Laboratories, A300-498A )"
SRX3554405,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"21301697,91.9,43.2,21493",GSM2931698: ERα FI ChIP-seq replicate 2; Homo sapiens; ChIP-Seq,"source_name=ERα FI ChIP-seq	cell line=MDA-MB-134	cell type=Epithelial ERalpha positive breast cancer cell line	passage=between 10 and 12	treated with=a cocktail of 10 µM forskolin plus 100 µM 3-isobutyl-1-methylxanthine (FI) for 1hr	chip antibodies=ERα (Bethyl Laboratories, A300-498A )"
SRX355609,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"89345471,97.5,8.9,3282",GSM1235008: E-ER ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=Mammary epithelial cells	cell type=invasive lobular carcinoma cells	cell line=MDA-MB-134	cell passage=40-50	chip antibody=ERα (Santa Cruz, HC-20)"
SRX355611,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"97710371,97.8,9.7,1983",GSM1235010: V-ER ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=Mammary epithelial cells	cell type=invasive lobular carcinoma cells	cell line=MDA-MB-134	cell passage=40-50	chip antibody=ERα (Santa Cruz, HC-20)"
SRX3583179,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38524135,98.7,3.8,7775",GSM2913221: ChIPseq TIME0 ER1; Homo sapiens; ChIP-Seq,source_name=MCF7L parental	cell types=immortalized breast epithelial cell line	chip antibody=ERα	agent=untreated
SRX3583187,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38031199,98.2,5.0,7938",GSM2913229: ChIPseq TIME1 ER1; Homo sapiens; ChIP-Seq,source_name=MCF7L parental	cell types=immortalized breast epithelial cell line	chip antibody=ERα	agent=treated with E2	time point=1 hour
SRX3583195,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40122602,98.4,3.9,5378",GSM2913237: ChIPseq TIME4 ER1; Homo sapiens; ChIP-Seq,source_name=MCF7L parental	cell types=immortalized breast epithelial cell line	chip antibody=ERα	agent=treated with E2	time point=4 hours
SRX3583203,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42073940,98.3,4.6,7903",GSM2913245: ChIPseq TIME16 ER1; Homo sapiens; ChIP-Seq,source_name=MCF7L parental	cell types=immortalized breast epithelial cell line	chip antibody=ERα	agent=treated with E2	time point=16 hours
SRX3583211,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36851361,97.9,7.1,4750",GSM2913253: ChIPseq TIME24 ER1; Homo sapiens; ChIP-Seq,source_name=MCF7L parental	cell types=immortalized breast epithelial cell line	chip antibody=ERα	agent=treated with E2	time point=24 hours
SRX3583224,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"71688716,98.0,7.8,2814",GSM2913265: ChIPseq TAMR ER1; Homo sapiens; ChIP-Seq,source_name=MCF7L Tamoxifen Resistant	cell types=immortalized breast epithelial cell line	chip antibody=ERα
SRX3592678,hg38,TFs and others,JUN,Pluripotent stem cell,hESC HUES8,,"34814240,90.4,20.2,16438",GSM2945827: ChIP-seq Control DE Day1-JUN; Homo sapiens; ChIP-Seq,source_name=HUES8 human embryonic stem cells (hESCs)	genotype=SOX17-GFP knockin	parental cell line=HUES8	parental cell type=human embryonic stem cells (hESCs)	differentiation status=DE	antibody=JUN (Cell Signaling Techology 9165S)
SRX3592686,hg38,TFs and others,JUN,Pluripotent stem cell,hESC HUES8,,"14826018,97.5,36.8,8546",GSM2945834: ChIP-seq ESC JUN; Homo sapiens; ChIP-Seq,source_name=HUES8 human embryonic stem cells (hESCs)	genotype=SOX17-GFP knockin	parental cell line=HUES8	parental cell type=human embryonic stem cells (hESCs)	differentiation status=ESC	antibody=JUN (Cell Signaling Techology 9165S)
SRX359825,hg38,TFs and others,FOS,Digestive tract,LoVo,Primary Tissue=Colon|Tissue Diagnosis=Adenocarcinoma,"23294386,67.0,9.3,584",GSM1239393: batch3 chrom1 LoVo FOSB Goat FailedQC; Homo sapiens; ChIP-Seq,"source_name=LoVo	cell line=LoVo	cell type=colon adenocarcinoma	hgn=FOS	antibody=Santa Cruz Biotechnology, Inc. : sc-166940 X	control sample=batch3_chrom1_LoVo_IgG_Goat	qc successful=FailedQC	fraction of peaks close to tss=0.039474	lowest e-value for a high complexity de novo motif=3.1"
SRX359899,hg38,TFs and others,JUN,Digestive tract,LoVo,Primary Tissue=Colon|Tissue Diagnosis=Adenocarcinoma,"17835408,92.2,11.5,19041",GSM1239467: batch4 chrom1 LoVo JUN Rabbit PassedQC; Homo sapiens; ChIP-Seq,source_name=LoVo	cell line=LoVo	cell type=colon adenocarcinoma	hgn=JUN	antibody=Abcam : ab31419	control sample=batch4_chrom1_LoVo_IgG_Rabbit	qc successful=PassedQC	fraction of peaks close to tss=0.206769	lowest e-value for a high complexity de novo motif=0
SRX3599304,hg38,TFs and others,JUN,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"12060645,97.8,4.9,1325",GSM2947449: JUN-0hour; Homo sapiens; ChIP-Seq,"source_name=Human Endothlial cell line	cell type=Primary Human Umbilical Vein Endothelial Cells	passage=P3-6	antibody=JUN, Cell Signaling	agent=VEGF	time point=0hour"
SRX3599305,hg38,TFs and others,JUN,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"16448180,97.8,7.8,2394",GSM2947450: JUN-1hour; Homo sapiens; ChIP-Seq,"source_name=Human Endothlial cell line	cell type=Primary Human Umbilical Vein Endothelial Cells	passage=P3-6	antibody=JUN, Cell Signaling	agent=VEGF	time point=1hour"
SRX3599306,hg38,TFs and others,JUN,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"33959703,97.7,14.1,1698",GSM2947451: JUN-4hour; Homo sapiens; ChIP-Seq,"source_name=Human Endothlial cell line	cell type=Primary Human Umbilical Vein Endothelial Cells	passage=P3-6	antibody=JUN, Cell Signaling	agent=VEGF	time point=4hour"
SRX3599307,hg38,TFs and others,JUN,Cardiovascular,HUVEC,Primary Tissue=Umbilical Cord|Tissue Diagnosis=Normal,"24936825,97.2,19.7,2971",GSM2947452: JUN-12hour; Homo sapiens; ChIP-Seq,"source_name=Human Endothlial cell line	cell type=Primary Human Umbilical Vein Endothelial Cells	passage=P3-6	antibody=JUN, Cell Signaling	agent=VEGF	time point=12hour"
SRX3629592,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8293008,98.6,0.4,110",GSM2970402: ER Ctrl 1; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629593,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"6074435,99.2,2.1,9489",GSM2970403: ER E2 45min 1; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629594,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8629080,98.7,2.6,11408",GSM2970404: ER E2 90min 1; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629595,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"9152821,98.8,0.4,91",GSM2970405: ER Ctrl 2; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629596,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8436191,98.9,2.1,8493",GSM2970406: ER E2 45min 2; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629597,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"5018072,99.2,1.2,5539",GSM2970407: ER E2 90min 2; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629598,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8328550,98.6,0.3,89",GSM2970408: ER Ctrl 3; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629599,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"10003864,98.9,1.7,8761",GSM2970409: ER E2 45min 3; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629600,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"5566487,99.1,0.8,4363",GSM2970410: ER E2 90min 3; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629601,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"5524897,99.0,0.3,162",GSM2970411: ER Ctrl 4; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629602,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8459632,98.9,1.8,9438",GSM2970412: ER E2 45min 4; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3629604,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8584019,98.8,1.3,6924",GSM2970413: ER E2 90min 4; Homo sapiens; ChIP-Seq,source_name=MCF7	tissue=Breast	chip-antibody=SC-543
SRX3630814,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22073897,51.3,10.4,8753",GSM2973394: Ishi Dex E2 ChIP ER; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=100 nM Dexamethasone and 10 nM Estradiol for 1 hour	target protein=ER	antibody=ER HC-20 (Santa Cruz sc-543)
SRX3630816,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22736491,59.1,11.8,13198",GSM2973396: Ishi E2 ChIP ER; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=10 nM Estradiol for 1 hour	target protein=ER	antibody=ER HC-20 (Santa Cruz sc-543)
SRX3630818,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21113959,24.6,3.8,1145",GSM2973398: Ishi DMSO ChIP ER; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=DMSO (vehicle) for 1 hour	target protein=ER	antibody=ER HC-20 (Santa Cruz sc-543)
SRX3630820,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"16841451,94.1,17.8,24209",GSM2973400: Ishi E2 ChIP H3K27ac; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=10 nM Estradiol for 8 hours	target protein=H3K27ac	antibody=H3K27ac pAb (Active Motif 39133)
SRX3630821,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18221990,81.0,21.2,19260",GSM2973401: Ishi E2 Dex ChIP H3K27ac; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=100 nM Dexamethasone and 10 nM Estradiol for 8 hours	target protein=H3K27ac	antibody=H3K27ac pAb (Active Motif 39133)
SRX3630822,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20408329,78.3,31.0,10282",GSM2973402: Ishi Dex ChIP H3K27ac; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=100 nM Dexamethasone for 8 hours	target protein=H3K27ac	antibody=H3K27ac pAb (Active Motif 39133)
SRX3630823,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"29385875,93.1,16.9,26679",GSM2973403: Ishi DMSO ChIP H3K27ac; Homo sapiens; ChIP-Seq,source_name=Ishikawa	cell line=Ishikawa	treatment=DMSO (vehicle) for 8 hours	target protein=H3K27ac	antibody=H3K27ac pAb (Active Motif 39133)
SRX3630825,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"47076789,94.2,54.5,13672",GSM2973390: Ishi Dex ATAC Seq; Homo sapiens; ATAC-seq,source_name=Ishikawa	cell line=Ishikawa	treatment=100 nM Dexamethasone 1 Hr
SRX3630826,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"26909633,95.8,45.1,3159",GSM2973391: Ishi DMSO ATAC Seq; Homo sapiens; ATAC-seq,source_name=Ishikawa	cell line=Ishikawa	treatment=DMSO 1 Hr
SRX3630827,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"48888757,94.5,40.7,7838",GSM2973392: Ishi E2 ATAC Seq; Homo sapiens; ATAC-seq,source_name=Ishikawa	cell line=Ishikawa	treatment=10 nM Estradiol 1 Hr
SRX3630828,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21248255,93.3,44.5,414",GSM2973393: Ishi E2 Dex ATAC Seq; Homo sapiens; ATAC-seq,source_name=Ishikawa	cell line=Ishikawa	treatment=100 nM Dexamethasone and 10 nM Estradiol 1 Hr
SRX3654155,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"19872224,98.4,6.2,5152",GSM2982894: ChIP H3K27ac HeLa K untreated; Homo sapiens; ChIP-Seq,"source_name=Human cervical carcinoma cell line	treatment=untreated	antibody=anti-H3K27ac (Abcam, ab4729)	cell line=HeLa Kyoto cells"
SRX3654156,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"30690053,98.6,8.6,12440",GSM2982895: ChIP H3K27ac HeLa K Luci siRNA; Homo sapiens; ChIP-Seq,"source_name=Human cervical carcinoma cell line	treatment=treated with Luciferase control siRNA	antibody=anti-H3K27ac (Abcam, ab4729)	cell line=HeLa Kyoto cells"
SRX3654157,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"20076076,98.2,6.6,7518",GSM2982896: ChIP H3K27ac HeLa K PWWP2A  siRNA 1; Homo sapiens; ChIP-Seq,"source_name=Human cervical carcinoma cell line	treatment=treated with PWWP2A specific siRNA 1	antibody=anti-H3K27ac (Abcam, ab4729)	cell line=HeLa Kyoto cells"
SRX3654158,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"29016699,98.5,9.7,18268",GSM2982897: ChIP H3K27ac HeLa K PWWP2A  siRNA 2; Homo sapiens; ChIP-Seq,"source_name=Human cervical carcinoma cell line	treatment=treated with PWWP2A specific siRNA 2	antibody=anti-H3K27ac (Abcam, ab4729)	cell line=HeLa Kyoto cells"
SRX365497,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"21612818,53.2,76.9,101",GSM1245253: PR-ChIP-seq; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=T47D	cell type=breast cancer cell line	passages=5-8	chip antibody=PR	chip antibody manufacturer=Santa Cruz
SRX3675843,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"116625195,97.5,36.0,59858",GSM2990403: H3K27ac ChIP-seq in G34L; Homo sapiens; ChIP-Seq,source_name=HeLa_G34L H3.3	cell line=HeLa	genotype/variation=stably expressing mutant (G34L) H3.3	chip antibody=H3K27ac
SRX3675852,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"110108002,97.7,35.1,56165",GSM2990412: H3K27ac ChIP-seq in WT; Homo sapiens; ChIP-Seq,source_name=HeLa_WT H3.3	cell line=HeLa	genotype/variation=stably expressing WT or mutant (G34L/G34W) H3.3	chip antibody=H3K27ac
SRX3675858,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"113635685,97.1,35.0,58218",GSM2990418: H3K27ac ChIP-seq in G34W; Homo sapiens; ChIP-Seq,source_name=HeLa_G34W H3.3	cell line=HeLa	genotype/variation=stably expressing mutant (G34W) H3.3	chip antibody=H3K27ac
SRX368849,hg38,TFs and others,CDK8,Blood,MM.1S,Primary Tissue=Blood|Tissue Diagnosis=Multiple Myeloma,"43719232,97.2,5.9,6669",GSM1252090: MM1S CDK8; Homo sapiens; ChIP-Seq,source_name=Multiple myeloma	cell line=MM1.S	chip antibody=CDK8	chip antibody=Santa Cruz	chip antibody=SC-1521	barcode removed=CAGATC
SRX371427,hg38,TFs and others,ESR1,Others,Tumour tissues,,"12386220,99.5,6.6,3530",GSM798383: SLX-1201.250.s 4; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=BT82597	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371428,hg38,TFs and others,ESR1,Others,Tumour tissues,,"17748550,99.0,64.6,1293",GSM798384: SLX-1881.334.s 1; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=BT82590	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371429,hg38,TFs and others,ESR1,Others,Tumour tissues,,"14597953,99.8,4.4,625",GSM798385: SLX-2626.438.s 4; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=CC106585_T3	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371430,hg38,TFs and others,ESR1,Others,Tumour tissues,,"14448521,99.8,3.1,16676",GSM798386: SLX-2627.438.s 5; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=CX627219_T4	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371431,hg38,TFs and others,ESR1,Others,Tumour tissues,,"7909114,99.7,8.7,562",GSM798387: SLX-4104.665.s 3; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=NT2304	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371432,hg38,TFs and others,ESR1,Others,Tumour tissues,,"16096770,99.6,4.5,610",GSM798388: SLX-4105.665.s 4; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=NT2304	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371433,hg38,TFs and others,ESR1,Others,Tumour tissues,,"13465938,99.7,6.2,2149",GSM798389: SLX-4106.665.s 5; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=NT2433	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371434,hg38,TFs and others,ESR1,Others,Tumour tissues,,"22808916,99.7,3.6,262",GSM798390: SLX-4107.665.s 6; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=NT2360	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371435,hg38,TFs and others,ESR1,Others,Tumour tissues,,"20280727,99.5,10.5,971",GSM798391: SLX-4111.666.s 2; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Responder	tissue=NT2289	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371436,hg38,TFs and others,ESR1,Others,Tumour tissues,,"15345243,99.8,6.6,460",GSM798392: SLX-2624.438.s 2; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=CC316812_T1	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371437,hg38,TFs and others,ESR1,Others,Tumour tissues,,"18824114,99.8,6.9,38848",GSM798393: SLX-2625.438.s 3; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=CC135745_T2	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371438,hg38,TFs and others,ESR1,Others,Tumour tissues,,"19145570,99.8,2.1,1654",GSM798394: SLX-2707.446.s 4; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=NT2138	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371439,hg38,TFs and others,ESR1,Others,Tumour tissues,,"17058991,99.8,7.4,18040",GSM798395: SLX-2706.446.s 3; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=NT2171	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371440,hg38,TFs and others,ESR1,Others,Tumour tissues,,"14531657,99.6,4.0,295",GSM798396: SLX-4102.665.s 1; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=NT2350	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371441,hg38,TFs and others,ESR1,Others,Tumour tissues,,"14371404,99.7,7.7,1682",GSM798397: SLX-4103.665.s 2; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=NT2350	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371442,hg38,TFs and others,ESR1,Others,Tumour tissues,,"19899253,99.8,2.8,945",GSM798398: SLX-4108.665.s 7; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=BT81585	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371443,hg38,TFs and others,ESR1,Others,Tumour tissues,,"19306200,99.7,4.9,3067",GSM798399: SLX-4109.665.s 8; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=BT81585	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371444,hg38,TFs and others,ESR1,Others,Tumour tissues,,"23486884,99.3,2.1,1780",GSM798400: SLX-4110.666.s 1; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Non-responder	tissue=BT81583	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371445,hg38,TFs and others,ESR1,Others,Tumour tissues,,"11278800,98.8,2.2,6575",GSM798401: SLX-1843.327.s 6; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Metastasis	tissue=Met_T1	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371446,hg38,TFs and others,ESR1,Others,Tumour tissues,,"21176171,99.7,17.9,56242",GSM798402: SLX-1845.332.s 5; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Metastasis	tissue=Met_T3	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371447,hg38,TFs and others,ESR1,Others,Tumour tissues,,"20479581,99.3,2.5,6673",GSM798403: SLX-1846.331.s 1; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=Metastasis	tissue=Met_T4	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371448,hg38,TFs and others,ESR1,Others,Tumour tissues,,"7382313,99.6,7.1,37",GSM798404: SLX-4112.666.s 3; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=ER-	tissue=NT2229	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371449,hg38,TFs and others,ESR1,Others,Tumour tissues,,"22933128,99.5,2.7,224",GSM798405: SLX-4113.666.s 4; Homo sapiens; ChIP-Seq,"source_name=Human tumour tissue	condition=ER-	tissue=NT2079	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371467,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22274527,99.7,23.9,48667",GSM798423: SLX-2640.438.s 1; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=MCF7	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371468,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22658264,99.7,6.7,34282",GSM798424: SLX-2773.448.s 1; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=MCF7	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371469,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29151735,99.7,12.7,50796",GSM798425: SLX-2943.469.s 2; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=MCF7	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371470,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23663743,99.7,16.6,56457",GSM798426: SLX-2774.448.s 2; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=ZR75	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371471,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"82873603,99.6,24.2,67792",GSM798427: SLX-2866.466.s 7; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=ZR75	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371472,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23594475,99.7,10.7,18002",GSM798428: SLX-2775.448.s 3; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=T47D	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371473,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"81554082,99.6,11.3,18179",GSM798429: SLX-2867.466.s 6; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Responsive	tissue=T47D	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371474,hg38,TFs and others,ESR1,Breast,BT-474,Primary Tissue=Breast|Site of Extraction=Soft Tissue|Tissue Diagnosis=Adenocarcinoma Ductal,"23906420,99.7,12.6,30656",GSM798430: SLX-2645.443.s 5; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Resist	tissue=BT474	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371475,hg38,TFs and others,ESR1,Breast,BT-474,Primary Tissue=Breast|Site of Extraction=Soft Tissue|Tissue Diagnosis=Adenocarcinoma Ductal,"23792852,99.8,11.2,31124",GSM798431: SLX-2576.443.s 7; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Resist	tissue=BT474	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371476,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26690330,98.3,15.0,41138",GSM798432: SLX-3229.521.s 5; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Resist	tissue=TAMR	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371477,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32136321,99.8,7.3,31860",GSM798433: SLX-3230.526.s 4; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Tam-Resist	tissue=TAMR	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371478,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29205525,99.8,12.5,53795",GSM798434: SLX-2945.469.s 4; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Cocktail_90	tissue=MCF7	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX371479,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19164231,99.8,11.4,40522",GSM798435: SLX-2642.442.s 8; Homo sapiens; ChIP-Seq,"source_name=Human breast cancer cell line	condition=Cocktail_90	tissue=MCF7	antibody=anti-ER (SC-543, Santa Cruz Biotechnologies)"
SRX3722703,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"27476475,92.3,33.0,63437",GSM3017266: AB555B-x2 ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=PDX01	biomaterial_provider=Caldas Lab, CRUK CI	tissue id=AB555B-x2	tissue=Breast Cancer patient-derived xenograft (PDX)	chip antibody=ER (sc-543)	parallel chip antibody=CTCF (D31H2)"
SRX3722704,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"924692,62.3,15.6,11",GSM3017267: VHI0244o2-x4 ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=PDX02	biomaterial_provider=Caldas Lab, CRUK CI	tissue id=VHI0244o2-x4	tissue=Breast Cancer patient-derived xenograft (PDX)	chip antibody=ER (sc-543)	parallel chip antibody=CTCF (D31H2)"
SRX3722705,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"28596984,57.0,27.3,31468",GSM3017268: AB580-x1 ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=PDX03	biomaterial_provider=Caldas Lab, CRUK CI	tissue id=AB580-x1	tissue=Breast Cancer patient-derived xenograft (PDX)	chip antibody=ER (sc-543)	parallel chip antibody=CTCF (D31H2)"
SRX3722706,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"55059236,71.8,62.1,34966",GSM3017269: STG195-x4 ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=PDX04	biomaterial_provider=Caldas Lab, CRUK CI	tissue id=STG195-x4	tissue=Breast Cancer patient-derived xenograft (PDX)	chip antibody=ER (sc-543)	parallel chip antibody=CTCF (D31H2)"
SRX3722707,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"63252197,81.5,68.9,33606",GSM3017270: V0980U-x2 ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=PDX05	biomaterial_provider=Caldas Lab, CRUK CI	tissue id=V0980U-x2	tissue=Breast Cancer patient-derived xenograft (PDX)	chip antibody=ER (sc-543)	parallel chip antibody=CTCF (D31H2)"
SRX3856992,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","33722169,96.4,33.0,51468",GSM3070216: MDA-MB-231 cJun ChIPSeq-rep1; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231	cell line=MDA-MB-231	cell type=cancer cells	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856993,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","43673227,94.4,22.8,46720",GSM3070217: MDA-MB-231 cJun ChIPSeq-rep2; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231	cell line=MDA-MB-231	cell type=cancer cells	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856994,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","44622984,97.6,36.9,63023",GSM3070218: MDA-MB-231p27CK-DD cJun ChIPSeq-rep1; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231p27CK-DD	cell line=derived from MDA-MB-231	cell type=cancer cells (phosphomimetic p27 line)	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856995,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","48155885,95.4,34.7,63467",GSM3070219: MDA-MB-231p27CK-DD cJun ChIPSeq-rep2; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231p27CK-DD	cell line=derived from MDA-MB-231	cell type=cancer cells (phosphomimetic p27 line)	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856996,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","36878716,96.4,35.1,51114",GSM3070220: MDA-MB-231-1833 cJun ChIPSeq-rep1; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231-1833	cell line=derived from MDA-MB-231	cell type=cancer cells (a bone-tropic metastatic line)	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856997,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","41527284,92.8,26.3,48032",GSM3070221: MDA-MB-231-1833 cJun ChIPSeq-rep2; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231-1833	cell line=derived from MDA-MB-231	cell type=cancer cells (a bone-tropic metastatic line)	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856998,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","25940105,91.2,35.4,38823",GSM3070222: MDA-MB-231-1833shp27 cJun ChIPSeq-rep1; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231-1833shp27	cell line=derived from MDA-MB-231	cell type=cancer cells (p27 knockdown line)	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX3856999,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","36872939,88.0,21.3,35124",GSM3070223: MDA-MB-231-1833shp27 cJun ChIPSeq-rep2; Homo sapiens; ChIP-Seq,source_name=MDA-MB-231-1833shp27	cell line=derived from MDA-MB-231	cell type=cancer cells (p27 knockdown line)	tissue=breast	chip antibody=cJun (Cell Signaling; 9165S)
SRX396818,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"53673423,84.6,13.1,4768",GSM1295590: siCTL ChIP-Seq; Homo sapiens; ChIP-Seq,"source_name=mammary gland, adenocarcinoma	cell line=MCF-7	chip antibody=ERα (Santa Cruz Biotechnology; sc-534X, sc-7207X)	transfection=siCTL"
SRX396819,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"49388965,88.0,20.9,1632",GSM1295591: siERα ChIP-Seq; Homo sapiens; ChIP-Seq,"source_name=mammary gland, adenocarcinoma	cell line=MCF-7	chip antibody=ERα (Santa Cruz Biotechnology; sc-534X, sc-7207X)	transfection=siERα"
SRX398298,hg38,TFs and others,CDK8,Digestive tract,HT-29,Primary Tissue=Colon|Tissue Diagnosis=Adenocarcinoma,"60079752,95.3,35.9,13998",GSM1296641: HT29 CDK8 ChipSeq; Homo sapiens; ChIP-Seq,source_name=Colon Carcinoma	chip antibody=CDK8	antibody catalog number=Santa Cruz SC-1521	cell line=HT29	cell type=Colon Carcinoma
SRX398302,hg38,TFs and others,CDK8,Digestive tract,SW 480,Primary Tissue=unresolved|Tissue Diagnosis=unresolved,"48784023,97.5,54.6,5461",GSM1296645: SW480 CDK8 ChipSeq; Homo sapiens; ChIP-Seq,source_name=Colon Carcinoma	chip antibody=CDK8	antibody catalog number=Santa Cruz SC-1521	cell line=SW480	cell type=Colon Carcinoma
SRX3990976,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29401474,98.0,40.2,1784",GSM3110056: T47D VC PR-1; Homo sapiens; ChIP-Seq,source_name=T47D_VC_PR	cell line=T47D	treatment=VC	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990978,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36651125,98.6,8.3,684",GSM3110058: T47D VC PR-2; Homo sapiens; ChIP-Seq,source_name=T47D_VC_PR	cell line=T47D	treatment=VC	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990980,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30403865,98.4,24.5,659",GSM3110060: T47D VC PR-3; Homo sapiens; ChIP-Seq,source_name=T47D_VC_PR	cell line=T47D	treatment=VC	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990982,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22116014,98.0,14.4,30512",GSM3110062: T47D R5020 PR-1; Homo sapiens; ChIP-Seq,source_name=T47D_R5020_PR	cell line=T47D	treatment=R5020	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990984,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36402118,98.0,12.3,49802",GSM3110064: T47D R5020 PR-2; Homo sapiens; ChIP-Seq,source_name=T47D_R5020_PR	cell line=T47D	treatment=R5020	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990986,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22728968,98.4,12.0,49586",GSM3110066: T47D R5020 PR-3; Homo sapiens; ChIP-Seq,source_name=T47D_R5020_PR	cell line=T47D	treatment=R5020	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990988,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"25178669,97.8,38.9,24696",GSM3110068: T47D TPA PR-1; Homo sapiens; ChIP-Seq,source_name=T47D_TPA_PR	cell line=T47D	treatment=TPA	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990990,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"34729470,98.7,9.5,15639",GSM3110070: T47D TPA PR-2; Homo sapiens; ChIP-Seq,source_name=T47D_TPA_PR	cell line=T47D	treatment=TPA	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990992,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"32704037,98.2,26.3,26371",GSM3110072: T47D TPA PR-3; Homo sapiens; ChIP-Seq,source_name=T47D_TPA_PR	cell line=T47D	treatment=TPA	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990994,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"18526847,97.6,12.5,18823",GSM3110074: T47D R5020+TPA PR-1; Homo sapiens; ChIP-Seq,source_name=T47D_R5020+TPA_PR	cell line=T47D	treatment=R5020+TPA	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990996,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"33899745,97.7,12.3,40317",GSM3110076: T47D R5020+TPA PR-2; Homo sapiens; ChIP-Seq,source_name=T47D_R5020+TPA_PR	cell line=T47D	treatment=R5020+TPA	chip antibody=PR (Santa Cruz SC-7208X)
SRX3990998,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26706862,97.6,11.6,32760",GSM3110078: T47D R5020+TPA PR-3; Homo sapiens; ChIP-Seq,source_name=T47D_R5020+TPA_PR	cell line=T47D	treatment=R5020+TPA	chip antibody=PR (Santa Cruz SC-7208X)
SRX4001968,hg38,TFs and others,FOS,Blood,THP-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"13127083,97.3,18.6,657",GSM3112113: THP1-Fos-eGFP-Pam3csk-0h; Homo sapiens; ChIP-Seq,"source_name=THP-1 monocyte AML cell line	cell type=THP-1 monocyte AML cell line	treatment=untreated	treatment time=04h	donor or replicate=rep1	electroporated mrna=eGFP	sirna=none	chip antibody=FOS, Santa Cruz: sc-7202"
SRX4001969,hg38,TFs and others,FOS,Blood,THP-1,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"19118043,96.4,45.6,1295",GSM3112114: THP1-Fos-eGFP-Pam3csk-4h; Homo sapiens; ChIP-Seq,"source_name=THP-1 monocyte AML cell line	cell type=THP-1 monocyte AML cell line	treatment=Pam3csk4 treated (4h)	treatment time=04h	donor or replicate=rep1	electroporated mrna=eGFP	sirna=none	chip antibody=FOS, Santa Cruz: sc-7202"
SRX4009690,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"58440849,97.6,50.2,1715",GSM3120578: Ishikawa E2 H3K27Ac; Homo sapiens; ChIP-Seq,source_name=Ishikawa_E2	cell line=Ishikawa	cell type=endometrial cancer cell line	treatment=10nM estradiol	chip antibody=H3K27Ac (Abcam #ab4729)
SRX4009694,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"53275730,96.8,23.6,1456",GSM3120582: Ishikawa Veh H3K27Ac; Homo sapiens; ChIP-Seq,source_name=Ishikawa_Veh	cell line=Ishikawa	cell type=endometrial cancer cell line	treatment=10nM DMSO	chip antibody=H3K27Ac (Abcam #ab4729)
SRX4009698,hg38,Histone,H3K27ac,Uterus,JHUEM-14,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"42900411,94.7,29.9,1846",GSM3120586: JHUEM14 E2 H3K27Ac; Homo sapiens; ChIP-Seq,source_name=JHUEM14_E2	cell line=JHUEM-14	cell type=endometrial cancer cell line	treatment=10nM estradiol	chip antibody=H3K27Ac (Abcam #ab4729)
SRX4009702,hg38,Histone,H3K27ac,Uterus,JHUEM-14,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"41870721,94.2,31.5,1992",GSM3120590: JHUEM14 Veh H3K27Ac; Homo sapiens; ChIP-Seq,source_name=JHUEM14_Veh	cell line=JHUEM-14	cell type=endometrial cancer cell line	treatment=10nM DMSO	chip antibody=H3K27Ac (Abcam #ab4729)
SRX4115992,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12497694,99.9,1.4,2469",GSM3149030: MCF7 ER FA; Homo sapiens; ChIP-Seq,source_name=MCF7 cell line	chip antibody=ER (Santa Cruz; sc-543)	patient id=MCF7_ER_FA	case/control=FA
SRX4115993,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17563584,99.9,1.5,8060",GSM3149031: MCF7 ER DSG; Homo sapiens; ChIP-Seq,source_name=MCF7 cell line	chip antibody=ER (Santa Cruz; sc-543)	patient id=MCF7_ER_DSG	case/control=DSG
SRX4116025,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"30272257,99.9,0.8,381",GSM3149062: B1 ER FA; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B1_ER_FA	case/control=FA
SRX4116026,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"19072816,99.9,1.4,2850",GSM3149063: B1 ER DSG; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B1_ER_DSG	case/control=DSG
SRX4116033,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"24101180,99.9,0.7,186",GSM3149070: B2 ER FA; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B2_ER_FA	case/control=FA
SRX4116034,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"16595136,99.9,1.8,6581",GSM3149071: B2 ER DSG; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B2_ER_DSG	case/control=DSG
SRX4116041,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"21683990,99.9,0.7,245",GSM3149078: B3 ER FA; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B3_ER_FA	case/control=FA
SRX4116042,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"22344603,99.9,1.1,216",GSM3149079: B3 ER DSG; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B3_ER_DSG	case/control=DSG
SRX4116050,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"27828387,99.9,0.8,299",GSM3149086: B4 ER FA; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B4_ER_FA	case/control=FA
SRX4116051,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"16869852,99.9,0.9,488",GSM3149087: B4 ER DSG; Homo sapiens; ChIP-Seq,source_name=primary breast cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=B4_ER_DSG	case/control=DSG
SRX4116058,hg38,TFs and others,ESR1,Uterus,Endometrium cancer,,"21391084,99.9,0.8,830",GSM3149094: E1 ER FA; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=E1_ER_FA	case/control=FA
SRX4116059,hg38,TFs and others,ESR1,Uterus,Endometrium cancer,,"21734715,99.9,1.3,14976",GSM3149095: E1 ER DSG; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=E1_ER_DSG	case/control=DSG
SRX4116060,hg38,Histone,H3K27ac,Uterus,Endometrium cancer,,"19142946,99.9,1.7,21314",GSM3149096: E1 H3K27ac FA; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=H3K27ac (Active Motif; 39133)	patient id=E1_H3K27ac_FA	case/control=FA
SRX4116061,hg38,Histone,H3K27ac,Uterus,Endometrium cancer,,"19654902,99.9,3.0,31667",GSM3149097: E1 H3K27ac DSG; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=H3K27ac (Active Motif; 39133)	patient id=E1_H3K27ac_DSG	case/control=DSG
SRX4116062,hg38,TFs and others,ESR1,Uterus,Endometrium cancer,,"23532172,99.9,0.8,239",GSM3149098: E2 ER FA; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=E2_ER_FA	case/control=FA
SRX4116063,hg38,TFs and others,ESR1,Uterus,Endometrium cancer,,"20701593,99.9,0.9,2094",GSM3149099: E2 ER DSG; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=E2_ER_DSG	case/control=DSG
SRX4116064,hg38,Histone,H3K27ac,Uterus,Endometrium cancer,,"19108991,99.9,1.2,15253",GSM3149100: E2 H3K27ac FA; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=H3K27ac (Active Motif; 39133)	patient id=E2_H3K27ac_FA	case/control=FA
SRX4116065,hg38,Histone,H3K27ac,Uterus,Endometrium cancer,,"19848693,99.9,2.4,27384",GSM3149101: E2 H3K27ac DSG; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=H3K27ac (Active Motif; 39133)	patient id=E2_H3K27ac_DSG	case/control=DSG
SRX4116066,hg38,TFs and others,ESR1,Uterus,Endometrium cancer,,"24061734,99.9,0.8,316",GSM3149102: E3 ER FA; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=E3_ER_FA	case/control=FA
SRX4116067,hg38,TFs and others,ESR1,Uterus,Endometrium cancer,,"21368431,99.9,0.8,640",GSM3149103: E3 ER DSG; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=ER (Santa Cruz; sc-543)	patient id=E3_ER_DSG	case/control=DSG
SRX4116068,hg38,Histone,H3K27ac,Uterus,Endometrium cancer,,"18713861,99.9,1.2,14225",GSM3149104: E3 H3K27ac FA; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=H3K27ac (Active Motif; 39133)	patient id=E3_H3K27ac_FA	case/control=FA
SRX4116069,hg38,Histone,H3K27ac,Uterus,Endometrium cancer,,"21352301,99.9,2.3,21644",GSM3149105: E3 H3K27ac DSG; Homo sapiens; ChIP-Seq,source_name=Primary endometrium cancer	chip antibody=H3K27ac (Active Motif; 39133)	patient id=E3_H3K27ac_DSG	case/control=DSG
SRX4132347,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"41093964,89.3,35.9,42946",GSM3161710: AN3 CA ATAC-seq replicate 1; Homo sapiens; ATAC-seq,source_name=Endometrial adenocarcinoma	cell line=AN3_CA	tissue=Endometrial adenocarcinoma
SRX4132348,hg38,ATAC-Seq,ATAC-Seq,Uterus,AN3 CA,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"36054045,89.8,36.6,37901",GSM3161711: AN3 CA ATAC-seq replicate 2; Homo sapiens; ATAC-seq,source_name=Endometrial adenocarcinoma	cell line=AN3_CA	tissue=Endometrial adenocarcinoma
SRX4132351,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35446296,91.7,38.5,46787",GSM3161714: Ishikawa ATAC-seq replicate 1; Homo sapiens; ATAC-seq,source_name=Endometrial adenocarcinoma	cell line=Ishikawa	tissue=Endometrial adenocarcinoma
SRX4132352,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"39996174,91.3,44.4,48111",GSM3161715: Ishikawa ATAC-seq replicate 2; Homo sapiens; ATAC-seq,source_name=Endometrial adenocarcinoma	cell line=Ishikawa	tissue=Endometrial adenocarcinoma
SRX4132353,hg38,ATAC-Seq,ATAC-Seq,Uterus,JHUCS-1,Primary Tissue=Uterus|Tissue Diagnosis=Carcinoma,"37657815,88.3,20.5,28404",GSM3161716: JHUCS 1 ATAC-seq replicate 1; Homo sapiens; ATAC-seq,source_name=Uterine carcinosarcoma	cell line=JHUCS_1	tissue=Uterine carcinosarcoma
SRX4132354,hg38,ATAC-Seq,ATAC-Seq,Uterus,JHUCS-1,Primary Tissue=Uterus|Tissue Diagnosis=Carcinoma,"39145751,88.5,17.6,30758",GSM3161717: JHUCS 1 ATAC-seq replicate 2; Homo sapiens; ATAC-seq,source_name=Uterine carcinosarcoma	cell line=JHUCS_1	tissue=Uterine carcinosarcoma
SRX4132355,hg38,ATAC-Seq,ATAC-Seq,Uterus,KLE,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"36052766,91.0,41.4,59144",GSM3161718: KLE ATAC-seq replicate 1; Homo sapiens; ATAC-seq,source_name=Endometrial adenocarcinoma	cell line=KLE	tissue=Endometrial adenocarcinoma
SRX4132356,hg38,ATAC-Seq,ATAC-Seq,Uterus,KLE,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"39889504,91.0,45.1,62173",GSM3161719: KLE ATAC-seq replicate 2; Homo sapiens; ATAC-seq,source_name=Endometrial adenocarcinoma	cell line=KLE	tissue=Endometrial adenocarcinoma
SRX4132363,hg38,ATAC-Seq,ATAC-Seq,Uterus,SNU-685,,"44743039,90.2,24.6,86087",GSM3161726: SNU685 ATAC-seq replicate 1; Homo sapiens; ATAC-seq,source_name=Uterine carcinosarcoma	cell line=SNU685	tissue=Uterine carcinosarcoma
SRX4132364,hg38,ATAC-Seq,ATAC-Seq,Uterus,SNU-685,,"52075853,90.5,33.9,87794",GSM3161727: SNU685 ATAC-seq replicate 2; Homo sapiens; ATAC-seq,source_name=Uterine carcinosarcoma	cell line=SNU685	tissue=Uterine carcinosarcoma
SRX4132365,hg38,ATAC-Seq,ATAC-Seq,Uterus,RL95-2,Primary Tissue=Uterus|Tissue Diagnosis=Carcinoma,"37030703,87.7,37.7,37155",GSM3161728: RL95 2 ATAC-seq replicate 1; Homo sapiens; ATAC-seq,source_name=Endometrial adenosquamous carcinoma	cell line=RL95_2	tissue=Endometrial adenosquamous carcinoma
SRX4132366,hg38,ATAC-Seq,ATAC-Seq,Uterus,RL95-2,Primary Tissue=Uterus|Tissue Diagnosis=Carcinoma,"35213002,86.3,32.9,33921",GSM3161729: RL95 2 ATAC-seq replicate 2; Homo sapiens; ATAC-seq,source_name=Endometrial adenosquamous carcinoma	cell line=RL95_2	tissue=Endometrial adenosquamous carcinoma
SRX4192879,hg38,TFs and others,FOS,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"31170121,93.8,17.0,60189",GSM3184657: FOS EtOH ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF10A-ER-Src cell	tissue=Breast	cell line=MCF10A-ER-Src	chip target=FOS	transformation status=non-transformed
SRX4192880,hg38,TFs and others,FOS,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"34372115,98.6,19.3,80862",GSM3184658: FOS TAM ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF10A-ER-Src cell	tissue=Breast	cell line=MCF10A-ER-Src	chip target=FOS	transformation status=transformed
SRX4192883,hg38,TFs and others,JUN,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"29445070,91.6,21.9,17210",GSM3184661: JUN EtOH ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF10A-ER-Src cell	tissue=Breast	cell line=MCF10A-ER-Src	chip target=JUN	transformation status=non-transformed
SRX4192884,hg38,TFs and others,JUN,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"28093687,96.9,13.4,46128",GSM3184662: JUN TAM ChIPseq; Homo sapiens; ChIP-Seq,source_name=MCF10A-ER-Src cell	tissue=Breast	cell line=MCF10A-ER-Src	chip target=JUN	transformation status=transformed
SRX4193141,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32233446,97.2,12.7,5530",GSM3184871: ERalpha s1 DMSO ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=DMSO"
SRX4193142,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33293026,96.9,18.2,11185",GSM3184872: ERalpha s2 6545 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=H3B-6545"
SRX4193143,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32211019,96.9,20.0,9767",GSM3184873: ERalpha s3 s6545 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=Saturated H3B-6545"
SRX4193144,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36005432,95.8,18.2,10366",GSM3184874: ERalpha s4 800 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=800"
SRX4193145,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31834192,95.7,17.5,10338",GSM3184875: ERalpha s5 RAD1901 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=Rad1901"
SRX4193146,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30876709,96.0,21.0,8167",GSM3184876: ERalpha s6 5942 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=H3B-5942"
SRX4193147,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32131648,95.6,18.1,9435",GSM3184877: ERalpha s7 s5942 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=Saturated H3B-5942"
SRX4193148,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30998392,90.4,34.8,6255",GSM3184878: ERalpha s8 Tam ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=Tamoxifen"
SRX4193149,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31675330,94.9,34.6,11295",GSM3184879: ERalpha s9 Fulv ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=Fulvestrant"
SRX4193150,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30308917,96.1,30.7,10581",GSM3184880: ERalpha s10 E2 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	chip antibody=Estrogen Receptor alpha (Santa Cruz, sc-543, lot F1716)	cell type=breast cancer cell line	treatment=E2"
SRX4240288,hg38,TFs and others,ESR1,Gonad,SK-OV-3,Primary Tissue=Ovary|Tissue Diagnosis=Adenocarcinoma,"15490331,85.5,8.3,23169",GSM3206462: ERα ChIPSeq E2 rep1; Homo sapiens; ChIP-Seq,source_name=Ovarian cancer	cell line=SKOV3	antibody=anti-ERα	treatment=10 nm E2 for 24 hours
SRX4240289,hg38,TFs and others,ESR1,Gonad,SK-OV-3,Primary Tissue=Ovary|Tissue Diagnosis=Adenocarcinoma,"24864382,0.0,0.0,0",GSM3206463: ERα ChIPSeq E2 rep2; Homo sapiens; ChIP-Seq,source_name=Ovarian cancer	cell line=SKOV3	antibody=anti-ERα	treatment=10 nm E2 for 24 hours
SRX4240290,hg38,TFs and others,ESR1,Gonad,SK-OV-3,Primary Tissue=Ovary|Tissue Diagnosis=Adenocarcinoma,"8892981,77.3,4.9,1875",GSM3206464: ERα ChIPSeq EtOH rep1; Homo sapiens; ChIP-Seq,source_name=Ovarian cancer	cell line=SKOV3	antibody=anti-ERα	treatment=EtOH for 24 hours
SRX4240291,hg38,TFs and others,ESR1,Gonad,SK-OV-3,Primary Tissue=Ovary|Tissue Diagnosis=Adenocarcinoma,"5013273,85.6,4.0,2161",GSM3206465: ERα ChIPSeq EtOH rep2; Homo sapiens; ChIP-Seq,source_name=Ovarian cancer	cell line=SKOV3	antibody=anti-ERα	treatment=EtOH for 24 hours
SRX4345362,hg38,TFs and others,FOS,Blood,CD4+ T cells,,"39761618,92.1,15.8,3963",GSM3258569: ChIP-seq cFOS Act.5 h; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_cFOS_Act.5 h	subject status=healthy donor	tissue=peripheral blood	cell type=primary naive CD4 T cells	activation=Act. 5 h with anti-CD3 and -CD28 antibodies	chip antibody=cFOS Cell Signaling #2250
SRX4367192,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"80975256,67.1,61.7,77625",GSM3261517: ER ChIP rep1; Homo sapiens; ChIP-Seq,source_name=Mcf7_ER ChIP	cell line=Mcf7	chip antibody=Santa Cruz HC-20 and the monoclonal ER Ab10 antibodies
SRX4367193,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"124179620,88.9,59.0,112434",GSM3261518: ER ChIP rep2; Homo sapiens; ChIP-Seq,source_name=Mcf7_ER ChIP	cell line=Mcf7	chip antibody=Santa Cruz HC-20 and the monoclonal ER Ab10 antibodies
SRX4417022,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41925565,98.8,4.4,14573",GSM3301930: ChIP-Seq ER alpha + E2; Homo sapiens; ChIP-Seq,source_name=ER alpha ChIP-seq on MCF7 cell stimulated with Estrogen	biomaterial_provider=ATCC	cell line=MCF7	chip antibody=Santacruz biotechnology (HC-20)
SRX4417023,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20456619,98.8,2.5,5220","GSM3301931: ChIP-Seq ER alpha + E2 + 1,6-HD; Homo sapiens; ChIP-Seq","source_name=ER alpha ChIP-seq on MCF7 cell stimulated with Estrogen + 1,6-Hexanediol	biomaterial_provider=ATCC	cell line=MCF7	chip antibody=Santacruz biotechnology (HC-20)"
SRX4451194,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30521293,99.1,5.2,4335",GSM3303975: MCF7 Alarid 1pER E2 rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Cell Signaling, #2511, lot 16J4)"
SRX4451195,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44557675,98.9,9.4,5493",GSM3303976: MCF7 Alarid 1pER E2 rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Cell Signaling, #2511, lot 16J4)"
SRX4451196,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46292492,98.7,9.1,6059",GSM3303977: MCF7 Alarid 1pER E2 rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Cell Signaling, #2511, lot 16J4)"
SRX4451197,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"70648115,99.1,12.2,7742",GSM3303978: MCF7 Alarid 1pER Veh rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Cell Signaling, #2511, lot 16J4)"
SRX4451198,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"54204024,99.1,8.0,6749",GSM3303979: MCF7 Alarid 1pER Veh rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Cell Signaling, #2511, lot 16J4)"
SRX4451199,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35803707,99.1,7.3,3967",GSM3303980: MCF7 Alarid 1pER Veh rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Cell Signaling, #2511, lot 16J4)"
SRX4451200,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"53507235,99.3,21.6,2290",GSM3303981: MCF7 Alarid 2pER E2 rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Abcam, ab32396, lot GR139357-5)"
SRX4451201,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"52797307,99.4,17.5,6003",GSM3303982: MCF7 Alarid 2pER E2 rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Abcam, ab32396, lot GR139357-5)"
SRX4451202,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44410926,99.4,13.8,3327",GSM3303983: MCF7 Alarid 2pER E2 rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Abcam, ab32396, lot GR139357-5)"
SRX4451203,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"44986602,99.4,18.1,644",GSM3303984: MCF7 Alarid 2pER Veh rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Abcam, ab32396, lot GR139357-5)"
SRX4451204,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55378730,98.4,11.4,549",GSM3303985: MCF7 Alarid 2pER Veh rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Abcam, ab32396, lot GR139357-5)"
SRX4451205,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"50791729,99.4,15.6,578",GSM3303986: MCF7 Alarid 2pER Veh rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Abcam, ab32396, lot GR139357-5)"
SRX4451206,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46344415,99.4,44.9,11674",GSM3303987: MCF7 Alarid 3pER E2 rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Santa Cruz, sc-12915, lot A1614)"
SRX4451207,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"49693768,99.4,24.5,20075",GSM3303988: MCF7 Alarid 3pER E2 rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Santa Cruz, sc-12915, lot A1614)"
SRX4451208,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"47105271,99.3,28.9,17604",GSM3303989: MCF7 Alarid 3pER E2 rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=pS118-ER (Santa Cruz, sc-12915, lot A1614)"
SRX4451209,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41263385,99.4,22.6,4218",GSM3303990: MCF7 Alarid 3pER Veh rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Santa Cruz, sc-12915, lot A1614)"
SRX4451210,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"56701921,99.4,13.6,2096",GSM3303991: MCF7 Alarid 3pER Veh rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Santa Cruz, sc-12915, lot A1614)"
SRX4451211,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35579558,99.3,33.5,3442",GSM3303992: MCF7 Alarid 3pER Veh rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=pS118-ER (Santa Cruz, sc-12915, lot A1614)"
SRX4451212,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40279938,98.9,25.5,50279",GSM3303993: MCF7 Alarid ER E2 rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=ER (Santa Cruz, sc-543, lot F0316)"
SRX4451213,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42733921,98.9,25.8,52129",GSM3303994: MCF7 Alarid ER E2 rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=ER (Santa Cruz, sc-543, lot F0316)"
SRX4451214,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35571409,98.9,26.8,47453",GSM3303995: MCF7 Alarid ER E2 rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=E2	chip antibody=ER (Santa Cruz, sc-543, lot F0316)"
SRX4451215,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42022420,98.9,15.8,15057",GSM3303996: MCF7 Alarid ER Veh rep1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=ER (Santa Cruz, sc-543, lot F0316)"
SRX4451216,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36221664,98.9,14.2,17361",GSM3303997: MCF7 Alarid ER Veh rep2; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=ER (Santa Cruz, sc-543, lot F0316)"
SRX4451217,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37787446,98.9,16.9,19136",GSM3303998: MCF7 Alarid ER Veh rep3; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=vehicle	chip antibody=ER (Santa Cruz, sc-543, lot F0316)"
SRX457212,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31783311,98.3,2.8,379",GSM1319623: ER LET-R Andro 01; Homo sapiens; ChIP-Seq,source_name=ER_LET-R_Andro	cell line=Let-R	cell type=Letrozole-resistant breast cancer cells	treated with=Androstenedione for 45min	chip antibody=anti-ER	chip antibody vendor=Santa Cruz Biotechnologies
SRX457213,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31660367,98.2,9.1,687",GSM1319624: ER LET-R Andro 02; Homo sapiens; ChIP-Seq,source_name=ER_LET-R_Andro	cell line=Let-R	cell type=Letrozole-resistant breast cancer cells	treated with=Androstenedione for 45min	chip antibody=anti-ER	chip antibody vendor=Santa Cruz Biotechnologies
SRX457214,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24847436,97.8,5.3,482",GSM1319625: ER LET-R Veh 01; Homo sapiens; ChIP-Seq,source_name=ER_LET-R_Veh	cell line=Let-R	cell type=Letrozole-resistant breast cancer cells	treated with=10% ethanol (vehicle control) for 45min	chip antibody=anti-ER	chip antibody vendor=Santa Cruz Biotechnologies
SRX457215,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28030814,98.2,2.6,786",GSM1319626: ER LET-R Veh 02; Homo sapiens; ChIP-Seq,source_name=ER_LET-R_Veh	cell line=Let-R	cell type=Letrozole-resistant breast cancer cells	treated with=10% ethanol (vehicle control) for 45min	chip antibody=anti-ER	chip antibody vendor=Santa Cruz Biotechnologies
SRX4611687,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29098826,92.1,15.2,56108",GSM3357114: ER t30 Rep 6 [t30.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t30	cell line=MCF7	replicate=6	time=t30	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611688,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27981732,99.4,3.6,49892",GSM3357115: ER t60 Rep 1 [t60.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t60	cell line=MCF7	replicate=1	time=t60	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611689,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27912906,99.3,3.8,54113",GSM3357116: ER t90 Rep 3 [t90.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t90	cell line=MCF7	replicate=3	time=t90	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611690,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31408249,99.3,5.6,68058",GSM3357117: ER t20 Rep 4 [t20.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t20	cell line=MCF7	replicate=4	time=t20	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611691,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30426351,99.2,5.0,57352",GSM3357118: ER t30 Rep 1 [t30.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t30	cell line=MCF7	replicate=1	time=t30	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611692,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24581325,99.2,2.5,52573",GSM3357119: ER t70 Rep 5 [t70.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t70	cell line=MCF7	replicate=5	time=t70	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611693,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24527876,99.2,6.5,49422",GSM3357120: ER t40 Rep 6 [t40.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t40	cell line=MCF7	replicate=6	time=t40	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611694,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30038890,99.3,3.3,60017",GSM3357121: ER t80 Rep 3 [t80.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t80	cell line=MCF7	replicate=3	time=t80	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611695,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29217702,99.3,5.8,61935",GSM3357122: ER t10 Rep 1 [t10.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t10	cell line=MCF7	replicate=1	time=t10	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611696,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30865954,98.6,5.6,56239",GSM3357123: ER t10 Rep 4 [t10.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t10	cell line=MCF7	replicate=4	time=t10	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611697,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30085528,99.4,4.7,61700",GSM3357124: ER t50 Rep 3 [t50.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t50	cell line=MCF7	replicate=3	time=t50	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611698,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28017033,99.4,3.9,56133",GSM3357125: ER t30 Rep 3 [t30.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t30	cell line=MCF7	replicate=3	time=t30	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611699,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31242774,99.4,3.9,55852",GSM3357126: ER t20 Rep 1 [t20.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t20	cell line=MCF7	replicate=1	time=t20	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611700,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25093515,99.4,2.7,52438",GSM3357127: ER t90 Rep 5 [t90.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t90	cell line=MCF7	replicate=5	time=t90	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611701,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30139416,99.3,3.8,53495",GSM3357128: ER t80 Rep 4 [t80.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t80	cell line=MCF7	replicate=4	time=t80	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611702,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29095225,99.3,3.1,59173",GSM3357129: ER t0 Rep 4 [t0.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t0	cell line=MCF7	replicate=4	time=t0	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611703,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25678639,99.3,3.4,64266",GSM3357130: ER t40 Rep 4 [t40.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t40	cell line=MCF7	replicate=4	time=t40	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611704,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30874087,99.4,4.6,54105",GSM3357131: ER t90 Rep 6 [t90.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t90	cell line=MCF7	replicate=6	time=t90	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611705,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25057584,99.3,2.6,56078",GSM3357132: ER t50 Rep 2 [t50.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t50	cell line=MCF7	replicate=2	time=t50	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611706,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33149999,99.3,4.7,62088",GSM3357133: ER t50 Rep 4 [t50.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t50	cell line=MCF7	replicate=4	time=t50	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611707,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25039619,85.3,21.0,33148",GSM3357134: ER t0 Rep 6 [t0.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t0	cell line=MCF7	replicate=6	time=t0	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611708,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26867874,99.3,2.1,50824",GSM3357135: ER t60 Rep 4 [t60.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t60	cell line=MCF7	replicate=4	time=t60	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611709,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32823539,99.3,4.1,56276",GSM3357136: ER t70 Rep 2 [t70.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t70	cell line=MCF7	replicate=2	time=t70	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611710,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32294710,99.4,3.1,49968",GSM3357137: ER t40 Rep 1 [t40.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t40	cell line=MCF7	replicate=1	time=t40	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611711,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29681160,99.1,4.8,55292",GSM3357138: ER t80 Rep 1 [t80.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t80	cell line=MCF7	replicate=1	time=t80	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611712,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28294385,99.4,3.8,60946",GSM3357139: ER t20 Rep 5 [t20.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t20	cell line=MCF7	replicate=5	time=t20	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611713,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30239376,99.4,6.0,63614",GSM3357140: ER t60 Rep 5 [t60.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t60	cell line=MCF7	replicate=5	time=t60	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611714,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30140919,99.3,4.8,60881",GSM3357141: ER t40 Rep 5 [t40.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t40	cell line=MCF7	replicate=5	time=t40	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611715,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20028430,99.2,14.5,43715",GSM3357142: ER t70 Rep 1 [t70.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t70	cell line=MCF7	replicate=1	time=t70	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611716,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28507572,99.4,3.3,50438",GSM3357143: ER t20 Rep 3 [t20.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t20	cell line=MCF7	replicate=3	time=t20	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611717,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26215172,99.3,2.8,56178",GSM3357144: ER t80 Rep 5 [t80.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t80	cell line=MCF7	replicate=5	time=t80	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611718,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28182426,99.1,4.9,50003",GSM3357145: ER t60 Rep 3 [t60.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t60	cell line=MCF7	replicate=3	time=t60	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611719,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23847369,99.3,20.4,48079",GSM3357146: ER t90 Rep 1 [t90.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t90	cell line=MCF7	replicate=1	time=t90	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611720,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25253951,99.3,3.4,52933",GSM3357147: ER t10 Rep 2 [t10.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t10	cell line=MCF7	replicate=2	time=t10	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611721,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33449879,99.3,3.8,54525",GSM3357148: ER t60 Rep 2 [t60.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t60	cell line=MCF7	replicate=2	time=t60	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611722,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25340181,99.3,3.1,61825",GSM3357149: ER t30 Rep 2 [t30.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t30	cell line=MCF7	replicate=2	time=t30	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611723,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24117427,98.8,4.3,62528",GSM3357150: ER t20 Rep 2 [t20.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t20	cell line=MCF7	replicate=2	time=t20	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611724,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25169569,99.3,3.2,57779",GSM3357151: ER t70 Rep 6 [t70.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t70	cell line=MCF7	replicate=6	time=t70	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611725,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26516170,99.3,3.0,61799",GSM3357152: ER t30 Rep 4 [t30.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t30	cell line=MCF7	replicate=4	time=t30	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611726,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25933038,99.2,2.7,56860",GSM3357153: ER t80 Rep 2 [t80.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t80	cell line=MCF7	replicate=2	time=t80	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611727,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29389330,99.3,5.3,59056",GSM3357154: ER t50 Rep 6 [t50.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t50	cell line=MCF7	replicate=6	time=t50	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611728,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24970909,99.4,4.8,58727",GSM3357155: ER t0 Rep 1 [t0.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t0	cell line=MCF7	replicate=1	time=t0	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611729,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29243647,99.0,5.9,53064",GSM3357156: ER t20 Rep 6 [t20.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t20	cell line=MCF7	replicate=6	time=t20	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611730,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30830046,96.3,4.8,49587",GSM3357157: ER t40 Rep 3 [t40.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t40	cell line=MCF7	replicate=3	time=t40	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611731,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30274076,99.3,2.4,56404",GSM3357158: ER t90 Rep 4 [t90.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t90	cell line=MCF7	replicate=4	time=t90	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611732,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15149195,93.2,19.6,39821",GSM3357159: ER t0 Rep 2 [t0.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t0	cell line=MCF7	replicate=2	time=t0	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611733,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24879520,99.2,2.3,48621",GSM3357160: ER t40 Rep 2 [t40.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t40	cell line=MCF7	replicate=2	time=t40	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611734,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27199140,99.3,3.3,61096",GSM3357161: ER t10 Rep 6 [t10.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t10	cell line=MCF7	replicate=6	time=t10	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611735,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25225331,99.2,2.4,57769",GSM3357162: ER t10 Rep 5 [t10.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t10	cell line=MCF7	replicate=5	time=t10	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611736,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26388776,99.3,18.9,46664",GSM3357163: ER t70 Rep 4 [t70.4]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t70	cell line=MCF7	replicate=4	time=t70	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611737,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28928075,99.3,3.1,60079",GSM3357164: ER t90 Rep 2 [t90.2]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t90	cell line=MCF7	replicate=2	time=t90	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611738,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24788402,99.3,4.1,60084",GSM3357165: ER t0 Rep 3 [t0.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t0	cell line=MCF7	replicate=3	time=t0	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611739,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32635925,99.4,2.9,59817",GSM3357166: ER t10 Rep 3 [t10.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t10	cell line=MCF7	replicate=3	time=t10	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611740,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31673350,99.3,3.5,54060",GSM3357167: ER t60 Rep 6 [t60.6]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t60	cell line=MCF7	replicate=6	time=t60	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611741,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23480317,99.3,3.9,61699",GSM3357168: ER t50 Rep 5 [t50.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t50	cell line=MCF7	replicate=5	time=t50	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611742,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28066294,99.3,3.3,60589",GSM3357169: ER t50 Rep 1 [t50.1]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t50	cell line=MCF7	replicate=1	time=t50	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611743,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25840461,99.4,3.1,57581",GSM3357170: ER t70 Rep 3 [t70.3]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t70	cell line=MCF7	replicate=3	time=t70	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4611744,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26126711,99.1,3.1,55614",GSM3357171: ER t0 Rep 5 [t0.5]; Homo sapiens; ChIP-Seq,source_name=MCF7_ER t0	cell line=MCF7	replicate=5	time=t0	control antibody=CTCF Cell signaling D31H2 Lot: 3	target antibody=ER Millipore 06-965 Lot:3008172	factor=ER
SRX4663584,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"45401974,96.0,18.4,6875",GSM3381042: eralpha Control E2-ER; Homo sapiens; ChIP-Seq,source_name=eralpha_Control_E2	cell line=MCF-7	cell type=breast cancer cell line	treatment=Control-E2	chip antibody=ER (CST:D8H8)
SRX4663585,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37977632,95.5,17.9,11571",GSM3381043: eralpha Control E2+4OHT-ER; Homo sapiens; ChIP-Seq,source_name=eralpha_Control_E2+4OHT	cell line=MCF-7	cell type=breast cancer cell line	treatment=Control-E2+4OHT	chip antibody=ER (CST:D8H8)
SRX4663586,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37706069,96.3,21.5,11852",GSM3381044: eralpha shFbxo E2-ER; Homo sapiens; ChIP-Seq,source_name=eralpha_shFbxo_E2	cell line=MCF-7	cell type=breast cancer cell line	treatment=Fbxo22 depletion-E2	chip antibody=ER (CST:D8H8)
SRX4663587,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43250704,95.1,18.2,10528",GSM3381045: eralpha shFbxo E2+4OHT-ER; Homo sapiens; ChIP-Seq,source_name=eralpha_shFbxo_E2+4OHT	cell line=MCF-7	cell type=breast cancer cell line	treatment=Fbxo22 depletion-E2+4OHT	chip antibody=ER (CST:D8H8)
SRX4677295,hg38,TFs and others,FOS,Pancreas,CFPAC-1,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma Ductal,"35729181,96.6,31.4,23711",GSM3387454: CFPAC1.ChIP.FOS; Homo sapiens; ChIP-Seq,source_name=CFPAC1.ChIP.FOS	cell line=original CFPAC1 cell line	cell type=Pancreatic Ductal Adenocarcinoma (PDAC) cell line	antibody=Anti-FOS (Antibody Sigma HPA018531 - Lot E106326)
SRX469393,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26256379,48.2,17.1,490",GSM1325246: ER 0min 1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=100nM estradiol 0 min	antibody=ER (Santa Cruz, sc-542)"
SRX469394,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12113857,71.4,15.0,1649",GSM1325247: ER 2min 1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=100nM estradiol 2 mins	antibody=ER (Santa Cruz, sc-542)"
SRX469395,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12136736,77.5,11.2,2635",GSM1325248: ER 5min 1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=100nM estradiol 5 mins	antibody=ER (Santa Cruz, sc-542)"
SRX469396,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24198691,47.4,19.2,8062",GSM1325249: ER 10min 1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=100nM estradiol 10 mins	antibody=ER (Santa Cruz, sc-542)"
SRX469397,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26130460,31.0,47.6,4501",GSM1325250: ER 40min 1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=100nM estradiol 40 mins	antibody=ER (Santa Cruz, sc-542)"
SRX469398,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12686556,18.2,31.3,428",GSM1325251: ER 160min 1; Homo sapiens; ChIP-Seq,"source_name=MCF-7	cell line=MCF-7	treatment=100nM estradiol1 60 mins	antibody=ER (Santa Cruz, sc-542)"
SRX4786537,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36906053,98.0,7.3,1226",GSM3414760: ER-a MCF7 TET2 WT DMSO; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	cell type=Breast cancer cell	genotype/variation=Wild type TET2	passages=Low passages (6-10)	treatment=DMSO	chip antibody=anti-ERa (Santa Cruz Biotechnology, sc-543)"
SRX4786539,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39821124,98.2,9.0,8870",GSM3414762: ER-a MCF7 TET2 WT E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	cell type=Breast cancer cell	genotype/variation=Wild type TET2	passages=Low passages (6-10)	treatment=E2	chip antibody=anti-ERa (Santa Cruz Biotechnology, sc-543)"
SRX4786541,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37410671,97.9,7.0,1469",GSM3414764: ER-a MCF7 TET2 KO DMSO; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	cell type=Breast cancer cell	genotype/variation=TET2 knockout	passages=Low passages (6-10)	treatment=DMSO	chip antibody=anti-ERa (Santa Cruz Biotechnology, sc-543)"
SRX4786543,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28703241,97.9,7.8,6339",GSM3414766: ER-a MCF7 TET2 KO E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	cell type=Breast cancer cell	genotype/variation=TET2 knockout	passages=Low passages (6-10)	treatment=E2	chip antibody=anti-ERa (Santa Cruz Biotechnology, sc-543)"
SRX4786548,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34902232,91.6,8.4,4321",GSM3414771: ERa DMSO; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	cell type=Breast cancer cell	genotype/variation=Wild type TET2	passages=Low passages (6-10)	treatment=DMSO	chip antibody=anti-ERa (Santa Cruz Biotechnology, sc-543)"
SRX4786549,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34762392,95.1,14.0,20378",GSM3414772: ERa E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	cell line=MCF7	cell type=Breast cancer cell	genotype/variation=Wild type TET2	passages=Low passages (6-10)	treatment=E2	chip antibody=anti-ERa (Santa Cruz Biotechnology, sc-543)"
SRX484461,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","38874001,74.0,23.3,15901",GSM1342615: MDA::ER::pCDNA ER ChIP; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	gender=female	cell line=MDA-MB231	cell type=breast cancer	integrated vector=pCDNA3.1-Hygro-ER/pCDNA6-TR/pCDNA4-TO	transfected sirna=no	hormone treatment=10-8M Estradiol (Sigma)	chip antibody=Antibody Mix: HC20 (Santa Cruz) + ab10 (TE111-SD11, NeoMarker)"
SRX484476,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","46426485,50.4,25.7,5093",GSM1342630: MDA::ER::pCDNA siLuc ER ChIP; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	gender=female	cell line=MDA-MB231	cell type=breast cancer	integrated vector=pCDNA3.1-Hygro-ER/pCDNA6-TR/pCDNA4-TO	transfected sirna=yes: control siRNA directed against Luciferase	hormone treatment=10-8M Estradiol (Sigma)	chip antibody=Antibody Mix: HC20 (Santa Cruz) + ab10 (TE111-SD11, NeoMarker)"
SRX484477,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","45002139,66.2,11.5,9777",GSM1342631: MDA::ER::pCDNA siFOXA2 ER ChIP; Homo sapiens; ChIP-Seq,"source_name=breast cancer cell line	gender=female	cell line=MDA-MB231	cell type=breast cancer	integrated vector=pCDNA3.1-Hygro-ER/pCDNA6-TR/pCDNA4-TO	transfected sirna=yes: siRNA directed against FOXA2	hormone treatment=10-8M Estradiol (Sigma)	chip antibody=Antibody Mix: HC20 (Santa Cruz) + ab10 (TE111-SD11, NeoMarker)"
SRX490432,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14674808,30.4,2.2,655",GSM1348521: ERα E2 rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell type=Human breast adenocarcinoma	cell line=MCF7	passages=20-30	chip-seq antibody=ERα HC-20 (sc543 from Santa Cruz, 1 µg used)"
SRX490433,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12856740,32.2,2.8,744",GSM1348522: ERα E2 rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell type=Human breast adenocarcinoma	cell line=MCF7	passages=20-30	chip-seq antibody=ERα HC-20 (sc543 from Santa Cruz, 1 µg used)"
SRX490434,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14794164,48.8,3.8,1940",GSM1348523: ERα E2 rep3; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell type=Human breast adenocarcinoma	cell line=MCF7	passages=20-30	chip-seq antibody=ERα HC-20 (sc543 from Santa Cruz, 1 µg used)"
SRX490435,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12980105,29.8,3.8,361",GSM1348524: ERα JQ1 E2 rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell type=Human breast adenocarcinoma	cell line=MCF7	passages=20-30	chip-seq antibody=ERα HC-20 (sc543 from Santa Cruz, 1 µg used)"
SRX490436,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"11121507,35.7,2.8,829",GSM1348525: ERα JQ1 E2 rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell type=Human breast adenocarcinoma	cell line=MCF7	passages=20-30	chip-seq antibody=ERα HC-20 (sc543 from Santa Cruz, 1 µg used)"
SRX490437,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12445874,52.2,2.8,658",GSM1348526: ERα JQ1 E2 rep3; Homo sapiens; ChIP-Seq,"source_name=MCF7 breast cancer cells	cell type=Human breast adenocarcinoma	cell line=MCF7	passages=20-30	chip-seq antibody=ERα HC-20 (sc543 from Santa Cruz, 1 µg used)"
SRX4928881,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47760140,99.1,66.3,6791",GSM3444399: ATAC DMSO-0min; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=DMSO	timepoint=0min
SRX4928882,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"51434749,99.2,66.7,5396",GSM3444400: ATAC DMSO-30min; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=DMSO	timepoint=30min
SRX4928883,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"44291399,99.2,63.0,8472",GSM3444401: ATAC DMSO-1hr; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=DMSO	timepoint=1hr
SRX4928884,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"55653233,99.0,66.9,9064",GSM3444402: ATAC DMSO-4hr; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=DMSO	timepoint=4hr
SRX4928885,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"49101651,99.1,65.9,6868",GSM3444403: ATAC I-BRD9-0min; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=I-BRD9	timepoint=0min
SRX4928886,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47119993,99.1,67.8,3758",GSM3444404: ATAC I-BRD9-30min; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=I-BRD9	timepoint=30min
SRX4928887,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47391541,99.1,65.7,9966",GSM3444405: ATAC I-BRD9-1hr; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=I-BRD9	timepoint=1hr
SRX4928888,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"53203835,99.0,61.2,12106",GSM3444406: ATAC I-BRD9-4hr; Homo sapiens; ATAC-seq,source_name=HeLa	cell type=immortalized cervical cancer cells	treatment=I-BRD9	timepoint=4hr
SRX4991877,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"1204,69.7,0.0,0",GSM3462835: HeLa Mitotic Chromatin (frozen) ATAC-seq R2T4; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991878,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"590,69.1,0.0,0",GSM3462836: HeLa Mitotic Chromatin (frozen) ATAC-seq R2T3; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991879,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"32399861,79.5,3.4,14631",GSM3462837: HeLa Mitotic Chromatin (frozen) ATAC-seq R2T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991880,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"33340735,77.9,3.6,14904",GSM3462838: HeLa Mitotic Chromatin (frozen) ATAC-seq R2T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991881,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"250,57.6,0.0,0",GSM3462839: HeLa Mitotic Cell ATAC-seq R2T4; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991882,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"1399,57.4,0.1,0",GSM3462840: HeLa Mitotic Cell ATAC-seq R2T3; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991883,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"37153287,60.9,27.3,1841",GSM3462841: HeLa Mitotic Cell ATAC-seq R2T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991884,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"20186769,58.8,23.0,509",GSM3462842: HeLa Mitotic Cell ATAC-seq R2T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991885,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"149666106,61.1,68.1,19544",GSM3462843: HeLa Non Sync ATAC-seq R2T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991886,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"225816926,61.6,78.1,8681",GSM3462844: HeLa Non Sync ATAC-seq R2T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991887,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"37265865,92.9,24.2,8667",GSM3462845: HeLa Mitotic Chromatin (frozen) ATAC-seq R1T4; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991888,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"47920410,92.0,30.1,9670",GSM3462846: HeLa Mitotic Chromatin (frozen) ATAC-seq R1T3; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991889,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"42063425,89.8,16.3,9053",GSM3462847: HeLa Mitotic Chromatin (frozen) ATAC-seq R1T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991890,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"41829135,90.3,16.0,9079",GSM3462848: HeLa Mitotic Chromatin (frozen) ATAC-seq R1T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991891,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35659402,92.8,24.0,9482",GSM3462849: HeLa Mitotic Chromatin (fresh) ATAC-seq R1T4; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991892,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"38533818,92.9,25.1,9896",GSM3462850: HeLa Mitotic Chromatin (fresh) ATAC-seq R1T3; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991893,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"33055188,92.0,9.8,9916",GSM3462851: HeLa Mitotic Chromatin (fresh) ATAC-seq R1T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991894,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"36128389,91.8,11.3,10389",GSM3462852: HeLa Mitotic Chromatin (fresh) ATAC-seq R1T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991895,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"56513981,90.8,61.5,1229",GSM3462853: HeLa Mitotic Cell ATAC-seq R1T4; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991896,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"21141672,90.7,46.6,446",GSM3462854: HeLa Mitotic Cell ATAC-seq R1T3; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991897,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"37820309,88.7,40.1,1495",GSM3462855: HeLa Mitotic Cell ATAC-seq R1T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991898,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"23075558,88.9,44.6,465",GSM3462856: HeLa Mitotic Cell ATAC-seq R1T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991899,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"55413380,92.1,64.4,1504",GSM3462857: HeLa Non Sync ATAC-seq R1T4; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991900,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"62051453,92.0,69.5,1380",GSM3462858: HeLa Non Sync ATAC-seq R1T3; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991901,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"102162364,73.5,65.0,6742",GSM3462859: HeLa Non Sync ATAC-seq R1T2; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX4991902,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"95438349,77.9,64.4,6030",GSM3462860: HeLa Non Sync ATAC-seq R1T1; Homo sapiens; ATAC-seq,source_name=HeLa-S3 cells	protocol=ATAC-seq	enzyme=Transposase-Tn5	cell type=Human adenocarcinoma cells	cell line=HeLa-S3 (CCL-2.2)
SRX5089445,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33953039,97.6,27.7,18903",GSM3499099: MCF7-parental ER Vehicle rep 1; Homo sapiens; ChIP-Seq,source_name=MCF7-parental_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=20-35	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089446,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34596834,98.3,26.5,15615",GSM3499100: MCF7-parental ER Vehicle rep 2; Homo sapiens; ChIP-Seq,source_name=MCF7-parental_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=20-35	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089447,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34266165,98.2,27.6,25768",GSM3499101: MCF7-parental ER Vehicle rep 3; Homo sapiens; ChIP-Seq,source_name=MCF7-parental_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=20-35	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089448,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34264671,98.1,28.0,20246",GSM3499102: MCF7-parental ER 4-hydroxy tamoxifen rep 1; Homo sapiens; ChIP-Seq,source_name=MCF7-parental_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=20-35	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089449,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28156292,98.6,29.3,23782",GSM3499103: MCF7-parental ER 4-hydroxy tamoxifen rep 2; Homo sapiens; ChIP-Seq,source_name=MCF7-parental_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=20-35	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089450,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27362483,98.7,26.8,29878",GSM3499104: MCF7-parental ER 4-hydroxy tamoxifen rep 3; Homo sapiens; ChIP-Seq,source_name=MCF7-parental_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=20-35	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089451,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31438049,98.4,26.3,20499",GSM3499105: MCF7-ARID1A KO Clone 11 ER Vehicle rep 1; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 11_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089452,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31920587,98.7,25.7,8051",GSM3499106: MCF7-ARID1A KO Clone 11 ER Vehicle rep 2; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 11_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089453,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29962413,98.5,24.2,4706",GSM3499107: MCF7-ARID1A KO Clone 11 ER Vehicle rep 3; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 11_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089454,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35395437,98.4,28.1,18548",GSM3499108: MCF7-ARID1A KO Clone 11 ER 4-hydroxy tamoxifen rep 1; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 11_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089455,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25811485,98.6,26.9,8517",GSM3499109: MCF7-ARID1A KO Clone 11 ER 4-hydroxy tamoxifen rep 2; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 11_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089456,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31583552,98.7,30.3,15717",GSM3499110: MCF7-ARID1A KO Clone 11 ER 4-hydroxy tamoxifen rep 3; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 11_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089457,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32659414,98.2,24.4,10049",GSM3499111: MCF7-ARID1A KO Clone 14 ER Vehicle rep 1; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 14_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089458,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32604591,98.7,26.7,16279",GSM3499112: MCF7-ARID1A KO Clone 14 ER Vehicle rep 2; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 14_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089459,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28309850,98.6,28.8,16700",GSM3499113: MCF7-ARID1A KO Clone 14 ER Vehicle rep 3; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 14_ER ChIP-seq_Vehicle	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=Vehicle	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089460,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40736382,98.8,26.2,7611",GSM3499114: MCF7-ARID1A KO Clone 14 ER 4-hydroxy tamoxifen rep 1; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 14_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089461,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32058494,99.0,27.9,12544",GSM3499115: MCF7-ARID1A KO Clone 14 ER 4-hydroxy tamoxifen rep 2; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 14_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5089462,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34066289,99.1,28.0,22686",GSM3499116: MCF7-ARID1A KO Clone 14 ER 4-hydroxy tamoxifen rep 3; Homo sapiens; ChIP-Seq,source_name=MCF7-ARID1A KO Clone 14_ER ChIP-seq_4-hydroxytamoxifen	cell line=MCF7	cell type=ER+ Breast Cancer Cell Line	passages=35-45	treatment=100 nM 4-hydroxy tamoxifen for 6 hours	chip antibody=Abcam ab3575 and Millipore 06-935 antibody mix
SRX5128104,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"81317847,89.7,2.6,4833",GSM3511049: ZR-75-1 xeno ER Veh; Homo sapiens; ChIP-Seq,source_name=ZR-75-1 cell line xenograft tumour	tissue=ZR-75-1 cell line xenograft tumour	treatment=Vehicle	time point=Short-term (5 days treatment)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)
SRX5128105,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"111542886,89.7,3.4,3189",GSM3511050: ZR-75-1 xeno ER DHT; Homo sapiens; ChIP-Seq,source_name=ZR-75-1 cell line xenograft tumour	tissue=ZR-75-1 cell line xenograft tumour	treatment=DHT	time point=Short-term (5 days treatment)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)
SRX5128106,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"115140845,91.3,3.1,4352",GSM3511051: ZR-75-1 xeno ER Sarm; Homo sapiens; ChIP-Seq,source_name=ZR-75-1 cell line xenograft tumour	tissue=ZR-75-1 cell line xenograft tumour	treatment=Enobosarm	time point=Short-term (5 days treatment)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)
SRX5128132,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"62789505,98.3,6.3,11075",GSM3511084: ZR-75-1 ER ChIP E2 Consensus; Homo sapiens; ChIP-Seq,source_name=ZR-75-1_E2	cell line=ZR-75-1	cell type=Breast cancer cell line	passages=14-17 (where replicates represent sequential passages)	treatment=E2	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)
SRX5128133,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"63951097,98.2,6.2,10935",GSM3511085: ZR-75-1 ER ChIP E2+DHT Consensus; Homo sapiens; ChIP-Seq,source_name=ZR-75-1_E2+DHT	cell line=ZR-75-1	cell type=Breast cancer cell line	passages=14-17 (where replicates represent sequential passages)	treatment=E2+DHT	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)
SRX5172067,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33754131,98.9,11.3,579",GSM3526002: ChIP-Seq Sample DMSO sg12 Control ER 1; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=MCF-7	chip-antibody=ER	genotype=Control	sgguide=sgNT-1
SRX5172068,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34185065,98.6,10.5,726",GSM3526003: ChIP-Seq Sample DMSO sg12 Control ER 2; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=MCF-7	chip-antibody=ER	genotype=Control	sgguide=sgNT-1
SRX5172069,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35590984,98.9,9.8,632",GSM3526004: ChIP-Seq Sample DMSO sg1 KO ER 1; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=MCF-7	chip-antibody=ER	genotype=ARID1A KO	sgguide=sgARID1A-1
SRX5172070,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34975371,99.0,8.8,666",GSM3526005: ChIP-Seq Sample DMSO sg1 KO ER 2; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=MCF-7	chip-antibody=ER	genotype=ARID1A KO	sgguide=sgARID1A-1
SRX5172071,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35362956,98.6,17.5,1344",GSM3526006: ChIP-Seq Sample DMSO sg2 KO ER 1; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=MCF-7	chip-antibody=ER	genotype=ARID1A KO	sgguide=sgARID1A-2
SRX5172072,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35753948,98.9,12.3,627",GSM3526007: ChIP-Seq Sample DMSO sg2 KO ER 2; Homo sapiens; ChIP-Seq,source_name=Breast Cancer Cell	cell line=MCF-7	chip-antibody=ER	genotype=ARID1A KO	sgguide=sgARID1A-2
SRX5185602,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16449269,80.0,15.8,676",GSM3533470: ChIP-Seq MCF7 Med12 siCTL; Homo sapiens; ChIP-Seq,source_name=breast cancer	cell line=MCF7	chip antibody=A399-774A	treatment=ethanol+siCTL
SRX5185603,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15181844,81.7,14.0,1217",GSM3533471: ChIP-Seq MCF7 Med12 siCTL E2; Homo sapiens; ChIP-Seq,source_name=breast cancer	cell line=MCF7	chip antibody=A399-774A	treatment=estrogen+siCTL
SRX5185604,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19144679,66.0,21.4,572",GSM3533472: ChIP-Seq MCF7 Med12 siCARM1; Homo sapiens; ChIP-Seq,source_name=breast cancer	cell line=MCF7	chip antibody=A399-774A	treatment=ethanol+siRNA
SRX5185605,hg38,TFs and others,MED12,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18127575,80.9,26.3,1210",GSM3533473: ChIP-Seq MCF7 Med12 siCARM1 E2; Homo sapiens; ChIP-Seq,source_name=breast cancer	cell line=MCF7	chip antibody=A399-774A	treatment=estrogen+siRNA
SRX5195699,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"37188325,96.3,22.6,2940",GSM3537249: ChIP-Seq: ARID1A-WT1 H3K27Ac rep1; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=1	technical replicate=1	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195700,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"26385151,95.8,20.7,2346",GSM3537250: ChIP-Seq: ARID1A-WT1 H3K27Ac rep2; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=1	technical replicate=2	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195701,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"33671978,96.8,17.1,2705",GSM3537251: ChIP-Seq: ARID1A-WT1 H3K27Ac rep3; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=1	technical replicate=3	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195702,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"34687338,92.8,18.6,2819",GSM3537252: ChIP-Seq: ARID1A-KO1 H3K27Ac rep1; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=1	technical replicate=1	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195719,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"27037651,90.5,14.3,2362",GSM3537253: ChIP-Seq: ARID1A-KO1 H3K27Ac rep2; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=1	technical replicate=2	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195720,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"31969532,90.6,17.8,2710",GSM3537254: ChIP-Seq: ARID1A-KO1 H3K27Ac rep3; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=1	technical replicate=3	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195721,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"31931693,97.8,12.0,24355",GSM3537255: ChIP-Seq: ARID1A-WT2 H3K27Ac rep1; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=2	technical replicate=1	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195722,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"24622158,98.1,9.8,20608",GSM3537256: ChIP-Seq: ARID1A-WT2 H3K27Ac rep2; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=2	technical replicate=2	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195723,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"31932234,98.1,12.1,24409",GSM3537257: ChIP-Seq: ARID1A-WT2 H3K27Ac rep3; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=2	technical replicate=3	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195724,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"36320614,92.4,12.6,23168",GSM3537258: ChIP-Seq: ARID1A-KO2 H3K27Ac rep1; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=2	technical replicate=1	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195725,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"24399554,91.9,11.6,20870",GSM3537259: ChIP-Seq: ARID1A-KO2 H3K27Ac rep2; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=2	technical replicate=2	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195726,hg38,Histone,H3K27ac,Uterus,Endometrial epithelial cells,,"28501447,94.9,14.6,21379",GSM3537260: ChIP-Seq: ARID1A-KO2 H3K27Ac rep3; Homo sapiens; ChIP-Seq,"source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=2	technical replicate=3	chip antibody=Acetyl-Histone H3 (Lys27) (CST, #8173)"
SRX5195741,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"37064630,90.0,67.8,8992",GSM3537177: ATAC-Seq: ARID1A-WT1 rep1; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=1	technical replicate=1
SRX5195742,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"36802269,89.9,67.5,8917",GSM3537178: ATAC-Seq: ARID1A-WT1 rep2; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=1	technical replicate=2
SRX5195743,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"40846163,90.0,68.0,10068",GSM3537179: ATAC-Seq: ARID1A-WT1 rep3; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=1	technical replicate=3
SRX5195744,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"32963396,87.9,44.4,19691",GSM3537180: ATAC-Seq: ARID1A-WT2 rep1; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=2	technical replicate=1
SRX5195745,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"35269305,88.1,44.8,20321",GSM3537181: ATAC-Seq: ARID1A-WT2 rep2; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=2	technical replicate=2
SRX5195746,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"30286377,87.9,44.2,18416",GSM3537182: ATAC-Seq: ARID1A-WT2 rep3; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A WT	biological replicate=2	technical replicate=3
SRX5195747,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"16688686,89.0,39.4,6858",GSM3537183: ATAC-Seq: ARID1A-KO1 rep1; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=1	technical replicate=1
SRX5195748,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"14560226,88.2,37.6,6242",GSM3537184: ATAC-Seq: ARID1A-KO1 rep2; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=1	technical replicate=2
SRX5195749,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"16207907,88.0,38.8,7050",GSM3537185: ATAC-Seq: ARID1A-KO1 rep3; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=1	technical replicate=3
SRX5195750,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"18715050,88.5,34.6,10545",GSM3537186: ATAC-Seq: ARID1A-KO2 rep1; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=2	technical replicate=1
SRX5195751,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"19864715,88.4,35.4,11199",GSM3537187: ATAC-Seq: ARID1A-KO2 rep2; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=2	technical replicate=2
SRX5195752,hg38,ATAC-Seq,ATAC-Seq,Uterus,Endometrial epithelial cells,,"19994366,88.7,35.0,11097",GSM3537188: ATAC-Seq: ARID1A-KO2 rep3; Homo sapiens; ATAC-seq,source_name=endometrial epithelial cells	cell type=endometrial epithelial cells	genotype=ARID1A KO	biological replicate=2	technical replicate=3
SRX5203293,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25832223,99.1,1.9,1815",GSM3539019: NT#10 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=Wild type	chip antibody=ERa	cell line=MCF-7
SRX5203297,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26899174,99.0,1.7,948",GSM3539023: CTCF2 1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=targeting chr20:47521695-47621796	chip antibody=ERa	cell line=MCF-7
SRX5203302,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23737726,98.8,2.1,1428",GSM3539028: 1117 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=targeting chr20:47407744-47407846	chip antibody=ERa	cell line=MCF-7
SRX5203306,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20478683,98.7,1.6,925",GSM3539032: 1118 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=targeting chr20:47407727-47407826	chip antibody=ERa	cell line=MCF-7
SRX5203310,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"22172832,98.4,3.0,784",GSM3539036: ESR1 1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=targeting chr20:47481433-47481536	chip antibody=ERa	cell line=MCF-7
SRX5203313,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24863862,98.2,2.3,818",GSM3539039: ESR2 1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=targeting chr20:47314838-47314940	chip antibody=ERa	cell line=MCF-7
SRX5203317,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20313509,98.2,3.0,901",GSM3539043: FoxA1 ERa; Homo sapiens; ChIP-Seq,source_name=MCF-7	sgrna=Targeting chr20:47407679-47407782	chip antibody=ERa	cell line=MCF-7
SRX524961,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"37682541,97.6,60.1,267",GSM1372852: H3K27ac case1 w/ EP; Homo sapiens; ChIP-Seq,"source_name=Human endometrial stromal cells	tissue=Endometrial stromal cells	condition=induction with estradiol (10-8 M) and medroxyprogesterone acetate (10-6 M)	chip antibody=H3K27ac (generous gifts from Dr. H. Kimura, Osaka University, Osaka, Japan)."
SRX524966,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"41862514,88.6,62.4,366",GSM1372858: H3K27ac case1 control; Homo sapiens; ChIP-Seq,"source_name=Human endometrial stromal cells	tissue=Endometrial stromal cells	condition=control (without any induction)	chip antibody=H3K27ac (generous gifts from Dr. H. Kimura, Osaka University, Osaka, Japan)."
SRX524971,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"33306045,99.4,46.3,231",GSM1372863: H3K27ac case2 w/ EP; Homo sapiens; ChIP-Seq,"source_name=Human endometrial stromal cells	tissue=Endometrial stromal cells	condition=induction with estradiol (10-8 M) and medroxyprogesterone acetate (10-6 M)	chip antibody=H3K27ac (generous gifts from Dr. H. Kimura, Osaka University, Osaka, Japan)."
SRX524976,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"41684393,99.3,39.8,384",GSM1372870: H3K27ac case2 control; Homo sapiens; ChIP-Seq,"source_name=Human endometrial stromal cells	tissue=Endometrial stromal cells	condition=control (without any induction)	chip antibody=H3K27ac (generous gifts from Dr. H. Kimura, Osaka University, Osaka, Japan)."
SRX5251414,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23445317,86.3,4.3,647",GSM3563750: MCF7 WT Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF7 cell line	esr1 genotype=Wild-type	treatments=Vehicle	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251415,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16374435,90.3,3.1,6076",GSM3563751: MCF7 WT E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cell line	esr1 genotype=Wild-type	treatments=1 nM E2	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251418,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20512828,91.9,3.2,819",GSM3563753: MCF7 Y537S Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF7 cell line	esr1 genotype=Y537S	treatments=Vehicle	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251419,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20676998,91.3,3.1,1345",GSM3563754: MCF7 Y537S E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cell line	esr1 genotype=Y537S	treatments=1 nM E2	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251421,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20217813,89.0,3.1,737",GSM3563756: MCF7 D538G Vehicle; Homo sapiens; ChIP-Seq,"source_name=MCF7 cell line	esr1 genotype=D538G	treatments=Vehicle	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251422,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20606853,92.4,3.7,2768",GSM3563757: MCF7 D538G E2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cell line	esr1 genotype=D538G	treatments=1 nM E2	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251424,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"21210993,91.3,3.5,864",GSM3563759: T47D WT Vehicle; Homo sapiens; ChIP-Seq,"source_name=T47D cell line	esr1 genotype=Wild-type	treatments=Vehicle	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251425,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22925286,93.1,3.8,1507",GSM3563760: T47D WT E2; Homo sapiens; ChIP-Seq,"source_name=T47D cell line	esr1 genotype=Wild-type	treatments=1 nM E2	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251427,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"19791648,89.1,3.6,1103",GSM3563762: T47D Y537S Vehicle; Homo sapiens; ChIP-Seq,"source_name=T47D cell line	esr1 genotype=Y537S	treatments=Vehicle	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251428,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"19579091,89.5,3.8,2155",GSM3563763: T47D Y537S E2; Homo sapiens; ChIP-Seq,"source_name=T47D cell line	esr1 genotype=Y537S	treatments=1 nM E2	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251430,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"21515072,90.6,4.6,1026",GSM3563765: T47D D538G Vehicle; Homo sapiens; ChIP-Seq,"source_name=T47D cell line	esr1 genotype=D538G	treatments=Vehicle	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5251431,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"20553877,87.7,5.6,5255",GSM3563766: T47D D538G E2; Homo sapiens; ChIP-Seq,"source_name=T47D cell line	esr1 genotype=D538G	treatments=1 nM E2	chip antibody=ERα (Santa Cruz Biotechnologies, sc543)"
SRX5283921,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"191210341,0.0,21.4,85974",GSM3576706: HeLa shINTS11 ctrl r1 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa	biomaterial_provider=ATCC#CCL-2	cell line=HeLa	cell type=cervical adenocarcinoma	modification=Tet-pLKO_shINTS11 stable cells	chip antibody=NA
SRX5283922,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"170061824,0.0,26.5,43406",GSM3576707: HeLa shINTS11 ctrl r2 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa	biomaterial_provider=ATCC#CCL-2	cell line=HeLa	cell type=cervical adenocarcinoma	modification=Tet-pLKO_shINTS11 stable cells	chip antibody=NA
SRX5287690,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28195327,91.6,18.9,3029",GSM3577940: T47D ER Veh ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D	cell type=Breast cancer cell line	treatment=Veh	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5287691,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23748956,95.8,17.1,5665",GSM3577941: T47D ER E2 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=T47D	cell line=T47D	cell type=Breast cancer cell line	treatment=E2	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5287696,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28936805,96.9,14.7,14784",GSM3577946: MCF7 ER shCtrl ChipSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	shRNA=Control	treatment=E2	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5287697,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21579000,97.7,16.9,25655",GSM3577947: MCF7 ER shTEAD4 ChipSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	shRNA=TEAD4	treatment=E2	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5287698,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21005533,97.1,16.0,19611",GSM3577948: MCF7 ER shYAP1 ChipSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	shRNA=YAP1	treatment=E2	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5287703,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24232762,98.5,30.1,32073",GSM3577953: MCF7 ER DMSO ChipSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	treatment=DMSO	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5287706,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21723695,98.3,17.8,11611",GSM3577956: MCF7 ER ICI ChipSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	treatment=ICI	chip antibody=ERalpha (Santa Cruz, sc-7207)"
SRX5323807,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31259144,99.2,14.1,4377",GSM3587721: JC4726 ER veh T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=7	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323808,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28851988,99.2,17.4,5552",GSM3587722: JC4727 ER IL6 T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=7	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323809,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27065275,99.2,14.6,2391",GSM3587723: JC4728 ER veh T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=8	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323810,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"20899968,99.3,14.3,3683",GSM3587724: JC4729 ER IL6 T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=8	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323811,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26937620,99.2,16.6,3966",GSM3587725: JC4730 ER veh T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=9	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323812,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"22136355,99.2,13.9,3247",GSM3587726: JC4731 ER IL6 T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=9	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323813,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"29182619,99.3,15.8,8338",GSM3587727: JC4732 ER veh T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=10	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323814,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23745660,99.2,14.1,6100",GSM3587728: JC4733 ER IL6 T47D; Homo sapiens; ChIP-Seq,source_name=T47D	cell type=Breast cancer	passages=10	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323871,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31764524,99.3,14.1,40032",GSM3587785: jc5849 ER Veh MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=22	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323872,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35151218,99.3,14.3,36996",GSM3587786: jc5850 ER IL6 MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=22	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323873,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42773567,99.3,14.9,42968",GSM3587787: jc5851 ER Veh MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=23	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323874,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20886314,99.3,11.6,25834",GSM3587788: jc5852 ER IL6 MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=23	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323875,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15292161,99.3,10.8,19728",GSM3587789: jc5853 ER Veh MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=24	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323876,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39470499,99.4,12.1,23870",GSM3587790: jc5854 ER IL6 MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=24	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323877,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34652620,99.4,13.0,32247",GSM3587791: jc5855 ER Veh MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=25	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323878,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43787732,99.3,14.4,36751",GSM3587792: jc5856 ER IL6 MCF7; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	passages=25	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323929,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"35984837,99.1,25.9,3627",GSM3587843: jc5572 ER 3840; Homo sapiens; ChIP-Seq,source_name=Primary breast tumour - ER+/pSTAT3+	cell type=Breast cancer	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5323930,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"35498516,98.9,23.1,7570",GSM3587844: jc5573 ER 3487; Homo sapiens; ChIP-Seq,source_name=Primary breast tumour - ER+/pSTAT3+	cell type=Breast cancer	chip antibody=ab3575 (abcam)/06-935 (Millipore)
SRX5350525,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15495386,0.0,13.1,0",GSM3595410: ChIPseq ER MCF7 WT E2 45min rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell line=MCF7 cells	treatment duration=45 minutes	treatment=10 nM E2	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350526,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17075811,0.0,10.4,0",GSM3595411: ChIPseq ER MCF7 WT Veh 45min rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell line=MCF7 cells	treatment duration=45 minutes	treatment=Vehicle	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350527,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16874377,0.0,11.8,0",GSM3595412: ChIPseq ER MCF7 WT E2 45min rep2; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell line=MCF7 cells	treatment duration=45 minutes	treatment=10 nM E2	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350528,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19795743,0.0,14.2,0",GSM3595413: ChIPseq ER MCF7 WT Veh 45min rep2; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	cell line=MCF7 cells	treatment duration=45 minutes	treatment=Vehicle	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350529,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23699765,0.0,24.6,0",GSM3595414: ChIPseq ER MCF7 CRISPR GRHL2 E2 45min rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells CRISPR_GRHL2	cell line=MCF7 cells CRISPR_GRHL2	treatment duration=45 minutes	treatment=10 nM E2	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350530,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13888680,0.0,14.7,0",GSM3595415: ChIPseq ER MCF7 CRISPR GRHL2 Veh 45min rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells CRISPR_GRHL2	cell line=MCF7 cells CRISPR_GRHL2	treatment duration=45 minutes	treatment=Vehicle	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350531,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24951901,0.0,22.7,0",GSM3595416: ChIPseq ER MCF7 CRISPR GRHL2 E2 45min rep2; Homo sapiens; ChIP-Seq,source_name=MCF7 cells CRISPR_GRHL2	cell line=MCF7 cells CRISPR_GRHL2	treatment duration=45 minutes	treatment=10 nM E2	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5350532,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20168504,0.0,17.7,0",GSM3595417: ChIPseq ER MCF7 CRISPR GRHL2 Veh 45min rep2; Homo sapiens; ChIP-Seq,source_name=MCF7 cells CRISPR_GRHL2	cell line=MCF7 cells CRISPR_GRHL2	treatment duration=45 minutes	treatment=Vehicle	antibody=Anti-ER HC-20 (Santa Cruz)
SRX5401863,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"57924322,98.3,9.1,1962",GSM3615489: PR T0 A1 2 ChIPseq; Homo sapiens; ChIP-Seq,"source_name=T47D A1/2 cells	cell type=Mammary epithelial cells	cell line=T47D A1/2 cells	chip antibody=anti-PR, H-190, sc-7208, Santa Cruz Biotechnology	agent=none"
SRX5401864,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"57028133,96.4,9.6,27129",GSM3615490: PR T60 R5020 A1 2 ChIPseq; Homo sapiens; ChIP-Seq,"source_name=T47D A1/2 cells	cell type=Mammary epithelial cells	cell line=T47D A1/2 cells	chip antibody=anti-PR, H-190, sc-7208, Santa Cruz Biotechnology	agent=R5020 (10 nM)"
SRX5401865,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"176618871,98.0,12.3,3820",GSM3615491: PR T0 MTVL WT ChIPseq; Homo sapiens; ChIP-Seq,"source_name=T47D MTVL WT (Ctrl)	cell type=Mammary epithelial cells	cell line=T47D MTVL WT cells (used as control in this work)	chip antibody=anti-PR, H-190, sc-7208, Santa Cruz Biotechnology"
SRX5401866,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"87706387,99.0,13.1,49742",GSM3615492: PR T60 R5020 MTVL WT ChIPseq; Homo sapiens; ChIP-Seq,"source_name=T47D MTVL WT (Ctrl)	cell type=Mammary epithelial cells	cell line=T47D MTVL WT cells (used as control in this work)	chip antibody=anti-PR, H-190, sc-7208, Santa Cruz Biotechnology	agent=R5020 (10 nM)"
SRX5465792,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30497619,98.6,1.7,5792",GSM3640247: MCF7 aERa repl1; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cell line	cell line=MCF7	cell type=Breast cancer cells	chip antibody=aERa (Santa Cruz, catalog# sc-543)	treatment=Full medium"
SRX5465793,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27171896,98.2,2.0,6345",GSM3640248: MCF7 aERa repl2; Homo sapiens; ChIP-Seq,"source_name=Breast cancer cell line	cell line=MCF7	cell type=Breast cancer cells	chip antibody=aERa (Santa Cruz, catalog# sc-543)	treatment=Full medium"
SRX5493763,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"21646968,85.8,23.5,3347",GSM3660485: S176 VEH ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493764,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"18660629,87.2,20.9,1353",GSM3660486: S177 VEH ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493765,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"23329557,80.4,9.6,840",GSM3660487: S179 VEH ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493766,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"24069169,95.1,6.5,405",GSM3660488: S181 ENOB ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493767,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"20279859,82.0,24.7,1252",GSM3660489: SS182 ENOB ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493768,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"19975760,89.3,18.0,1585",GSM3660490: S186 ENOB ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493769,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"21814304,93.5,11.3,6993",GSM3660491: S440 2187 VEH ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5493770,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"24104897,89.1,6.0,415",GSM3660492: S440 2190 ENOB ER; Homo sapiens; ChIP-Seq,"source_name=Patient derived xenograft, breast cancer	tissue=tumor tissue	chip antibody=ER	chip antibody vendor=Santa Cruz Biotechnology, Thermo"
SRX5511291,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40497837,99.2,17.2,4494",GSM3667085: MCF7 ERa Abcam Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	passages=P29	chip antibody=anti-ERalpha (Abcam, ab3575)"
SRX5511292,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39078005,99.2,16.3,4020",GSM3667086: MCF7 ERa Santacruz Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	passages=P29	chip antibody=anti-ERalpha (Santa Cruz, sc-543)"
SRX5511293,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"43627420,99.1,16.8,5203",GSM3667087: MCF7 ERa Millipore Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	passages=P29	chip antibody=anti-ERalpha (Millipore, 06-935)"
SRX5511296,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38034229,99.2,15.8,3721",GSM3667090: MCF7 ERa Abcam Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	passages=P29	chip antibody=anti-ERalpha (Abcam, ab3575)"
SRX5511297,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37483422,99.1,15.4,3982",GSM3667091: MCF7 ERa Santacruz Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	passages=P29	chip antibody=anti-ERalpha (Santa Cruz, sc-543)"
SRX5511298,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39259869,99.2,17.1,3817",GSM3667092: MCF7 ERa Millipore Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=Breast cancer cell line	passages=P29	chip antibody=anti-ERalpha (Millipore, 06-935)"
SRX5511301,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","36681307,99.1,15.1,711",GSM3667095: MDA MB 231 ERa Abcam Rep1; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P25	chip antibody=anti-ERalpha (Abcam, ab3575)"
SRX5511302,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","33658356,99.0,15.3,701",GSM3667096: MDA MB 231 ERa Santacruz Rep1; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P25	chip antibody=anti-ERalpha (Santa Cruz, sc-543)"
SRX5511303,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","41186581,99.2,16.0,767",GSM3667097: MDA MB 231 ERa Millipore Rep1; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P25	chip antibody=anti-ERalpha (Millipore, 06-935)"
SRX5511306,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","35381838,99.2,16.5,715",GSM3667100: MDA MB 231 ERa Abcam Rep2; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P26	chip antibody=anti-ERalpha (Abcam, ab3575)"
SRX5511307,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","42240744,99.2,16.2,922",GSM3667101: MDA MB 231 ERa Santacruz Rep2; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P26	chip antibody=anti-ERalpha (Santa Cruz, sc-543)"
SRX5511308,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","38053267,99.2,15.5,795",GSM3667102: MDA MB 231 ERa Millipore Rep2; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P26	chip antibody=anti-ERalpha (Millipore, 06-935)"
SRX5511311,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","39057679,99.0,15.4,839",GSM3667105: MDA MB 231 ERa Abcam Rep3; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P27	chip antibody=anti-ERalpha (Abcam, ab3575)"
SRX5511312,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","37406071,98.8,14.9,798",GSM3667106: MDA MB 231 ERa Santacruz Rep3; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P27	chip antibody=anti-ERalpha (Santa Cruz, sc-543)"
SRX5511313,hg38,TFs and others,ESR1,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","31657905,99.1,15.3,727",GSM3667107: MDA MB 231 ERa Millipore Rep3; Homo sapiens; ChIP-Seq,"source_name=MDA_MB_231	cell line=MDA_MB_231	cell type=Breast cancer cell line	passages=P27	chip antibody=anti-ERalpha (Millipore, 06-935)"
SRX5513976,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","40068569,97.3,9.7,15524",GSM3667599: PT848-MYO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513978,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","55377209,97.8,12.7,21388",GSM3667601: PT886-MYO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513980,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","48005929,97.6,12.5,27466",GSM3667603: PT916-MYO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513982,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","51752488,97.6,10.1,20732",GSM3667605: PT967-MYO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513984,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","58566144,97.7,10.7,20026",GSM3667607: PT1063-MYO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513986,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"61506965,97.9,14.3,36977",GSM3667609: PT848-LEIO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513988,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"57830661,97.9,13.4,19169",GSM3667611: PT886-LEIO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513990,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"51096057,97.9,11.7,20668",GSM3667613: PT916-LEIO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513992,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"47027295,97.8,8.6,12306",GSM3667615: PT967-LEIO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5513994,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"59187566,97.8,14.2,28975",GSM3667617: PT1063-LEIO-H3K27Ac; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 21516012)"
SRX5514006,hg38,TFs and others,FOS,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","15644035,95.1,7.0,3285",GSM3667629: PT848-MYO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514007,hg38,TFs and others,FOS,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","34729152,96.0,9.5,18756",GSM3667630: PT886-MYO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514008,hg38,TFs and others,FOS,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","29461970,92.3,7.4,3993",GSM3667631: PT916-MYO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514009,hg38,TFs and others,FOS,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","19140727,89.1,11.4,20258",GSM3667632: PT967-MYO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514010,hg38,TFs and others,FOS,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","21197616,94.0,8.9,9985",GSM3667633: PT1063-MYO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514011,hg38,TFs and others,FOS,Uterus,Uterin leiomyoma,,"15796033,94.7,7.3,7524",GSM3667634: PT848-LEIO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514012,hg38,TFs and others,FOS,Uterus,Uterin leiomyoma,,"43013528,96.1,9.8,19274",GSM3667635: PT886-LEIO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514013,hg38,TFs and others,FOS,Uterus,Uterin leiomyoma,,"19958439,91.5,7.8,5276",GSM3667636: PT916-LEIO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514014,hg38,TFs and others,FOS,Uterus,Uterin leiomyoma,,"21990356,92.1,7.6,10848",GSM3667637: PT967-LEIO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514015,hg38,TFs and others,FOS,Uterus,Uterin leiomyoma,,"22954028,93.6,10.4,10148",GSM3667638: PT1063-LEIO-FOS; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=FOS (Millipore, cat # 06-341)"
SRX5514016,hg38,TFs and others,JUN,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","23202288,95.1,7.7,8474",GSM3667639: PT848-MYO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514017,hg38,TFs and others,JUN,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","41535403,96.2,8.4,15531",GSM3667640: PT886-MYO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514018,hg38,TFs and others,JUN,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","32055009,93.6,7.7,4463",GSM3667641: PT916-MYO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514019,hg38,TFs and others,JUN,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","18376759,90.2,8.7,7603",GSM3667642: PT967-MYO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514020,hg38,TFs and others,JUN,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","22035276,93.2,9.0,7442",GSM3667643: PT1063-MYO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514021,hg38,TFs and others,JUN,Uterus,Uterin leiomyoma,,"18026983,93.8,7.3,9479",GSM3667644: PT848-LEIO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514022,hg38,TFs and others,JUN,Uterus,Uterin leiomyoma,,"26020429,95.3,6.8,6368",GSM3667645: PT886-LEIO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514023,hg38,TFs and others,JUN,Uterus,Uterin leiomyoma,,"26548671,92.0,8.4,3181",GSM3667646: PT916-LEIO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514024,hg38,TFs and others,JUN,Uterus,Uterin leiomyoma,,"23455115,91.7,7.2,4130",GSM3667647: PT967-LEIO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514025,hg38,TFs and others,JUN,Uterus,Uterin leiomyoma,,"19187722,91.5,9.8,4180",GSM3667648: PT1063-LEIO-JUN; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=JUN (abcam, cat # ab31419)"
SRX5514026,hg38,TFs and others,CDK8,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","17125115,76.1,12.3,3469",GSM3667649: PT848-MYO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514027,hg38,TFs and others,CDK8,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","37876946,96.0,9.2,14869",GSM3667650: PT886-MYO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514028,hg38,TFs and others,CDK8,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","28475988,92.3,8.6,6725",GSM3667651: PT916-MYO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514029,hg38,TFs and others,CDK8,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","17378188,89.1,9.7,11689",GSM3667652: PT967-MYO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514030,hg38,TFs and others,CDK8,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","21017776,93.7,9.6,11268",GSM3667653: PT1063-MYO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514031,hg38,TFs and others,CDK8,Uterus,Uterin leiomyoma,,"18666835,95.9,8.8,15916",GSM3667654: PT848-LEIO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514032,hg38,TFs and others,CDK8,Uterus,Uterin leiomyoma,,"38821964,95.9,11.6,17664",GSM3667655: PT886-LEIO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514033,hg38,TFs and others,CDK8,Uterus,Uterin leiomyoma,,"19985078,92.4,8.3,3691",GSM3667656: PT916-LEIO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514034,hg38,TFs and others,CDK8,Uterus,Uterin leiomyoma,,"20666736,92.7,8.3,11114",GSM3667657: PT967-LEIO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514035,hg38,TFs and others,CDK8,Uterus,Uterin leiomyoma,,"25870395,94.3,11.7,8007",GSM3667658: PT1063-LEIO-CDK8; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=CDK8 (Bethyl, cat # A302-500A)"
SRX5514036,hg38,TFs and others,MED12,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","18919149,94.2,8.0,7514",GSM3667659: PT848-MYO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514037,hg38,TFs and others,MED12,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","37231806,95.8,9.9,19086",GSM3667660: PT886-MYO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514038,hg38,TFs and others,MED12,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","29710757,94.2,8.5,15547",GSM3667661: PT916-MYO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514039,hg38,TFs and others,MED12,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","14098347,89.0,8.0,10829",GSM3667662: PT967-MYO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514040,hg38,TFs and others,MED12,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","15221676,91.4,8.4,6934",GSM3667663: PT1063-MYO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine muscle tissue	tissue=Myometrium	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514041,hg38,TFs and others,MED12,Uterus,Uterin leiomyoma,,"19060944,95.4,8.8,20651",GSM3667664: PT848-LEIO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514042,hg38,TFs and others,MED12,Uterus,Uterin leiomyoma,,"36864245,95.8,10.4,20571",GSM3667665: PT886-LEIO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514043,hg38,TFs and others,MED12,Uterus,Uterin leiomyoma,,"21154277,91.2,8.2,4104",GSM3667666: PT916-LEIO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514044,hg38,TFs and others,MED12,Uterus,Uterin leiomyoma,,"21736848,91.9,8.2,14919",GSM3667667: PT967-LEIO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5514045,hg38,TFs and others,MED12,Uterus,Uterin leiomyoma,,"23088731,94.2,9.8,8900",GSM3667668: PT1063-LEIO-MED12; Homo sapiens; ChIP-Seq,"source_name=Uterine tumor	tissue=Leiomyoma	chip antibody=MED12 (Bethyl, cat # A300-774A)"
SRX5534831,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"40852531,98.9,22.4,37399",GSM3675294: MCF7 Full ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534832,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25877630,99.1,18.9,42304",GSM3675295: TamR Full ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=TamR	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534843,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19549394,96.9,9.9,5642",GSM3675306: TamR shCtrl ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=TamR	treatment=TamR cells were infected with Control shRNA (scramble)	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534844,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"9029745,95.5,9.9,326",GSM3675307: TamR shJUN ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=TamR	treatment=TamR cells were infected with JUN shRNA(sh9591)	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534847,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14894836,95.8,7.3,4257",GSM3675310: MCF7 shCtrl ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	treatment=MCF7 cells were infected with Control shRNA (scramble)	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534848,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"10281937,96.1,7.6,628",GSM3675311: MCF7 shGATA3 ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	treatment=MCF7 cells were infected with GATA3 shRNA(sh9301)	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534853,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19897362,96.6,11.3,5061",GSM3675316: MCF7 oeCtrl ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	treatment=MCF7 parental cells with DOX-inducible expression of JUN-without DOX treatment	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534854,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15343907,96.3,11.0,3543",GSM3675317: MCF7 oeJUN ER Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	treatment=MCF7 parental cells with DOX-inducible expression of JUN-with DOX treatment	growth medium=Full media	chip antibody=ERalpha (Santa Cruz, sc-543)"
SRX5534871,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12352709,97.5,12.4,1213",GSM3675334: MCF7 JUN CST9165 Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	growth medium=Full media	chip antibody=JUN (Cell Signaling, CST9165)"
SRX5534872,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"10234424,96.5,10.4,10453",GSM3675335: TamR JUN CST9165 Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=TamR	growth medium=Full media	chip antibody=JUN (Cell Signaling, CST9165)"
SRX5534873,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15241619,92.9,19.0,1238",GSM3675336: MCF7 JUN BD610326 Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=control (parental cell)	growth medium=Full media	chip antibody=JUN (BD, 610326)"
SRX5534874,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17794556,96.5,52.0,7819",GSM3675337: TamR JUN BD610326 Chipseq; Homo sapiens; ChIP-Seq,"source_name=breast cancer cells	cell line=MCF7	growth protocol=TamR	growth medium=Full media	chip antibody=JUN (BD, 610326)"
SRX5683074,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"26454409,96.5,20.6,3265",GSM3722307: ChIP-seq Ishi E21hr ER; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=WT
SRX5683075,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18011027,94.7,26.0,742",GSM3722308: ChIP-seq Ishi ETV4KO1 E21hr ER; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa ETV4 KO clone 1	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 KO
SRX5683076,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23852911,95.1,15.2,704",GSM3722309: ChIP-seq Ishi ETV4KO2 E21hr ER; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa ETV4 KO clone 2	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 KO
SRX5683077,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35048477,94.1,3.1,1018",GSM3722310: ChIP-seq Ishi Ishi DMSO Input; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 0.1% DMSO	genotype=WT
SRX5683078,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"32436778,81.6,15.6,6987",GSM3722311: ChIP-seq Ishi Ishi E21hr ER B; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=WT
SRX5683079,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35835295,98.0,21.2,7024",GSM3722312: ChIP-seq Ishi ETV4KO1 E21hr ER B; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa ETV4 KO clone 1	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 KO
SRX5683080,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"15535842,79.6,28.0,1058",GSM3722313: ChIP-seq Ishi ETV4KO2 E21hr ER B; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa ETV4 KO clone 2	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 KO
SRX5683081,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"11886121,91.0,16.3,10022",GSM3722314: ChIP-seq Ishi WT ETV4Overexpression ER E2; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=Ishikawa ETV4 ectopic expression	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 ectopic expression
SRX5683082,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"7368752,49.5,40.4,993",GSM3722315: ChIP-seq Ishi ETV4KO1 Rescue ER E2; Homo sapiens; ChIP-Seq,"source_name=ER ChIP-seq	cell line=Ishikawa ETV4 KO clone1, ETV4 ectopic expression	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 KO, ETV4 ectopic expression"
SRX5683083,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"9762708,82.6,31.7,3716",GSM3722316: ChIP-seq Ishi ETV4KO2 Rescue ER E2; Homo sapiens; ChIP-Seq,"source_name=ER ChIP-seq	cell line=Ishikawa ETV4 KO clone 2, ETV4 ectopic expression	cell type=Endometrioid adenocarcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 KO, ETV4 ectopic expression"
SRX5683084,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"13248369,79.3,40.0,662",GSM3722317: ChIP-seq Ishi T47D ER E2; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=T-47D ETV4 ectopic expression	cell type=ER+ breast ductal carcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2	genotype=ETV4 ectopic expression
SRX5683086,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"47917928,92.6,7.1,3180",GSM3722319: ChIP-seq Ishi T47D DMSO Input; Homo sapiens; ChIP-Seq,source_name=ER ChIP-seq	cell line=T-47D	cell type=ER+ breast ductal carcinoma cell line	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 0.1% DMSO	genotype=WT
SRX5683087,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38759502,97.2,68.0,32480",GSM3722301: ATAC-seq ETV4KO1 DMSO; Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma_1 hr 0.1% DMSO	cell line=Ishikawa ETV4 KO clone 1	cell type=Endometrioid adenocarcinoma	treatment=1 hr 0.1% DMSO	treatment=ETV4 KO
SRX5683088,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"33717574,97.2,67.4,25621",GSM3722302: ATAC-seq ETV4KO1 1hrE2; Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma_1 hr 10nM E2	cell line=Ishikawa ETV4 KO clone 1	cell type=Endometrioid adenocarcinoma	treatment=1 hr 10nM E2	treatment=ETV4 KO
SRX5683089,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"39239331,97.3,75.2,29885",GSM3722303: ATAC-seq ETV4KO2 DMSO; Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma_1 hr 0.1% DMSO	cell line=Ishikawa ETV4 KO clone 2	cell type=Endometrioid adenocarcinoma	treatment=1 hr 0.1% DMSO	treatment=ETV4 KO
SRX5683090,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28806335,97.8,76.8,18971",GSM3722304: ATAC-seq ETV4KO2 1hrE2; Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma_1 hr 10nM E2	cell line=Ishikawa ETV4 KO clone 2	cell type=Endometrioid adenocarcinoma	treatment=1 hr 10nM E2	treatment=ETV4 KO
SRX5683091,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"32143952,97.7,70.6,16729",GSM3722305: ATAC-seq WTIshikawa DMSO; Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma_1 hr 0.1% DMSO	cell line=Ishikawa	cell type=Endometrioid adenocarcinoma	treatment=1 hr 0.1% DMSO	treatment=WT
SRX5683092,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"34356754,97.2,72.6,17822",GSM3722306: ATAC-seq WTIshikawa 1hrE2; Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma_1 hr 10nM E2	cell line=Ishikawa	cell type=Endometrioid adenocarcinoma	treatment=1 hr 10nM E2	treatment=WT
SRX5702620,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"67307877,95.4,13.1,18413",GSM3728287: T-47D ER ChIP E2 Consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=T-47D	passages=14-16 (where replicates represent sequential passages)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)	treatment=E2
SRX5702621,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"60460959,94.7,13.6,17982",GSM3728288: T-47D ER ChIP E2+DHT Consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=T-47D	passages=14-16 (where replicates represent sequential passages)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)	treatment=E2+DHT
SRX5702623,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"114282127,72.9,10.1,27866",GSM3728290: HCI-005 ER Veh; Homo sapiens; ChIP-Seq,source_name=Breast cancer PDX HCI-005 tumour	tissue=PDX model HCI-005	time point=Short-term (5 days treatment)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)	treatment=Vehicle
SRX5702624,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"120127012,74.0,8.5,18087",GSM3728291: HCI-005 ER Sarm; Homo sapiens; ChIP-Seq,source_name=Breast cancer PDX HCI-005 tumour	tissue=PDX model HCI-005	time point=Short-term (5 days treatment)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)	treatment=Enobosarm
SRX5702625,hg38,TFs and others,ESR1,Breast,Breast cancer cells,,"102415955,77.4,7.3,6831",GSM3728292: HCI-005 ER DHT; Homo sapiens; ChIP-Seq,source_name=Breast cancer PDX HCI-005 tumour	tissue=PDX model HCI-005	time point=Short-term (5 days treatment)	chip antibody=ERα (HC-20)X (Santa Cruz SC-543X)	treatment=DHT
SRX5817845,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"32930062,95.2,30.0,5535",GSM3759932: 1 siGFP-1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	genotype=WT	replicate=1	sirna=siCont
SRX5817846,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"40644098,92.7,27.0,4299",GSM3759933: 2 siGFP-2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	genotype=WT	replicate=2	sirna=siCont
SRX5817847,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"38466367,94.7,34.9,10847",GSM3759934: 9 TLK1 siGFP-1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	genotype=TLK1 KO	replicate=1	sirna=siCont
SRX5817848,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"38064992,93.4,27.7,7386",GSM3759935: 10 TLK1 siGFP-2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	genotype=TLK1 KO	replicate=2	sirna=siCont
SRX5817849,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"36343831,92.5,25.1,970",GSM3759936: 11 TLK1 siTLK2-1; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	genotype=TLK1 KO	replicate=1	sirna=siTLK2
SRX5817850,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35341214,92.5,24.1,982",GSM3759937: 12 TLK1 siTLK2-2; Homo sapiens; ATAC-seq,source_name=HeLa	cell line=HeLa	genotype=TLK1 KO	replicate=2	sirna=siTLK2
SRX589472,hg38,TFs and others,PGR,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"10483562,95.6,24.1,0",ZR-75-1 ChIP seq INPUT channel,"isolate=ZR-75-1	age=p18	biomaterial_provider=Grant Buchanan, Cancer Biology Group, The University of Adelaide, School of Medicine, Basil Hetzel Institute for Translational Health Research, 28 Woodville Rd, Woodville South SA 5011 Australia	sex=female	tissue=Breast	cell_line=ZR-75-1	cell_type=Breast Carcinoma	culture_collection=ATCC:CRL-1500	disease=Breast Cancer	sample_type=ChIP-sequencing	treatment=4h 10nM Progesterone	Antibody=PR H-190"
SRX594728,hg38,TFs and others,PGR,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"9599889,78.7,28.1,2305","Estrogen primed, progesterone treated cells immunoprecipitated with PR antibody","isolate=ZR-75-1	age=P18	biomaterial_provider=Grant Buchanan, Cancer Biology Group, The University of Adelaide, School of Medicine, Basil Hetzel Institute for Translational Health Research, 28 Woodville Rd, Woodville South SA 5011, Australia	sex=female	tissue=Breast	cell_line=ZR-75-1	cell_type=Breast Carcinoma	culture_collection=ATCC:CRL-1500	Antibody=PR H190"
SRX6027682,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38128059,98.8,8.5,13360",GSM3863225: WTClone1 Rep1 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027683,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"36509060,98.9,5.2,1224",GSM3863226: WTClone1 Rep1 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027684,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20566479,91.2,25.5,34415",GSM3863227: WTClone1 Rep2 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027685,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22973121,93.3,3.5,23168",GSM3863228: WTClone1 Rep2 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027686,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"44742762,98.9,8.2,11225",GSM3863229: WTClone2 Rep1 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027687,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30724538,92.4,16.3,839",GSM3863230: WTClone2 Rep1 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027688,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21484473,88.3,13.2,30641",GSM3863231: WTClone2 Rep2 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027689,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18382175,86.6,3.0,1026",GSM3863232: WTClone2 Rep2 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027690,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"12528349,81.5,37.2,4948",GSM3863233: D538GClone1 Rep1 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 1	genotype=D538G ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027691,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22632646,95.4,11.2,8331",GSM3863234: D538GClone1 Rep1 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 1	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027692,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21468125,88.0,8.4,6849",GSM3863235: D538GClone1 Rep2 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 1	genotype=D538G ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027693,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28047295,95.8,15.7,45843",GSM3863236: D538GClone1 Rep2 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 1	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027694,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"27960076,97.7,17.1,18958",GSM3863237: D538GClone2 Rep1 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 2	genotype=D538G ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027695,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"47367922,97.4,3.4,5522",GSM3863238: D538GClone2 Rep1 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 2	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027696,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23028215,89.2,7.8,2811",GSM3863239: D538GClone2 Rep2 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 2	genotype=D538G ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027697,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30715872,80.7,3.6,27827",GSM3863240: D538GClone2 Rep2 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 2	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027698,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"44695279,96.8,11.0,23460",GSM3863241: D538GClone3 Rep1 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 3	genotype=D538G ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027699,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21358473,94.7,7.6,7030",GSM3863242: D538GClone3 Rep1 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 3	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027700,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"34016690,69.4,6.6,24204",GSM3863243: D538GClone3 Rep2 E2 (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 3	genotype=D538G ESR1	treatment=10nM E2	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027701,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"34685951,41.7,3.7,1987",GSM3863244: D538GClone3 Rep2 DMSO (ChIP-seq); Homo sapiens; ChIP-Seq,"source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 3	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr	chip antibody=Anti-FLAG (Sigma-Aldrich M2, lot# SLBX2256) antibody that recognizes FLAG tag on ESR1"
SRX6027740,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33572923,92.5,9.1,7241",GSM3863285: MCF7-shCTRL-ER ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7-shCTRL-ER_ChIPSeq	cell line=MCF-7	cell type=breast cancer cell line	genotype/variation=shCTRL	chip antibody=ERa (santa cruze, sc-543x,Lot # E3014 )"
SRX6027746,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"199844,92.8,8.4,2",GSM3863291: MCF7-shNR2F2-ER ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MCF7-shNR2F2-ER_ChIPSeq	cell line=MCF-7	cell type=breast cancer cell line	genotype/variation=shNR2F2	chip antibody=ERa (santa cruze, sc-543x,Lot # E3014 )"
SRX6031075,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"27463423,98.0,38.2,12059",GSM3863153: WTClone1 DMSO 1hr (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=0.1% DMSO	time=1 hr
SRX6031076,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"33446391,98.1,50.3,11871",GSM3863154: WTClone1 E2 1hr (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=1 hr
SRX6031077,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"17593538,97.3,88.6,5548",GSM3863155: WTClone1 E2 8hrs (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=8 hrs
SRX6031078,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"36411094,98.0,26.7,9323",GSM3863156: WTClone2 DMSO 1hr (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=0.1% DMSO	time=1 hr
SRX6031079,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"33803900,98.0,28.4,10012",GSM3863157: WTClone2 E2 1hr (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=1 hr
SRX6031080,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"13764334,96.9,87.6,4584",GSM3863158: WTClone2 E2 8hrs (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=8 hrs
SRX6031081,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"31376293,96.1,84.7,11452",GSM3863159: WTClone1 E2 10D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=10 days
SRX6031082,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30764188,95.5,90.5,13016",GSM3863160: WTClone1 E2 15D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=15 days
SRX6031083,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38922079,95.6,88.8,13835",GSM3863161: WTClone1 E2 20D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=20 days
SRX6031084,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"27476314,97.0,89.9,9392",GSM3863162: WTClone1 E2 25D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 1	genotype=WT ESR1	treatment=10nM E2	time=25 days
SRX6031085,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23275800,96.0,86.2,8238",GSM3863163: WTClone2 E2 10D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=10 days
SRX6031086,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"25583969,95.9,90.8,8437",GSM3863164: WTClone2 E2 15D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=15 days
SRX6031087,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"24628955,96.5,88.5,7418",GSM3863165: WTClone2 E2 20D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=20 days
SRX6031088,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"31943637,97.3,90.4,7621",GSM3863166: WTClone2 E2 25D (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa WT ESR1 clone 2	genotype=WT ESR1	treatment=10nM E2	time=25 days
SRX6031089,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"17680032,96.3,52.1,4997",GSM3863167: D538GClone1 DMSO (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 1	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr
SRX6031090,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"41684038,96.3,77.5,22516",GSM3863168: D538GClone1 E2 (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 1	genotype=D538G ESR1	treatment=10nM E2	time=1 hr
SRX6031091,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"89268099,96.5,75.8,31417",GSM3863169: D538GClone2 DMSO (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 2	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr
SRX6031093,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28527409,96.1,76.2,9843",GSM3863170: D538GClone2 E2 (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 2	genotype=D538G ESR1	treatment=10nM E2	time=1 hr
SRX6031094,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"56173440,96.5,75.9,32596",GSM3863171: D538GClone3 DMSO (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 3	genotype=D538G ESR1	treatment=0.1% DMSO	time=1 hr
SRX6031095,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"45809532,97.0,72.8,18091",GSM3863172: D538GClone3 E2 (ATAC-seq); Homo sapiens; ATAC-seq,source_name=Endometrioid adenocarcinoma	cell line=Ishikawa D538G ESR1 clone 3	genotype=D538G ESR1	treatment=10nM E2	time=1 hr
SRX6054274,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"92584508,98.0,24.2,47232",GSM3882322: H3K27ac WT ChIP; Homo sapiens; ChIP-Seq,"source_name=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	strain=na	chip antibody=H3K27ac (Abcam, ab4729)"
SRX6054275,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"86313492,97.4,20.5,18404",GSM3882323: H3K27ac H4KO ChIP; Homo sapiens; ChIP-Seq,"source_name=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	strain=na	chip antibody=H3K27ac (Abcam, ab4729)"
SRX6054276,hg38,Histone,H3K27ac,Uterus,SK-UT-1,Primary Tissue=Uterus|Tissue Diagnosis=Leiomyosarcoma,"79274727,97.3,25.0,44477",GSM3882324: H3K27ac H9KO ChIP; Homo sapiens; ChIP-Seq,"source_name=SK-UT-1	cell type=Leiomyosarcoma cells	passages=below 20	strain=na	chip antibody=H3K27ac (Abcam, ab4729)"
SRX6058753,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"81085546,99.4,6.0,13091",GSM3884751: ChIP-PR – Progesterone; Homo sapiens; ChIP-Seq,source_name=ChIP-PR – Progesterone	cell line=T47D	passages=18-20	chip antibody=H190 Santa Cruz
SRX6058756,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"76448352,99.3,5.4,1578",GSM3884754: ChIP-PR – Untreated; Homo sapiens; ChIP-Seq,source_name=ChIP-PR – Untreated	cell line=T47D	passages=18-20	chip antibody=H190 Santa Cruz
SRX6058759,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"71696817,97.8,4.6,2161",GSM3884757: ChIP-PR - Untreated – siControl; Homo sapiens; ChIP-Seq,source_name=ChIP-PR - Untreated – siControl	cell line=T47D	passages=18-20	chip antibody=H190 Santa Cruz
SRX6058760,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"64017222,97.8,4.6,7718",GSM3884758: ChIP-PR - Progesterone – siControl; Homo sapiens; ChIP-Seq,source_name=ChIP-PR - Progesterone – siControl	cell line=T47D	passages=18-20	chip antibody=H190 Santa Cruz
SRX6058761,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"51676238,97.9,4.2,1617",GSM3884759: ChIP-PR - Untreated – siCEBPa; Homo sapiens; ChIP-Seq,source_name=ChIP-PR - Untreated – siCEBPa	cell line=T47D	passages=18-20	chip antibody=H190 Santa Cruz
SRX6058762,hg38,TFs and others,PGR,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"61165819,97.8,4.3,5746",GSM3884760: ChIP-PR - Progesterone – siCEBPa; Homo sapiens; ChIP-Seq,source_name=ChIP-PR - Progesterone – siCEBPa	cell line=T47D	passages=18-20	chip antibody=H190 Santa Cruz
SRX6068069,hg38,TFs and others,PGR,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","35407096,97.7,28.0,23983",GSM3890632: Proliferative rep1 PGR-ChIPseq; Homo sapiens; ChIP-Seq,"source_name=Proliferative rep1 PGR-ChIPseq	menstrual cycle phase=proliferative	tissue=endometrium/whole endometrium	chip antibody=Progesterone Receptor (Santa Cruz, sc-7208)"
SRX6068070,hg38,TFs and others,PGR,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","45908838,98.1,7.0,1581",GSM3890633: Midsecretory rep1 PGR-ChIPseq; Homo sapiens; ChIP-Seq,"source_name=Midsecretory rep1 PGR-ChIPseq	menstrual cycle phase=mid-secretory	tissue=endometrium/whole endometrium	chip antibody=Progesterone Receptor (Santa Cruz, sc-7208)"
SRX6068072,hg38,TFs and others,PGR,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","40881459,97.5,45.0,12091",GSM3890635: Proliferative rep2 PGR-ChIPseq; Homo sapiens; ChIP-Seq,"source_name=Proliferative rep2 PGR-ChIPseq	menstrual cycle phase=proliferative	tissue=endometrium/whole endometrium	chip antibody=Progesterone Receptor (Santa Cruz, sc-7208)"
SRX6068073,hg38,TFs and others,PGR,Uterus,Endometrium,"MeSH Description=The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.","40415205,97.9,32.2,30641",GSM3890636: Midsecretory rep2 PGR-ChIPseq; Homo sapiens; ChIP-Seq,"source_name=Midsecretory rep2 PGR-ChIPseq	menstrual cycle phase=mid-secretory	tissue=endometrium/whole endometrium	chip antibody=Progesterone Receptor (Santa Cruz, sc-7208)"
SRX6102122,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"173277064,94.1,31.6,110300",GSM3900496: HeLa shINTS11 dox r1 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa_shINTS11_dox_ATAC-Seq	cell line=HeLa	cell type=cervical adenocarcinoma	cell source=ATCC#CCL-2	modification=Tet-pLKO_shINTS11 stable cells
SRX6102123,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"212389651,91.0,20.4,85712",GSM3900497: HeLa shINTS11 dox r2 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa_shINTS11_dox_ATAC-Seq	cell line=HeLa	cell type=cervical adenocarcinoma	cell source=ATCC#CCL-2	modification=Tet-pLKO_shINTS11 stable cells
SRX6102124,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"187965131,91.6,22.3,84736",GSM3900498: HeLa shControl ctrl r1 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa_shControl_ctrl_ATAC-Seq	cell line=HeLa	cell type=cervical adenocarcinoma	cell source=ATCC#CCL-2	modification=Tet-pLKO_shControl stable cells
SRX6102125,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"215679839,90.0,35.3,102927",GSM3900499: HeLa shControl ctrl r2 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa_shControl_ctrl_ATAC-Seq	cell line=HeLa	cell type=cervical adenocarcinoma	cell source=ATCC#CCL-2	modification=Tet-pLKO_shControl stable cells
SRX6102126,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"157772966,91.8,20.7,115820",GSM3900500: HeLa shControl dox r1 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa_shControl_dox_ATAC-Seq	cell line=HeLa	cell type=cervical adenocarcinoma	cell source=ATCC#CCL-2	modification=Tet-pLKO_shControl stable cells
SRX6102127,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"157366334,92.1,21.7,125261",GSM3900501: HeLa shControl dox r2 ATAC-Seq; Homo sapiens; ATAC-seq,source_name=HeLa_shControl_dox_ATAC-Seq	cell line=HeLa	cell type=cervical adenocarcinoma	cell source=ATCC#CCL-2	modification=Tet-pLKO_shControl stable cells
SRX6366561,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23866655,85.8,22.2,25068",GSM3905442: h3k27ac p300 adjacent r1: H3K27ac P300 Adjacent rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Adjacent
SRX6366562,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23157826,65.7,19.4,17759",GSM3905443: h3k27ac p300 adjacent r2: H3K27ac P300 Adjacent rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Adjacent
SRX6366563,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21591045,82.7,17.3,21242",GSM3905444: h3k27ac p300 il1rn: H3K27ac P300 Control/IL1RN rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=IL1RN
SRX6366564,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"26965040,98.0,5.4,3348",GSM3905445: 4pI stringent: H3K27ac P300 Control/IL1RN rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=IL1RN
SRX6366565,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"17480566,77.4,8.7,6610",GSM3905446: h3k27ac p300 pool1: H3K27ac P300 Pool1 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Pool 1
SRX6366566,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21571199,98.0,17.1,2572",GSM3905447: 1p1 stringent: H3K27ac P300 Pool1 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Pool 1
SRX6366567,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18200182,81.3,8.5,11387",GSM3905448: h3k27ac p300 pool2: H3K27ac P300 Pool2 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Pool 2
SRX6366568,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"24646377,97.9,8.7,1957",GSM3905449: 2p2 stringent: H3K27ac P300 Pool2 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Pool 2
SRX6366569,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21043398,80.2,10.0,6710",GSM3905450: h3k27ac p300 pool3: H3K27ac P300 Pool3 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Pool 3
SRX6366570,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"29119825,98.1,6.4,2279",GSM3905451: 3p3 stringent: H3K27ac P300 Pool3 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-P300	targeted pools=Pool 3
SRX6366571,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"19334018,95.2,12.3,28955",GSM3905452: H3k27ac off il1rn stringent: H3K27ac VP16(10x) Adjacent rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Adjacent + IL1RN
SRX6366572,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"34281919,89.9,25.8,30594",GSM3905453: h3k27ac vp160 adjacent: H3K27ac VP16(10x) Adjacent rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Adjacent
SRX6366573,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"42604278,27.4,21.6,18478",GSM3905454: h3k27ac vp160 il1rn: H3K27ac VP16(10x) Control/IL1RN rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=IL1RN
SRX6366574,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"36651955,97.7,8.8,30827",GSM3905455: 8vI stringent: H3K27ac VP16(10x) Control/IL1RN rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=IL1RN
SRX6366575,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"24316777,86.3,26.0,23804",GSM3905456: h3k27ac vp160 pool1: H3K27ac VP16(10x) Pool1 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Pool 1
SRX6366576,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35544108,97.9,9.6,33740",GSM3905457: 5v1 stringent: H3K27ac VP16(10x) Pool1 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Pool 1
SRX6366577,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"19291309,80.3,10.3,20794",GSM3905458: h3k27ac vp160 pool2: H3K27ac VP16(10x) Pool2 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Pool 2
SRX6366578,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"25729042,97.8,10.2,33664",GSM3905459: 6v2 stringent: H3K27ac VP16(10x) Pool2 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Pool 2
SRX6366579,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22608636,7.7,1.4,2059",GSM3905460: h3k27ac vp160 pool3: H3K27ac VP16(10x) Pool3 rep1; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Pool 3
SRX6366580,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"26992747,97.6,8.3,26575",GSM3905461: 7v3 stringent: H3K27ac VP16(10x) Pool3 rep2; Homo sapiens; ChIP-Seq,source_name=Ishikawa Cell Line (endometrial carcinoma)	cell line=Ishikawa	cell type=endometrial carcinoma	antibody target=H3K27ac	activation construct=dCas9-VP16(10x)	targeted pools=Pool 3
SRX6413748,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41568239,97.1,6.1,2450",GSM3930420: MCF7-DMSO-ERA 1hr; Homo sapiens; ChIP-Seq,"source_name=MCF7_DMSO	cell line=MCF7	tissue source=Mammary gland, breast	cell type=derived from metastatic site; pleural effusion	treatment=DMSO	treatment time=for 1 hour	chip antibody=ERA (Estrogen Receptor α (D8H8) Rabbit mAb #8644, from CST)"
SRX6413749,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37268536,97.5,5.8,15009",GSM3930421: MCF7-Estrogen-ERA 1hr; Homo sapiens; ChIP-Seq,"source_name=MCF7_10 nM estrogen	cell line=MCF7	tissue source=Mammary gland, breast	cell type=derived from metastatic site; pleural effusion	treatment=10 nM estrogen	treatment time=for 1 hour	chip antibody=ERA (Estrogen Receptor α (D8H8) Rabbit mAb #8644, from CST)"
SRX6413750,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31445269,97.2,5.9,12629",GSM3930422: MCF7-OBHS-ERA 1hr; Homo sapiens; ChIP-Seq,"source_name=MCF7_20 uM OBHS	cell line=MCF7	tissue source=Mammary gland, breast	cell type=derived from metastatic site; pleural effusion	treatment=20 uM OBHS	treatment time=for 1 hour	chip antibody=ERA (Estrogen Receptor α (D8H8) Rabbit mAb #8644, from CST)"
SRX6427762,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"16399168,44.7,57.2,1821",GSM3936826: Hela-0 ATAC-seq; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=control
SRX6427763,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"14238979,35.5,52.5,528",GSM3936827: Hela-15 ATAC-seq; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=20ng/mL TNF-α for 15min
SRX6427764,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"15346039,49.9,55.5,2654",GSM3936828: Hela-30 ATAC-seq; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=20ng/mL TNF-α for 30min
SRX6427765,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"16850607,35.8,55.1,527",GSM3936829: Hela-60 ATAC-seq; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=20ng/mL TNF-α for 60min
SRX643281,hg38,TFs and others,ESR1,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"15494522,98.3,2.9,14979",GSM1423725: MCF10A HC20 MYC-ER ChIP-Seq; Homo sapiens; ChIP-Seq,"source_name=MCF10A MYC-ER cells, MYC-ER ChIP	cell line=MCF10A	stable expression=MYC-ER	chip antibody=anti-ER-alpha (HC20)"
SRX6457574,hg38,ATAC-Seq,ATAC-Seq,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"82615523,47.5,18.5,75229",GSM3946565: ATAC-seq KB; Homo sapiens; ATAC-seq,source_name=KB cells	treatment_1=none	treatment_2=none
SRX6457575,hg38,ATAC-Seq,ATAC-Seq,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"86340408,44.5,19.1,77566",GSM3946566: ATAC-seq KB IL1; Homo sapiens; ATAC-seq,source_name=KB cells	treatment_1=10ng/ml IL-1alpha for 1 h	treatment_2=none
SRX6457576,hg38,ATAC-Seq,ATAC-Seq,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"83998750,49.6,15.7,71749",GSM3946567: ATAC-seq KB 5Z; Homo sapiens; ATAC-seq,source_name=KB cells	treatment_1=none	treatment_2=1uM 5Z-7-oxozeaenol for 1 h
SRX6457577,hg38,ATAC-Seq,ATAC-Seq,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"74373299,42.2,14.0,51246",GSM3946568: ATAC-seq KB IL1 5Z; Homo sapiens; ATAC-seq,source_name=KB cells	treatment_1=10ng/ml IL-1alpha for 1 h	treatment_2=1uM 5Z-7-oxozeaenol for 1 h
SRX647365,hg38,TFs and others,ESR1,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"15462820,98.5,3.3,5352",GSM1429415: MCF10A HC20 MYC-ERVD OHT ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=MCF10A cells	cell line=MCF10A	tissue=mammary gland/breast	antibody=HC20	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody lot number=K1512
SRX647366,hg38,TFs and others,ESR1,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"15516792,98.2,3.8,543",GSM1429416: MCF10A HC20 MYC-ERVD control ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=MCF10A cells	cell line=MCF10A	tissue=mammary gland/breast	antibody=HC20	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody lot number=K1512
SRX647367,hg38,TFs and others,ESR1,Breast,MCF 10A,Primary Tissue=Breast|Tissue Diagnosis=Fibrocystic Disease,"15513606,98.3,2.5,1898",GSM1429417: MCF10A HC20 MYC-ER control ChIP-Seq; Homo sapiens; ChIP-Seq,source_name=MCF10A cells	cell line=MCF10A	tissue=mammary gland/breast	antibody=HC20	antibody manufacturer=Santa Cruz	antibody catalog number=sc-543	antibody lot number=K1512
SRX6582163,hg38,TFs and others,JUN,Epidermis,BJ-5ta,,"20566115,87.4,27.9,43943",GSM3970380: KI138 JUN BJ5ta; Homo sapiens; ChIP-Seq,source_name=BJ-5ta	lmna genotype=Wild type	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX6582164,hg38,TFs and others,JUN,Epidermis,BJ-5ta,,"21620003,87.8,20.8,43873",GSM3970381: KI141 JUN BJ5ta; Homo sapiens; ChIP-Seq,source_name=BJ-5ta	lmna genotype=Wild type	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX6582165,hg38,TFs and others,JUN,Epidermis,BJ-5ta,,"18683050,98.3,13.1,57593",GSM3970382: KI167 JUN BJ5ta; Homo sapiens; ChIP-Seq,source_name=BJ-5ta	lmna genotype=Wild type	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX6582171,hg38,TFs and others,JUN,Others,GM07492,,"29947749,98.9,58.0,62825",GSM3970388: KI609 JUN GM07492; Homo sapiens; ChIP-Seq,source_name=GM07492 normal fibroblast	lmna genotype=Wild type	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX6582172,hg38,TFs and others,JUN,Others,Fibroblasts,,"28632678,98.4,64.8,50462",GSM3970389: KI611 JUN AG11498; Homo sapiens; ChIP-Seq,source_name=AG11498 HGPS fibroblast	lmna genotype=LMNA G608G	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX6712576,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"52195104,97.9,7.3,49418",GSM4030498: ChIP-seq CTCF E2 MCF7; Homo sapiens; ChIP-Seq,source_name=Human breast cancers	cell line=MCF7	treatment=E2	chip antibody=ERalpha (HC20) Santa Cruz Biotechnology sc-543 (Lot# I0514)
SRX6712577,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"46822564,97.6,6.3,45908",GSM4030499: ChIP-seq CTCF Veh MCF7; Homo sapiens; ChIP-Seq,source_name=Human breast cancers	cell line=MCF7	treatment=Veh	chip antibody=ERalpha (HC20) Santa Cruz Biotechnology sc-543 (Lot# I0514)
SRX673709,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31360303,58.2,22.3,2896",GSM1469979: ERa ChIPseq Veh Exp1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=1hr treatment with vehicle control"
SRX673710,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"119841250,68.5,48.4,21110",GSM1469980: ERa ChIPseq E2 Exp1; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=1hr treatment with 100nM E2"
SRX673737,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20671653,95.6,6.6,468",GSM1470007: pERaS118 ChIPseq shCTL Veh Exp12; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-12915-R	treatment=shCTL, 1hr treatment with vehicle control"
SRX673738,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21386762,96.9,68.3,603",GSM1470008: pERaS118 ChIPseq shCTL E2 Exp12; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-12915-R	treatment=shCTL, 1hr treatment with 100nM E2"
SRX673739,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"49710350,97.2,16.6,966",GSM1470009: pERaS118 ChIPseq shRARs Veh Exp12; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-12915-R	treatment=shRARs, 1hr treatment with vehicle control"
SRX673740,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31958530,96.8,65.3,394",GSM1470010: pERaS118 ChIPseq shRARs E2 Exp12; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-12915-R	treatment=shRARs, 1hr treatment with 100nM E2"
SRX673741,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"19875951,96.0,12.0,3446",GSM1470011: ERa ChIPseq shCTL E2 Exp13; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=shCTL, 1hr treatment with 100nM E2"
SRX673742,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20445155,94.7,8.4,4126",GSM1470012: ERa ChIPseq shRARs E2 Exp13; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=shRARs, 1hr treatment with 100nM E2"
SRX673751,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24633019,35.8,9.6,1355",GSM1470021: ERa ChIPseq siCTL E2 Exp16; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=siCTL, 1hr treatment with 100nM E2"
SRX673752,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17815012,85.4,22.4,1944",GSM1470022: ERa ChIPseq siGATA3 E2 Exp16; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=siGATA3, 1hr treatment with 100nM E2"
SRX673753,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"59978179,91.5,7.9,8993",GSM1470023: ERa ChIPseq siCTL E2 Exp17; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=siCTL, 1hr treatment with 100nM E2"
SRX673754,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"30275236,89.2,11.3,1207",GSM1470024: ERa ChIPseq siFoxA1 E2 Exp17; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell description=beast cancer cell line	chip antibody or biotin-streptavidin pulldown of blrp-tagged proteins=Santa Cruz Biotech, SC-543	treatment=siFoxA1, 1hr treatment with 100nM E2"
SRX6757650,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"6335518,97.2,4.3,6719",GSM4044324: ERa ChIP-seq E2 treatment DTFF1 persistent site Rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells with PS deletion	treatments=Estradiol 1 hr	antibody=sc-8002 and ab32063	cell type=MCF7 cells with PS deletion
SRX6757651,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"59067651,97.5,3.4,3917",GSM4044325: ERa ChIP-seq E2 treatment DTFF1 persistent site Rep2; Homo sapiens; ChIP-Seq,source_name=MCF7 cells with PS deletion	treatments=Estradiol 1 hr	antibody=sc-8002 and ab32063	cell type=MCF7 cells with PS deletion
SRX6757656,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34869796,98.5,2.9,2398",GSM4044330: ERa ChIP-seq 7days stripping; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	treatments=7 days stripped cells	antibody=sc-8002 and ab32063	cell type=MCF7 cells
SRX6757657,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55146465,97.9,3.5,4531",GSM4044331: ERa ChIP-seq E2 treatment WT Rep1; Homo sapiens; ChIP-Seq,source_name=MCF7 cells	treatments=Estradiol 1 hr	antibody=sc-8002 and ab32063	cell type=MCF7 cells
SRX6777396,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"9291211,89.9,6.4,3522",GSM4054997: MCF7 TET2WT-E2 ER ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	genotype=wild type	chip antibody=anti-ERα, Cell Signaling Technology, 8644S"
SRX6777397,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"9106321,61.0,5.5,2566",GSM4054998: MCF7 TET2WT-EtOH ER ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	genotype=wild type	chip antibody=anti-ERα, Cell Signaling Technology, 8644S"
SRX6777399,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"10146291,55.5,7.1,2831",GSM4055000: MCF7 TET2KO-E2 ER ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	genotype=TET2 knockout	chip antibody=anti-ERα, Cell Signaling Technology, 8644S"
SRX6777400,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13801762,68.8,7.2,2870",GSM4055001: MCF7 TET2KO-EtOH ER ChIP-seq; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells	genotype=TET2 knockout	chip antibody=anti-ERα, Cell Signaling Technology, 8644S"
SRX6800703,hg38,TFs and others,JUN,Blood,CAR-T cells,,"39179370,79.7,11.1,1357","GSM4059674: HA only, replicate 1  [ha-1-jun-TGACCA S3]; Homo sapiens; ChIP-Seq","source_name=patient-derived CAR-T_HA only	cell type=patient-derived CAR-T	genotype/variation=Retroviral transduction with HA construct	growth protocol=T cell media + IL-2	chip antibody=JUN (Active Motif, #39309)"
SRX6800706,hg38,TFs and others,JUN,Blood,CAR-T cells,,"44848378,98.6,17.6,1148","GSM4059677: JUN-HA, replicate 1  [jun-1-inp-ACAGTG S4]; Homo sapiens; ChIP-Seq",source_name=patient-derived CAR-T_JUN-HA	cell type=patient-derived CAR-T	genotype/variation=Retroviral transduction with JUN-HA construct	growth protocol=T cell media + IL-2
SRX6800708,hg38,TFs and others,JUN,Blood,CAR-T cells,,"40936287,79.5,12.0,4332","GSM4059679: JUN-HA, replicate 1  [jun-1-jun-CAGATC S6]; Homo sapiens; ChIP-Seq","source_name=patient-derived CAR-T_JUN-HA	cell type=patient-derived CAR-T	genotype/variation=Retroviral transduction with JUN-HA construct	growth protocol=T cell media + IL-2	chip antibody=JUN (Active Motif, #39309)"
SRX6800709,hg38,TFs and others,JUN,Blood,CAR-T cells,,"35517907,98.6,8.5,1005","GSM4059680: JUN-HA, replicate 2  [jun-2-inp-TAGCTT S9]; Homo sapiens; ChIP-Seq",source_name=patient-derived CAR-T_JUN-HA	cell type=patient-derived CAR-T	genotype/variation=Retroviral transduction with JUN-HA construct	growth protocol=T cell media + IL-2
SRX6800711,hg38,TFs and others,JUN,Blood,CAR-T cells,,"33277050,85.4,9.7,3453","GSM4059682: JUN-HA, replicate 2  [jun-2-jun-CTTGTA S11]; Homo sapiens; ChIP-Seq","source_name=patient-derived CAR-T_JUN-HA	cell type=patient-derived CAR-T	genotype/variation=Retroviral transduction with JUN-HA construct	growth protocol=T cell media + IL-2	chip antibody=JUN (Active Motif, #39309)"
SRX6857964,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","68319021,89.4,2.9,3026","GSM4081675: Myometrial tissue, subject NP5 (ATAC-Seq); Homo sapiens; ATAC-seq",source_name=Myometrium	Stage=Nonpregnant at the proliferative phase	tissue=myometrial tissue
SRX6857965,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","159333552,0.0,2.3,1909","GSM4081676: Myometrial tissue, subject NP6 (ATAC-Seq); Homo sapiens; ATAC-seq",source_name=Myometrium	Stage=Nonpregnant at the proliferative phase	tissue=myometrial tissue
SRX6857966,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","106353539,90.5,13.8,32267","GSM4081677: Myometrial tissue, subject NP7 (ATAC-Seq); Homo sapiens; ATAC-seq",source_name=Myometrium	Stage=Nonpregnant at the proliferative phase	tissue=myometrial tissue
SRX6857967,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","91925832,82.7,21.0,28533","GSM4081678: Myometrial tissue, subject TP4 (ATAC-Seq); Homo sapiens; ATAC-seq",source_name=Myometrium	Stage=38-42 weeks estimated gestational age	tissue=myometrial tissue
SRX6857968,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","94519397,83.1,20.0,50939","GSM4081679: Myometrial tissue, subject TP3 (ATAC-Seq); Homo sapiens; ATAC-seq",source_name=Myometrium	Stage=38-42 weeks estimated gestational age	tissue=myometrial tissue
SRX6857969,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","62288771,90.2,6.6,11390","GSM4081680: Myometrial tissue, subject TP5 (ATAC-Seq); Homo sapiens; ATAC-seq",source_name=Myometrium	Stage=38-42 weeks estimated gestational age	tissue=myometrial tissue
SRX6857970,hg38,TFs and others,PGR,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","33058724,94.9,19.0,25325","GSM4081681: Myometrial tissue, subject NP1 (ChIP-Seq); Homo sapiens; ChIP-Seq","source_name=Myometrium	Stage=Nonpregnant at the proliferative phase	tissue=myometrial tissue	chip antibody=Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)"
SRX6857971,hg38,TFs and others,PGR,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","38276951,95.7,19.7,16373","GSM4081682: Myometrial tissue, subject NP2 (ChIP-Seq); Homo sapiens; ChIP-Seq","source_name=Myometrium	Stage=Nonpregnant at the proliferative phase	tissue=myometrial tissue	chip antibody=Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)"
SRX6857972,hg38,TFs and others,PGR,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","40271323,93.8,62.1,3807","GSM4081683: Myometrial tissue, subject TP1 (ChIP-Seq); Homo sapiens; ChIP-Seq","source_name=Myometrium	Stage=38-42 weeks estimated gestational age	tissue=myometrial tissue	chip antibody=Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)"
SRX6857973,hg38,TFs and others,PGR,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","42724026,85.0,65.1,3588","GSM4081684: Myometrial tissue, subject TP2 (ChIP-Seq); Homo sapiens; ChIP-Seq","source_name=Myometrium	Stage=38-42 weeks estimated gestational age	tissue=myometrial tissue	chip antibody=Anti-PGR antibody (sc-7208, Santa Cruz Biotechnology, Dallas, TX)"
SRX6860624,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43887390,97.4,8.0,1357",GSM4081967: T47D shCtrl 8hr ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=LT3GEPIR-shRenilla Luciferase dox inducible	chip antibody=Diagenode C15100061
SRX6860628,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43384957,97.5,9.6,1442",GSM4081971: T47D shRING1B 8hr ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=pLKO-tet-on-shRING1B dox-inducible	chip antibody=Diagenode C15100061
SRX6860636,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"42114060,98.1,11.0,2576",GSM4081957: T47D shCtrl 45min ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=LT3GEPIR-shRenilla Luciferase dox inducible	chip antibody=Diagenode C15100061
SRX6860641,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"41450599,98.2,11.0,2145",GSM4081962: T47D shRING1B 45min ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=pLKO-tet-on-shRING1B dox-inducible	chip antibody=Diagenode C15100061
SRX6860647,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36224720,96.4,8.8,1615",GSM4081976: T47D shCtrl 24hr ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=LT3GEPIR-shRenilla Luciferase dox inducible	chip antibody=Diagenode C15100061
SRX6860652,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"43452697,97.4,8.6,1516",GSM4081981: T47D shRING1B 24hr ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=pLKO-tet-on-shRING1B dox-inducible	chip antibody=Diagenode C15100061
SRX6860691,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"37895512,98.3,9.0,1145",GSM4081947: T47D shCtrl 0hr ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=LT3GEPIR-shRenilla Luciferase dox inducible	chip antibody=Diagenode C15100061
SRX6860696,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36718911,98.2,11.4,1114",GSM4081952: T47D shRING1B 0 ER chipseq; Homo sapiens; ChIP-Seq,source_name=T47D	cell line=T47D	cell type=Mammary gland ductal carcarcinoma epithelial cells derived from metastatic site	cell source=ATCC #HTB-133	modifications=pLKO-tet-on-shRING1B dox-inducible	chip antibody=Diagenode C15100061
SRX6910062,hg38,TFs and others,PGR,Uterus,Uterin leiomyoma,,"36535677,98.0,7.3,15180",GSM4097440: PT4 PGR ChIP; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Fresh frozen tissue	patient id=Patient 4	cell type=uterine leiomyoma	chip antibody=anti-PGR Santa Cruz (sc-7208X)
SRX6910063,hg38,TFs and others,PGR,Uterus,Uterin leiomyoma,,"40442263,97.2,6.9,23706",GSM4097441: PT5 PGR ChIP; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Fresh frozen tissue	patient id=Patient 5	cell type=uterine leiomyoma	chip antibody=anti-PGR Santa Cruz (sc-7208X)
SRX6910069,hg38,TFs and others,PGR,Uterus,Uterin leiomyoma,,"52614363,98.5,8.5,26975",GSM4097437: PT1 PGR ChIP; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Fresh frozen tissue	patient id=Patient 1	cell type=uterine leiomyoma	chip antibody=anti-PGR Santa Cruz (sc-7208X)
SRX6910070,hg38,TFs and others,PGR,Uterus,Uterin leiomyoma,,"46384273,84.8,5.6,3531",GSM4097438: PT2 PGR ChIP; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Fresh frozen tissue	patient id=Patient 2	cell type=uterine leiomyoma	chip antibody=anti-PGR Santa Cruz (sc-7208X)
SRX6910071,hg38,TFs and others,PGR,Uterus,Uterin leiomyoma,,"50223765,98.0,6.0,6422",GSM4097439: PT3 PGR ChIP; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Fresh frozen tissue	patient id=Patient 3	cell type=uterine leiomyoma	chip antibody=anti-PGR Santa Cruz (sc-7208X)
SRX6913740,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"63953904,94.3,40.3,18945",GSM4097398: H3K27Ac ChIP LSC merge; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Primary P0 cells	cell population=CD34+/CD49b+ Leiomyoma stem cell	cell type=uterine leiomyoma	chip antibody=H3K27Ac: Active Motif (39133)
SRX6913741,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"35795456,77.5,40.4,63615",GSM4097399: H3K27Ac ChIP LIC merge; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Primary P0 cells	cell population=CD34+/CD49b- Leiomyoma intermediate cell	cell type=uterine leiomyoma	chip antibody=H3K27Ac: Active Motif (39133)
SRX6913742,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"41299289,90.0,38.5,69277",GSM4097400: H3K27Ac ChIP LDC merge; Homo sapiens; ChIP-Seq,source_name=Primary uterine leiomyoma cells	tissue preparation=Primary P0 cells	cell population=CD34-/CD49b- Leiomyoma differentiated cell	cell type=uterine leiomyoma	chip antibody=H3K27Ac: Active Motif (39133)
SRX6944145,hg38,TFs and others,FOS,Blood,CD4+ T cells,,"11474056,96.4,66.8,246",GSM4106146: cFOS Act.5 h + GFP with fly DNA; Homo sapiens; ChIP-Seq,source_name=E5h_GFP_cFOS_060619_with_flyDNA	cell type=Primary naive CD4 T cells from peripheral blood	treatment=Act. 5 h with anti-CD3 and -CD28 antibodies	passages=Primary	donor=healthy donor	chip antibody=cFOS Santa Cruz Biotechnology #sc-7202	biowardrobe id=8041
SRX6944146,hg38,TFs and others,FOS,Blood,CD4+ T cells,,"11590247,93.1,81.0,148",GSM4106147: cFOS Act.5 h + A-FOS with fly DNA; Homo sapiens; ChIP-Seq,source_name=E5h_A-FOS_cFOS_060619_with_flyDNA	cell type=Primary naive CD4 T cells from peripheral blood	treatment=Act. 5 h with anti-CD3 and -CD28 antibodies	passages=Primary	donor=healthy donor	chip antibody=cFOS Santa Cruz Biotechnology #sc-7202	biowardrobe id=8042
SRX6944149,hg38,TFs and others,FOS,Blood,CD4+ T cells,,"20574913,58.2,96.5,69",GSM4106150: cFOS Naive with fly DNA; Homo sapiens; ChIP-Seq,source_name=Naive_cFOS_060619_with_flyDNA	cell type=Primary naive CD4 T cells from peripheral blood	treatment=No activation	passages=Primary	donor=healthy donor	chip antibody=cFOS Santa Cruz Biotechnology #sc-7202	biowardrobe id=8034
SRX6944150,hg38,TFs and others,FOS,Blood,CD4+ T cells,,"22446184,92.5,89.4,336",GSM4106151: cFOS Act.5 h with fly DNA; Homo sapiens; ChIP-Seq,source_name=E5h_cFOS_060619_with_flyDNA	cell type=Primary naive CD4 T cells from peripheral blood	treatment=Act. 5 h with anti-CD3 and -CD28 antibodies	passages=Primary	donor=healthy donor	chip antibody=cFOS Santa Cruz Biotechnology #sc-7202	biowardrobe id=8032
SRX6944151,hg38,TFs and others,FOS,Blood,CD4+ T cells,,"19109369,87.0,91.6,137",GSM4106152: cFOS Act.5 h with fly DNA without CD28; Homo sapiens; ChIP-Seq,source_name=A5h_cFOS_060619_with_flyDNA	cell type=Primary naive CD4 T cells from peripheral blood	treatment=Act. 5 h with anti-CD3 antibody	passages=Primary	donor=healthy donor	chip antibody=cFOS Santa Cruz Biotechnology #sc-7202	biowardrobe id=8033
SRX699737,hg38,TFs and others,JUN,Cardiovascular,HCASMC,,"66033270,90.2,12.1,46123",GSM1503219: JUN ChIPseq; Homo sapiens; ChIP-Seq,source_name=HCASMC Lonza 0000317155	cell type=coronary artery smooth muscle	chip antibody=JUN	chip antibody manufacturer and catalog number=Santa Cruz sc-1694
SRX7057542,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"43200247,98.2,8.6,1406",GSM4140462: PR T0 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from untreated cells
SRX7057543,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"54497436,97.4,9.3,1664",GSM4140463: PR R5 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 5min R5020-treated cells
SRX7057544,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"60235063,98.0,8.3,2969",GSM4140464: PR R30 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 30min R5020-treated cells
SRX7057545,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"43889449,98.6,8.9,2456",GSM4140465: PR 60 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 60min R5020-treated cells
SRX7057546,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"51619842,98.4,5.1,1134",GSM4140466: ER T0 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=ERalfa HC-20X/H184X (Santa Cruz)	treatment=ER-immunoprecipitated DNA from untreated cells
SRX7057547,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"58168061,98.2,4.9,1438",GSM4140467: ER E5 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=ERalfa HC-20X/H184X (Santa Cruz)	treatment=ER-immunoprecipitated DNA from 5min E2-treated cells
SRX7057548,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"58595500,98.4,5.8,3442",GSM4140468: ER E60 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=ERalfa HC-20X/H184X (Santa Cruz)	treatment=ER-immunoprecipitated DNA from 60min E2-treated cells
SRX7057549,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"50021725,98.2,6.3,3256",GSM4140469: ER E360 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=ERalfa HC-20X/H184X (Santa Cruz)	treatment=ER-immunoprecipitated DNA from 360min E2-treated cells
SRX7057551,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"70566965,97.3,8.0,1294",GSM4140471: FPR T0 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=exogenous PR overexpression	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from untreated cells
SRX7057552,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"76567614,97.5,6.2,2085",GSM4140472: FPR R5 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=exogenous PR overexpression	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 5min R5020-treated cells
SRX7057553,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"71557287,97.6,10.8,3823",GSM4140473: FPR R30 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=exogenous PR overexpression	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 30min R5020-treated cells
SRX7057554,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"74162422,97.7,9.3,3464",GSM4140474: FPR R60 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=exogenous PR overexpression	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 60min R5020-treated cells
SRX7057555,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"79417614,98.1,12.0,1206",GSM4140475: prePR T0 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from untreated cells
SRX7057556,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38284458,97.6,6.2,3161",GSM4140476: prePR R30 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 5min R5020-treated cells
SRX7057557,hg38,TFs and others,PGR,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38067717,95.9,9.1,5409",GSM4140477: prePR R60 ChIPseq; Homo sapiens; ChIP-Seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	cell modification=none	passages=20-26	cell type=epithelial-like	growth mode=adherent	chip antibody=PR H190 (Santa Cruz)	treatment=PR-immunoprecipitated DNA from 30min R5020-treated cells
SRX7057561,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20919761,52.2,21.1,15074",GSM4140481: ATAC T0; Homo sapiens; ATAC-seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	passages=20-26	cell type=epithelial-like	growth mode=adherent	treatment=untreated Ishikawa cells
SRX7057562,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"19636241,51.2,13.4,13776",GSM4140482: ATAC R60; Homo sapiens; ATAC-seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	passages=20-26	cell type=epithelial-like	growth mode=adherent	treatment=60min R5020-treated Ishikawa cells
SRX7057563,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"21842981,51.8,19.9,16201",GSM4140483: ATAC E60; Homo sapiens; ATAC-seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	passages=20-26	cell type=epithelial-like	growth mode=adherent	treatment=60min E2-treated Ishikawa cells
SRX7057564,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23523240,38.1,16.3,10251",GSM4140484: ATAC preT0; Homo sapiens; ATAC-seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	passages=20-26	cell type=epithelial-like	growth mode=adherent	treatment=12h E2-pretreated Ishikawa cells
SRX7057565,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"27334610,38.8,19.8,14432",GSM4140485: ATAC preR60; Homo sapiens; ATAC-seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	passages=20-26	cell type=epithelial-like	growth mode=adherent	treatment=60min R5020-treated 12h E2-pretreated Ishikawa cells
SRX7057566,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"45417387,45.8,22.8,24539",GSM4140486: ATAC preE60; Homo sapiens; ATAC-seq,source_name=endometrial adenocarcinoma	disease state=endometrial adenocarcinoma	cell line=Ishikawa	passages=20-26	cell type=epithelial-like	growth mode=adherent	treatment=60min E2-treated 12h E2-pretreated Ishikawa cells
SRX7061820,hg38,TFs and others,MED12,Blood,SEM,Primary Tissue=Blood|Tissue Diagnosis=Leukemia,"27471513,92.9,16.6,40846",GSM4141658: SEM MED12; Homo sapiens; ChIP-Seq,source_name=MED12 ChIP-seq in SEM cells	cell line=Leukemia cell line (SEM)	treatment=N/A	cell type=Paediatric pro B-cell line derived from ALL with t(4;11)(q21;q23) translocation	chip antibody=MED12
SRX7071213,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","40537176,97.7,15.8,68634",GSM4143965: HUtSMC-crAP-1-H3K27Ac-Rep-1; Homo sapiens; ChIP-Seq,"source_name=Human uterine smooth muscle cells (HUtSMCs)	genotype=AP-1 depleted	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 14517014)"
SRX7071214,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","38198173,97.4,14.5,63231",GSM4143966: HUtSMC-crAP-1-H3K27Ac-Rep-2; Homo sapiens; ChIP-Seq,"source_name=Human uterine smooth muscle cells (HUtSMCs)	genotype=AP-1 depleted	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 14517014)"
SRX7071215,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","45904490,97.7,17.3,74312",GSM4143967: HUtSMC-crAP-1-H3K27Ac-Rep-3; Homo sapiens; ChIP-Seq,"source_name=Human uterine smooth muscle cells (HUtSMCs)	genotype=AP-1 depleted	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 14517014)"
SRX7071216,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","43285841,97.6,15.9,67284",GSM4143968: HUtSMC-crCtrl-H3K27Ac-Rep-1; Homo sapiens; ChIP-Seq,"source_name=Human uterine smooth muscle cells (HUtSMCs)	genotype=control	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 14517014)"
SRX7071217,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","40674842,97.5,16.9,73755",GSM4143969: HUtSMC-crCtrl-H3K27Ac-Rep-2; Homo sapiens; ChIP-Seq,"source_name=Human uterine smooth muscle cells (HUtSMCs)	genotype=control	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 14517014)"
SRX7071218,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","38054984,97.6,14.3,66867",GSM4143970: HUtSMC-crCtrl-H3K27Ac-Rep-3; Homo sapiens; ChIP-Seq,"source_name=Human uterine smooth muscle cells (HUtSMCs)	genotype=control	tissue=Myometrium	chip antibody=H3K27Ac (Active motif, cat # 39685, clone 0309, lot # 14517014)"
SRX717853,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"31819639,98.7,16.1,51615",GSM1517089: H3K27ac DMSO; Homo sapiens; ChIP-Seq,"source_name=HeLa B2 cells	cell line=HeLa	treatment protocol=none	chip antibody=H3K27ac (C15410196, Diagenode)"
SRX717854,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"25633768,98.4,16.5,40441",GSM1517090: H3K27ac TA+TNFα; Homo sapiens; ChIP-Seq,"source_name=HeLa B2 cells	cell line=HeLa	treatment protocol=1µM of Triamcinolonacetonide (T6501, Sigma-Aldrich) with 10ng/ml Tumor necrosis factor a (T0157, Sigma-Aldrich) for the last 1 hour.	chip antibody=H3K27ac (C15410196, Diagenode)"
SRX7277179,hg38,TFs and others,JUN,Others,Fibroblasts,,"26880588,76.6,67.8,9573",GSM4204853: KI804 JUN AG11498; Homo sapiens; ChIP-Seq,source_name=AG11498 HGPS fibroblast	lmna genotype=LMNA G608G	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX7277180,hg38,TFs and others,JUN,Others,GM07492,,"34898343,87.6,68.6,33970",GSM4204854: KI805 JUN GM07492; Homo sapiens; ChIP-Seq,source_name=GM07492 normal fibroblast	lmna genotype=Wild type	transgene=No	cell sorting=No sorting	antibody=anti-Jun (Santa Cruz H-79 sc-1694)
SRX7282934,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"87047119,99.3,5.6,5162",GSM4209184: ZR-75-1 ER ChIP E2 consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=ZR-75-1	passages=14-16 (where replicates represent sequential passages)	chip antibody=ER (Millipore 06-935)	treatment=E2
SRX7282935,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"86436142,99.3,5.7,5313",GSM4209186: ZR-75-1 ER ChIP E2+Bic consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=ZR-75-1	passages=14-16 (where replicates represent sequential passages)	chip antibody=ER (Millipore 06-935)	treatment=E2+Bic
SRX7282936,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"86300157,99.3,5.8,4857",GSM4209189: ZR-75-1 ER ChIP E2+DHT consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=ZR-75-1	passages=14-16 (where replicates represent sequential passages)	chip antibody=ER (Millipore 06-935)	treatment=E2+DHT
SRX730425,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"54610929,73.9,19.6,1561",GSM1523056: ERa-EtOH repeat1 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=beast cancer cell line	cell line=MCF7	chip antibody=ERa	treatment=1hr with ethanol, crosslinked with 1% formaldehyde"
SRX730426,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41014965,84.0,36.0,6929",GSM1523057: ERa-E2 repeat1 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=beast cancer cell line	cell line=MCF7	chip antibody=ERa	treatment=1hr with 100nM E2, crosslinked with 1% formaldehyde"
SRX730450,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16099944,94.2,25.9,12774",GSM1523081: ERa-E2-siCTL repeat1 ChIPSeq (v.s. ERa-E2-siNCAPG); Homo sapiens; ChIP-Seq,"source_name=beast cancer cell line	cell line=MCF7	chip antibody=ERa	treatment=cells transfected with siCTL, and 1hr with 100nM E2, double crosslinked"
SRX730451,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16144928,78.1,12.2,6804",GSM1523082: ERa-E2-siNCAPG ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=beast cancer cell line	cell line=MCF7	chip antibody=ERa	treatment=cells transfected with siNCAPG, and 1hr with 100nM E2, double crosslinked"
SRX730452,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38080042,96.0,2.2,2095",GSM1523083: ERa-E2-siCTL repeat2 ChIPSeq (v.s. ERa-E2-siNCAPD3/H2); Homo sapiens; ChIP-Seq,"source_name=beast cancer cell line	cell line=MCF7	chip antibody=ERa	treatment=cells transfected with siCTL, and 1hr with 100nM E2, double crosslinked"
SRX730453,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"41550843,96.6,2.5,2924",GSM1523084: ERa-E2-siNCAPD3/H2 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=beast cancer cell line	cell line=MCF7	chip antibody=ERa	treatment=cells transfected with siNCAPD3 and H2 together, and 1hr with 100nM E2, double crosslinked"
SRX7405963,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"82143158,99.3,5.1,2189",GSM4223986: ZR-75-1 ER ChIP Veh consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=ZR-75-1	passages=14-16 (where replicates represent sequential passages)	chip antibody=ER (Millipore 06-935)	treatment=Veh
SRX7405964,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"87279495,99.2,5.5,2298",GSM4223987: ZR-75-1 ER ChIP Bic consensus; Homo sapiens; ChIP-Seq,source_name=Breast cancer cell line	cell line=ZR-75-1	passages=14-16 (where replicates represent sequential passages)	chip antibody=ER (Millipore 06-935)	treatment=Bic
SRX7415660,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","31029736,98.6,9.2,5532",GSM4225326: pt1 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=1	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415664,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"31218293,98.2,6.6,1685",GSM4225330: pt1 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=1	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415668,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","31044848,97.9,6.7,3342",GSM4225366: pt6 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=6	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415672,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"35903310,98.2,7.1,485",GSM4225370: pt6 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=6	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415676,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","43232393,98.2,8.6,7573",GSM4225374: pt7 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=7	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415680,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"43308515,98.4,7.5,1606",GSM4225378: pt7 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=7	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415684,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","17541704,99.2,5.7,911",GSM4225382: pt8 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=8	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415688,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"13645194,99.1,4.5,245",GSM4225386: pt8 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=8	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415692,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","29535303,98.1,6.0,472",GSM4225390: pt9 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=9	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415696,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"30418625,98.1,5.9,919",GSM4225394: pt9 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=9	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415700,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","29810283,98.3,7.5,1418",GSM4225398: pt10 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=10	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415704,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"27436962,98.4,7.8,4700",GSM4225402: pt10 1 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=10	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415708,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","25622698,99.0,6.0,2057",GSM4225406: pt11 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=11	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415712,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"26585464,98.9,7.7,7521",GSM4225410: pt11 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=11	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415716,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","31336048,98.7,6.7,498",GSM4225414: pt12 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=12	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415720,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"31405215,98.7,8.1,5585",GSM4225418: pt12 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=12	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415724,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","25167404,98.0,6.1,2317",GSM4225422: pt13 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=13	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415728,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"25258782,97.9,5.6,1739",GSM4225426: pt13 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=13	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415732,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","22552701,98.7,6.8,1799",GSM4225430: pt14 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=14	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415736,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"28768446,98.7,8.1,749",GSM4225434: pt14 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=14	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415740,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","16411589,98.9,5.5,1931",GSM4225438: pt15 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=15	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415744,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"17373394,98.7,7.0,2264",GSM4225442: pt15 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=15	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415748,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","24473725,98.7,6.9,1785",GSM4225446: pt16 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=16	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415752,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"29426864,98.7,8.0,4344",GSM4225450: pt16 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=16	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415756,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","28056563,99.1,6.8,5504",GSM4225454: pt17 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=17	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415760,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"25576957,99.0,7.4,7433",GSM4225458: pt17 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=17	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415764,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","23195144,98.7,7.5,5245",GSM4225462: pt18 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=18	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415768,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"23237969,98.7,6.7,1238",GSM4225466: pt18 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=18	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415772,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","20165558,99.0,6.8,905",GSM4225470: pt19 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=19	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415776,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"27674681,99.0,8.1,425",GSM4225474: pt19 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=19	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415780,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","29726020,98.5,5.7,731",GSM4225478: pt20 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=20	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415784,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"19375552,98.5,5.4,805",GSM4225482: pt20 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=20	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415788,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","44524560,98.1,9.2,5642",GSM4225486: pt21 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=21	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415792,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"16096285,98.5,5.9,1199",GSM4225490: pt21 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=21	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415796,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"24379826,98.6,5.4,932",GSM4225494: pt22 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=22	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415800,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"30960928,98.1,8.0,4852",GSM4225498: pt23 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=23	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415804,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"23912115,98.5,6.4,6628",GSM4225502: pt24 1 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=24	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415808,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"30223077,98.0,6.3,1435",GSM4225506: pt24 2 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=24	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415812,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"26232919,98.4,7.3,1574",GSM4225510: pt25 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=25	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415816,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"28759070,98.0,7.4,7823",GSM4225514: pt26 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=26	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415820,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","26507527,98.8,5.8,500",GSM4225334: pt2 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=2	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415824,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"20333871,98.6,4.9,263",GSM4225338: pt2 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=2	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415828,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"21257545,98.2,7.4,6604",GSM4225518: pt10 2 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=10	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415832,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","37392342,98.7,7.8,1346",GSM4225342: pt3 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=3	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415836,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"36809780,98.7,7.8,1410",GSM4225346: pt3 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=3	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415840,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","28322358,98.8,6.9,3145",GSM4225350: pt4 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=4	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415844,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"27280299,98.7,6.1,872",GSM4225354: pt4 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=4	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415848,hg38,Histone,H3K27ac,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","26993814,98.6,7.0,8318",GSM4225358: pt5 myo H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine myometrium	patient id=5	disease condition=myometrium	chip antibody=Active motif, 39133"
SRX7415852,hg38,Histone,H3K27ac,Uterus,Uterin leiomyoma,,"21260093,98.4,6.2,4707",GSM4225362: pt5 leio H3K27ac; Homo sapiens; ChIP-Seq,"source_name=Uterine leiomyoma	patient id=5	disease condition=leiomyoma	chip antibody=Active motif, 39133"
SRX7415908,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","47414571,95.7,7.5,5765",GSM4225561: pt3 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=3	condition=myometrium
SRX7415909,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"44447620,94.7,6.5,574",GSM4225562: pt3 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=3	condition=leiomyoma
SRX7415910,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","47955614,94.5,4.6,674",GSM4225563: pt4 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=4	condition=myometrium
SRX7415911,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"37654981,94.1,4.8,4641",GSM4225564: pt4 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=4	condition=leiomyoma
SRX7415912,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","37780695,95.9,5.1,3637",GSM4225565: pt5 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=5	condition=myometrium
SRX7415913,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"50230826,94.9,11.5,17213",GSM4225566: pt5 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=5	condition=leiomyoma
SRX7415914,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","45878896,93.7,12.1,17554",GSM4225567: pt6 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=6	condition=myometrium
SRX7415915,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"50310330,94.0,14.8,9605",GSM4225568: pt6 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=6	condition=leiomyoma
SRX7415916,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","53487336,93.5,5.8,752",GSM4225569: pt7 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=7	condition=myometrium
SRX7415917,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"56274901,94.2,6.0,683",GSM4225570: pt7 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=7	condition=leiomyoma
SRX7415918,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","62622322,94.8,7.7,6476",GSM4225571: pt8 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=8	condition=myometrium
SRX7415919,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"52611096,94.8,5.8,2061",GSM4225572: pt8 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=8	condition=leiomyoma
SRX7415920,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","56921470,94.8,5.1,2279",GSM4225573: pt11 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=11	condition=myometrium
SRX7415921,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"92565281,95.0,10.7,15132",GSM4225574: pt11 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=11	condition=leiomyoma
SRX7415922,hg38,ATAC-Seq,ATAC-Seq,Uterus,Myometrium,"MeSH Description=The smooth muscle coat of the uterus, which forms the main mass of the organ.","44835255,94.2,6.5,6120",GSM4225575: pt12 myo ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine myometrium	patient id=12	condition=myometrium
SRX7415923,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterin leiomyoma,,"55130482,94.9,8.3,8941",GSM4225576: pt12 leio ATACseq; Homo sapiens; ATAC-seq,source_name=Uterine leiomyoma	patient id=12	condition=leiomyoma
SRX7427506,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"55315340,94.0,25.2,13164",GSM4230210: MCF7 minusDOX Veh ER-ChIP; Homo sapiens; ChIP-Seq,"source_name=MCF7_minusDOX_Veh_ER-ChIP	cell type=Luminal breast carcinoma epithelial MCF-7 cells	cell subtype=Doxycycline inducible NF1 knockdown model	cell line=MCF7	condition=Hormone-deprived media	chip antibody=ER (Santa Cruz, sc-8002, clone F-10)"
SRX7427508,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"52174708,98.4,31.2,24325",GSM4230212: MCF7 minusDOX E2 ER-ChIP; Homo sapiens; ChIP-Seq,"source_name=MCF7_minusDOX_E2_ER-ChIP	cell type=Luminal breast carcinoma epithelial MCF-7 cells	cell subtype=Doxycycline inducible NF1 knockdown model	cell line=MCF7	condition=Hormone-deprived media + E2	chip antibody=ER (Santa Cruz, sc-8002, clone F-10)"
SRX7427510,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"51947883,97.2,29.0,23290",GSM4230214: MCF7 plusDOX Veh ER-ChIP; Homo sapiens; ChIP-Seq,"source_name=MCF7_plusDOX_Veh_ER-ChIP	cell type=Luminal breast carcinoma epithelial MCF-7 cells	cell subtype=Doxycycline inducible NF1 knockdown model	cell line=MCF7	condition=Hormone-deprived media	chip antibody=ER (Santa Cruz, sc-8002, clone F-10)"
SRX7427512,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"62221791,97.5,45.5,44150",GSM4230216: MCF7 plusDOX E2 ER-ChIP; Homo sapiens; ChIP-Seq,"source_name=MCF7_plusDOX_E2_ER-ChIP	cell type=Luminal breast carcinoma epithelial MCF-7 cells	cell subtype=Doxycycline inducible NF1 knockdown model	cell line=MCF7	condition=Hormone-deprived media + E2	chip antibody=ER (Santa Cruz, sc-8002, clone F-10)"
SRX747775,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21431127,94.1,28.0,738",GSM1534720: ChIP-seq ER Vehicle rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_Vehicle	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=Vehicle	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747776,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31176088,93.4,29.3,860",GSM1534721: ChIP-seq ER Vehicle rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_Vehicle	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=Vehicle	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747777,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24321992,95.9,26.0,12046",GSM1534722: ChIP-seq ER E2 rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_E2	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747778,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25988693,94.1,40.8,13623",GSM1534723: ChIP-seq ER E2 rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_E2	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747779,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26413290,96.3,28.6,557",GSM1534724: ChIP-seq ER TNF rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747780,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26733296,93.7,34.7,853",GSM1534725: ChIP-seq ER TNF rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747781,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24212500,96.5,34.6,9287",GSM1534726: ChIP-seq ER E2+TNF rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_E2+TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2+TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747782,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16016021,93.9,18.8,11615",GSM1534727: ChIP-seq ER E2+TNF rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_E2+TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2+TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747801,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18055284,97.2,49.4,12027",GSM1534746: ChIP-seq ER siCTRL E2+TNF rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_siCTRL_E2+TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2+TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747802,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"24249051,97.4,83.8,6395",GSM1534747: ChIP-seq ER siCTRL E2+TNF rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_siCTRL_E2+TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2+TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747805,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26991740,98.0,38.1,12474",GSM1534750: ChIP-seq ER siFOXA1 E2+TNF rep1; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_siFOXA1_E2+TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2+TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX747806,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28753197,97.6,61.4,5209",GSM1534751: ChIP-seq ER siFOXA1 E2+TNF rep2; Homo sapiens; ChIP-Seq,source_name=ChIP-seq_ER_siFOXA1_E2+TNF	cell line=MCF-7	cell type=ER Positive Breast Cancer Cells	treatment=E2+TNFa	chip antibody=ER alpha (rabbit polyclonal generated in the Kraus Lab)
SRX7498520,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ca Ski,Primary Tissue=Cervix|Tissue Diagnosis=Carcinoma,"46485702,52.9,4.2,43477",GSM4249094: ATAC-seq Caski; Homo sapiens; ATAC-seq,source_name=Caski	cell line=Caski	chip antibody=n/a	sequencing type=Paired
SRX7498523,hg38,ATAC-Seq,ATAC-Seq,Uterus,SiHa,Primary Tissue=Cervix|Tissue Diagnosis=Carcinoma Squamous Cell,"70518402,61.0,5.4,80638",GSM4249097: ATAC-seq SiHa; Homo sapiens; ATAC-seq,source_name=SiHa	cell line=SiHa	chip antibody=n/a	sequencing type=Paired
SRX7509272,hg38,Histone,H3K27ac,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","44688510,95.0,4.0,32432",GSM4247275: Histone ChIP-seq from uterus (ENCLB197BQD); Homo sapiens; ChIP-Seq,"sample_type=tissue	tissue=uterus	sex=female	dev_stage=adult	age=51 year	donor ID=ENCDO271OUW	lab=Bradley Bernstein, Broad"
SRX7509273,hg38,Histone,H3K27ac,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","13133678,98.0,2.4,10569",GSM4247276: Histone ChIP-seq from uterus (ENCLB785VDS); Homo sapiens; ChIP-Seq,"sample_type=tissue	tissue=uterus	sex=female	dev_stage=adult	age=51 year	donor ID=ENCDO271OUW	lab=Bradley Bernstein, Broad"
SRX7540321,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20301672,94.2,6.7,616",GSM4259524: MCF7 EtOH siCTL ER-a ChIP-Seq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=human breast cancer cell line	treatment=EtOH 60 mins,siCTL	antibody=Era,Santa Cruz,sc-543"
SRX7540322,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"34583784,98.6,8.2,5741",GSM4259525: MCF7 E2 siCTL ER-a ChIP-Seq; Homo sapiens; ChIP-Seq,"source_name=MCF7	cell line=MCF7	cell type=human breast cancer cell line	treatment=E2 60 mins,siCTL	antibody=Era,Santa Cruz,sc-543"
SRX7544087,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"35073088,95.5,12.2,27798",GSM4260324: WTIshikawa MilliER E2; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa	chip antibody=Millipore ERalpha (06-935)	treatment=1 hr 10nM E2
SRX7544088,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"17308077,91.0,7.5,18767",GSM4260325: ETV4KO1 MilliER E2; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa ETV4 KO clone 1	chip antibody=Millipore ERalpha (06-935)	treatment=1 hr 10nM E2
SRX7544089,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28753231,95.2,9.2,23787",GSM4260326: ETV4KO2 MilliER E2; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa ETV4 KO clone 2	chip antibody=Millipore ERalpha (06-935)	treatment=1 hr 10nM E2
SRX7544090,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"27574233,97.0,21.8,29786",GSM4260327: siNTC 72hr ER; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2 and 72 hours non-targeting siRNA
SRX7544091,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"26384237,96.7,24.2,31889",GSM4260328: siNTC 96hr ER; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2 and 96 hours non-targeting siRNA
SRX7544092,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28854258,97.2,24.1,29674",GSM4260329: siETV4 72hr ER; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2 and 72 hours ETV4 targeting siRNA
SRX7544093,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"15729495,90.5,9.9,7695",GSM4260330: siETV4 96hr ER; Homo sapiens; ChIP-Seq,source_name=Endometrioid adenocarcinoma cell line	cell line=Ishikawa	chip antibody=Santa Cruz ERalpha (HC-20)	treatment=1 hr 10nM E2 and 96 hours ETV4 targeting siRNA
SRX7624156,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25898362,96.1,16.1,71436",ER alpha ChIP-Seq of MCF-7 breast cancer cells replicate 1,"isolate=isolated from a 69 years female	age=69	biomaterial_provider=Sigma Aldrich	sex=female	tissue=mammary gland, breast	cell_line=MCF-7	cell_type=breast adenocarcinoma cells	treatment=none	replicate=biological replicate 1	antibody=ER alpha"
SRX7624157,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"56133221,96.3,24.8,100966",ER alpha ChIP-Seq of MCF-7 breast cancer cells replicate 2,"isolate=isolated from a 69 years female	age=69	biomaterial_provider=Sigma Aldrich	sex=female	tissue=mammary gland, breast	cell_line=MCF-7	cell_type=breast adenocarcinoma cells	treatment=none	replicate=biological replicate 2	antibody=ER alpha"
SRX7624161,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28421166,95.1,19.4,33190",ER alpha ChIP-Seq of T47D breast cancer cells replicate 1,"isolate=isolated from a 54 years female	age=54	biomaterial_provider=University of Debrecen, Ivan Uray	sex=female	tissue=mammary gland, breast	cell_line=T47D	cell_type=breast adenocarcinoma cells	treatment=none	replicate=biological replicate 1	antibody=ER alpha"
SRX7624162,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"25113717,95.1,18.9,32867",ER alpha ChIP-Seq of T47D breast cancer cells replicate 1,"isolate=isolated from a 54 years female	age=54	biomaterial_provider=University of Debrecen, Ivan Uray	sex=female	tissue=mammary gland, breast	cell_line=T47D	cell_type=breast adenocarcinoma cells	treatment=none	replicate=biological replicate 2	antibody=ER alpha"
SRX7760063,hg38,TFs and others,FOS,Pancreas,CFPAC-1,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma Ductal,"48626897,97.8,5.5,25040",GSM4322506: CFPAC1.ChIP.FOS.Rep1; Homo sapiens; ChIP-Seq,source_name=Pancreatic Ductal Adenocarcinoma (PDAC) cell line	cell type=CFPAC1 clonal cell line	antibody=Anti-FOS (Antibody Sigma HPA018531 - Lot E106326 )
SRX7760064,hg38,TFs and others,FOS,Pancreas,CFPAC-1,Primary Tissue=Pancreas|Tissue Diagnosis=Adenocarcinoma Ductal,"45436077,97.0,6.6,28266",GSM4322507: CFPAC1.ChIP.FOS.Rep2; Homo sapiens; ChIP-Seq,source_name=Pancreatic Ductal Adenocarcinoma (PDAC) cell line	cell type=CFPAC1 clonal cell line	antibody=Anti-FOS (Antibody Sigma HPA018531 - Lot E106326 )
SRX7846776,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28002454,98.7,1.7,2302",GSM4378260: Chip-seq of ERα in MCF-7 cells stimulated for 30 min with E2 and pretreated with vehicle; Homo sapiens; ChIP-Seq,source_name=ERα 30 min E2 Vehicle	cell line=MCF-7
SRX7846777,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29574615,98.7,1.7,1188",GSM4378261: Chip-seq of ERα in MCF-7 cells stimulated for 30 min with E2 and pretreated with FEN1 inhibitor; Homo sapiens; ChIP-Seq,source_name=ERα 30 min E2 FEN1 inhibitor	cell line=MCF-7
SRX7846778,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18623813,98.0,1.6,8034",GSM4378262: Chip-seq of ERα in proliferating MCF-7 cells treated with vehicle; Homo sapiens; ChIP-Seq,source_name=ERα proliferating vehicle	cell line=MCF-7
SRX7846779,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20017342,98.0,1.3,2282",GSM4378263: Chip-seq of ERα in proliferating MCF-7 cells treated with FEN1 inhibitor; Homo sapiens; ChIP-Seq,source_name=ERα proliferating FEN1 inhibitor	cell line=MCF-7
SRX792932,hg38,TFs and others,ESR1,Breast,LY2,,"29778303,98.6,9.0,23971",GSM1556928: ER LY2 Veh 01; Homo sapiens; ChIP-Seq,source_name=LY2 Breast Cancer Cell Line	treatment=Untreated	cell line=LY2	chip antibody=ER
SRX792933,hg38,TFs and others,ESR1,Breast,LY2,,"33179871,99.0,20.5,51267",GSM1556929: ER LY2 Veh 02; Homo sapiens; ChIP-Seq,source_name=LY2 Breast Cancer Cell Line	treatment=Untreated	cell line=LY2	chip antibody=ER
SRX7944482,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"29829418,98.0,62.6,26326",GSM4419143: ATAC DMSO C1-5; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=DMSO 1hr
SRX7944483,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23861768,97.8,59.8,25799",GSM4419144: ATAC DMSO C1-8; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=DMSO 1hr
SRX7944484,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"25928248,97.6,50.8,14626",GSM4419145: ATAC DMSO C2-14; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=DMSO 1hr
SRX7944485,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"27964202,98.1,58.2,25716",GSM4419146: ATAC DMSO C2-3; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=DMSO 1hr
SRX7944486,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"43913878,97.7,73.7,17195",GSM4419147: ATAC DMSO M1-66; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=DMSO 1hr
SRX7944487,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28940816,97.6,56.3,14407",GSM4419148: ATAC DMSO M1-91; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=DMSO 1hr
SRX7944488,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38435316,97.8,72.0,23220",GSM4419149: ATAC DMSO M2-3; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=DMSO 1hr
SRX7944489,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"26135076,97.7,59.4,17094",GSM4419150: ATAC DMSO M2-5; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=DMSO 1hr
SRX7944490,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23500720,97.6,50.4,9607",GSM4419151: ATAC E2 C1-5; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=10nM E2 1 hr
SRX7944491,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"15161725,97.6,59.1,13388",GSM4419152: ATAC E2 C1-8; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=10nM E2 1 hr
SRX7944492,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18925269,97.6,59.7,15351",GSM4419153: ATAC E2 C2-14; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=10nM E2 1 hr
SRX7944493,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"24369600,97.7,49.8,12537",GSM4419154: ATAC E2 C2-3; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=10nM E2 1 hr
SRX7944494,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"66014558,96.8,78.9,22508",GSM4419155: ATAC E2 M1-66; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=10nM E2 1 hr
SRX7944495,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"32028169,97.5,54.0,14654",GSM4419156: ATAC E2 M1-91; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=10nM E2 1 hr
SRX7944496,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"44372980,97.7,70.1,23090",GSM4419157: ATAC E2 M2-3; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=10nM E2 1 hr
SRX7944497,hg38,ATAC-Seq,ATAC-Seq,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"34903585,96.8,59.5,25785",GSM4419158: ATAC E2 M2-5; Homo sapiens; ATAC-seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=10nM E2 1 hr
SRX7944498,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"14002914,88.0,22.5,17612",GSM4419159: ER ChIP E2 C1-12; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944499,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"13791546,86.0,14.7,15411",GSM4419160: ER ChIP E2 C1-5; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944500,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"19536752,94.7,16.6,19952",GSM4419161: ER ChIP E2 C2-14; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944501,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"14197391,88.3,21.0,20544",GSM4419162: ER ChIP E2 C2-3; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944502,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18194602,98.5,18.6,11829",GSM4419163: ER ChIP E2 M1-66; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944503,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"13295036,85.7,16.9,10913",GSM4419164: ER ChIP E2 M1-9-1; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944504,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"14724106,90.1,20.6,16732",GSM4419165: ER ChIP E2 M2-3; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944505,hg38,TFs and others,ESR1,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"13477208,83.7,16.9,14034",GSM4419166: ER ChIP E2 M2-5; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=10nM E2 1hr	antibody target=Estrogen Receptor alpha
SRX7944506,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"28609243,98.8,19.1,38701",GSM4419167: h3k27ac ChIP DMSO C1-5; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944507,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"18561688,93.2,25.3,24434",GSM4419168: h3k27ac ChIP DMSO C1-8; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944508,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"41194882,99.1,18.2,44190",GSM4419169: h3k27ac ChIP DMSO C2-14; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944509,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"43807021,99.0,18.9,37965",GSM4419170: h3k27ac ChIP DMSO C2-3; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944510,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"19130012,93.4,24.2,20183",GSM4419171: h3k27ac ChIP DMSO M1-66; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944511,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"34698219,98.7,21.5,42694",GSM4419172: h3k27ac ChIP DMSO M1-91; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944512,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"38815795,98.9,20.4,35655",GSM4419173: h3k27ac ChIP DMSO M2-3; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944513,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30565798,98.8,17.2,32988",GSM4419174: h3k27ac ChIP DMSO M2-5; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=DMSO 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944514,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22534421,94.9,18.6,27464",GSM4419175: h3k27ac ChIP E2 C1-12; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944515,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"20833989,91.5,21.3,24714",GSM4419176: h3k27ac ChIP E2 C1-5; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-1	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944516,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22237680,94.3,18.9,25810",GSM4419177: h3k27ac ChIP E2 C2-14; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944517,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"22972906,96.6,18.5,28860",GSM4419178: h3k27ac ChIP E2 C2-3; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=CISH-2	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944518,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"14508894,98.4,12.0,25331",GSM4419179: h3k27ac ChIP E2 M1-66; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944519,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"32275396,97.9,12.7,36065",GSM4419180: h3k27ac ChIP E2 M1-9-1; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-1	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944520,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"23772952,96.3,18.6,29128",GSM4419181: h3k27ac ChIP E2 M2-3; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7944521,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"30723265,97.9,20.4,38678",GSM4419182: h3k27ac ChIP E2 M2-5; Homo sapiens; ChIP-Seq,source_name=Ishikawa (Endometrioid adenocarcinoma)	cell line=Ishikawa	enhancer deleted=MMP17-2	treatment=10nM E2 8hr	antibody target=Histone 3 Lysine 27 acetylation (H3K27ac)
SRX7959034,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"52593146,98.4,10.8,21327",GSM4420173: ChIPSeq H3K27ac mE1; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B	cell type=human endometrial adenocarcinoma	genotype=mE1	antibody=H3K27ac (Abcam, ab4729 )"
SRX7959035,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"43893463,98.8,11.0,26509",GSM4420174: ChIPSeq H3K27ac mE2; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B	cell type=human endometrial adenocarcinoma	genotype=mE2	antibody=H3K27ac (Abcam, ab4729 )"
SRX7959036,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"41386537,98.7,19.7,18852",GSM4420175: ChIPSeq H3K27ac mE1 mut; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B	cell type=human endometrial adenocarcinoma	genotype=mE1_CBSmutation	antibody=H3K27ac (Abcam, ab4729 )"
SRX7959850,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"41451061,98.0,19.6,13742",GSM4423377: ChIPSeq H3K27ac HEC1B WT; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B	cell type=human endometrial adenocarcinoma	genotype=wildtype	antibody=H3K27ac (Abcam, ab4729 )"
SRX8111580,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"78539607,99.3,9.5,489",GSM4475254: Control; Homo sapiens; ChIP-Seq,source_name=endometrial stromal cells	cell type=endometrial stromal cells	transfection=control	agent=no treatment	antibody=H3K27ac
SRX8111581,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"91796400,98.9,14.0,733",GSM4475255: cAMP; Homo sapiens; ChIP-Seq,source_name=endometrial stromal cells	cell type=endometrial stromal cells	transfection=control	agent=cAMP treatment	antibody=H3K27ac
SRX8111582,hg38,Histone,H3K27ac,Uterus,Endometrial stromal cells,,"85028169,99.1,10.8,522",GSM4475256: cAMP under C/EBPb-knockdown; Homo sapiens; ChIP-Seq,source_name=endometrial stromal cells	cell type=endometrial stromal cells	transfection=C/EBPb siRNA	agent=cAMP treatment	antibody=H3K27ac
SRX811383,hg38,Histone,H3K27ac,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"48802195,90.6,71.1,30275",GSM1566557: ChIP-seq analysis of H3K27Ac in KB cells (H3K27Ac IL1); Homo sapiens; ChIP-Seq,"source_name=KB cells	treatment_1=10ng/ml IL-1alpha for 1 h	treatment_2=none	antibody=Anti-H3K27Ac (Diagenode, catalog# 174-050, Lot #A7071-001P)"
SRX811384,hg38,Histone,H3K27ac,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"35481486,93.2,68.8,25726",GSM1566558: ChIP-seq analysis of H3K27Ac in KB cells (H3K27Ac); Homo sapiens; ChIP-Seq,"source_name=KB cells	treatment_1=none	treatment_2=none	antibody=Anti-H3K27Ac (Diagenode, catalog# 174-050, Lot #A7071-001P)"
SRX811385,hg38,Histone,H3K27ac,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"43842976,94.5,68.2,34778",GSM1566559: ChIP-seq analysis of H3K27Ac in KB cells (H3K27Ac 5Z); Homo sapiens; ChIP-Seq,"source_name=KB cells	treatment_1=none	treatment_2=1µM 5Z-7-oxozeaenol for 1 h	antibody=Anti-H3K27Ac (Diagenode, catalog# 174-050, Lot #A7071-001P)"
SRX811386,hg38,Histone,H3K27ac,Uterus,KB,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"61646186,93.5,74.3,39941",GSM1566560: ChIP-seq analysis of H3K27Ac in KB cells (H3K27Ac IL1 5Z); Homo sapiens; ChIP-Seq,"source_name=KB cells	treatment_1=10ng/ml IL-1alpha for 1 h	treatment_2=1µM 5Z-7-oxozeaenol for 1 h	antibody=Anti-H3K27Ac (Diagenode, catalog# 174-050, Lot #A7071-001P)"
SRX8257606,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"14974073,96.7,13.9,7631",GSM4518155: H3K27ac A2 rep1 ChIP-seq; Homo sapiens; ChIP-Seq,source_name=HEC-1-B cells	cell type=human endometrial adenocarcinoma	restriction enzyme=tumor stage	genotype=wild-type	antibody=H3K27ac
SRX8257607,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"14462248,96.2,16.4,9509",GSM4518156: H3K27ac A2 rep2 ChIP-seq; Homo sapiens; ChIP-Seq,source_name=HEC-1-B cells	cell type=human endometrial adenocarcinoma	restriction enzyme=tumor stage	genotype=wild-type	antibody=H3K27ac
SRX8257608,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"15183060,97.5,17.8,10700",GSM4518157: H3K27ac 2E8 rep1 ChIP-seq; Homo sapiens; ChIP-Seq,source_name=HEC-1-B cells	cell type=human endometrial adenocarcinoma	restriction enzyme=tumor stage	genotype=eRNA TSS deletion	antibody=H3K27ac
SRX8257609,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"13447342,97.7,18.0,6861",GSM4518158: H3K27ac 2E8 rep2 ChIP-seq; Homo sapiens; ChIP-Seq,source_name=HEC-1-B cells	cell type=human endometrial adenocarcinoma	restriction enzyme=tumor stage	genotype=eRNA TSS deletion	antibody=H3K27ac
SRX8257610,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"16158979,96.1,13.5,6957",GSM4518159: H3K27ac 14G1 rep1 ChIP-seq; Homo sapiens; ChIP-Seq,source_name=HEC-1-B cells	cell type=human endometrial adenocarcinoma	restriction enzyme=tumor stage	genotype=polyadenylation sequence insertion	antibody=H3K27ac
SRX8257611,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"12063480,96.0,14.9,8383",GSM4518160: H3K27ac 14G1 rep2 ChIP-seq; Homo sapiens; ChIP-Seq,source_name=HEC-1-B cells	cell type=human endometrial adenocarcinoma	restriction enzyme=tumor stage	genotype=polyadenylation sequence insertion	antibody=H3K27ac
SRX8299192,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"121901001,97.3,55.4,30766",GSM4542948: ChIP-seq H3K27ac naive; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa	treatment=naive cells	chip antibody=H3K27ac (Abcam, ab4729)"
SRX8299193,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"95320171,97.7,41.6,24452",GSM4542949: ChIP-seq H3K27ac priming; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa	treatment=cells induced with interferon gamma for 24h	chip antibody=H3K27ac (Abcam, ab4729)"
SRX8299194,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"139797550,97.4,56.9,37476",GSM4542950: ChIP-seq H3K27ac 2 days washout; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa	treatment=cells 2 days after interferon gamma washout	chip antibody=H3K27ac (Abcam, ab4729)"
SRX8299195,hg38,Histone,H3K27ac,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"160358108,97.5,62.6,31357",GSM4542951: ChIP-seq H3K27ac 7 days washout; Homo sapiens; ChIP-Seq,"source_name=HeLa cells	cell line=HeLa	treatment=cells 7 days after interferon gamma washout	chip antibody=H3K27ac (Abcam, ab4729)"
SRX8299213,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"142725684,98.7,62.7,82684",GSM4542935: ATAC-seq naive; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=naive cells
SRX8299214,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"135879540,98.7,58.5,93620",GSM4542936: ATAC-seq priming; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=cells induced with interferon gamma for 24h
SRX8299215,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"118963950,98.8,64.2,80870",GSM4542937: ATAC-seq 2 days washout; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=cells 2 days after interferon gamma washout
SRX8299216,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"146641872,97.9,79.2,71728",GSM4542938: ATAC-seq 7 days washout; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=cells 7 days after interferon gamma washout
SRX8299217,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"144058833,92.7,21.5,8114",GSM4542939: ATAC input; Homo sapiens; ATAC-seq,source_name=HeLa cells	cell line=HeLa	treatment=input
SRX8380644,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","33955651,85.6,12.3,19409",GSM4564694: U2OS Cells - ER alpa construct - 10nM 17alpha E2 - rep 3 [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=10nM 17alpha E2	antibody=Flag-tagged ER alpha
SRX8380645,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","34213845,79.5,10.2,16926",GSM4564695: U2OS Cells - ER alpa construct - 100nM 17alpha E2 - rep 1  [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=100nM 17alpha E2	antibody=Flag-tagged ER alpha
SRX8380646,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","51148798,80.6,11.8,22096",GSM4564696: U2OS Cells - ER alpa construct - 100nM 17alpha E2 - rep 2 [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=100nM 17alpha E2	antibody=Flag-tagged ER alpha
SRX8380647,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","30352642,84.0,10.9,12983",GSM4564697: U2OS Cells - ER alpa construct - 100nM 17alpha E2 - rep 3 [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=100nM 17alpha E2	antibody=Flag-tagged ER alpha
SRX8380648,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","37517475,81.5,11.3,17511",GSM4564698: U2OS Cells - ER alpa construct - 10nM 17beta E2 - rep 1  [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=10nM 17beta E2	antibody=Flag-tagged ER alpha
SRX8380649,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","40451438,84.4,14.4,19545",GSM4564699: U2OS Cells - ER alpa construct - 10nM 17beta E2 - rep 2 [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=10nM 17beta E2	antibody=Flag-tagged ER alpha
SRX8380650,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","39971635,82.9,12.0,16745",GSM4564700: U2OS Cells - ER alpa construct - 10nM 17beta E2 - rep 3 [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=10nM 17beta E2	antibody=Flag-tagged ER alpha
SRX8380651,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","32084146,82.9,12.1,8715",GSM4564701: U2OS Cells - ER alpa construct - Vehicle (EtOH) - rep 1  [RNA-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=Vehicle (EtOH)	antibody=Flag-tagged ER alpha
SRX8380652,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","39683952,82.2,13.9,3743",GSM4564702: U2OS Cells - ER alpa construct - Vehicle (EtOH) - rep 2 [RNA-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=Vehicle (EtOH)	antibody=Flag-tagged ER alpha
SRX8380653,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","39402531,84.0,14.5,5323",GSM4564703: U2OS Cells - ER alpa construct - Vehicle (EtOH) - rep 3 [RNA-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=Vehicle (EtOH)	antibody=Flag-tagged ER alpha
SRX8380668,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","42584709,81.4,13.9,20277",GSM4564692: U2OS Cells - ER alpa construct - 10nM 17alpha E2 - rep 1  [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=10nM 17alpha E2	antibody=Flag-tagged ER alpha
SRX8380669,hg38,TFs and others,ESR1,Bone,U2OS,"Tissue=bone|Lineage=mesoderm|Description=osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)","34071859,82.8,14.2,8106",GSM4564693: U2OS Cells - ER alpa construct - 10nM 17alpha E2 - rep 2 [ChIP-Seq]; Homo sapiens; ChIP-Seq,source_name=U2OS Cells	cell type=Human Bone Osteosarcoma Epithelial Cells	cell line=U2OS Cells	agent=10nM 17alpha E2	antibody=Flag-tagged ER alpha
SRX8418755,hg38,TFs and others,ESR1,Uterus,Endometrial stromal cells,,"43365991,100.0,7.1,319",GSM4577178: PT1 ESR1 E2 ChIP DNA; Homo sapiens; ChIP-Seq,source_name=Isolated stromal cells post-hysterectomy	cell type=Primary endometrial stromal cells	individual=Patient 1	antibody target=ESR1
SRX8420196,hg38,TFs and others,JUN,Blood,KARPAS-299,Primary Tissue=Blood|Tissue Diagnosis=Lymphoma Non-Hodgkins,"33008844,97.5,17.2,27598",GSM4577660: c-Jun ippt; Homo sapiens; ChIP-Seq,source_name=ALK+ ALCL tumour	cell line=Karpas 299	chip antibody=H-79; Santa Cruz Biotechnology
SRX849376,hg38,TFs and others,CDK8,Blood,MOLM-14,,"12309923,99.2,1.1,5981",GSM1587899: MOLM14 CDK8 b1 untreated 4; Homo sapiens; ChIP-Seq,source_name=MOLM14	cell line=MOLM14	cell type=MLL-AF9-rearranged AML	treatment protocol=untreated	chip epitope=CDK8_b1	ca sensitivity=sensitive
SRX849378,hg38,TFs and others,CDK8,Blood,MOLM-14,,"13222910,99.1,1.2,8436",GSM1587901: MOLM14 CDK8 b1 untreated 5; Homo sapiens; ChIP-Seq,source_name=MOLM14	cell line=MOLM14	cell type=MLL-AF9-rearranged AML	treatment protocol=untreated	chip epitope=CDK8_b1	ca sensitivity=sensitive
SRX849394,hg38,TFs and others,CDK8,Blood,SET-2,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"28756954,96.5,3.3,6709",GSM1587917: SET2 CDK8 untreated 13; Homo sapiens; ChIP-Seq,source_name=SET2	cell line=SET2	cell type=essential thrombocythemia	treatment protocol=untreated	chip epitope=CDK8	ca sensitivity=sensitive
SRX849396,hg38,TFs and others,CDK8,Blood,SET-2,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"37545912,96.4,3.2,9271",GSM1587919: SET2 CDK8 untreated 14; Homo sapiens; ChIP-Seq,source_name=SET2	cell line=SET2	cell type=essential thrombocythemia	treatment protocol=untreated	chip epitope=CDK8	ca sensitivity=sensitive
SRX849400,hg38,TFs and others,CDK8,Blood,MV-4-11,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Acute Myelogenous,"37687867,99.0,2.2,7208",GSM1587923: MV411 CDK8 untreated 16; Homo sapiens; ChIP-Seq,source_name=MV411	cell line=MV411	cell type=MLL-AF4-rearranged AML	treatment protocol=untreated	chip epitope=CDK8	ca sensitivity=sensitive
SRX849404,hg38,TFs and others,CDK8,Blood,K-562,Primary Tissue=Blood|Tissue Diagnosis=Leukemia Chronic Myelogenous,"38051817,99.1,2.8,6832",GSM1587927: K562 CDK8 untreated 18; Homo sapiens; ChIP-Seq,source_name=K562	cell line=K562	cell type=CML	treatment protocol=untreated	chip epitope=CDK8	ca sensitivity=insensitive
SRX8512767,hg38,TFs and others,FOS,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"31558551,98.5,12.5,7300",GSM4604709: FOS 1A7; Homo sapiens; ChIP-Seq,source_name=HCT116	cell line=HCT116	cell type=colorectal carcinoma	antibody=FOS_1A7	associated input=Input_Batch_F
SRX8537714,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29288838,97.5,8.1,14283",GSM4613548: MCF7-WM-E2-ER Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7-WM-E2-ER	cell line=MCF7 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537715,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29696151,97.2,8.3,14013",GSM4613549: MCF7-WM-E2-ER Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7-WM-E2-ER	cell line=MCF7 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537716,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"19878637,97.2,5.6,12366",GSM4613550: MDA134-WM-E2-ER Rep1; Homo sapiens; ChIP-Seq,"source_name=MDA134-WM-E2-ER	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537717,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"25567363,97.7,9.2,17419",GSM4613551: MDA134-WM-E2-ER Rep2; Homo sapiens; ChIP-Seq,"source_name=MDA134-WM-E2-ER	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537718,hg38,TFs and others,ESR1,Breast,SUM 44PE,Primary Tissue=Breast|Tissue Diagnosis=Unknown,"24184774,94.4,23.4,36177",GSM4613552: SUM44-WM-E2-ER Rep1; Homo sapiens; ChIP-Seq,"source_name=SUM44-WM-E2-ER	cell line=SUM44PE breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537719,hg38,TFs and others,ESR1,Breast,SUM 44PE,Primary Tissue=Breast|Tissue Diagnosis=Unknown,"26178607,93.5,25.9,37133",GSM4613553: SUM44-WM-E2-ER Rep2; Homo sapiens; ChIP-Seq,"source_name=SUM44-WM-E2-ER	cell line=SUM44PE breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537720,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"36867861,97.5,7.1,3408",GSM4613554: T47D-WM-E2-ER Rep1; Homo sapiens; ChIP-Seq,"source_name=T47D-WM-E2-ER	cell line=T47D breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537721,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"41696011,97.4,10.3,4229",GSM4613555: T47D-WM-E2-ER Rep2; Homo sapiens; ChIP-Seq,"source_name=T47D-WM-E2-ER	cell line=T47D breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537722,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"39381002,98.2,13.9,38551",GSM4613556: MCF7-WM-E2-ER-batch2 Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7-WM-E2-ER-batch2	cell line=MCF7 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537723,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"38356143,98.5,12.7,34757",GSM4613557: MCF7-WM-E2-ER-batch2 Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7-WM-E2-ER-batch2	cell line=MCF7 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537724,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36724731,98.4,9.5,4542",GSM4613558: MCF7-WM-Tam-ER-batch2 Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7-WM-Tam-ER-batch2	cell line=MCF7 breast carcinoma cell line	agent=Tamoxifen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537725,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37315223,98.2,7.6,4502",GSM4613559: MCF7-WM-Tam-ER-batch2 Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7-WM-Tam-ER-batch2	cell line=MCF7 breast carcinoma cell line	agent=Tamoxifen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537726,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"23940571,98.5,6.9,5432",GSM4613560: MDA134-WM-E2-ER-batch2 Rep1; Homo sapiens; ChIP-Seq,"source_name=MDA134-WM-E2-ER-batch2	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537727,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"19173609,98.5,7.4,4791",GSM4613561: MDA134-WM-E2-ER-batch2 Rep2; Homo sapiens; ChIP-Seq,"source_name=MDA134-WM-E2-ER-batch2	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537728,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"25081481,98.3,6.4,4977",GSM4613562: MDA134-WM-Tam-ER-batch2 Rep1; Homo sapiens; ChIP-Seq,"source_name=MDA134-WM-Tam-ER-batch2	cell line=MDA_MB134 breast carcinoma cell line	agent=Tamoxifen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537729,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"24287240,98.4,5.9,5795",GSM4613563: MDA134-WM-Tam-ER-batch2 Rep2; Homo sapiens; ChIP-Seq,"source_name=MDA134-WM-Tam-ER-batch2	cell line=MDA_MB134 breast carcinoma cell line	agent=Tamoxifen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8537730,hg38,TFs and others,ESR1,Breast,PE1B,,"25103255,96.4,16.4,22590",GSM4613564: Pleural-Effusion-ER; Homo sapiens; ChIP-Seq,"source_name=Pleural-Effusion-ER	cell line=PE1B	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8616797,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"17904020,98.9,10.5,16781",GSM4636791: A549 cJun FLAG cells untreated - rep1; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells untreated - rep1	biomaterial_provider=ATCC	time point=00h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616798,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"47224237,99.0,27.2,24264",GSM4636792: A549 cJun FLAG cells untreated - rep2; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells untreated - rep2	biomaterial_provider=ATCC	time point=00h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616799,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"21222821,98.9,15.1,6638",GSM4636793: A549 cJun FLAG cells untreated - rep3; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells untreated - rep3	biomaterial_provider=ATCC	time point=00h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616800,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"18407530,99.0,14.7,3812",GSM4636794: A549 cJun FLAG cells treated with DEX for 01h - rep1; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 01h - rep1	biomaterial_provider=ATCC	time point=01h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616801,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"14354018,98.8,16.8,7692",GSM4636795: A549 cJun FLAG cells treated with DEX for 01h - rep2; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 01h - rep2	biomaterial_provider=ATCC	time point=01h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616802,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"17140960,98.8,16.3,5881",GSM4636796: A549 cJun FLAG cells treated with DEX for 01h - rep3; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 01h - rep3	biomaterial_provider=ATCC	time point=01h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616803,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"15191972,98.9,13.9,3665",GSM4636797: A549 cJun FLAG cells treated with DEX for 04h - rep1; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 04h - rep1	biomaterial_provider=ATCC	time point=04h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616804,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"15475509,98.6,18.2,3813",GSM4636798: A549 cJun FLAG cells treated with DEX for 04h - rep2; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 04h - rep2	biomaterial_provider=ATCC	time point=04h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616805,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"15074015,99.0,11.3,503",GSM4636799: A549 cJun FLAG cells treated with DEX for 04h - rep3; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 04h - rep3	biomaterial_provider=ATCC	time point=04h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616806,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"14580645,98.6,12.1,297",GSM4636800: A549 cJun FLAG cells treated with DEX for 08h - rep1; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 08h - rep1	biomaterial_provider=ATCC	time point=08h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616807,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"16820535,98.0,19.9,5552",GSM4636801: A549 cJun FLAG cells treated with DEX for 08h - rep2; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 08h - rep2	biomaterial_provider=ATCC	time point=08h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616808,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"18259744,99.0,11.7,435",GSM4636802: A549 cJun FLAG cells treated with DEX for 12h - rep1; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 12h - rep1	biomaterial_provider=ATCC	time point=12h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616809,hg38,TFs and others,JUN,Lung,A549,Primary Tissue=Lung|Tissue Diagnosis=Carcinoma,"25203407,99.0,13.5,1231",GSM4636803: A549 cJun FLAG cells treated with DEX for 12h - rep2; Homo sapiens; ChIP-Seq,source_name=A549_cJun_FLAG cells treated with DEX for 12h - rep2	biomaterial_provider=ATCC	time point=12h	cell line=A549	tissue=adenocarcinomic human alveolar basal epithelial
SRX8616961,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25114792,99.3,14.5,5839",GSM4636741: jc5613 ER siNT 72h MCF7; Homo sapiens; ChIP-Seq,source_name=ER siNT 72h MCF7	cell line=MCF7	cell type=Breast cancer	treatment=Control siRNA 72hr	chip antibody=ab3575 (Abcam)
SRX8616962,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25830457,99.1,15.2,6794",GSM4636742: jc5614 ER siTET2 72h MCF7; Homo sapiens; ChIP-Seq,source_name=ER siTET2 72h MCF7	cell line=MCF7	cell type=Breast cancer	treatment=TET2 siRNA 72hr	chip antibody=ab3575 (Abcam)
SRX8616977,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"32377390,99.2,22.1,9150",GSM4636725: jc5402 ER Untreated ZR75-1; Homo sapiens; ChIP-Seq,source_name=ER Untreated ZR75-1	cell line=ZR75-1	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8616979,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"32731309,98.4,19.4,8034",GSM4636727: jc5405 ER Untreated ZR75-1; Homo sapiens; ChIP-Seq,source_name=ER Untreated ZR75-1	cell line=ZR75-1	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8616981,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"49241609,99.2,19.1,5322",GSM4636729: jc5408 ER Untreated ZR75-1; Homo sapiens; ChIP-Seq,source_name=ER Untreated ZR75-1	cell line=ZR75-1	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8616985,hg38,TFs and others,ESR1,Breast,STG195,,"32346662,92.6,22.3,8475",GSM4636733: jc5535 ER Untreated STG195; Homo sapiens; ChIP-Seq,source_name=ER Untreated STG195	cell line=STG195	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8616986,hg38,TFs and others,ESR1,Breast,AB555,,"37973443,94.9,21.2,9629",GSM4636734: jc5536 ER Untreated AB555; Homo sapiens; ChIP-Seq,source_name=ER Untreated AB555	cell line=AB555	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8616989,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31843176,99.0,14.6,12614",GSM4636737: jc5607 ER siNT 72h MCF7; Homo sapiens; ChIP-Seq,source_name=ER siNT 72h MCF7	cell line=MCF7	cell type=Breast cancer	treatment=Control siRNA 72hr	chip antibody=ab3575 (Abcam)
SRX8616990,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36444764,99.3,15.0,9362",GSM4636738: jc5608 ER siTET2 72h MCF7; Homo sapiens; ChIP-Seq,source_name=ER siTET2 72h MCF7	cell line=MCF7	cell type=Breast cancer	treatment=TET2 siRNA 72hr	chip antibody=ab3575 (Abcam)
SRX8616991,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33239647,99.2,14.6,9908",GSM4636739: jc5609 ER siNT 72h MCF7; Homo sapiens; ChIP-Seq,source_name=ER siNT 72h MCF7	cell line=MCF7	cell type=Breast cancer	treatment=Control siRNA 72hr	chip antibody=ab3575 (Abcam)
SRX8616992,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"33188279,99.1,15.2,7612",GSM4636740: jc5610 ER siTET2 72h MCF7; Homo sapiens; ChIP-Seq,source_name=ER siTET2 72h MCF7	cell line=MCF7	cell type=Breast cancer	treatment=TET2 siRNA 72hr	chip antibody=ab3575 (Abcam)
SRX8617015,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18030497,99.3,18.8,12163",GSM4636715: jc5375 ER Untreated MCF7; Homo sapiens; ChIP-Seq,source_name=ER Untreated MCF7	cell line=MCF7	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8617017,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23607185,99.0,20.8,14470",GSM4636717: jc5378 ER Untreated MCF7; Homo sapiens; ChIP-Seq,source_name=ER Untreated MCF7	cell line=MCF7	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8617019,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"42514639,99.1,20.3,13951",GSM4636719: jc5381 ER Untreated MCF7; Homo sapiens; ChIP-Seq,source_name=ER Untreated MCF7	cell line=MCF7	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8617021,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16139089,98.8,20.6,9202",GSM4636721: jc5384 ER Untreated MCF7; Homo sapiens; ChIP-Seq,source_name=ER Untreated MCF7	cell line=MCF7	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8617023,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"72352590,99.2,24.4,17006",GSM4636723: jc5399 ER Untreated ZR75-1; Homo sapiens; ChIP-Seq,source_name=ER Untreated ZR75-1	cell line=ZR75-1	cell type=Breast cancer	treatment=No treatment	chip antibody=ab3575 (Abcam)/06-935 (Millipore)
SRX8622030,hg38,TFs and others,MED12,Blood,HAP1,,"38953698,98.5,1.8,18448",GSM4640489: Hap1 MED12 ChIPseq; Homo sapiens; ChIP-Seq,source_name=Hap1	cell type=Hap1	genotype/variation=wild type	chip antibody=MED12 (A300-774A Bethyl)
SRX8639778,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"17164135,97.7,7.9,2271",GSM4646924: MDA134-shFOXA1-DOX-WM-E2-ER rep1; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen + DOX	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8639779,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"20859755,97.0,9.0,3045",GSM4646925: MDA134-shFOXA1-DOX-WM-E2-ER rep2; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen + DOX	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8639780,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"22543796,97.5,20.8,3410",GSM4646926: MDA134-shFOXA1-DOX-WM-Tam-ER rep2; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Tamoxifen + DOX	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8639781,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"17629949,98.0,8.2,2173",GSM4646927: MDA134-shFOXA1-ND-WM-E2-ER rep2; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8639782,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"24218410,97.9,9.8,5537",GSM4646928: MDA134-shFOXA1-ND-WM-Tam-ER rep1; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Tamoxifen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8639783,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"36357942,98.5,8.2,8080",GSM4646929: MDA134-shFOXA1-ND-WM-Tam-ER rep2; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Tamoxifen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX8639784,hg38,TFs and others,ESR1,Breast,MDA-MB-134-VI,Primary Tissue=Breast|Tissue Diagnosis=Carcinoma,"28550963,94.5,5.8,3031",GSM4646930: MDA134-shFOXA1-ND-WM-E2-ER input; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MDA_MB134 breast carcinoma cell line	agent=Estrogen	chip antibody=ER (Ab10 Thermo Fisher Scientific, SC-543 Santa cruz)"
SRX883584,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","90104400,97.3,16.2,52349",GSM1614036: JUN rep1 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-231 breast cancer cells	cell line=MDA-MB-231	chip antibody=JUN (BD Bioscience, 610326, lot 3263734)"
SRX883585,hg38,TFs and others,JUN,Breast,MDA-MB-231,"Primary Tissue=Breast|Site of Extraction=Effusion, Pleural|Tissue Diagnosis=Adenocarcinoma","85747303,98.1,10.2,37569",GSM1614037: JUN rep2 ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=MDA-MB-231 breast cancer cells	cell line=MDA-MB-231	chip antibody=JUN (BD Bioscience, 610326, lot 3263734)"
SRX8861813,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23306356,98.8,25.8,3752",GSM4705577: T47D ER ChIP-seq siCont Veh rep1; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siCont_Veh	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861814,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26865952,98.8,19.8,12490",GSM4705578: T47D ER ChIP-seq siCont Veh rep2; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siCont_Veh	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861815,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"23790423,98.7,28.3,8538",GSM4705579: T47D ER ChIP-seq siCont Veh rep3; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siCont_Veh	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861816,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31711782,98.7,13.2,4485",GSM4705580: T47D ER ChIP-seq siCont IL6 rep1; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siCont_IL6	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861817,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"33578370,99.1,15.6,16708",GSM4705581: T47D ER ChIP-seq siCont IL6 rep2; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siCont_IL6	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861818,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31637345,99.1,21.8,33222",GSM4705582: T47D ER ChIP-seq siCont IL6 rep3; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siCont_IL6	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861819,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30057533,98.9,17.6,4971",GSM4705583: T47D ER ChIP-seq siFOXA1 Veh rep1; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siFOXA1_Veh	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861820,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"31520017,99.0,14.4,7297",GSM4705584: T47D ER ChIP-seq siFOXA1 Veh rep2; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siFOXA1_Veh	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861821,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"28820506,98.9,17.0,11124",GSM4705585: T47D ER ChIP-seq siFOXA1 Veh rep3; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siFOXA1_Veh	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861822,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"27827176,98.7,16.7,4204",GSM4705586: T47D ER ChIP-seq siFOXA1 IL6 rep1; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siFOXA1_IL6	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861823,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"30267167,98.9,20.4,18960",GSM4705587: T47D ER ChIP-seq siFOXA1 IL6 rep2; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siFOXA1_IL6	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX8861824,hg38,TFs and others,ESR1,Breast,T-47D,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26893931,98.9,35.1,4828",GSM4705588: T47D ER ChIP-seq siFOXA1 IL6 rep3; Homo sapiens; ChIP-Seq,source_name=T47D cells	cell line=ER+ Breast Cancer Cell Line T47D	passages=27-30	treatment=siFOXA1_IL6	chip antibody=ERα ab3575 and Merck Millipore 06-935 antibody mix
SRX9045668,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"32238109,98.6,4.0,867",GSM4759004: MCF7-2 DMSO; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell type=MCF7 breast carcinoma cell line	treatment=DMSO	treatment length=7 days	chip antibody=ER (Santacruz, Cat# sc-543, clone HC-20, Lot # A1F0316)"
SRX9045669,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27680014,97.9,7.0,3138",GSM4759005: MCF7-2 Abemaciclib; Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell type=MCF7 breast carcinoma cell line	treatment=abemaciclib	treatment length=7 days	chip antibody=ER (Santacruz, Cat# sc-543, clone HC-20, Lot # A1F0316)"
SRX9063419,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"23577247,94.5,33.3,12932",GSM4763931: MCF7 DMSO (replicate 1); Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MCF7 breast carcinoma cell line	treatment=DMSO	treatment length=7 days	chip antibody=c-Jun (Cell Signaling Technologies, Cat# 9165)"
SRX9063420,hg38,TFs and others,JUN,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"25737076,94.7,44.9,9058",GSM4763932: MCF7 Abemaciclib (replicate 1); Homo sapiens; ChIP-Seq,"source_name=Breast carcinoma cell line	cell line=MCF7 breast carcinoma cell line	treatment=abemaciclib	treatment length=7 days	chip antibody=c-Jun (Cell Signaling Technologies, Cat# 9165)"
SRX9067323,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"59412191,98.5,1.5,65592",GSM4764092: Starved - HeLa; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=--	induction=serum starved
SRX9067324,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"62310801,99.0,4.7,113808",GSM4764093: Steady - HeLa; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=--	induction=--
SRX9067325,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"64175268,99.1,2.0,157596",GSM4764094: Induced - HeLa rep. 1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=--	induction=treated with serum and PMA
SRX9067326,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"49558373,99.1,2.8,141168",GSM4764095: Induced - HeLa rep. 2; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=--	induction=treated with serum and PMA
SRX9067327,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"61447711,98.8,3.7,68580",GSM4764096: Starved - HeLa p300gCox2; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCox2	induction=serum starved
SRX9067328,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"58402822,99.0,6.1,118273",GSM4764097: Steady - HeLa p300gCox2 rep. 1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCox2	induction=--
SRX9067329,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"63471015,99.1,5.3,125539",GSM4764098: Steady - HeLa p300gCox2 rep. 2; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCox2	induction=--
SRX9067330,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"48707385,99.2,6.3,124150",GSM4764099: Induced - HeLa p300gCox2 rep. 1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCox2	induction=treated with serum and PMA
SRX9067331,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"57246892,98.6,1.7,32301",GSM4764100: Induced - HeLa p300gCox2 rep. 2; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCox2	induction=treated with serum and PMA
SRX9067332,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"60400203,98.9,8.8,86777",GSM4764101: Steady - HeLa p300gCol1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCol1	induction=--
SRX9067333,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"57779845,99.1,4.5,128092",GSM4764102: Induced - HeLa p300gCol1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa p300gCol1	induction=treated with serum and PMA
SRX9067334,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"53061413,99.0,7.0,116465",GSM4764103: Steady - HeLa GCN10xp300gCol1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa GCN10xp300gCol1	induction=--
SRX9067335,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"42625915,98.5,7.5,107370",GSM4764104: Induced - HeLa GCN10xp300gCol1 rep. 1; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa GCN10xp300gCol1	induction=treated with serum and PMA
SRX9067336,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"48205310,99.2,8.3,119461",GSM4764105: Induced - HeLa GCN10xp300gCol1 rep. 2; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa GCN10xp300gCol1	induction=treated with serum and PMA
SRX9067337,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"62007742,99.1,7.2,120082",GSM4764106: Steady - HeLa GCN10xp300gControl; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa GCN10xp300gControl	induction=--
SRX9067338,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"5773090,98.6,1.2,50138",GSM4764107: Induced - HeLa GCN10xp300gControl; Homo sapiens; ATAC-seq,source_name=cervical adenocarcinoma	cell line=HeLa	genotype/variation=HeLa GCN10xp300gControl	induction=treated with serum and PMA
SRX9221932,hg38,TFs and others,ESR1,Liver,Hepatocytes,MeSH Description=The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.,"37078372,93.8,61.5,2113",GSM4812272: ESR1 Hep E2Treated ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=Primary Hepatocytes	tissue/cell type=Primary hepatocytes	treatment=17 β-estradiol (1 µM)	treatment time=8 hours	chip-antibody=sc-543 (Santa Cruz, Ca, USA)"
SRX9221933,hg38,TFs and others,ESR1,Liver,Hepatocytes,MeSH Description=The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.,"34719274,93.5,55.2,2332",GSM4812273: ESR1 Hep DMSO ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=Primary Hepatocytes	tissue/cell type=Primary hepatocytes	treatment=DMSO	treatment time=8 hours	chip-antibody=sc-543 (Santa Cruz, Ca, USA)"
SRX9221935,hg38,TFs and others,ESR1,Liver,Liver,"MeSH Description=A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.","42978474,97.0,49.4,3383",GSM4812275: ESR1 Liver ChIPSeq; Homo sapiens; ChIP-Seq,"source_name=Liver Tissue	tissue/cell type=Liver Tissue	chip-antibody=sc-543 (Santa Cruz, Ca, USA)"
SRX9322279,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26401967,97.5,4.2,687","GSM4838750: MCF7 cells, WT control; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=WT	treatment=control	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322280,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29484012,98.2,5.6,5034","GSM4838751: MCF7 cells, WT estrogen 30min; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=WT	treatment=estrogen_30min	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322281,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29013498,97.9,4.6,5508","GSM4838752: MCF7 cells, WT estrogen 1h; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=WT	treatment=estrogen_1h	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322282,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29611149,97.7,5.4,983","GSM4838753: MCF7 cells, MIX (pooled control clones) control; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=MIX (pooled control clones)	treatment=control	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322283,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"29883529,97.6,6.4,2675","GSM4838754: MCF7 cells, MIX (pooled control clones) estrogen 30min; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=MIX (pooled control clones)	treatment=estrogen_30min	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322284,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28763811,97.9,5.9,2227","GSM4838755: MCF7 cells, MIX (pooled control clones) estrogen 1h; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=MIX (pooled control clones)	treatment=estrogen_1h	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322285,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"28582832,97.6,6.3,1328","GSM4838756: MCF7 cells, KO#2 (clone with HSF1 knockout) control; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=KO#2 (clone with HSF1 knockout)	treatment=control	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322286,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"26391708,98.1,4.3,2548","GSM4838757: MCF7 cells, KO#2 (clone with HSF1 knockout) estrogen 30min; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=KO#2 (clone with HSF1 knockout)	treatment=estrogen_30min	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9322287,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"27628234,98.2,4.5,2474","GSM4838758: MCF7 cells, KO#2 (clone with HSF1 knockout) estrogen 1h; Homo sapiens; ChIP-Seq","source_name=MCF7 cells	cell line=MCF7	tumor=adenocarcinoma	Sex=female	age=69 years	tissue=breast	genotype=KO#2 (clone with HSF1 knockout)	treatment=estrogen_1h	chip antibody=Eralpha monoclonal antibody (Diagenode, C15100066)"
SRX9350645,hg38,TFs and others,FOS,Epidermis,Melanoma cell line,,"73267859,83.3,24.6,13266",GSM4851833: MM099 ChIP-seq cFos; Homo sapiens; ChIP-Seq,"source_name=MM099 ChIP-seq cFos	cell line=MM099	cell type=melanoma cell line	chip antibody=c-Fos antibody (sc-166940 X, Santa Cruz Biotechnology)"
SRX9350646,hg38,TFs and others,JUN,Epidermis,Melanoma cell line,,"234355022,87.9,10.1,48809",GSM4851834: MM099 ChIP-seq cJun; Homo sapiens; ChIP-Seq,"source_name=MM099 ChIP-seq cJun	cell line=MM099	cell type=melanoma cell line	chip antibody=c-Jun antibody (sc-74543 X, Santa Cruz Biotechnology)"
SRX9534927,hg38,TFs and others,FOS,Breast,Breast cancer cells,,"8504089,67.6,10.4,1840",GSM4915981: FOS BRx82 day100 ovary; Homo sapiens; ChIP-Seq,source_name=Breast cancer circulating tumor cells	patient id=BRx82	tissue=xenograft ovary metastasis	timepoint=day 100	cell type=breast cancer circulating tumor cells	gender=female	chip antibody=FOS (Santa Cruz Biotechnology; Cat#sc-271243X)
SRX957905,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"5343539,99.6,1.7,15293",GSM1635579: Ishikawa K27ac Rep1; Homo sapiens; ChIP-Seq,source_name=Cancer cell line	tumor type=Endometrial carcinomas	antibody=H3K27ac ab4729	cell line=Ishikawa
SRX957906,hg38,Histone,H3K27ac,Uterus,Ishikawa,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma,"5498447,99.6,1.8,16194",GSM1635580: Ishikawa K27ac Rep2; Homo sapiens; ChIP-Seq,source_name=Cancer cell line	tumor type=Endometrial carcinomas	antibody=H3K27ac ab4729	cell line=Ishikawa
SRX9599276,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"23943150,93.4,16.7,16750",GSM4948236: H3K27ac HEC shGFP; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B cells	tissue=endometrium	disease state=adenocarcinoma	chip antibody=H3K27ac(Abcam, ab4729)"
SRX9599277,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"18334608,93.9,16.6,16196",GSM4948237: H3K27ac HEC shNRSF; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B cells	tissue=endometrium	disease state=adenocarcinoma	chip antibody=H3K27ac(Abcam, ab4729)"
SRX9599284,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"22374554,0.0,0.0,0",GSM4948244: H3K27ac HEC wt; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B cells	tissue=kidney	age=fetus	chip antibody=H3K27ac(Abcam, ab4729)"
SRX9599285,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"21545768,0.0,0.0,0",GSM4948245: H3K27ac M46; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B cells	tissue=kidney	age=fetus	chip antibody=H3K27ac(Abcam, ab4729)"
SRX9599286,hg38,Histone,H3K27ac,Uterus,HEC-1-B,Primary Tissue=Uterus|Tissue Diagnosis=Adenocarcinoma Endometrioid,"20149679,0.0,0.0,0",GSM4948246: H3K27ac M47; Homo sapiens; ChIP-Seq,"source_name=HEC-1-B cells	tissue=kidney	age=fetus	chip antibody=H3K27ac(Abcam, ab4729)"
SRX9628492,hg38,TFs and others,JUN,Gonad,SCCOHT-1,,"34538097,79.0,26.1,1779",GSM4955619: HT1 CTRL c-Jun JR634; Homo sapiens; ChIP-Seq,source_name=SCCOHT-1 Ovarian Cancer Cell Line	cell line=SCCOHT-1	transfected vector=Control	antibody=c-Jun
SRX9628495,hg38,TFs and others,JUN,Gonad,SCCOHT-1,,"24022151,87.6,30.2,1672",GSM4955622: HT1 BRG1 c-Jun JR638; Homo sapiens; ChIP-Seq,source_name=SCCOHT-1 Ovarian Cancer Cell Line	cell line=SCCOHT-1	transfected vector=BRG1	antibody=c-Jun
SRX9628497,hg38,TFs and others,JUN,Gonad,SCCOHT-1,,"26134144,47.9,23.2,4180",GSM4955624: HT1 CTRL c-Jun JR642; Homo sapiens; ChIP-Seq,source_name=SCCOHT-1 Ovarian Cancer Cell Line	cell line=SCCOHT-1	transfected vector=Control	antibody=c-Jun
SRX9628498,hg38,TFs and others,JUN,Gonad,SCCOHT-1,,"19493143,74.0,23.1,1730",GSM4955625: HT1 BRG1 c-Jun JR646; Homo sapiens; ChIP-Seq,source_name=SCCOHT-1 Ovarian Cancer Cell Line	cell line=SCCOHT-1	transfected vector=BRG1	antibody=c-Jun
SRX9628504,hg38,TFs and others,JUN,Gonad,BIN-67,,"25944736,73.0,3.9,584",GSM4955631: Bin67 CTRL Jun JR736; Homo sapiens; ChIP-Seq,source_name=Bin67 Ovarian Cancer Cell Line	cell line=Bin67	transfected vector=Control	antibody=c-Jun
SRX9628505,hg38,TFs and others,JUN,Gonad,BIN-67,,"26672326,74.9,4.6,713",GSM4955632: Bin67 CTRL Jun JR737; Homo sapiens; ChIP-Seq,source_name=Bin67 Ovarian Cancer Cell Line	cell line=Bin67	transfected vector=Control	antibody=c-Jun
SRX9628508,hg38,TFs and others,JUN,Gonad,BIN-67,,"26249126,83.0,8.4,2885",GSM4955635: Bin67 BRG1 Jun JR740; Homo sapiens; ChIP-Seq,source_name=Bin67 Ovarian Cancer Cell Line	cell line=Bin67	transfected vector=BRG1	antibody=c-Jun
SRX9628509,hg38,TFs and others,JUN,Gonad,BIN-67,,"40441448,83.8,9.0,3599",GSM4955636: Bin67 BRG1 Jun JR741; Homo sapiens; ChIP-Seq,source_name=Bin67 Ovarian Cancer Cell Line	cell line=Bin67	transfected vector=BRG1	antibody=c-Jun
SRX9633371,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"11113132,19.2,3.3,5526",GSM4957245: BulkATAC HeLa-RepA; Homo sapiens; ATAC-seq,"source_name=Immortalized cell line	cell line=HeLa	source=ATCC	growth media=DMEM, 10% FBS, penicillin/streptomycin"
SRX9633372,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"13351166,24.4,3.8,10961",GSM4957246: BulkATAC HeLa-RepB; Homo sapiens; ATAC-seq,"source_name=Immortalized cell line	cell line=HeLa	source=ATCC	growth media=DMEM, 10% FBS, penicillin/streptomycin"
SRX9688332,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"44431011,98.7,46.6,1258",GSM4976295: ZR751shMLL3 ERa rep1; Homo sapiens; ChIP-Seq,source_name=ZR75-1 cell line	cell line=breast cancer cell line ZR75-1	genotype=shMLL3	chip antibody=anti-ERalpha(Santa Cruz Biotechnology sc-543X)
SRX9688333,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"17864479,95.1,29.4,646",GSM4976296: ZR751shMLL3 ERa rep2; Homo sapiens; ChIP-Seq,source_name=ZR75-1 cell line	cell line=breast cancer cell line ZR75-1	genotype=shMLL3	chip antibody=anti-ERalpha(Santa Cruz Biotechnology sc-543X)
SRX9688334,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"10442815,95.7,22.8,239",GSM4976297: ZR751shLucif ERa rep1; Homo sapiens; ChIP-Seq,source_name=ZR75-1 cell line	cell line=breast cancer cell line ZR75-1	genotype=shLucif/control	chip antibody=anti-ERalpha(Santa Cruz Biotechnology sc-543X)
SRX9688335,hg38,TFs and others,ESR1,Breast,ZR-75-1,Primary Tissue=Breast|Tissue Diagnosis=Adenocarcinoma Ductal,"26566766,98.0,56.4,1103",GSM4976298: ZR751shLucif ERa rep2; Homo sapiens; ChIP-Seq,source_name=ZR75-1 cell line	cell line=breast cancer cell line ZR75-1	genotype=shLucif/control	chip antibody=anti-ERalpha(Santa Cruz Biotechnology sc-543X)
SRX968961,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"21490258,42.7,64.2,401",GSM1643946: ERa ChIP-Seq Veh Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, Veh, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=vehicle	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968962,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"20059549,53.6,13.4,8902",GSM1643947: ERa ChIP-Seq Veh Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, Veh, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=vehicle	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968963,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"8157915,73.0,33.8,27991",GSM1643948: ERa ChIP-Seq E2 Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, E2, 45m, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=E2 for 45m	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968964,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"18453468,69.2,9.7,14172",GSM1643949: ERa ChIP-Seq E2 Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, E2, 45m, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=E2 for 45m	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968965,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"15256750,63.2,16.2,8520",GSM1643950: ERa ChIP-Seq IL1b Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, IL1b, 45m, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=IL1b for 45m	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968966,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"16684948,65.8,9.3,4245",GSM1643951: ERa ChIP-Seq IL1b Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, IL1b, 45m, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=IL1b for 45m	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968967,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"13665717,61.9,21.5,10511",GSM1643952: ERa ChIP-Seq TNFa Rep1; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, TNFa, 45m, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=TNFa for 45m	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968968,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"6453126,51.7,1.4,1643",GSM1643953: ERa ChIP-Seq TNFa Rep2; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, TNFa, 45m, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=TNFa for 45m	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968969,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"12663375,38.9,6.1,1650",GSM1643954: ERa ChIP-Seq Veh+IKK7; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, IKK7, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=IKK7	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX968970,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"9768642,93.5,2.7,572",GSM1643955: ERa ChIP-Seq IL1b+IKK7; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, IL1b+IKK7, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=IL1b+IKK7	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX969013,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"5892241,50.9,4.7,2183",GSM1643998: ERa ChIP-Seq E2+ICI; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, E2+ICI, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=E2+ICI	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX969014,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14549543,26.1,5.6,4376",GSM1643999: ERa ChIP-Seq IL1b+ICI; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, IL1b+ICI, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=IL1b+ICI	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX969015,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"17556925,92.6,13.2,1456",GSM1644000: p65 ChIP-Seq E2+ICI; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, E2+ICI, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=E2+ICI	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX969016,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"14376940,45.5,26.4,3441",GSM1644001: p65 ChIP-Seq IL1b+ICI; Homo sapiens; ChIP-Seq,"source_name=MCF7 cells, IL1b+ICI, ERa ChIP	cell line=MCF7	cell type=breast cancer cell line	treatment=IL1b+ICI	chip antibody=ERa (Vendor: Santa Cruz, cat# sc-543, lot# C2114)"
SRX9719167,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"36938008,96.9,15.2,22313",GSM4984572: jc7428 MCF7 ER vehicle wild type GATA3; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	treatment=Vehicle	genotype/variation=wild type	chip antibody=mix_of_millipore_06_935_&amp;_ab3575
SRX9719168,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"37170344,95.2,16.8,17837",GSM4984573: jc7429 MCF7 ER vehicle wild type GATA3; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	treatment=Vehicle	genotype/variation=wild type	chip antibody=mix_of_millipore_06_935_&amp;_ab3575
SRX9719169,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"31252813,95.1,15.7,18400",GSM4984574: jc7430 MCF7 ER vehicle wild type GATA3; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	treatment=Vehicle	genotype/variation=wild type	chip antibody=mix_of_millipore_06_935_&amp;_ab3575
SRX9719170,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"10113677,95.3,63.9,2626",GSM4984575: jc7434 MCF7 ER vehicle mutant GATA3; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	treatment=Vehicle	genotype/variation=mutant	chip antibody=mix_of_millipore_06_935_&amp;_ab3575
SRX9719171,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"35621686,95.9,18.5,14994",GSM4984576: jc7435 MCF7 ER vehicle mutant GATA3; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	treatment=Vehicle	genotype/variation=mutant	chip antibody=mix_of_millipore_06_935_&amp;_ab3575
SRX9719172,hg38,TFs and others,ESR1,Breast,MCF-7,Primary Tissue=Breast|Site of Extraction=Pleura|Tissue Diagnosis=Adenocarcinoma,"10831551,95.8,61.9,2726",GSM4984577: jc7436 MCF7 ER vehicle mutant GATA3; Homo sapiens; ChIP-Seq,source_name=MCF7	cell type=Breast cancer	treatment=Vehicle	genotype/variation=mutant	chip antibody=mix_of_millipore_06_935_&amp;_ab3575
SRX9721691,hg38,TFs and others,MED12,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"44850735,95.7,13.9,2333",GSM4985147: HCT116 MED12; Homo sapiens; ChIP-Seq,source_name=Colon carcinoma	cell line=HCT116	crispr knockout=Parental	chip antibody=MED12; A300-774A - M (Bethyl Laboratories)
SRX9721692,hg38,TFs and others,MED12,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"46804504,95.3,35.1,4362",GSM4985148: DKO-C1 MED12; Homo sapiens; ChIP-Seq,source_name=Colon carcinoma	cell line=HCT116	crispr knockout=CDK8/19 KO-C1	chip antibody=MED12; A300-774A - M (Bethyl Laboratories)
SRX9721693,hg38,TFs and others,MED12,Digestive tract,HCT 116,Primary Tissue=Colon|Tissue Diagnosis=Carcinoma,"42694541,95.8,28.4,9869",GSM4985149: DKO-C2 MED12; Homo sapiens; ChIP-Seq,source_name=Colon carcinoma	cell line=HCT116	crispr knockout=CDK8/19 KO-C2	chip antibody=MED12; A300-774A - M (Bethyl Laboratories)
SRX9843988,hg38,TFs and others,ESR1,Unclassified,Unclassified,,"39982354,97.6,6.1,1854",GSM5018487: Suboptimal Thickness CC4 [ChIP]; Homo sapiens; ChIP-Seq,source_name=Suboptimal Thickness	endometrial thickness=Suboptimal Thickness	antibody=Eralpha
SRX9843992,hg38,TFs and others,ESR1,Unclassified,Unclassified,,"42477000,97.6,10.4,3839",GSM5018486: Suboptimal Thickness CC2 [ChIP]; Homo sapiens; ChIP-Seq,source_name=Suboptimal Thickness	endometrial thickness=Suboptimal Thickness	antibody=Eralpha
SRX9938027,hg38,ATAC-Seq,ATAC-Seq,Uterus,HeLa,Primary Tissue=Cervix|Tissue Diagnosis=Adenocarcinoma,"22969508,41.0,25.7,202",GSM5035029: Hela; Homo sapiens; ATAC-seq,source_name=cervix	cell line=Hela	disease=adenocarcinoma	treatment=untreated	malignancy=malignant
SRX9963832,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","194758495,98.2,43.7,12089",GSM5047891: uterus SM-A87A2; Homo sapiens; ATAC-seq,source_name=uterus	sample type=normal	sample preparation=flash-frozen tissue	donor sex=female	race=asian	Cause of death=cerebral vascular accident
SRX9963833,hg38,ATAC-Seq,ATAC-Seq,Uterus,Uterus,"MeSH Description=The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.","72970298,98.0,38.5,22888",GSM5047892: uterus SM-IOBHX; Homo sapiens; ATAC-seq,source_name=uterus	sample type=normal	sample preparation=flash-frozen tissue	donor sex=female	race=asian	Cause of death=cerebral vascular accident
SRX9963834,hg38,ATAC-Seq,ATAC-Seq,Uterus,Vagina,"MeSH Description=The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)","116549824,98.1,54.5,21219",GSM5047893: vagina SM-A9HOS; Homo sapiens; ATAC-seq,source_name=vagina	sample type=normal	sample preparation=flash-frozen tissue	donor sex=female	race=asian	Cause of death=cerebral vascular accident
